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Previous work has suggested that there exists a relationship between chondrocyte 
morphology and matrix metabolism. Changes to chondrocyte morphology have been 
reported in human cartilage however it is unclear if these are involved in the 
degenerative process associated with osteoarthritis (OA). In this work, the 
morphology of human and bovine chondrocytes has been characterised under a range 
of conditions. Bovine chondrocytes have been utilised in these experiments as bovine 
cartilage is non-degenerate and the chondrocytes have ‘normal’ morphology. 
However, if human cartilage have been used instead then there is possibility of 
having chondrocytes of mixed shapes i.e. both ‘normal’ and ‘abnormal’ cells. The 
thesis aimed at experimentally inducing morphological changes to chondrocytes to 
determine whether these changes resemble those observed in human cartilage. The 
ultimate aim is to model these changes to clarify the link between morphology and 
matrix metabolism by determining how morphological changes influence matrix 
metabolism. 
A classification system was developed for chondrocyte morphology allowing the 
quantification of chondrocyte shapes under different conditions permitting statistical 
comparisons. The different conditions utilised were (1) non-degenerate and mildly-
degenerate human articular cartilage and (2) two in vitro models (a) weak 3D agarose 
gels to study the effect of gel strength and increasing concentrations of foetal calf 
serum (FCS) on morphology of bovine chondrocytes and (b) scalpel induced 
mechanically-injured bovine cartilage model to study in situ chondrocyte viability 
and morphology at the injured site in various culture conditions. Additionally, the 
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effect of raised medium osmolarity on the response of chondrocytes to injury was 
studied to determine if the abnormal morphology could be reversed. 
Using fluorescence-mode confocal laser scanning microscopy (CLSM), chondrocyte 
viability, volume and morphology were determined and quantified by using 
Volocity
TM
 3D image analysis software. Histological evaluation of matrix by using 
Haematoxylin and eosin, Alcian blue and Masson’s trichrome staining of matrix 
produced by chondrocytes cultured in strong or weak agarose gels and in injured 
cartilage was determined. Additionally, immunohistochemical evaluation of matrix 
(collagen Types I & II) produced by chondrocytes was also performed.  
Results demonstrated that in non-degenerate human femoral head cartilage, ~83% 
chondrocytes were normal in morphology and 17±2% chondrocytes had cytoplasmic 
processes as compared to mildly-degenerate cartilage where 35±5% abnormal 
chondrocytes with cytoplasmic processes were present. In non-degenerate cartilage, 
11±3% chondrocytes formed small sized clusters however clustering was quite 
evident in the superficial zone of mildly-degenerate human femoral head cartilage 
where 43±16% chondrocytes had formed large clusters. In mildly-degenerate 
cartilage the number of abnormal chondrocytes with processes, length of processes 
and number of processes per cell were greater in the superficial as compared to mid 
and deep zones.  
A model was developed to study the effect of external supporting agarose gel on 
chondrocyte morphology and also to determine the influence of FCS. Bovine 
chondrocytes cultured in weak gels after 7 days developed similar morphological 
changes as those observed in degenerate human cartilage. However, in the strong 
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gels only few chondrocytes with morphological changes were present i.e. similar to 
non-degenerate cartilage. These morphological changes (development of clusters and 
processes) occurred more rapidly with increasing concentrations of FCS. Histology 
revealed less Alcian blue staining intensity around chondrocytes cultured in weak 
gels as compared to strong gels suggesting altered matrix produced by abnormal 
chondrocytes. FCS and gel strength were therefore proposed as related factors in 
regulating chondrocyte morphology. 
In the bovine injured cartilage explant model, after 14 days chondrocytes at the 
injury in the presence of FCS or synovial fluid (SF) produced morphological 
changes. These changes comprised cell enlargement, flattening, elongation and 
production of cytoplasmic processes. In the absence of FCS or SF, chondrocytes at 
the injury remained unaffected and were morphologically ‘normal’. Throughout the 
cartilage and even in the absence of subchondral bone, chondrocytes displayed 
morphological abnormalities in the presence of FCS or SF. These findings suggested 
that this is not the property of chondrocytes in the superficial layers alone rather it is 
due to the extent of penetration of the ‘factors’ into the matrix and there is no 
possibility of interference of injured site with osteocytes or bone factors. Histology 
revealed that these abnormal chondrocytes showed less staining with Alcian blue at 
the injury suggesting that these morphological changes might play a role in the 
changes to matrix metabolism. By raising the osmolarity of the culture medium these 
changes were inhibited and chondrocytes maintained their normal morphology.  
The results suggest that morphogenic/proliferative factors in FCS or SF and 
strength/damage to the matrix may be inter-related and act as potent controllers of 
chondrocyte morphology. Raised osmolarity was found to inhibit the morphological 
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changes suggesting the possibly that hyperosmolarity can antagonise the effects of 
these factors. The key conclusions from the thesis were (a) in non-degenerate human 
femoral cartilage a large percentage of chondrocytes ~83% were normal in 
morphology and the rest were abnormal however in mildly-degenerate cartilage 
35±5% abnormal chondrocytes with processes were present (b) the changes to 
chondrocyte morphology (development of clusters and processes) were exacerbated 
with cartilage degeneration (c) chondrocytes cultured in the weak gels produced 
morphological changes as compared to strong gels (d) chondrocytes at the injury 
displayed marked morphological changes in the presence of FCS or SF (e) by raising 
the medium osmolarity these morphological changes to chondrocytes at the injury 
were inhibited. These results show that chondrocyte morphology is complex and 
strongly dependent on the environmental settings. Experimental conditions were 
therefore identified which showed increased chondrocyte volume, abnormal 
morphology with cytoplasmic processes, enhanced proliferation/cluster formation 
and matrix changes. These changes to volume and morphology of chondrocytes in 
the models studied in this work had certain similarities to the changes observed in 
human cartilage suggesting that these shape changes may play a role in the changes 
to matrix metabolism occurring in OA. 
These findings may be of translational relevance in clinical and experimental 
research into cartilage injury and degeneration by providing new insights in 
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1.1 Articular cartilage (AC) 
1.1.1 Structure and functions 
 
AC is a form of hyaline cartilage, smooth and glassy material covering the ends of 
bones within synovial joints. AC is an aneural, avascular, alymphatic but highly 
resilient structure. It is designed with a  remarkable property of load bearing, 
distributing the load across the joint by preventing localised/focused loading and 
reducing friction at movement of articulating joint surfaces (Buckwalter and Mankin, 
1997b). The cell density, thickness, composition and properties of AC vary within 
the same joint, between different joints and between species (Athanasiou et al., 
1991). However, the basic structural and functional properties of the tissue remain 
the same. AC is an avascular tissue (Jackson and Gu, 2009, Milner et al., 2012). It is 
nourished by diffusion through the synovial fluid and subchondral bone with 
synovial fluid being the predominant source (Wang et al., 2013b). The mechanical 
properties of AC and functional responses of chondrocytes are maintained by the 
structure and biochemical composition of various components of extracellular matrix 
(ECM) (Jeffery et al., 1991, Kuettner et al., 1991) and via the complex interactions 
(such as mechanotransduction by which mechanical loading is transduced into 
intracellular  signals) between chondrocytes and ECM (Loeser, 2002).  
1.1.2 Composition 
 
AC is composed of chondrocytes entrenched within highly organised structure of 
ECM comprising of interstitial fluid and macromolecular framework containing 
collagens, proteoglycans (PGs) and non-collagenous proteins (Huber et al., 2000). 
The composition of matrix provides mechanical properties to the tissue and 
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chondrocytes are responsible for matrix remodelling. A detailed account of various 
components of AC is given in the following sections.  
 ECM 1.1.2.1
It is comprised of two components: tissue fluid and the framework of 







Figure 1.1: Extracellular matrix of articular cartilage.  
Two major macromolecules are present in articular cartilage: collagens (mainly, type 
II) and PGs (notably, aggrecan). Smaller molecules, such as non-collagenous 
proteins and smaller PGs, are present in smaller amounts. The interaction between 
the highly negatively charged cartilage PGs and type II collagen provides the 
compressive and tensile strength of the tissue. (Chen et al., 2006). 
 
It is the interaction between these two components which gives AC its unique 
mechanical properties and the resilience (Fox et al., 2009). In healthy cartilage 65%-
80% of the total weight of cartilage is tissue fluid contributing to the wet weight and 
the remainder is responsible for the dry weight of cartilage (Fox et al., 2009). Water 
constitutes 80% of the total weight of cartilage and the hydration status of cartilage is 
maintained through interactions of water and large aggregating PGs (Maroudas and 
Schneiderman, 1987). The macromolecular framework consists of three classes: 
collagens, PGs and non-collagenous proteins (Huber et al., 2000). Out of the total dry 
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weight of cartilage, 60% is contributed by collagens, 20%-25% by PGs and 15%-
20% non-collagenous proteins.  
 PGs 1.1.2.1.1
PGs have a protein core with one or more glycosaminoglycan (GAG) chains attached 
to it having at least one negatively charged carboxylate or sulphate group. AC 
contains two varieties of PGs: large aggrecans and small PGs [(i.e. decorin, biglycan 
and fibromodulin (Table 1.1)] (Roughley and Lee, 1994).  






































Binds with type 


















Binds with type 





Table 1.1: Properties of PGs in the cartilage.  
Different classes of PGs exist in variable quantities, composition and functions in the 
AC. (Roughley and Lee, 1994, Buckwalter and Mankin, 1997b).  
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PGs are highly negatively charged molecules responsible for holding water 
molecules and they attract cations and repel anions, thereby, creating high osmotic 
pressure in the cartilage via Gibb’s-Donnan equilibrium conditions (Urban, 1994, 
Hopewell and Urban, 2003). The osmolarity of extracellular fluid ranges from 350 
mOsm to 480 mOsm depending on zone of cartilage (Maroudas, 1975, Hopewell and 
Urban, 2003). Extracellular osmolarity varies between the cartilage zones depending 
upon the concentration of PGs, being lowest in the superficial zone (SZ), highest in 
middle zone (MZ) and lower in the deep zone (DZ) with osmolarity around 350 
mOsm in the SZ and around 450 mOsm in the MZ (Urban et al., 1993). These high 
osmotic pressure levels inside cartilage as compared to the surrounding tissues such 
as plasma with osmotic pressure of 280 mOsm (Bhalla et al., 2000) and synovial 
fluid with osmolarity of 400 mOsm (Bertram and Krawetz, 2012) increases the 
tendency of water movement into the cartilage.  The movement of water into the 
cartilage is restricted by the collagen network which resists the Donnan osmotic 
pressure (Maroudas, 1976, Lai et al., 1991, Buckwalter et al., 2005). During dynamic 
loading of cartilage plasma membrane is deformed, the physico-chemical 
environment of the cartilage is altered because the hydrostatic pressure increases and 
the fluid flows out/fluid loss resulting in changes to ionic content (Urban, 1994). In 
osteoarthritis (OA), the PG content is reduced and the fluid fraction in the cartilage 
increases (Maroudas and Venn, 1977, Stockwell, 1991) leading to cartilage swelling. 
The possible explanation for this apparent paradox is weakened collagen structure 
and loss of elastic restraint of collagen network causing swelling of PGs (Maroudas 
et al., 1973, Maroudas, 1976, Bank et al., 2000). In the swollen cartilage the 
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extracellular osmolarity decreases and chondrocyte volume increases (Urban et al., 
1993, Bush and Hall, 2003).  
 Collagen 1.1.2.1.2
 
Multiple types of collagen are present in AC especially type II, VI, IX, X and XI 
arranged in the form of bands of fibrils. The most abundant collagen present is type 
II which constitutes 90%-95% of the whole collagen content and is responsible for 
providing tensile strength to the cartilage (Eyre, 2002). The fibres of collagen extend 
out into the territorial matrix and further in the interterritorial matrix. Embedded in 
the meshwork of collagen are large aggregating PGs (aggrecans) which provide 
stiffness and resilience to the tissue (Dudhia, 2005). Collagen type IX and XI are 
presumably responsible for the reinforcement of the fibrillar meshwork established 
primarily by collagen type II (Kuettner et al., 1991, Buckwalter and Mankin, 1998, 
Eyre, 2004). Collagen type VI is present in the immediate vicinity of chondrocytes in 
the PCM and provides attachment of chondrocytes to the matrix (Guilak et al., 2006). 
Collagen type X is present in the calcified zone close to tidemark in normal cartilage 
(Rucklidge et al., 1996).  
 Non-collagenous proteins 1.1.2.1.3
 
In normal cartilage in addition to PGs and collagens, the ECM also contains a variety 
of non-collagenous proteins and glycoproteins but details of only few of them are so 
far studied in detail (Roughley, 2001). They appear to have structural and regulatory 
importance in cartilage integrity (Roughley, 2001, Buckwalter et al., 2005) including 
matrix metabolism, matrix assembly and cell-matrix interactions. The only well 
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described non-collagenous proteins are Anchorin CII, Cartilage oligomeric matrix 
protein (COMP), tenascin and fibronectin. Anchorin CII, a surface protein present in 
the membranes of chondrocytes, is considered to bind chondrocytes to the collagen 
fibrils in the matrix (Mollenhauer et al., 1984). COMP belongs to the family of 
Thrombospondins (TSP) and termed as TSP-5 and thought to be associated to 
collagen type IX (Roughley, 2001). COMP is present within territorial matrix 
(DiCesare et al., 1994) interacting with other proteins in ECM thus playing an 
important role in structural integrity of cartilage (Acharya et al., 2014). In early OA, 
COMP is up-regulated and hence considered a potential biomarker for cartilage 
degeneration (Salminen et al., 2000). Tenascin and fibronectin are important for 
interactions between chondrocytes and the matrix (Buckwalter and Mankin, 1998). 
Tenascin is a glycoprotein present in very small quantities in the ECM of normal 
cartilage (pericellular areas) in all the zones. It interacts with fibronectin and thus 
influences connections of chondrocytes with PCM and its expression increases in OA 
(Chevalier et al., 1994). Fibronectin is also present in small quantities in normal 
cartilage with a potential role in maintaining chondrocyte phenotype and its levels 
have been observed to increase in OA (Chevalier, 1993).  
 Chondrocytes 1.1.2.1.4
 
Chondrocytes present in human AC constitute only 10% of the total volume of the 
tissue (Stockwell, 1979). Chondrocytes are normally rounded in morphology except 
at the tissue surface where they are flattened (Archer and Francis-West, 2003). 
Chondrocytes residing in various zones of cartilage differ in size, shape and function 
(Stockwell, 1979, Aydelotte et al., 1988, Mort and Billington, 2001, Goldring, 2012). 
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The key function of chondrocytes is matrix turnover i.e. synthesis and degradation of 
macromolecules constituting the framework of cartilage especially PGs and 
collagens (Muir, 1995, Archer and Francis-West, 2003, Bhosale and Richardson, 
2008). The cartilage is an avascular tissue and chondrocytes receive nutrients and 
oxygen by diffusion (Ge et al., 2006). Therefore chondrocytes obtain principal 
supply of ATP from substrate-level phosphorylation in glycolysis (Lee and Urban, 
1997) and only 10% from oxidative phosphorylation (Otte, 1991). The rate of 
glycolysis in chondrocytes is comparable with other tissues but overall metabolic 
activity of the tissue is low because of lower cell density (Buckwalter and Mankin, 
1997b). Normal chondrocytic phenotype is characterised by spheroidal shape, Type 
II collagen synthesis (Eyre, 2002) and production of aggrecans (large aggregating 
PGs) (Dudhia, 2005). Chondrocytes have various properties for example, they have 
to withstand high compressive forces in vivo, have high matrix to cell volume ratio, 
do not divide after skeletal maturity unless there is a pathological condition, obtain 
nutrition by diffusion and survive in low oxygen tension environment  (Muir, 1995, 
Archer and Francis-West, 2003, Bhosale and Richardson, 2008). 
1.1.3 Zones of AC 
 
Various researchers have agreed at dividing the AC into four  discrete zones (Fig. 
1.2): superficial, intermediate/transitional/mid, deep/radial and calcified zones 
(Buckwalter et al., 1988, James and Uhl, 2001, Bhosale and Richardson, 2008, Fox 
et al., 2009). However, this division into various zones is arbitrary and there exists no 
definite demarcation between the various zones of cartilage. The division is typically 
based upon the morphology and arrangement of chondrocytes and arrangement of 
collagen fibrils. It is difficult to define the intermediate and deep zones of cartilage 
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because the arrangement of chondrocytes and collagen fibres is quite similar in these 
two zones. However, SZ and calcified zones are easily distinguishable because the 
morphology of chondrocytes in the SZ is typical (ellipsoid) and the calcified zone 
lies behind the tide line. 
Chondrocyte morphology and density varies across the different zones of AC 
(Siczkowski and Watt, 1990). Additionally, the matrix composition and properties 
also differ across the various zones (Aydelotte et al., 1988, Wong et al., 1996 , Mort 
and Billington, 2001, Darling et al., 2006). In human cartilage the water content 
decreases from superficial to the deep zones of the tissue and is lowest in the DZ 
(Pearle et al., 2005). The packing and arrangement of collagen fibres changes from 
superficial to deep zones of cartilage from thin tangential orientation to thick radial 
ones (Ghadially et al., 1978, Poole et al., 1982, Siczkowski and Watt, 1990). The 
varied orientation of collagen fibres in various zones of cartilage has a functional 
significance. The tangential arrangement of collagen fibrils in SZ protects the deeper 
zones from shear stress and is designed to resist tensile and compressive forces of 
articulation, in the transitional/mid zone deeper to the SZ collagen fibrils are 
arranged obliquely and functionally provide first line of defence against the 
compressive forces transmitted from the surface, in the DZ collagen fibrils are thick 
and radial in disposition arranged perpendicular to the articular surface (Fig. 1.2B) 









Figure 1.2: Schematic, cross-sectional diagram of healthy articular cartilage.  
A, cellular organization in the zones of articular cartilage; B, collagen fiber 
architecture (Fox et al., 2009). Reprinted from the Journal of the American 
Academy of Orthopaedic Surgeons, 1994; 2:192-201. C, Haematoxylin & Eosin 
stained 10 µm thick histology section from bovine metacarpal-phalangeal joint 
(author’s results). Scale bar = 100 µm. 
 
The concentration of PGs in human cartilage differs across the various zones of 
cartilage being highest in the MZ, lower in the DZ and lowest in the SZ (Huber et al., 
2000). The demarcation of various zones and morphology of chondrocytes in various 
zones of human cartilage has been described (Humbree et al., 2007). In human 
cartilage SZ is a thin zone of elongated/ellipsoid chondrocytes comprising 10%-20% 
of the cartilage volume. The MZ constitutes 40%-60% of cartilage volume and 
comprises of rounded chondrocytes. The DZ comprises 30% of cartilage volume and 
contains rounded chondrocytes mostly arranged in vertical columns and biggest in 
size as compared to chondrocytes in SZ and MZ. Underneath the DZ lies a 
demarcation, tidemark marking the separation of underlying calcified zone from SZ, 




underlying subchondral bone through the attachment of collagen fibrils and this zone 
contains hypertrophied chondrocytes (Fox et al., 2009). 
The histological evaluation revealed that human and bovine cartilage samples differ 
in the overall cartilage thickness, average zonal thickness, diameter of chondrocytes 
and cell density (Pedersen et al., 2013). In the study by Pedersen et al, cartilage was 
divided into four zones superficial zone (SZ), transitional zone (TZ), radial zone 
(RZ) and deep zone (DZ) and various parameters of cartilage were studied. Various 
properties of cartilage and chondrocytes in these cartilage zones are given in Table 
1.2 based upon the previous study (Pedersen et al., 2013). The interspecies 
differences should be taken into account while interpreting observations from bovine 





Zonal cartilage thickness 
(% of depth) 










8-10   34-38   38-42    11-16 117-271   63-108    66-83    70-91 16.9       19.7 
Bovine 1.9mm 6.5         25       41        26 321        212         225       184 16.9        19.7 
 
Table 1.2: Comparison of properties of human and bovine cartilage.  
Full cartilage thickness, cartilage zone ratios, zonal cell densities and diameter of 




It is a painful joint disorder accompanied by joint dysfunction and physical disability 
at later stages (Buckwalter and Mankin, 1997a). It is the commonest type of arthritis 
and the worldwide estimates state that 9.6% of men and 18% of women aged >60 
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yrs. suffer from OA asymptomatically (Murray and Lopez, 1996). In the United 
States and European population the radiographic observations showed the highest 
rate of knee OA at the age ≥45 yrs., 14.1% for men and 22.8% for women (Woolf 
and Pfleger, 2003). Since the incidence increases with age, longer life expectancy 
will increase the incidence of OA in future according to WHO (Woolf and Pfleger, 
2003). OA can affect any synovial joint of the body but its prevalence has been 
reported to be greatest (85%) in the knee joint (Buckwalter and Brown, 2004). The 
physical disability caused by OA has a negative effect on self-esteem of patients and 
they suffer from anxiety, depression, feelings of helplessness and being a burden on 
society and family (Murphy et al., 2012). As the incidence of OA is increasing it has 
a high negative impact on UK economy and the total cost has been determined to be 
1% of the gross national product (GNP) (March and Bachmeier, 1997). OA is 
broadly divided into two types: primary OA (idiopathic) and secondary OA/post 
traumatic OA (PTOA). 
 
1.2.1 Primary OA  
The aetiology of primary OA is unknown but is most likely a multifactorial disease 
(Wieland et al., 2005). In a very recent study several risk factors have been identified 
to be responsible for causing OA (Apold et al., 2014) and these include age (Li et al., 
2013), ethnicity (Felson et al., 2002), genetics (Spector et al., 1996), gender (Srikanth 
et al., 2005), injury, physical activity, smoking (Toivanen et al., 2010), malalignment 
(Felson et al., 2013), and overweight/body mass index (BMI) (Martin et al., 2013). 
Most of the risk factors associated with the development of OA such as ethnicity, 
genetics, gender, smoking, physical activity and malalignment have conflicting 
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results in the literature. These risk factors have been reported to be either associated 
or not associated with OA disease progression and have been reviewed previously 
(Chaganti and Lane, 2011). However, age, knee injury and obesity have been 
consistently identified to be associated with radiographic knee OA (Wieland et al., 
2005, Chaganti and Lane, 2011). The paradigm of OA is that it is the disease of the 
whole joint which involves structures of the entire joint including AC, membrane, 
joint capsule, ligament, muscle and the bone (Wieland et al., 2005). The 
characteristics of the disease include cartilage degeneration, active bone remodelling 
and synovitis leading to failure of joint function (Aaron and Racine, 2013). When the 
cartilage is degenerated and lost, the joint spaces are narrowed down (Lohmander, 
2000). The loss of cartilage causes bone to rub on bone which is exceedingly painful 
as subchondral bone contains pain receptors (Sofat et al., 2011). Changes in the joint 
structure cause stiffening of the capsule and various symptoms as joint pain, crepitus 
and restricted movements render the joint non-functional (Buckwalter and Mankin, 
1997a). Various pharmacological, non-pharmacological approaches and surgical 
interventions have been devised with the aim of improving symptoms of OA, but the 
problem of OA has not been solved as no effective treatment targets the cause of the 
disease (Buckwalter and Martin, 2006). After the exhaustion of non-operative 
management for OA, total knee arthroplasty (TKA) is considered to be highly 
beneficial (Caracciolo and Giaquinto, 2005) and cost effective treatment strategy 
(Lavernia et al., 1997). Although, TKA is an effective treatment for end stage OA, 
this technique is accompanied with several post-operative complications including 
femoropatellar problems, infections and stiffness of the joint  (Ronn et al., 2011). 
The pre-operative condition of the patient affects the outcomes of TKA, patients with 
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poor health status and severe pain have worse outcomes of this surgery (Lingard et 
al., 2004).   
 
 Matrix degradation in OA  1.2.1.1
In healthy cartilage, chondrocytes remain quiescent and are responsible for the 
maintenance/turn-over of matrix through their metabolic activities (Aigner et al., 
2007). However, in OA chondrocytes become ‘activated’ with rapid proliferation, 
cluster formation and enhanced production of matrix and degradative enzymes 
(Aigner et al., 1992, Sandell and Aigner, 2001, Pearle et al., 2005, Goldring and 
Marcu, 2009, Goldring, 2012). However, these activated chondrocytes are unable to 
produce ECM with the same characteristics as those of healthy matrix synthesized 
during cartilage development (Goldring, 2012). The genetic analysis of intact and 
OA cartilage revealed several mutations in genes encoding for ECM in OA 
(Loughlin, 2011). The role of various growth factors in stimulating the proliferative 
ability of chondrocytes in this phase has also been established (Fortier et al., 2011). 
However, this short-lived phase is soon followed by the destructive phase 
characterised by enhanced production of cytokines and degrading enzymes involved 
in the pathogenesis of OA (Goldring, 2000a). Chondrocytes in normal cartilage are 
known to produce many matrix metalloproteinases (MMPs) (Yoshihara et al., 2000) 
various serine and cysteine proteases (Mort and Billington, 2001). These are 
produced during normal matrix turnover in healthy cartilage in response to varying 
mechanical load. In OA the activities of these enzymes are increased (Dean et al., 
1989) leading to the greater breakdown of matrix collagens and proteoglycans over 
their production. The levels of various MMPs including membrane-type I MMP 
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(Imai et al., 1997), MMP-7 (Ohta et al., 1998), MMP-8 (Shlopov et al., 1997), 
aggrecanase (Lohmander et al., 1993), ADAM-10 (Chubinskaya et al., 1998) and 
ADAM-15 (Böhm et al., 1999) and recently MMP-2 and MMP-9 (Galasso et al., 
2012) have been known to increase in OA causing matrix destruction.  
In normal conditions many cytokines and growth factors are produced but at low 
levels to maintain homeostasis of the cartilage (Goldring, 2000b, Sandell and Aigner, 
2001). However, in OA it has been suggested that there is an imbalance between the 
various types of cytokines leading to cartilage degeneration as catabolism overrides 
anabolism (Martel-Pelletier et al., 1999, Fernandes et al., 2002). These earlier signs 
of cartilage catabolism are associated with enhanced breakdown of PGs and collagen 
disruption predominantly at the surface of the cartilage (Stockwell et al., 1983, 
Guilak et al., 1994, Billinghurst et al., 1997, Stoop et al., 2001). With the progression 
of disease, proteolytic enzymes cause degradation of PGs (Lark et al., 1997), causing 
matrix weakening (Aigner and McKenna, 2002), increased permeability of the 
matrix and increased hydration/swelling of the cartilage (Lai et al., 1991, Wang et 
al., 2010, Wang et al., 2013a) and decreased tensile stiffness (Maroudas, 1976). 
Additionally, there is enhanced destruction of collagen type II due to the catabolic 
effect of degradative enzymes (Poole et al., 2003). The degenerative processes 
appear to occur predominantly in the SZ of cartilage and around the chondrocytes 
residing in this zone (Guilak et al., 1994).  
Aging leads to certain changes in cartilage matrix causing a decrease in tensile 
strength thus leaving the tissue inflexible/brittle and susceptible to fatigue failure 
(Bank et al., 1998). The macromolecules of cartilage matrix i.e. collagen and PGs 
(aggrecan) show certain changes in relation to the aging process such as collagen 
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cross linking and shortening of aggrecan molecules (Hugle et al., 2012). Although 
certain age-related changes in cartilage have been known as critical factors in OA 
and might play a role in the development of the disease, all OA is not due to aging 
(Li et al., 2013, Loeser, 2013).  
 
 Chondrocyte clusters in OA 1.2.1.2
A relatively late event in the pathogenesis of OA and a hallmark of this disease is the 
presence of clusters of chondrocytes (Weiss and Mirow, 1972, Rothwell and Bentley, 
1973, Mitchell et al., 1992, Kouri et al., 1996b, Pfander et al., 2001) suggesting 
proliferative activity of chondrocytes in OA (Mankin et al., 1971, Hulth et al., 1972, 
Rothwell and Bentley, 1973). In comparison to OA cartilage, in healthy cartilage 
chondrocytes rarely divide and their proliferative activity is almost zero (Mankin, 
1964). Chondrocyte proliferation by active mitosis has been seen in human OA 
cartilage leading to cluster formation (Hulth et al., 1972). The clusters of 
chondrocytes are often seen near fissures/fibrillations of the superficial cartilage 
layer (Lotz et al., 2010). The presence of these clusters of chondrocytes in the 
superficial layers of cartilage may be explained due to enhanced admittance of 
proliferative factors from the damaged collagen matrix in the superficial layers of 
cartilage (Meachim and Collins, 1962, Hollander et al., 1995). Additionally, these 
clusters of chondrocytes present in the superficial layers do not appear to increase the 
anabolism of cartilage (Aigner et al., 1997). This may be because in addition to 
cluster formation, cell death is also a key player in cartilage degeneration as 
evidenced by the presence of areas of hypo-cellularity and with increasing severity of 
disease, cell density decreases (Mistry et al., 2004). This can possibly be the reason 
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that even chondrocytes proliferate and form clusters during cartilage degeneration 
but they are unable to compensate for and maintain metabolic homeostasis.  
 
 Cell death in OA 1.2.1.3
Another characteristic histological finding of OA cartilage is the presence of empty 
lacunae (Stockwell, 1971) suggesting cell death involved in the pathogenesis of the 
disease (Blanco et al., 1998, Sharif et al., 2004). The exact mode of cell death in OA 
is unclear and still controversial with several possible mechanisms proposed such as 
necrosis, apoptosis, chondroptosis or a combination of these types (Kim et al., 2000, 
Roach et al., 2004, Wei et al., 2006, Thomas et al., 2007, Almonte-Becerril et al., 
2010). Two major types of cell death in OA are characterised as necrosis and 
apoptosis but it is unclear which type of cell death predominates (Wei et al., 2006). It 
is suggested that there is an overlap between the two forms of cell death; the 
apoptosis can lead to necrosis (Carlo and Loeser, 2008). Various studies conducted 
on animals (Thomas et al., 2007, Carames et al., 2010) and humans (Kim et al., 2000, 
Sharif et al., 2004) to study the pathogenesis of OA showed a significant correlation 
between the disease severity and levels of chondrocyte death by apoptosis. Apoptosis 
is a physiological process which encompasses programmed cell death required for 
the normal cell turn-over during development and removal of damaged and 
cancerous cells (Kerr et al., 1972). Apoptosis is measured by the TUNEL method, a 
specific type of immunohistochemistry that causes staining of 3ʹ-OH ends of DNA 
present in the apoptotic bodies as described earlier (Gavrieli et al., 1992) is 
considered a specific method for detecting apoptotic chondrocytes as utilised in a 
recent study (Zamli et al., 2013). However, whether apoptosis is a mode of cell death 
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in OA is controversial. A variant of apoptosis called chondroptosis was coined as an 
alternative mechanism of cell death in OA cartilage (Roach et al., 2004). 
Chondroptosis differs from standard apoptosis in the morphological features 
especially in terms of cytoplasmic changes with increased rough endoplasmic 
reticulum and Golgi apparatus, presence of vacuoles, expulsion of cellular material 
and final fragmentation of cell (Roach et al., 2004).  
 
 Chondrocytes hypertrophy-like changes in OA 1.2.1.4
The role of chondrocyte hypertrophy-like changes has been observed in the initiation 
and progression of OA (Dreier, 2010, van der Krann and van den Berg, 2012) and 
considered one of the characteristics of this disease (Tchetina et al., 2007) (Fig.1.3). 
Morphometric analysis of chondrocyte hypertrophy revealed an increase in the 
volume of cells and organelles (Buckwalter et al., 1986). There are several markers 
of hypertrophied chondrocytes in OA cartilage but the classical ones are collagen 
type X (von der Mark et al., 1992) and MMP-13 (Shlopov et al., 1997). Additionally, 
an increase in chondrocyte volume was observed in degenerated human cartilage 
suggesting the possible role of this increase in volume to the altered chondrocyte 




Figure 1.3: Chondrocyte hypertrophy-like changes in a conceptual model of 
human primary OA.  
Cells that have acquired a “hypertrophy-like” phenotype (black) play an essential 
role in cartilage breakdown by synthesis of MMP13 and ADAMTS4 and 5. Of note, 
besides TGF-β numerous other signaling molecules, enzymes and matrix molecules 




 Changes to chondrocyte phenotype in OA 1.2.1.5
Chondrocytes are phenotypically unstable cells (Darling and Athanasiou, 2005) and 
changes to chondrocyte phenotype have been observed in OA (Kouri et al., 1996a, 
Miosge et al., 1998, Wang et al., 2003, Yagi et al., 2005). Phenotype switching was 
observed in chondrocytes which dedifferentiated into flattened fibroblast cells after 
culture on plastic surface (von der Mark et al., 1977). However, when chondrocytes 
were cultured in 3D environment using alginate (Bonaventure et al., 1994) or agarose 
culture conditions they regained their chondrocytic phenotype with the production of 
mechanically functional matrix macromolecules (Benya and Shaffer, 1982). Normal 
52 
 
chondrocytic phenotype of rabbit cartilage has been characterised by spheroidal 
shape of the cell with the production of normal cartilaginous matrix (mainly collagen 
type II and large aggregating PGs i.e. aggrecan) (Benya and Shaffer, 1982). In 
addition to changes in chondrocyte metabolism and synthetic activity, another 
important characteristic of OA is phenotypic switching of chondrocytes (Benya et al., 
1978, Tesche and Miosge, 2005). There are several studies on human AC which have 
reported changes to chondrocyte phenotype in OA as reported in a study the presence 
of fibro-cartilaginous tissue with high content of fibrillar matrix (Miosge et al., 1998, 
Poole, 1999). In other studies, fibroblast-like chondrocytes were also observed in 
deep zones of AC with the production of collagen type I and III especially in the 
advanced stages of disease (Miosge et al., 1998, Sandell and Aigner, 2001, Tesche 
and Miosge, 2005). Additionally, chondrocytes with abnormal (irregular) 
morphology were identified as elongated cells and named as secretory type 2 cells 
(Kouri et al., 1996b). Chondrocytes were studied in OA and compared for the 
expression of specific markers used for identification of phenotype. In OA cartilage, 
mostly in the middle zone activated chondrocytes expressing aggrecan and collagen 
type II were present (Sandell and Aigner, 2001). These cells also produced collagen 
type IIA thereby, indicating the presence of chondrogenic progenitor cells in the 
middle layers of OA cartilage (Sandell and Aigner, 2001). However, cells in the 
deeper layers of OA cartilage showed presence of type X collagen indicating 





 Chondrogenic progenitor cells (CPCs) in OA 1.2.1.6
 
Chondrocytes have been long considered the only cell type present in AC (Stockwell, 
1978, Buckwalter and Mankin, 1997b). However, for the first time in 2003 in a 
culture modified by growth factors, a cell population with multilineage 
differentiation potential was observed among the de-differentiated adult human 
articular chondrocytes (Barbero et al., 2003). Later population of cells called CPCs 
was observed in the SZ of cartilage (Dowthwaite et al., 2004). In several other 
studies the presence of mesenchymal progenitor cells in normal cartilage and an 
increase during OA was reported (Alsalameh et al., 2004, Fickert et al., 2004, 
Hiraoka et al., 2006, Grogan et al., 2009). CPCs have migratory potential and have 
been seen to migrate to the site of blunt impact or scratch injury in cartilage (Seol et 
al., 2012). In cartilage injuries the implantation of these CPCs have shown 
encouraging results in terms of cartilage regeneration (Jiang et al., 2012). These 
migratory cells were obtained from the late stages of OA cartilage tissue and they 
possessed the ability of differentiation especially towards chondrogenesis and the 
properties of progenitor cells (Koelling et al., 2009). The chondrogenic 
differentiation properties of these cells are regulated by two transcription factors: 
RUNX-2 and SOX9 being osteogenic and chondrogenic transcription factors 
respectively. Moreover, enhanced expression of SOX9 was observed in the CPCs 
when RUNX-2 was down regulated leading to an increase in the expression of type 
II collagen and aggrecan. The discovery of these migratory progenitor cells from the 
diseased tissue and having high chondrogenic potential opens new possibilities for 




 Chondrocyte-matrix interactions  1.2.1.7
 
Chondrocytes are responsible for maintaining the homeostasis of the cartilage by 
keeping a balance between the anabolic and catabolic activities (Sandell and Aigner, 
2001). The cell-matrix interactions are very important key players in regulating 
chondrocyte functions (Lee and Loeser, 1998). A family of ECM receptors present 
on chondrocyte surface is the integrin family of receptors responsible for cell-matrix 
interactions in cartilage (Loeser, 2014). It is the interaction of ligands from ECM and 
activation of integrin receptors via these ligands that chondrocytes receive chemical 
signals from the matrix and transmit mechanical signals to the cell interior. There are 
several key functions of chondrocytes including cell proliferation, survival, 
differentiation, morphogenesis and remodelling of cartilage matrix which are 
regulated by integrin mediated signalling by chondrocytes (Adams and Watt, 1993, 
Gumbiner, 1996, Giancotti, 2000). There are dual components of integrin mediated 
signalling in chondrocytes, firstly the organisation of the cytoskeletal elements 
internally (Wolfenson et al., 2013) and secondly interaction with the growth factors 
and cytokines externally (Danen and Yamada, 2001, Legate et al., 2009). In normal 
articular cartilage, several types of integrin receptors are present (Camper et al., 
1998). In OA, the expression of several integrin receptors is increased as compared 
to normal cartilage (Loeser et al., 1995). Of special interest is the increased 
expression of α1ß1 in OA which has the capability to bind to collagen type II and 
collagen type VI (present in PCM) in comparison to healthy cartilage (Loeser et al., 
1995, Parekh et al., 2014). Additionally, appearance of three types of integrin 
receptors namely α2ß1, α4ß1 and may be α6ß1 were noticed to be expressed on OA 
chondrocytes which are not normally present on healthy chondrocytes (Lapadula et 
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al., 1997, Ostergaard et al., 1998, Loeser, 2014). In OA, fibronectin fragments are 
produced which signal through integrin α5ß1 and lead to activation of inflammatory 
and catabolic responses which will eventually lead to cartilage degradation (Loeser, 
2014). Chondrocytes when kept in monolayer cultures, de-differentiate and it has 
been suggested that integrin receptors αVß5 play a role in this phenotype switching 
through ERK signalling pathway (Fukui et al., 2011). Several integrin receptors for 
binding with fibronectin, laminin and collagen are expressed by chondrocytes 
(Loeser, 2000, Loeser, 2002, Egerbacher and Haeusler, 2003). ß1 chain is a 
component of most of these integrin receptors. Inactivation of cartilage specific ß1 
chain in knock out mice resulted in chondrodysplasia, shown by abnormal growth 
plate with distorted proliferative columns and abnormal shapes of cells (Aszodi et al., 
2003). This suggested that integrin receptors play a vital role in regulation of 
chondrocyte phenotype. 
 
 Heterogeneity to chondrocyte morphology in OA 1.2.1.8
In OA, phenotypic modulation of chondrocytes in terms of their biosynthetic activity 








Reference Source of specimen Technique Key findings 
(Stockwell, 1978) Human femoral condylar 
cartilage 
Electron microscopy Projecting cell processes several micrometres long may 
extend beyond the lacuna 
(Cancedda et al., 1995) Chick chondrocytes Electron microscopy Chondrocytes differentiate 
(Kouri et al., 1996a) Human knee OA AC Light and TEM Variability in the chondrocyte phenotype 
(Kouri et al., 1996b) Human knee OA AC Electron microscopy Chondrocytes with variable morphologic phenotype coined 
as Type 2b secretory cells  
(Poole, 1997) 
[Review] 
Canine   Remodelling of chondrons at the initiation and progression 
of  OA and migration of progenitor chondrocytes  within 
the microenvironment of chondrons undergoing 
remodelling 
(Miosge et al., 1998) Human AC In situ hybridization at 
the light and electron 
microscopic level 
In the late stage OA, in the deep layers irregular shaped 
secretory chondrocytes were seen which resembled type 2b 
secretory cells defined by Kouri et al (Kouri et al., 1996b) 
(Kouri et al., 1998) Human OA AC Electron and confocal 
microscopy 
Heterogeneity to chondrocyte morphology was observed  
(Lee and Loeser, 1998) Human OA AC Confocal microscopy Chondrocyte in 3D alginate cultures produced processes 
through the PCM 
(Sandell and Aigner, 
2001) [Review] 
  Several factors induce ’de-differentiation’ of chondrocyte 
phenotype to fibroblast-like phenotype in OA. 
(Goldring, 2002) 
[Perspective article] 





Electron microscopy Chondrocyte shape changes along with cytoplasmic 
projections were observed after 45 days of osteoarthrosis 
induction 
(Aigner and McKenna, 
2002) [Review article] 
  In OA chondrocytes react by changing their cellular 
phenotype 
(Wang et al., 2003) Human AC Flow cytometry In OA tissue cartilage superficial layers were partly lost 
and replaced by new chondrocyte population with different 
phenotype 
(Bush and Hall, 2003) Human AC Confocal microscopy Chondrocytes exhibited cytoplasmic processes in non-
degenerate and degenerate human AC  
(Holloway et al., 2004) Human AC Epi-fluorescence and 
confocal microscopy 
In non-OA and OA samples cells with multiple elongated 
processes upto 30µm extending into ECM, fewer in non-
OA as compared to OA. 
(Tesche and Miosge, 
2004) 
Human AC Light and electron 
microscopy 
In OA irregular shaped chondrocytes with numerous 
filopodia were seen  
(Tchetina et al., 2005) Human AC ELISA, RT-PCR Very early changes in OA are accompanied with 
chondrocyte terminal differentiation and matrix 
degradation 
(Yagi et al., 2005) Human AC Quantitative RT-PCR Loss of chondrocyte phenotype in OA was observed 
(Tesche and Miosge, 
2005) [Review article] 
  In late stages of OA fibroblast-like cells are present 
(Kouri and Lavalle, 
2006)[Review article] 
  Variability of chondrocyte phenotype was found in rat and 
human OA cartilage 
(Ross et al., 2006) AC from tibial plateaux 
of adult dogs 
Confocal microscopy Presence of cytoplasmic cell processes 2-5µm long 
extending into the surrounding matrix were seen  
(Gonzalez et al., 2007) Human AC ATM and TEM In normal human AC in the SZ chondrocytes had 
cytoplasmic processes  
(Lyman et al., 2012) Human AC Confocal and TEM Chondrocytes showed morphological changes as cell 
flattening and produced cytoplasmic processes in response 
to injury  
 
Table 1.3: Historical perspective of heterogeneity to chondrocyte morphology in OA.  
TEM - Transmission electron microscopy, ELISA–Enzyme-linked immunosorbent assay, 




Although chondrocyte ultrastructure and biochemical changes during OA have been 
studied in detail, chondrocyte morphology has received less attention. The main 
reason could be that in majority of these studies classical histological techniques 
were used and they rendered it difficult to visualise the fine morphological details of 
chondrocytes caused by shrinkage due to tissue fixation techniques (Buckwalter et 
al., 1986) and single slice observations. By using confocal laser scanning microscopy 
(CLSM) 3D images of chondrocytes can be obtained and fine details of morphology 
can be studied in thick samples and even in fixed tissue without much disturbance to 
the tissue architecture (Brakenhoff et al., 1990).  
CLSM with the use of intracellular fluorescent dyes is a very powerful technique for 
obtaining several optical sections permitting visualisation of 3D morphology and 
volume calculation of living in situ chondrocytes without much disruption to ECM 
(Guilak et al., 1995, Errington et al., 1997, Kouri et al., 1998, Bush and Hall, 2001a, 
Bush and Hall, 2001b). CLSM also rendered it possible to study the morphological 
details of chondrocytes and thus altered chondrocyte morphology with the presence 
of cytoplasmic processes in non-degenerate and degenerate tibial plateau cartilage 
was reported (Bush and Hall, 2003). Furthermore two possible (a) passive and (b) 
active theories of the existence of these processes were proposed by the scientists in 
this study. The passive theory stated that possibly the damage to the PCM would 
provide a pathway for production of processes. The active theory suggested that 
production of degradative enzymes by altered chondrocyte metabolism would cause 
local matrix weakening and production of processes. Later in another study on 
osteoarthritic human femoral head pannus tissue by using CLSM chondrocytes with 
multiple elongated processes were observed (Holloway et al., 2004). It is unlikely for 
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these cytoplasmic processes to be cilia because of two main reasons: (1) bovine 
primary cilia are much smaller (~1.5µm) than these processes (McGlashan et al., 
2008) and (2) cilia cannot be visualised with CLSM unless labelled specifically.  
The relation between abnormal morphology and altered metabolism was reported in 
a study conducted on non-degenerate and degenerate human tibial plateau cartilage 
which stated that abnormal chondrocytes with cytoplasmic processes displayed 
increased levels if IL1ß and loss of collagen type VI in the PCM (Murray et al., 







Figure 1.4: Cell morphology and quantification of cell-associated IL-1ß 
fluorescence.  
Examples of IL-1ß fluorescence immuno-histochemistry in cells with varying 
morphology are shown (images (A–D); bar for all =10µm). In image (A), a normal 
SZ chondrocyte is shown, with negligible levels of cell-associated IL-1ß immuno-
fluorescence, whereas the SZ cell shown in (B) was abnormal and demonstrated 
marked IL-1 ß labelling. A normal DZ chondrocyte is also shown with no detectable 
IL-1ß labelling (image (C)), and image (D) illustrates an abnormal DZ chondrocyte 







1.2.2 PTOA/Secondary OA 
 
 Incidence, causes and treatment strategies for PTOA 1.2.2.1
 
Secondary OA develops as a consequence of joint injury/trauma, characterised by 
pain and disability (Brown et al., 2006). It can be differentiated from primary OA on 
the basis of the fact that there is an underlying cause whereas primary OA is mostly 
idiopathic (Buckwalter and Mankin, 1997a). Mechanical traumas/acute joint injuries 
lead to progressive cartilage degeneration, remodelling of bone and changes in the 
soft tissues thereby, causing PTOA. These types of injuries include joint dislocations, 
tears of joint structures, intra articular fractures and direct blunt injuries (Buckwalter 
et al., 2013). Of the overall burden of primary and secondary OA, 12% is 
approximately as a consequence of joint injuries (Brown et al., 2006). The 
pharmacological and surgical treatment strategies devised so far had been 
unsuccessful in preventing the progression of PTOA (Anderson et al., 2011). In 
comparison to primary OA which occurs mainly in old age PTOA progresses slowly 
and affects specific joints like knee, hip etc. PTOA occurs in young age mostly, 
quickly progresses and depends upon the extent of injury to the joint (Thambyah, 
2005). However, it is difficult to differentiate between the process of degeneration in 
young adults with an identifiable cause and in old aged people with no known 
causative factor (Buckwalter and Martin, 2006). Articular cartilage possesses limited 
capacity for regeneration/repair (“repair” see foot note
1
) of the damaged tissue. 
Although there are numerous studies conducted on the regeneration of this tissue but  
Cartilage repair implies to the regeneration of damaged cartilage by synthesis of mechanically functional matrix. 
However, repair here suggests the response of chondrocytes towards damage in an effort to heal the defect and 
does not imply to the restoration of the normal mechanical properties of cartilage. 
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there is only minimal evidence that this tissue actually repairs itself (Buckwalter and 
Brown, 2004, Nishida et al., 2004). The treatment strategies employed to prevent and 
cure PTOA are both conservative and surgical procedures. The conservative 
treatment plans consist of some non-surgical procedures and medications to reduce 
the symptoms and are usually employed to patients where injury is minor. These 
non-operative procedures are done according to the severity of cartilage lesion 
(Farnworth, 2000). 
The surgical procedures are mostly done for the prevention of PTOA after injury, 
including fracture reduction, arthroscopic debridement, micro fracture, subchondral 
drilling, repair and reconstruction surgeries, osteochondral grafting, stabilisation 
procedures, autologous chondrocyte implantation, tissue engineered cartilage 
implantation and osteotomies (Buckwalter and Martin, 2006). The outcomes of these 
procedures are variable in different patients in preventing development of PTOA. 
Therefore, while selecting the best treatment for a patient one should consider the 
type of injury, potential for healing and effects of treatment on joint repair 
(Buckwalter, 1998, Marsh et al., 2002). 
 Pathogenesis of PTOA 1.2.2.2
 
The pathogenic mechanisms involved in the development and progression of PTOA 
can be categorised roughly into three main phases, immediate events after 
trauma/injury, acute phase and a chronic phase (Lotz, 2010). The immediate events 
include collagen rupture, loss of GAGs, haemarthrosis and chondrocyte necrotic 
death (Szczodry et al., 2009).  
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The acute phase consists of decreased lubricant properties of synovial fluid, 
additional cell death due to apoptosis, decreased synthesis of matrix macromolecules 
(collagen and PGs) and enhanced expression of degrading enzymes and mediators of 
inflammation (DiMicco et al., 2004, Lee et al., 2005). The chronic phase of PTOA 
progresses slowly from asymptomatic to symptomatic phase involving inflammation 
and joint remodelling, eventually causing joint pain and dysfunction (Lotz, 2010).  
Osteochondritis dissecans (OCD) is a joint disorder which leads to changes in 
subchondral bone and overlying cartilage with the progression from cartilage 
loosening to complete separation of osteochondral fragment called loose body 
(Paget, 1870). The exact aetiology of the disease is not known however trauma, 
vascular insults for example ischemia/necrosis and hereditary causes are considered 
the most frequent causes of OCD development (Andrew et al., 1981, Uozumi et al., 
2009). Trauma whether occurring once or several micro traumas are considered to be 
the most frequent cause of development of this disease as it was noticed that its 
incidence was highest amongst athletes (Cahill, 1995). The histological examination 
of OCD samples showed variable results in terms of necrosis of the subchondral 
bone (Chiroff and Cooke, 1975, Yonetani et al., 2010). The articular cartilage of the 
OCD samples also depicted a variable picture regarding the presence or absence of 
degeneration (Linden and Telhag, 1977, Koch et al., 1997, Yonetani et al., 2010). 
The treatment of OCD can be either preservative or restorative treatment where 
preservative is to preserve the cartilage by drilling or fixation of the fragment and 
restorative includes either chondrocyte implantation or osteochondral grafting to 
substitute the damaged cartilage with hyaline/hyaline-like tissue (Pascual-Garrido et 
al., 2009). This OCD tissue can be obtained at surgery and is a useful source for 
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studying the viability and morphology of chondrocytes in diseased cartilage. It is a 
valuable tissue source to be studied in the context of this thesis because the main aim 
of the thesis was to study the changes to chondrocyte morphology in various 
experimental and clinical conditions. Amongst the clinical conditions OCD is a 
common joint disease and the tissue is easily accessible after surgery. Determining 
chondrocyte morphology in OCD will provide insight into whether abnormal 
morphology is a feature of degenerating cartilage in OA alone or these changes also 
occur in other clinical conditions. 
 Chondrocyte cell death in PTOA 1.2.2.3
 
Cell death following injury to cartilage has been studied in various in vivo and in 
vitro studies (D’Lima et al., 2001b, Kim et al., 2002, Bush et al., 2005, Kurz et al., 
2005, Milentijevic et al., 2005). Cartilage cell death is considered the key event in 
the pathogenesis of development of PTOA (Kuhn et al., 2004). The mechanisms of 
cell death after traumatic impact to cartilage has given rise to considerable 
controversy. However, a general consensus is that it can occur in two phases, an 
immediate phase of necrotic cell death and a later phase comprising of cell death due 
to apoptosis (Quinn et al., 1998, D’Lima et al., 2001a, Duda et al., 2001). The author 
agrees to this general concept of initial necrotic and later apoptotic cell death 
associated with cartilage trauma. The compressive loading of cartilage leads to 
apoptosis (Chen et al., 2001, D’Lima et al., 2001a) around the injured matrix and the 
intensity of cell death has a linear relationship with the intensity of injury (Jeffrey et 
al., 1995). The surface zone chondrocytes are more susceptible to cell death (Torzilli 
et al., 1999). Matrix degradation is a consequence of chondrocyte death because the 
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remaining viable chondrocytes are unable to repair the injury effectively (D’Lima et 
al., 2001b). Moreover, cell death after injury has been found to be associated with 
loss of GAGs (D’Lima et al., 2001b).  
 Role of inflammatory cytokines in development of PTOA  1.2.2.4
 
The inflammatory cytokines are involved in the pathogenesis of PTOA and their 
levels are raised after joint injury (Abramson et al., 2001). IL-1, IL-6 and TNFα are 
the main cytokines involved in the development of PTOA (Lee et al., 2009). The 
inflammatory cytokines are responsible for the loss of PGs through an enhanced 
catabolic activity and decreased anabolic activity (Guilak et al., 2004).  
 Degradative enzymes in the pathogenesis of PTOA 1.2.2.5
 
The damage to the cartilage after trauma is significantly through the release of 
extracellular matrix degrading enzymes by the chondrocytes that survive injury 
(Kurz et al., 2005). These degrading enzymes breakdown the matrix components and 
produce fragments of collagen and fibronectin which will initiate a positive feedback 
cycle causing further production of degrading enzymes (Guo et al., 2009). Increased 
levels of MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, MMP-13, MMP-14 and 
ADAM-TS5 have been noticed in the cartilage explants after trauma and play a 
significant role in cartilage degradation and development of PTOA (Lotz, 2010, 
Kramer et al., 2011).  
 CPCs in cartilage repair 1.2.2.6
 
CPCs were first reported in the literature as a heterogeneous population of cells 
present in human AC having the properties of mesenchymal progenitor cells such as 
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self-renewal capacity and differentiation potential (Barbero et al., 2003). CPCs are 
capable of migration through the matrix and possess the potential for repair both in 
the injured and the OA cartilage (Koelling et al., 2009, Seol et al., 2012). The 
response of chondrocytes to mechanical injury has been reported in a study where 
chondrocytes produced cytoplasmic processes in reaction to the injury (Lyman et al., 
2012). Additionally, after a blunt trauma to the cartilage CPCs appeared at the site of 
injury after 7-14 days and possessed the migratory ability (Seol et al., 2012). 
Furthermore, it has been observed that cartilage insult caused by enzymatic 
degradation led to the migration of CPCs in cultured explants (Seol et al., 2014). The 
chemotactic factors released by the dead chondrocytes after injury are thought to 
recruit CPCs at the site of injury (Seol et al., 2012). There are several factors known 
to increase the chemotactic activity of chondrocytes such as platelet derived growth 
factor (PDGF) and insulin like growth factor 1 (IGF-1) (Joos et al., 2013). When the 
cartilage explants were exposed to low intensity ultrasound, the migration of CPCs 
was enhanced (Jang et al., 2014). In another study it has been proposed that calcium 
oscillations in CPCs are driven by autocrine/paracrine purinergic mechanism which 
might influence their differentiation potential (Matta et al., 2015). The role of CPCs 
in cartilage repair after injury is still unknown; however they are proliferative in 
nature but phenotypically different from chondrocytes. 
 Chondroprotective role of hyperosmolarity in cartilage injury 1.2.2.7
 
Chondrocytes are osmotically sensitive cells and react to changes in the osmolarity 
of ECM with corresponding changes in volume (Bush and Hall, 2001a). The 
detrimental effect of mechanical trauma has been observed to be accelerated by 
decrease in extracellular osmolarity (Bush et al., 2005, Amin et al., 2008b, Amin et 
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al., 2010, Amin et al., 2011). However, increasing the osmolarity of the ECM has a 
chondroprotective role with a significant reduction in cell death following cartilage 
trauma (Bush et al., 2005, Amin et al., 2008b). Additionally, in an in vivo study 
hyperosmotic saline has been reported to be related to reduced chondrocyte death 
and better repair outcomes following sharp scalpel injury (Eltawil et al., 2014). It has 
also been reported in a study that increasing the osmolarity of joint irrigation solution 
markedly reduced chondrocyte death during cartilage drilling (Farhan-Alanie and 
Hall, 2014). The chondroprotective effect of hyperosmolarity on injured cartilage in 
terms of chondrocyte viability has been studied extensively but the morphology of 
chondrocytes in response to injury in the presence of hyperosmolar environment has 
attained less attention. As there exists a close relationship between chondrocyte 
morphology and metabolism (Murray et al., 2010) therefore studying morphology of 
chondrocytes in response to hyperosmolarity will provide insight as to whether their 
metabolism is normal or altered. Thus whether exposing the cartilage to 
hyperosmolar environment following trauma helps chondrocytes to retain their 
normal morphology is an important research question which needs to be investigated.  
1.3 Chondrocytes in agarose gel culture 
 
Cellular morphology and cell-matrix connections are dissimilar in 2D as compared to 
3D environment (Cukierman et al., 2001). 3D culture conditions are more 
appropriate for culturing cells as they resemble the in vivo conditions. De-
differentiated chondrocytes restore their differentiated phenotype when cultured in 
3D hydrogel cultures (Benya and Shaffer, 1982, Adolphe and Demignot, 2000). 
Additionally the de-differentiated chondrocytes in agarose culture re-expressed 
collagen and PG levels similar to primary chondrocytes (Benya and Shaffer, 1982). 
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3D agarose gel cultures have been reported to be suitable for culturing chondrocytes 
as they produce mechanically functional matrix (Buschmann et al., 1992). Agarose 
does not directly affect phenotype and chondrocytes have been kept in agarose 
culture for 47 days without any obvious change in phenotype (Benya and Shaffer, 
1982, Buschmann et al., 1995). In the work by Buschmann et al & Benya and Shaffer 
the agarose gels with strengths of 2% and 0.5% were used respectively to culture 
chondrocytes successfully. In the work presented here agarose gel with 2% (strong) 
and 0.2% (weak) strengths have been utilised to culture chondrocytes. Therefore, the 
gel strengths used in this thesis to culture chondrocytes are in good agreement with 
the previously published work. Agarose culture system has been utilised successfully 
in various studies and is considered quite compatible to chondrocytes, inert in nature 
and its mechanical properties can be regulated/altered (Mauck et al., 2000, Balgude 
et al., 2001, Ahearne et al., 2005). In a recent study the effect of matrix elasticity was 
studied on the phenotype, proliferative ability and ECM expressed by chondrocytes 
cultured in agarose gels of various strengths (Schuh et al., 2012b). In this previous 
study by Schuh et al (2012b) it has been reported that chondrocytes cultured in weak 
gels proliferate and produce more ECM as compared to stiff gels. There are several 
differences between the previous work and the study presented here and they are (a) 
in the previous work the minimum gel strength used was 0.75% however, in the 
present study the minimum strength of agarose gel used is 0.2% (b) in the previous 
study the main focus was to determine chondrocyte behaviour in gel cultures 
whereas in the present study the main focus is on the chondrocyte morphology (c) in 
the previous study the effect of serum was not studied but in the present study the 
effect of increasing concentrations of serum on chondrocyte morphology is studied. 
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Therefore, by studying the effect of foetal calf serum (FCS) concentration and gel 
strength on chondrocyte morphology when cultured in agarose gels will build up on 
the previous work by Schuh et al (2012b). 
Although agarose gel model has been extensively utilised to study various aspects of 
chondrocytes yet the morphology has not been studied comprehensively. Therefore 
strong and weak agarose gel models can possibly be utilised to model healthy and 
degenerate/weakened matrix respectively. We have already highlighted the 
importance of chondrocyte morphology in OA (section 1.2.1.8) and agarose gels can 
possibly be the model to study some of the morphological changes in early OA. 
1.4 Confocal laser scanning microscopy (CLSM) 
 
In the classical histological procedures currently used to study in situ chondrocytes, 
the unquantified shrinkage of the chondrocytes may occur with histological fixation 
techniques (Buckwalter et al., 1986). These alterations may lead to inaccurate 
estimates of volume/morphology and thus obscuring the fine morphological details. 
Therefore, histological techniques limit the true examination of the tissue in 
unaltered physiological conditions and render it difficult to record the response of 
viable cells to various stimuli. Moreover, physical tissue sectioning involved in the 
conventional histological procedures is a big hurdle in providing 3D information 
regarding morphology of chondrocytes. However, CLSM is a type of fluorescence 
microscopy which allows the acquisition of high resolution 3D images from thick 
tissues in a relatively unperturbed environment (Brakenhoff et al., 1979). This 
relatively less destructive imaging technique enables the researchers to obtain 
morphological information which may possibly be comparable to in vivo conditions. 
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In this thesis the importance of CLSM as a research tool cannot be denied because of 
its ability to enable acquisition of 3D data on chondrocyte volume/morphology of 
chondrocytes in an unperturbed microenvironment. The main investigation of the 
research presented in this thesis involved determination of chondrocyte viability, 
volume and the cytoplasmic processes. In order to determine chondrocyte viability 
and morphological characteristics in the aetiological investigation of OA, detailed 
information regarding the fine morphological details of chondrocytes in an 
undisturbed microstructure of AC is important. The hypotheses investigated in this 
thesis involve CLSM as the major research tool and the basic principle of this 
technique is detailed in the following sections. 
1.4.1 Overview of CLSM 
 
Minsky (1988) defined the principle of CLSM in order to improve the resolution of 
imaging in comparison to the conventional ones (Minsky, 1988). However, Minsky 
could not utilise this method of imaging because the images were short-lived and 
couldn’t be captured or saved (Jones et al., 2005). Later on the idea of CLSM was 
reviewed and computers were used to display images. Advancements in computer 
processors now allow 3D image reconstruction, de-convolution and morphological 
analysis. CLSM provides several improved imaging properties in comparison to 
traditional microscopy. The most important of these is the improved resolution which 
determines image quality in any microscope system. A key characteristic of CLSM is 
to reject out-of-focus light above and below the focal plane thus creating a sharp 
image. A series of properly focussed images called optical sections are obtained at 
precisely defined increments in z-axis. These optical sections are then combined 
using software to create a 3D reconstruction of the imaged sample.  
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However, there are certain limitations and few imaging problems associated with this 
technique just as associated with other research techniques. These are basically the 
image artefacts associated with this technique. These artefacts can either result from 
weakening of the signal as the depth of imaging increases or image misrepresentation 
can occur due to refractive index discrepancy of the sample (Jones et al., 2005). 
However, it is unlikely that these artefacts can make cells to produce processes as 
these processes are the cytoplasmic extensions of cells with 5-
chloromethylfluorescein diacetate (CMFDA) labelling as strong as observed in the 
cell body. The other possible artefacts associated with CLSM fluorescent-mode 
imaging technique is the photo toxicity to the live cells caused by laser excitation of 
the tissue (Frigault et al., 2009). However, laser induced photo toxicity cannot be an 
issue for this study as the chondrocytes had been fixed after fluorescent labelling 
prior to imaging.   
1.4.2 Principle of CLSM 
 
In CLSM a laser source launches a laser beam which focusses light through the 
objective of the microscope on a single point on to the specimen (Fig. 1.5). 
Following this principle the scattering of light is less and thus a sharp image is 
created. This laser beam excites the fluorophores incorporated in the specimen and 
fluorescence is emitted. The fluorescent radiation is again received by the objective 
and directed towards the photo detector through the dichroic beam splitter. 
Additionally, the light coming from the specimen passes through a pinhole aperture 
which rejects unfocussed light. The beam of light passes through two band pass 
filters i.e. low pass and high pass band filters allowing only a narrow bandwidth of 
light before hitting the photo detector. The light is then focussed through a pinhole 
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aperture in front of the detector and out of focus light is eradicated before being 
registered by the detector. The light from above and below the focal plane does not 
pass through the pinhole and thus does not contribute in image formation. This light 
pathway focusses at a single point on the specimen, however a set of motorised 
rotatory mirrors allow laser to scan the whole specimen. This allows the acquisition 
of a series of optical sections along the z-axis. 
  
Figure 1.5: System set-up of CLSM. 
(A) Simplified diagram showing ray path in CLSM, broken lines indicate out of 
focus light above (green broken) and below (red broken) the focal plane 
(www.zeiss.de) (B) A photograph of the Zeiss LSM 510 Axioskop in the laboratory. 
 
1.4.3 CLSM in cartilage research 
 
Confocal microscopy with fluorescence has gained much importance in studying 
cartilage biology because of its advantage to image chondrocytes in situ as compared 
to the destructive histological conventional techniques (Jones et al., 2005). CLSM 
has been utilised in studying the structure of cartilage with chondrocytes arranged in 
columns (Hedlund et al., 1994) and under different loading conditions (He et al., 




characteristics of non-degenerate and degenerate AC (Bush and Hall, 2003, 
Holloway et al., 2004), ECM disruption associated with morphologically abnormal 
chondrocytes (Murray et al., 2010) and ECM components such as collagen (Poole et 
al., 1992). In various studies conducted on AC, live and dead cells have been labelled 
with fluorescent dyes and imaged with CLSM to determine chondrocyte death in 
mechanically injured AC (Bush et al., 2005, Amin et al., 2008b, Amin et al., 2011). 
By using CLSM the ultrastructure of human cartilage (Hunziker, 2001), shape and 
volume analysis of chondrocytes in relation to tissue deformation/loading was 
studied (Guilak et al., 1995). The effect of physiological loading on the biosynthetic 
response of chondrocytes has also been extensively studied by using CLSM (Kim et 
al., 1994, Clark et al., 2003). There are several algorithms used to determine volume 
of chondrocytes by CLSM, a comparison of these techniques was done in a study 
(Lucas et al., 1996). Additionally CLSM was used to study chondron structure 
(Poole, 1997) and immediate microenvironment of chondrons such as type VI 
collagen (Poole et al., 1992). The ECM components of cartilage have been studied 
using this tool (Wu et al., 2004). CLSM has been widely used to study the efficacy of 
various strategies employed in cartilage repair such as chondrocyte implantation 
(Manolopoulos et al., 1999), cell coating method (Dennis et al., 2004) and 
osteochondral allografts (Gole et al., 2004).  
In the work presented in this thesis, CLSM with fluorescence has been used as a key 
technique to study cell viability and volume/morphology of chondrocytes under 




1.5 Rationale and aims of the thesis 
 
The rationale of this work is based on determining chondrocyte morphology in non-
degenerate and mildly-degenerate human cartilage and then utilisation of in vitro 
models to induce morphological changes to chondrocytes. The studies, conducted in 
the scope of this thesis, hereby, cover the different possible scenarios of weak matrix 
i.e. mildly-degenerate cartilage, 3D gels with low concentration of agarose and 
injured cartilage for determining the morphological characteristics of human and 
bovine chondrocytes. Postulating a single hypothesis is complicated because the 
methodology involved in various studies presented in this thesis is different however, 
various aims are summarised below: 
1. To determine chondrocyte morphology in grade-0 and grade-1 human 
femoral head AC. 
2. To develop an in vitro model of weak matrix by altering agarose 
concentration to study its effects on chondrocyte morphology. To 
histologically evaluate alterations in ECM produced by abnormal 
chondrocytes in weak gels. 
3. To develop an in vitro partial thickness mechanical injury bovine AC model 
as a method for demonstrating a weak matrix with enhanced accessibility of 
FCS to chondrocytes. To evaluate alterations in ECM produced by abnormal 
chondrocytes at the injury. 
4. To utilise this injured bovine AC model as a mode to determine morphology 




1.6 Outline of the chapters 
 
Chapter 2 – Materials and Methods 
In this chapter the generalised biochemicals used in this work and methods for 
preparing standard and varied culture media and methodology involved in varying 
medium osmolarity have been detailed. Additionally, the fluorescent probes used to 
label chondrocytes for CLSM have also been mentioned. This chapter also includes 
the details of data presentation and statistical analyses of the results presented in this 
thesis. 
Chapters 3-8 comprise the main results section covering all the aims and objectives 
of the thesis. The specific materials and methods utilised in obtaining these results 
have been given in detail in the respective chapters.  
Chapter 3 - Morphological characteristics of chondrocytes in human articular 
cartilage 
- Non-degenerate (grade-0) and mildly-degenerate (grade-1) human femoral 
head articular cartilage 
- Articular cartilage in various clinical conditions   
Chapter 4 - Morphological characteristics of bovine chondrocytes cultured in 3D 
agarose gels 
- Effect of varying gel strength 
- Effect of increasing concentrations of FCS 
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Chapter 5 - Evaluation of matrix produced by chondrocytes cultured in strong or 
weak agarose gels 
Chapter 6 - Morphological characteristics of chondrocytes in injured cartilage 
cultured under various conditions 
- Effect of varying culture media 
Chapter 7 - Evaluation of ECM produced by chondrocytes in response to injury 
cultured under various conditions 
Chapter 8 - Effects of short-term and long-term exposure to varying medium 
osmolarity on chondrocyte morphology in injured cartilage cultured under various 
conditions 
This thesis is concluded by Chapter 9 where the merits and limitations of the work 
presented in this thesis have been discussed in general. The clinical and experimental 
relevance of the work and the potential benefits in the field of cartilage biology have 
been highlighted. 
 
Finally, the appendix includes the list of published abstracts, oral and poster 


























Biochemicals were obtained from Invitrogen Ltd. (Paisley, UK) or Sigma-Aldrich 
Co. Ltd. (Poole, UK) unless stated otherwise. Phosphate-buffered saline (PBS) was 
used to wash osteochondral samples and store them after fixation for microscopy. 
Formaldehyde solution (PFA; 4% v/v in saline; pH7.3) was used for fixation (Fisher 
Scientific, Leicestershire, UK). Other biochemicals used for cell isolation and culture 
were collagenase Type I, 255 units/mg and ultra-pure low melting point (LMP) 
agarose powder (Sigma-Aldrich Co. Ltd., Poole, UK).  
2.1.1 Standard and varied culture media 
 
The standard culture medium used was Dulbecco’s Modified Eagle’s Medium 
[standard-DMEM; cat # 41966; 343±2.6mOsm (N=3); 37°C; 5%CO2; pH7.4] 
containing penicillin and streptomycin (50U/ml and 50µg/ml
 
respectively) filtered 
through 0.2 µm pore size syringe filters. For experiments on bovine cartilage 
explants, standard-DMEM was modified with the addition of 10% foetal calf serum 
(FCS-DMEM; 339±2.6mOsm; cat # 16010-159, Invitrogen, Paisley, UK) or 10% 
bovine synovial fluid (SF-DMEM; 334±1.4mOsm). SF was taken aseptically from 
healthy bovine metacarpophalangeal joints using a sterile syringe at the beginning of 
dissection, centrifuged (Hettich Zentrifugen Universal 32R) at 21°C, 1500rpm for 10 
min. The supernatant SF was pipetted carefully and the remaining cell pellet was 
discarded, kept in aliquots and stored at -20°C until required. Tissue culture medium 
used for the culture of isolated chondrocytes in agarose gels was standard-DMEM 
with NaCl added to increase osmolarity to 383.6±0.8mOsm (380mOsm; N=3); 
within the range of osmolarity of chondrocytes in situ (Hopewell and Urban, 2003), 
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10% FCS and 50µg/ml ascorbic acid. The osmolarities of culture media were 
measured with freezing point osmometer (Advanced Micro Osmometer, Model 3300, 
Vitech Scientific Ltd, West Sussex) after adding antibiotics/FCS/SF/NaCl to the 
culture media. 
 Varying medium osmolarity 2.1.1.1
 
Medium osmolarity was measured using a freezing point osmometer. Three 
measurements were taken and mean osmolarity of these was calculated. For 
experiments on the response of injured cartilage to osmolarity, medium osmolarity 
was increased by adding sucrose to the solutions. Sucrose was used as it does not get 
metabolised by chondrocytes (Fell and Dingle, 1969). The osmolarity of the prepared 
solutions was varied between 300 to 600 mOsm. In the osmolarity experiments 
serum-free and serum-rich culture media with varied osmolarities were used as (a) 
standard-DMEM; 343±2.6 mOsm (DMEM-343) (b) FCS-DMEM; 339±2.6 mOsm 
(FCS-339) (c) standard-DMEM; 609±1.4 mOsm (DMEM-609) and (d) FCS-DMEM; 
606±0.8 mOsm (FCS-606) abbreviated as standard-DMEM, standard-FCS, 
hyperosmolar-DMEM and hyperosmolar-FCS respectively. 
2.1.2 Fluorescent probes  
 
CMFDA (chloromethylfluorescein diacetate) is highly membrane permeable and 
once inside cells, esterases convert it into 5-chloromethylfluorescein (an 
impermeable fluorescent compound) which then reacts with thiols of proteins and 
peptides and thus forms fixable conjugates which uniformly label the cytoplasm of 
living cells green (De Crombrugghe et al., 2000, Stoddart et al., 2006). Propidium 
iodide (PI), being impermeable to the intact membrane, penetrates dead cells only 
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and binds to their DNA emitting light at the red end of the spectrum following laser 
excitation (Chen et al., 2003). CMFDA labels living cells green and PI labels nuclei 
of dead cells red and it was reported in a recent study that the dead PI-labelled 
chondrocytes are incapable of green labelling and cannot recover viability even after 
16 days of culture (Smith et al., 2013). Therefore living cells are labelled green with 
CMFDA and dead cell nuclei labelled red with PI in the present work. 
DRAQ5 1, 5-bis 2-di-methylamino-ethyl-amino-4, 8-dihydroxyanthracene-9, 
10-dione (Biostatus, UK), far-red DNA dye was used to fluorescently label the 
nuclei of living chondrocytes. PI was used to label nuclei of dead cells whereas 
DRAQ5 was used to label nuclei of live cells in gel culture experiments. The main 
purpose of using DRAQ5 was to enable counting of cells in a cluster by counting 
number of nuclei. For the detailed analysis of clusters formed it was not possible to 
count number of cells involved in forming a cluster instead, nuclei labelled with 
DRAQ5 were counted. CMFDA was prepared in dimethyl sulphoxide (DMSO) as a 
1mM stock solution obtained from the manufacturer (Invitrogen, Paisley, UK) and PI 
was prepared as an aqueous 1mM stock solution. DRAQ5 (DNA probe) was 
obtained from manufacturer as 5mM stock solution and was diluted 1:50 in distilled 
water (D/W). DRAQ5 and PI both can bind to DNA but they differ in their ability to 
label nuclei such that PI is membrane impermeable and can bind to nuclei of dead 
cells only whereas DRAQ5 is membrane permeable and can rapidly stain nuclei of 
both live and fixed cells. The two dyes PI and DRAQ5 were therefore used for 
determining cell death and counting of chondrocytes in the clusters respectively. 
A series of pilot experiments were performed in order to find out suitable 
concentrations and incubation time for appropriate labelling of isolated 
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chondrocytes, bovine chondrocytes in situ and human chondrocytes in situ. The 
concentration and incubation time found appropriate for chondrocyte labelling in 
various experimental conditions have been detailed in the specific Materials and 
Methods sections of respective chapters. 
2.2 Data presentation and statistical analyses of results 
 
Data are presented as mean±SEM with N representing the number of different 
animals or patients, n the total number of explants and nʹ the total number of cells 
analysed for each experimental condition. The values for N, n & nʹ are detailed in the 
results section of each chapter.  Statistical tests applied and graphs generated were by 
using Graph Pad Prism 6 (GraphPad software, Inc., CA, USA). Unpaired, two-tailed, 
Student’s t-tests were used to compare means within groups and indicated by the 
symbol *. One way analysis of variance (one-way ANOVA) followed by post-hoc 
Tukey’s multiple comparison test was used to compare data between groups and 
indicated by the symbol #. In the human cartilage experiments, + showed a 
significant difference between grade-0 and grade-1 cartilage explants according to 
Student’s t-test. In the experiments performed on the bovine injured cartilage 
explants followed by culture in various conditions data obtained at and distant from 
the injury was compared using Student’s t-test and the significant difference 
indicated by the symbol ^. In the results obtained from the experiments performed to 
see the response of injured cartilage to osmolarity, significant difference between the 
two osmolarities was indicated by the symbol £. A significant difference was 
accepted when P<0.05. The single, double and triple symbols showed the level of 
significance for P<0.05, 0.01 and 0.001 respectively. 
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3 CHAPTER 3: RESULTS                                                       
MORPHOLOGICAL CHARACTERISTICS OF 
CHONDROCYTES IN NON-DEGENERATE (GRADE-0) AND 
MILDLY-DEGENERATE (GRADE-1) HUMAN ARTICULAR 






3.1 CHAPTER SUMMARY 
 
The main hypothesis of the work presented in this chapter is that in grade-0 human 
femoral head AC, chondrocytes show mild perturbation in morphology which 
exacerbates in grade-1 cartilage. The rationale of this chapter was to study 
chondrocyte viability and morphological characteristics within grade-0 and grade-1 
human femoral head and cartilage obtained from other joints in various clinical 
conditions. Using CLSM, in situ chondrocyte volume was quantified in various 
zones of grade-0 human femoral articular cartilage. Additionally, quantitative data 
regarding morphology of chondrocytes (clusters/cytoplasmic processes) were 
obtained and compared in grade-0 and grade-1 articular cartilage. In grade-0 
cartilage there was marked heterogeneity in chondrocyte volume across all the zones. 
The average volume of chondrocytes in the mid zone (MZ) was significantly greater 
than volume of superficial zone (SZ) and deep zone (DZ) chondrocytes (P<0.001 and 
P<0.01 respectively). In grade-1 cartilage, topographical arrangement of 
chondrocytes was disorganised, there were more PI-labelled chondrocytes in the SZ 
and MZ and marked areas of hypo-cellularity were observed. A significantly higher 
percentage of chondrocytes formed large sized clusters in the SZ of grade-1 
(43±16%) as compared to grade-0 cartilage (11±3%; P=0.008). A significantly 
higher percentage of chondrocytes had cytoplasmic processes throughout the whole 
thickness of grade-1 cartilage (35±5%) as compared to grade-0 cartilage (17±2%; 
P=0.0007). A detailed zone-wise analysis of these cytoplasmic processes revealed 
that in grade-0 cartilage, fine processes with an average length of ~5µm were present 
within cells of SZ/MZ and in the DZ the length of processes was only ~3µm. In 
comparison to this in the grade-1 cartilage, the average length of processes was 
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15.6±2 µm in the SZ, 6±0.5 µm in the MZ and 4±0.5 µm in the DZ. Regarding the 
presence of cytoplasmic processes there existed a general trend in grade-1 but no 
trend observed in grade-0. In grade-1 cartilage, cytoplasmic processes were seen 
mostly in the SZ, less in the MZ and least in the DZ. Similarly, the length of these 
processes and the number of processes per cell also decreased with cartilage depth 
from SZ to DZ. Moreover, in the cartilage samples obtained from joints with various 
pathological conditions such as osteochondritis dissecans (OCD) and avascular 
necrosis (AVN) of the joint there were numerous PI-labelled chondrocytes and the 
chondrocytes exhibited abnormal morphological characteristics in terms of cluster 
formation and the presence of cytoplasmic processes. These data suggested that in 
the grade-0 human femoral articular cartilage topographically chondrocytes were 
arranged in a regular manner, 17±2% chondrocytes had fewer fine cytoplasmic 
processes and only few cells were present in the form of clusters. However, in grade-
1 cartilage the arrangement of chondrocytes was disturbed, clustering was more 
evident and 35±5% abnormal chondrocytes with numerous long cytoplasmic 
processes were present. These morphological changes (clusters/processes) were 
greater in the SZ as compared to the MZ and DZ. These results strongly support the 
hypothesis that mild morphological changes present (cytoplasmic processes) in 
grade-0 cartilage are exacerbated in grade-1 cartilage. 
3.2 INTRODUCTION 
 
OA is a disease of the whole joint which involves all the structures of the joint such 
as cartilage, membrane, ligament, capsule, muscle and the bone (Wieland et al., 
2005). The main pathological features of the disease are cartilage degeneration, bone 
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remodelling and synovitis leading to joint failure ultimately (Aaron and Racine, 
2013). In OA there is progressive cartilage erosion as a consequence of imbalance 
between the anabolic and catabolic activities of chondrocytes (Goldring and 
Goldring, 2004). The changes to chondrocyte matrix metabolism are accompanied by 
collagen disruption and degradation of PGs (Malemud, 1991, Stoop et al., 2001). 
With the progression of the disease the matrix is weakened/loosened (Aigner and 
McKenna, 2002), increased permeability of the matrix, increased hydration and 
swelling of cartilage because the fluid fraction of the cartilage increases (Maroudas, 
1976, Stockwell, 1991, Wang et al., 2013a). This degradation process is manifested 
in the SZ of cartilage and becomes visible in the form of fissures and fibrillations of 
cartilage (Hollander et al., 1995, Kleemann et al., 2005). OA is regarded as the 
disease of the whole joint and the reaction pattern of chondrocytes to the destructive 
changes in the matrix is an important component in the pathophysiology of OA. 
However, the immediate response/reaction of chondrocytes is dependent upon the 
alterations in the pericellular matrix (PCM) (Vincent, 2013). Although the exact 
function of PCM is not known but the evidence suggests that PCM plays a 
significant role in controlling the immediate biochemical and mechanical 
microenvironment of chondrocytes (Guilak et al., 2006). The growth factors and 
enzymes released by chondrocytes are stored and modified in PCM (Macri et al., 
2007, Echtermeyer et al., 2009). In OA, marked changes occur in the PCM and it has 
been reported that in OA there is over production and enhanced destruction of type 
VI collagen (McDevitt et al., 1988, Ronzière et al., 1990, Lee et al., 2000, Murray et 
al., 2010). In a recent study on human OA cartilage by using atomic force 
microscopy, PCM enlargement and decreased mechanical function was observed as 
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compared to normal cartilage (Wilusz et al., 2013). The consequences of disruption 
in the PCM of chondrocytes in the disease pattern are largely unknown; however the 
proposed mechanism is reduced cell-matrix interactions via integrin receptors 
(Marcelino and McDevitt, 1995, Loeser, 1997, Knudson and Loeser, 2002). In 
another study the importance of immediate environment of chondrocytes has been 
highlighted by reporting that the disturbance in PCM could influence their synthetic 
and proliferative activities (Alexopoulos et al., 2009). Alteration in the PCM has 
been linked to the metabolic activity of chondrocytes but its relationship with 
chondrocyte morphology attained less attention. However, in a study (Murray et al., 
2010) morphologically abnormal chondrocytes in OA have been related to 
disturbance in pericellular Type VI collagen. 
There can be several responses of chondrocytes to OA and discussed in detail. 
Chondrocytes either undergo apoptotic/necrotic cell death (Kim et al., 2000, Thomas 
et al., 2007) or proliferate and form clusters (Rothwell and Bentley, 1973, Mitchell et 
al., 1992). Chondrocytes increase or decrease their metabolic activities (Murray et 
al., 2010, Goldring et al., 2011) and their phenotype is altered based upon gene 
expression (Lapadula et al., 1998). A typical histological finding of osteoarthritic 
cartilage is presence of empty lacunae and clusters of chondrocytes (Pauli et al., 
2011). Several studies have reported that in OA the proliferative activity of 
chondrocytes increases resulting in the formation of clusters (Lotz et al., 2010). It has 
also been suggested that these clusters are most numerous in the SZ of degenerating 
cartilage close to the fissures (Schumacher et al., 2002).  
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Another classical histological finding of osteoarthritic cartilage is areas of hypo-
cellularity indicating increased cell death as suggested by some authors (Blanco et 
al., 1998, Kim et al., 2000). Cell death in OA has been attributed to necrosis (Wei et 
al., 2006), apoptosis (Lee et al., 2004) or a variant of apoptosis termed 
‘chondroptosis’ (see foot note
1
) (Roach et al., 2004). Various studies were conducted 
to investigate the causes of cell death in degenerating cartilage and have reported 
mechanical injuries (Tew et al., 2000), age (Grogan and D’Lima, 2010), reactive 
oxygen species (Henrotin et al., 2003) and cytokines (Goldring and Goldring, 2004) 
to be the main contributing factors in inducing cell death in OA.  
The evidence of cell death in human OA cartilage has been reported in various 
studies but mostly the cartilage samples were obtained from patients at the time of 
joint replacement surgeries suggesting that they were from patients with OA at very 
advanced stage. This may suggest that one of the contributing factors for the 
presence of dead chondrocytes in these samples was end–stage disease. However, in 
a study carried out on early OA human cartilage tissue relatively less cell death was 
present (Aigner et al., 2001). It has been suggested that chondrocytes die in OA but 
the extent of cell death and disease stage when it occurs is controversial and has been 
highlighted in a review article (Carlo and Loeser, 2008). Thus there can be several 
factors responsible for these controversial results on cell death in OA such as the 
method of assessment of cell death, age of the patient and disease stage. Chondrocyte 
death is crucial for proper functioning of the cartilage as it leaves a greater burden on 
Chondroptosis is a variant of apoptotic cell death in chondrocytes undergoing apoptosis in a non-classical manner 
with increase in endoplasmic reticulum (ER) and golgi apparatus. The ER membranes segment and provide 
compartments for digestion of cytoplasm and organelles leading to self-destruction of chondrocyte. 
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the remaining chondrocytes to maintain tissue integrity thus leading to cartilage 
failure (Sharif et al., 2004).  
Chondrocytes have the ability to synthesize and degrade ECM with their synthetic 
(anabolic) and resorptive (catabolic) activities. In a healthy cartilage there exists a 
balance between these two metabolic activities and steady state equilibrium is 
maintained by chondrocytes (Wang et al., 2003). During degeneration, this 
equilibrium is disturbed and chondrocytes become hyperactive initially attempting to 
repair (“repair” see footnote
1
) cartilage (Aigner et al., 1992). However, eventually 
the catabolic activities override the anabolic activities and this imbalance in the 
metabolic processes leads to cartilage degeneration and ultimately loss of cartilage 
structure and function (Aigner and Dudhia, 1997).  
There can be various factors involved in the destruction of cartilage matrix and are 
ascribed to age-related changes, excessive joint mechanical loading and the 
dysregulation of cytokines. These factors are related to changes in matrix metabolism 
causing more catabolism than anabolism and thus predisposition to OA. Excessive 
joint loading has been observed to be a causative factor in development of OA 
(Buckwalter et al., 2013). Cytokines are molecules which either enter the cell or act 
on the surface, can be categorised into inflammatory and anti-inflammatory 
cytokines (Goldring and Goldring, 2004). The interplay between these catabolic and 
anti-catabolic cytokines is one of the factors responsible for cartilage remodelling  
Cartilage repair implies to the regeneration of damaged cartilage by synthesis of mechanically functional matrix. 
However, repair here suggests the response of chondrocytes towards damage in an effort to heal the defect and 
does not imply to the restoration of the normal mechanical properties of cartilage. 
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and the imbalance leads to cartilage destruction (Mueller and Tuan, 2011). There are 
many members of inflammatory cytokine group but the important ones involved in 
OA disease process are IL-1ß, TNFα, IL-6, IL-15, IL-17 and IL-18 (Westacott and 
Sharif, 1996, Martel-Pelletier et al., 1999, Goldring, 2000a, Wojdasiewicz et al., 
2014).  
The second group including anti-inflammatory cytokines consists of IL-4, IL-10 and 
IL-13 with the antagonist effect to the inflammatory cytokines. The inflammatory 
cytokines and most importantly IL-1ß and TNFα are the key players responsible for 
the destructive processes within cartilage leading to an imbalance in tissue 
homeostasis (Martel-Pelletier et al., 1999, Wojdasiewicz et al., 2014). The main 
catabolic effects produced by these inflammatory cytokines are induction of 
apoptosis, decreased synthesis of major components of ECM, enhanced release of 
proteolytic enzymes and increased synthesis of other inflammatory cytokines by 
chondrocytes (Fernandes et al., 2002). In contrast, anti-inflammatory cytokines act 
by antagonising these catabolic effects of inflammatory cytokines (Wojdasiewicz et 
al., 2014). Therefore, in OA an excess of inflammatory cytokines is one of the many 
factors responsible for cartilage degeneration (Melchiorri et al., 1998). Although OA 
is generally considered a non-inflammatory disease but the role of synovial 
inflammation cannot be denied in its pathogenesis and has been reviewed in detail 
(de Lange-Brokaar et al., 2012). In healthy cartilage several growth factors such as 
transforming growth factor ß (TGFß) play a critical role in regulating the metabolic 
activities of chondrocytes apart from cytokines and assist chondrocytes in 
maintaining normal homeostasis. Low levels of TGFß have been suggested to be 
involved in the development of OA (Shen et al., 2013). 
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Phenotypic changes (de-differentiation) in chondrocytes are another prominent 
feature of OA (Tesche and Miosge, 2005). The chondrocyte phenotype (“phenotype” 
see foot note
1
) is regulated through the cytoskeletal elements via morphogens and 
cytokines (Vinall et al., 2002). A specific chondrocytic phenotype with rounded 
morphology and the expression of type II collagen and aggrecan is required to 
maintain the normal architecture and functioning of articular cartilage (Eyre, 2002, 
Dudhia, 2005). In OA, chondrocytes dedifferentiate phenotypically and do not 
express cartilage specific genes thereby, leading to the anabolic failure of cartilage 
(Tchetina et al., 2005, Yagi et al., 2005). Phenotypic changes to chondrocytes were 
observed in human OA cartilage in several studies (Stockwell, 1978, Kouri et al., 
1996a, Kouri et al., 1996b, Kouri et al., 1998, Lee and Loeser, 1998, Goldring, 2002, 
Kouri and Abbud-Lozoya, 2002, Yagi et al., 2005, Kouri and Lavalle, 2006). These 
phenotypic changes included several shape changes such as presence of filopodia, 
irregular cells, fibroblast-like shapes of chondrocytes and altered metabolism in OA. 
In these studies although heterogeneity to chondrocyte morphology was reported but 
fine details were not comprehensively studied. However, abnormal chondrocyte 
morphology with the presence of cytoplasmic processes was first reported in a study 
on degenerate and non-degenerate cartilage which stated that in human tibia plateaus 
~40% chondrocytes had cytoplasmic processes of variable lengths emanating from 
their cell bodies (Bush and Hall, 2003). The presence of these cytoplasmic processes 
even in the non-degenerate cartilage raised the possibility that cytoplasmic processes 
might be an early event in degeneration of cartilage. 
 
Phenotype implies to appearance of cell shapes and their metabolism 
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A sub-population of abnormal cells with long cytoplasmic processes was observed in 
a study done on human OA femoral heads with pannus (Holloway et al., 2004). 
Morphology is an important component of phenotype it has been reported that 
morphologically abnormal chondrocytes (with cytoplasmic processes) caused 
disruption to collagen type VI and increased levels of IL-1ß (Murray et al., 2010). In 
summary, various studies have been conducted to investigate the alterations in 
mechanical and biochemical properties of chondrocytes during cartilage 
degeneration but the morphology of chondrocytes does not appear to be 
comprehensively probed.  
This study utilised CLSM to determine the morphological characteristics of 
chondrocytes in non-degenerate and mildly-degenerate human femoral head articular 
cartilage. This work has extended the previous work by Bush and co-workers in 
several aspects. Firstly, the samples under investigation in this work are obtained 
from a different joint i.e. hip joint (human femoral head) as compared to the earlier 
study performed on tibial plateau cartilage. As the biomechanics of hip and knee 
joints are different (Kirkwood et al., 2007) it is therefore possible that the 
morphology of chondrocytes will be different in the two joints. Comparison of the 
morphologies of chondrocytes in the hip and knee joint AC will provide further 
information on whether cytoplasmic processes are a unique property of knee 
cartilage alone. Secondly, the samples studied here have been obtained from healthy 
cartilage with no known degenerative disease of the cartilage as compared to the 
earlier study where cartilage originated from patients undergoing knee surgery due to 
OA. The importance of having samples from healthy cartilage in this study will 
enhance our knowledge regarding the presence of these cytoplasmic processes and 
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whether they are present on healthy cartilage also or they are only the characteristic 
feature of a joint failing due to OA.  
CLSM rendered it possible to study the fine 3D morphological details of in situ 
living chondrocytes in an unperturbed cartilage environment. In this study the grade-
0 and grade-1 cartilage samples were obtained from the same human femoral heads 
thereby, providing accurate control samples for comparison. There were eight human 
femoral heads obtained for this work, five of them had the whole sample with grade-
0 cartilage whereas three samples had some areas of grade-1 also. Moreover, in this 
study morphological details of chondrocytes in normal and in early stages of 





In grade-0 human femoral head AC, chondrocytes show morphological changes 








3.4 MATERIALS AND METHODS 
 
3.4.1 Human femoral articular cartilage explants 
 
Human articular cartilage explants from femoral heads of eight patients of which six 
were females and two males with an age of 79±3.5 yrs. (Mean±S.E.M; age range 65-
89 yrs.) were prepared as rectangular blocks and the technique for preparing these 
explants is outlined below. 
3.4.2 Source of human tissue 
 
During hip replacement surgeries, the femoral heads are normally resected out as a 
whole and are discarded later after the procedure. These femoral heads were obtained 
by courtesy of Dr. Anish Amin (Consultant orthopaedic surgeon) from the Edinburgh 
Royal Infirmary (ERI) with the ethical approval of Local Research Ethics 
Committee. Additionally, an informed consent for the use of material for 
experimental purposes was taken by Dr. Anish Amin from 8 patients undergoing hip 
replacement surgery due to fracture of the hip joint. The femoral heads were 
immediately transferred to sterile plastic jars containing standard-DMEM (section 
2.1.1) and were transported safely to the laboratory. The samples were dissected and 
osteochondral explants were obtained and prepared for CLSM within 6-8 hours 
following surgery. Additionally, after obtaining informed patient consent and ethical 
approval from the ethical committee five samples of patients with various clinical 
conditions were also obtained and the particulars of patients with clinical conditions 
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Duration of 
symptoms 























Table 3.1: Particulars of human cartilage samples. 
Details of patients and human cartilage explants obtained from various joints in 
different clinical conditions.  
3.4.3 Removal of osteochondral explants 
 
Most of the cartilage in the 8 human femoral heads obtained from patients 
undergoing hip replacement was normal and macroscopically graded by Dr. Anish 
Amin as grade-0 cartilage. However, in 3 of the samples it was possible to also 
obtain some cartilage that showed mild degeneration (grade-1). The grade-0 and 
grade-1 cartilage areas were both present on the same human femoral head. 
Macroscopically grade-1 cartilage areas were roughened, discoloured and showed 
splitting and pitting of cartilage (Fig. 3.4b). The samples were initially graded by Dr. 
Anish and then re-confirmed by the author. The grading methodology applied to 
differentiate between grade-0 and grade-1 cartilage samples comprised of earlier 
macroscopic examination and later on microscopic confirmation as summarised in 
Table 3.2. based on already described grading system (Pritzker et al., 2006). 
Osteochondral explants comprising full thickness of the cartilage with some 
underlying subchondral bone were harvested with scalpel # 24 from these graded 
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areas. The explants were then trimmed measuring approximately 4 mm x 4 mm and 
stored in standard culture medium (Fig. 3.1).  
 
 
Figure 3.1: Preparation of human femoral osteochondral explants. 
(a) Human femoral head indicating area (white outlined box) where explants were 
harvested, (b) rectangular osteochondral strip dissected into osteochondral explants 
by scalpel with measurements 4 mm x 4 mm (grade-0 cartilage). The broken arrow 
indicates the fovea. Photographs (a) and (b) kindly provided by Mr. Scott I Paterson, 
Centre for Integrative Physiology, University of Edinburgh. 
 
 
3.4.4 Staining, fixation and preparation of human osteochondral explants for 
CLSM 
The human femoral osteochondral explants were incubated with CMFDA and PI 
with final concentrations of 12.5 and 10µM respectively for 2 hours in dark on the 
rocking table to label the living and dead cells respectively. The explants were then 
washed in PBS to remove excess of dye and fixed in 4% PFA overnight at 4°C. The 
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samples were washed in PBS twice and mounted in the culture wells for microscopy 
and stored as described for the bovine explants until used (section 6.4.1.2). 
 
3.4.5 CLSM of human cartilage explants  
 
A Zeiss Axioskop LSM 510 upright CLSM was used with an Ar laser with excitation 
wavelength (EXλ) of 488nm and HeNe laser with EXλ 543 to excite the fluorophores 
CMFDA and PI respectively. The precise details of confocal settings utilised to 
image human femoral osteochondral explants were similar to those for the bovine 
cartilage explants in both axial and coronal planes and given in detail (section 
6.4.1.3). The images were obtained by utilising both low (Fig. 3.2) and high power 
(Fig. 3.3) magnification objectives in both the planes. The CLSM axial and coronal 
reconstructions were created using the Volocity
TM 
software as described for the 







Figure 3.2: Axial and coronal CLSM for human femoral articular cartilage 
explants imaged with low power (x10) objective.  
The x, y and z axes labelled on the diagram of the explant. (Left panel) Axial optical 
sections of the articular cartilage imaged top-down and the series of optical sections 
reconstructed in the axial plane, (Right panel) Coronal optical sections of cartilage 
imaged the full thickness of the cartilage and the series of optical sections 
reconstructed in the coronal plane. Chondrocytes labelled with CMFDA and PI for 





Figure 3.3: Axial and coronal CLSM for human femoral articular cartilage 
explants imaged with high power (x40DW) objective.  
The x, y and z axes labelled on the diagram of the explant.  (Left panel) Axial optical 
sections of the articular cartilage imaged top-down and the series of optical sections 
reconstructed in the axial plane, (Right panel) Coronal optical sections of grade-0 
cartilage imaged the full thickness of the cartilage and the series of optical sections 
reconstructed in the coronal plane. The yellow-coloured cells are possibly dying cells 
where PI could penetrate because the membrane is compromised but the cells could 
take up some CMFDA also as all the cytoplasm has not disintegrated yet. Scale bar = 
25µm for both axial and coronal reconstructed images. 
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3.4.6 Volume and morphological analysis of in situ human chondrocytes  
 
The volume and morphology of chondrocytes was determined in the three zones 
(zones defined in section 3.5.1.1) of cartilage using the high power (x40 DW) 
magnification images taken in the coronal plane. The volume measurement technique 
on Volocity
TM
 software was identical to the chondrocytes cultured in agarose gels 
and the same correction factor was also applied to obtain corrected measurements 
(sections 4.4.1.7.1. &  4.4.1.7.2).  
Various characteristics of chondrocyte clusters present in the human explants were 
determined by using the same methodology as described in the cultured chondrocytes 
in gels (section 4.4.1.7.1). The morphology of chondrocytes was categorised by 
modifying the classification method used for bovine chondrocytes to take account of 
wide range of shapes observed in human chondrocytes. The length of cytoplasmic 
processes was measured in 3D following the protocol mentioned in the methods 
section of cultured chondrocytes (4.4.1.7.3). However, the cells with processes were 
further categorised into 4 groups [length (L) 1-4; where L1<5µm, 5<L2≤10µm, 
10<L3≤15µm and L4>15µm) with respect to the length of processes. This 
categorisation was important as it allowed a detailed analysis of data obtained on the 
length of processes. The range of lengths of processes observed in human cartilage 
was categorised in a different way as compared to length of processes observed 
within chondrocytes cultured in agarose gels because of the differences in minimum 
and maximum lengths observed. The percentages of cells having cytoplasmic 
processes of specific length categories were determined with the formula 100 × 
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3.5.1 Morphological characteristics of chondrocytes within grade-0 and grade-
1 human femoral articular cartilage 
 
The axial and coronal CLSM images of fluorescently-labelled chondrocytes were 
visualised to compare the morphology of chondrocytes in grade-0 and grade-1 
human femoral head cartilage. A detailed analysis of quantitative data regarding 
chondrocyte morphology in the various zones of cartilage was performed on the 
coronal images. 
 Cartilage grading and demarcation of various zones 3.5.1.1
 
As a first step, cartilage of the whole joint surface was graded macroscopically 
(Pritzker et al., 2006) and then explants from selected graded areas were obtained for 
grade-0 and grade-1 cartilage. The cartilage grade was assessed by visualisation 
(Table 3.2) where most of the cartilage was non-degenerate however it was also 
possible to obtain some mildly degenerate cartilage explants from the same joint 
which permitted a comparison. Photographs of femoral heads (Fig. 3.4 a & b) and 
CLSM reconstructed images of the coronal views of cartilage explants (Fig. 3.5 a & 
b) represent examples of grade-0 and grade-1 cartilage regarding their macroscopic 




The second step was to define various zones of cartilage depending upon its cellular 
composition. CLSM low power images were used to delineate the zones of cartilage 
depending upon the criteria already described which defined SZ as first 100µm of the 
tissue (10% of cartilage thickness), MZ from 200µm to 400µm from surface (60% of 
tissue) and DZ as 300µm inward from tide mark (30% of tissue) (Humbree et al., 
2007). Average overall thickness of grade-0 cartilage was 1250±22µm (mean±SEM 
for n=5), the SZ was defined as the first 125µm which constituted approximately the 
top 10% of the articular cartilage containing cells mostly flattened in shape. The MZ 
was outlined as between 125-875µm from the surface of the cartilage which 
consisted of approximately 60% of the cartilage with cells mostly spheroidal in 
appearance. Finally the DZ was defined as 375µm upwards from the tide mark and 
this comprised of approximately 30% of the cartilage thickness (Fig. 3.5). Thickness 
of the cartilage varied between the samples therefore the zones were defined by 
measuring in micro-meters the thickness of each zone. 
The low power (x10) coronal images showed relatively less PI-labelled chondrocytes 
in the grade-0 as compared to grade-1 cartilage. In addition, chondrocyte clustering 
was obvious in the grade-1 as compared to grade-0 (Fig. 3.5). The quantitative data 
regarding detailed analysis of morphological characteristics of chondrocytes in 

















Figure 3.4: The appearance of grade-0 and grade-1 human femoral heads.  
In these representative photographs, examples of (a) Grade-0 and (b) Grade-1 human 
femoral articular cartilage are shown. The gross appearance of cartilage (identified 
by solid arrows) was used for grading the cartilage samples. The broken arrows 





Figure 3.5: An overview of chondrocyte arrangement in the grade-0 and grade-
1 human femoral head articular cartilage.  
Representative CLSM coronal low power (x10) reconstructed images of CMFDA 
and PI-labelled chondrocytes showing (a) Grade-0 and (b) Grade-1 cartilage. Grade-
0 cartilage showed smooth regular surface with minimal morphological changes to 
chondrocytes, whereas grade-1 displayed obvious surface roughness and erosions 
with clustering. Solid arrows indicate smooth and rough surfaces of grade-0 and 
grade-1 cartilage respectively and broken arrows indicate examples of chondrocyte 






 Morphology of chondrocytes in grade-0 and grade-1 human femoral 3.5.1.2
articular cartilage (Axial view) 
 
Although axial and coronal both CLSM images were obtained for grade-0 and grade-
1 human cartilage the quantitative analysis of chondrocytes was performed on the 
coronal images in order to determine chondrocyte morphology in all the zones of 
cartilage. The axial CLSM images of low and high power magnification were 
visualised and an initial overview of the cartilage was given in this section. Marked 
changes to chondrocyte morphology and large areas of hypo-cellularity were clearly 
evident in the grade-1 (axial view) as compared to grade-0 cartilage explants even at 
low magnification. There were hardly any PI-labelled cells observed in the grade-0 
and grade-1 cartilage samples (Fig. 3.6). 
When chondrocytes were viewed with a high power magnification objective 
(x40DW) marked heterogeneity to chondrocyte morphology (processes/clusters) was 
observed in the grade-1 cartilage. In grade-0 cartilage, chondrocytes were mostly 
relatively normal (spheroidal/elliptical) in shape and only few cells had fine 
cytoplasmic processes (Fig. 3.7a). In grade-0 cartilage occasionally abnormal cells 
with fine cytoplasmic processes were present but there were far more abnormal cells 
with long cytoplasmic processes in grade-1 cartilage (Fig. 3.7b). Moreover, 
chondrocyte density appeared to be less in the degenerate as compared to non-










Figure 3.6: Axial CLSM reconstructed images of chondrocytes within human 
femoral head articular cartilage.  
CLSM reconstructions of low magnification (x10) images of CMFDA and PI-
labelled chondrocytes (live and dead cells respectively) in human (a) Grade-0 and (b) 
Grade-1 articular cartilage explants. In these representative examples [N=8 & N=5] 
for grade-0 and grade-1 femoral heads respectively, chondrocytes within grade-0 and 
grade-1 cartilage are shown, which exhibit normal morphology in grade-0 and 
abnormal morphology in grade-1 (indicated by solid arrow) and areas of hypo-
cellularity (indicated by broken arrows). There were no PI-labelled chondrocytes 
detected in these images although this fluorescent indicator has been added. Scale bar 











Figure 3.7: Axial CLSM reconstructed images of fluorescently-labelled human 
chondrocytes in femoral head articular cartilage.  
CLSM reconstructed images at high magnification (x40DW) of CMFDA and PI-
labelled chondrocytes (live and dead cells respectively) within (a) Grade-0 and (b) 
Grade-1 human femoral articular cartilage. The solid arrows indicate examples of 
cytoplasmic processes and the broken arrows the examples of clusters present in 
these representative images. There were no PI-labelled chondrocytes detected in 
these images although this fluorescent indicator has been added. Scale bar for both 
panels = 25µm. 
 
 Volume of chondrocytes in grade-0 cartilage 3.5.1.3
 
Chondrocytes survive in a unique environment with tight volume regulation and it 
has been suggested that loss of this control plays a role in their viability and 
progression of OA (Bush and Hall, 2003, Bush et al., 2005). The volume of 
chondrocytes in SZ, MZ and DZ of cartilage was measured with the baseline 
threshold method (sections 4.4.1.7.1. & 4.4.1.7.2) and frequency distribution 
calculated (% of total number of cells studied in the particular zone). The frequency 
of chondrocyte’s volume in all the three zones of cartilage (Fig. 3.8d) displayed a 
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wide range. The cell volumes were ranked in the groups with a difference of 99µm
3 
and the number of cells in each group was expressed as a percentage of the total 
number of cells in the specified ROI typically to a depth of 50µm through the z-axis. 
In the SZ, MZ and DZ the volume of chondrocytes ranged from 254 to 2079 µm
3
, 
272 to 2686 µm
3
 and 255 to 2080 µm
3
 respectively (Figs. 3.8a-c). The median 
volume of cells in the SZ, MZ and DZ was 875, 1035 and 839 µm
3 
respectively. The 
cell volume varied hugely in all the three zones and there was an obvious overlap of 
the values in the three zones (Fig. 3.8d) suggesting that cell volume might not be a 
clear distinguishing characteristic for the cells in a specific zone. The average 
volume of chondrocytes in the MZ was significantly greater than in SZ and the DZ 
(P<0.001 and P<0.01 respectively; ANOVA; Fig. 3.8e). However, no difference in 
average volume was apparent between cells in SZ and DZ.  
These results indicated that in the grade-0 cartilage there was marked heterogeneity 







Figure 3.8: Volumes of chondrocytes in SZ, MZ and DZ in grade-0 human 
cartilage. 
Chondrocyte volume was ranked in bands of 99µm
3
, graphs in left panels show 
frequency distribution of volume of chondrocytes in (a) SZ (b) MZ and (c) DZ of 
cartilage. In the right panel graphs display (d) volume of cells in all the zones and (e) 
average volume of cells in the three zones of human femoral articular cartilage. Data 
were from [N(nʹ)=8(194, 127 and 120) for the SZ, MZ and DZ respectively]. # 
indicated a significant difference according to one-way ANOVA followed by 
Tukey’s multiple comparison post-hoc test. The single, double and triple symbols 
showed the level of significance for P<0.05, 0.01 and 0.001 respectively. 
 Morphological characteristics of chondrocytes in grade-0 and grade-1 3.5.1.4
human femoral articular cartilage (coronal view) 
In the earlier sections (3.5.1.1. and 3.5.1.2.) there were indications that the 
morphology of chondrocytes was different between grade-0 and grade-1 cartilage 
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explants and in this section a more detailed quantitative analysis was presented. 
Chondrocyte morphology was compared in the various zones of grade-0 and grade-1 
human cartilage explants.  
In the low power (x10) magnification coronal view of grade-0 cartilage explants, 
there was a pattern of distribution of chondrocytes in the various zones of cartilage as 
described already in the tibia plateau (Bush and Hall, 2003). There were flattened 
chondrocytes in the superficial zone oriented parallel to the surface of cartilage (Fig. 
3.9a). The cells beneath these were relatively spheroidal in shapes as compared to SZ 
chondrocytes and would represent primarily the MZ, and the chondrocytes with more 
rounded appearance, arranged mostly in vertical columns were considered to be the 
cells in the DZ (Fig. 3.9a, c). However, chondrocytes within the grade-1 cartilage 
had lost their normal distribution pattern in all the zones and their orientation was 
disorganised (Fig. 3.9b, d). Within the zones of cartilage particularly in the SZ and 
MZ, areas of hypo-cellularity were observed and were common in all the samples. 
The cells in the SZ and MZ were abnormal in morphology with cytoplasmic 
processes emanating from cell bodies and chondrocyte clustering was also present. 
However, in the DZ, chondrocytes were spheroidal in morphology (Fig. 3.9b, d). 
Chondrocyte density appeared to be less in the grade-1 as compared to grade-0 
cartilage. In grade-0 cartilage more PI-labelled chondrocytes were present in the SZ 
and DZ as compared to the MZ (Fig. 3.9a, c). In grade-1 cartilage more PI-labelled 
cells were present in the SZ compared to the cells in MZ and DZ (Fig. 3.9b, d).  
The high power magnification images of the coronal views of grade-0 and grade-1 
cartilage were analysed and quantitative data regarding the morphological 
characteristics of chondrocytes were obtained. Marked heterogeneity of chondrocyte 
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morphology (clusters/processes) was observed in grade-1 as compared to grade-0 
cartilage. The results were presented as related to changes in chondrocyte clustering 
and abnormal chondrocyte morphology as described in the following two sections.  
 
 
Figure 3.9: Coronal CLSM reconstructed images of human femoral articular 
cartilage. 
Low magnification (x10) reconstructed CLSM images of CMFDA and PI-labelled 
chondrocytes (live and dead cells respectively) in the SZ, MZ and DZ of (a, c) grade-
0 and (b, d) grade-1 human cartilage. Solid arrows indicate examples of abnormal 
cells with processes; broken arrows show examples of clusters formed and two-
headed arrows indicate the areas of hypo-cellularity in grade-1 cartilage. Scale bar 






 Chondrocyte cluster formation in the various zones of grade-0 and 3.5.1.4.1
grade-1 human femoral articular cartilage 
Quantitative data regarding morphology of chondrocytes was obtained from the 
coronal CLSM images in order to determine morphology of chondrocytes in all the 
zones of cartilage. The images presented here are the 2D images obtained by 
reconstruction of series of 3D optical images and might show presence of clusters 
when projections were made because cells come closer. However, the analysis was 
performed on 3D images with the Volocity
TM 
software which accounted for the 
presence of cells in 3D and therefore the actual clusters present were analysed. A 
characteristic feature routinely observed in grade-1 cartilage was the presence of 
chondrocyte clusters (Fig. 3.10). In order to quantify this so that non-degenerate and 
degenerate cartilage explants could be compared, various parameters of clusters were 
analysed (see Figs. 3.11 & 3.12). As a first step clusters were defined (section 
4.2.1.6.1) and then quantitative data in terms of number of clusters, number of 
cells/cluster, percentage of cells involved, volume of clusters and volume of 
individual cells in a cluster were obtained and compared in the three zones of grade-0 
and grade-1 cartilage. The zones of cartilage were defined as demonstrated in section 
3.4.1.1.  
3.5.1.4.1.1 Number of clusters 
 
In grade-0 cartilage, very few clusters were present in all the zones of cartilage. The 
average number of clusters was significantly higher in SZ than the DZ (P<0.01; 
ANOVA; Fig. 3.11a). Similarly, in grade-1 cartilage also the number of clusters 
present in the SZ was significantly greater in comparison to DZ (P<0.05; ANOVA; 
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Fig. 3.12a). The average number of clusters in the SZ of grade-1 cartilage was 
greater than that in the SZ of grade-0 cartilage but the difference was not statistically 
significant. This suggested an increasing number of clusters were formed in the SZ 
and MZ of grade-1 as compared to grade-0 cartilage. 
3.5.1.4.1.2 Number of cells per cluster 
 
The number of cells per cluster in grade-0 explants was significantly higher in the SZ 
and MZ as compared to the DZ (P<0.001; ANOVA for the three zones; Fig. 3.11b). 
In grade-1 cartilage, the number of cells per cluster was significantly higher in the SZ 
as compared to the DZ (P<0.05; ANOVA). The number of cells per cluster in the SZ 
and MZ of grade-1 cartilage (7.36±1.5 and 8.25±3.3 cells) were significantly higher 
than those in the SZ and MZ of grade-0 cartilage (3±0.3 and 3±0.1; P=0.009 and 
P=0.04; Student’s t-test respectively; Fig. 3.12b). 
3.5.1.4.1.3 Percentage of chondrocytes forming clusters 
 
The percentage of chondrocytes forming clusters was significantly higher in the SZ 
as compared to the DZ in both grade-0 and grade-1 cartilage explants (P<0.05; 
ANOVA both conditions; Figs. 3.11c & 3.12c). However, a comparison of grade-0 
and grade-1 osteochondral explants revealed that a significantly higher percentage of 
chondrocytes formed clusters in the SZ of grade-1 cartilage (43.3±16.04%) as 
compared to the SZ cells of grade-0 cartilage (11±3.3%; P=0.008; Fig. 3.12c), 
possibly because the number of cells per cluster increased involving more cells for 
cluster formation. In the MZ also a very high percentage of chondrocytes formed 
clusters in grade-1 (27.8±22.08%) as compared to grade-0 cartilage (9.2±3.9%) but 
the difference was not statistically significant. In the DZ, no clusters were detected in 
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grade-0 and grade-1 cartilage explants (Figs. 3.11c & 3.12c). This suggested that 
with cartilage degeneration, the percentage of chondrocytes within clusters increased 
in the SZ and MZ having more cells per cluster rather than an increase in the number 
of clusters however, no clusters were observed in the DZ.   
3.5.1.4.1.4 Volume of clusters 
 
In grade-0 cartilage explants, the average volume of clusters in the SZ and MZ were 
not statistically significantly different (Fig. 3.11d). Similarly, in grade-1 cartilage the 
volume of clusters was not significantly different between the SZ and MZ. However, 
the volume of clusters was significantly higher in the SZ in grade-1 cartilage as 
compared to grade-0 cartilage (P=0.005; Student’s t-test; Fig. 3.12d). This suggested 
that with degeneration, cluster volume increased in the SZ due to increasing number 
of cells per cluster and also because the volume of individual cells in the cluster 
increased. 
3.5.1.4.1.5 Volume of individual cells in a cluster 
 
The volume of individual cells in a cluster was calculated (see Materials and 
Methods) and compared between grade-0 and grade-1 cartilage explants. In grade-0 
and grade-1 cartilage the average volume of individual cells in a cluster was not 
significantly different in the SZ and MZ (Figs. 3.11e, 3.12e). However, the volume 
of individual cells in a cluster was significantly higher in the SZ of grade-1 cartilage 




Figure 3.10: Coronal CLSM reconstructed images of chondrocytes within 
grade-0 and grade-1 human femoral articular cartilage. 
High power (x40DW) coronal CLSM reconstructed images of fluorescently-labelled 
chondrocytes (CMFDA and PI for live and dead cells respectively) were imaged in 
SZ, MZ and DZ of the (a, c, e) grade-0 and (b, d, f) grade-1 cartilage. The cells in the 
DZ appear to be smaller than the cells in SZ and MZ of cartilage in grade-1 cartilage. 
The solid arrows show examples of cells with cytoplasmic processes and the broken 
arrows indicate examples of clusters present in various zones of cartilage. Scale bar 




Figure 3.11: Analysis of chondrocyte clusters formed in the human femoral 
grade-0 articular cartilage. 
Graphs show pooled data for (a) average number of clusters, (b) average number of 
cells per cluster, (c) percentage of cells present in clusters, (d) average volume of 
clusters (µm
3
) and (e) average volume of individual cell in a cluster (µm
3
) in grade-0 
explants. Data were from [N(nʹ)=8(1154)] for grade-0 cartilage explants. # indicated 
a significant difference according to one-way ANOVA followed by Tukey’s multiple 
comparison post-hoc test. The single, double and triple symbols showed the level of 





Figure 3.12: Analysis of chondrocyte clusters formed in the human femoral 
grade-1 articular cartilage. 
Graphs show pooled data for (a) average number of clusters, (b) average number of 
cells per cluster, (c) percentage of cells present in clusters, (d) average volume of 
clusters (µm
3
) and (e) average volume of individual cell in a cluster (µm
3
) in grade-1 
explants. Data were from [N(nʹ)=3(360)] for grade-1 cartilage explants. # indicated a 
significant difference according to one-way ANOVA followed by Tukey’s multiple 
comparison post-hoc test. + showed a significant difference between grade-0 and 
grade-1 cartilage explants according to Student’s t-test. The single, double and triple 
symbols showed the level of significance for P<0.05, 0.01 and 0.001 respectively. 
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To summarise this section, clustering was observed only in the SZ and MZ of grade-
0 and grade-1 human cartilage explants with none detected in the DZ. In grade-0 
cartilage, only few chondrocytes were present in clusters. In grade-1 cartilage, 
chondrocytes were present in large clusters with a greater number of cells per cluster. 
Clustering was more pronounced in the SZ of grade-1 as compared to grade-0 
cartilage. These results suggested that in grade-1 cartilage, numerous large clusters 
were present as compared to grade-0 cartilage where few small sized clusters were 
observed.  
 Abnormal morphology of in situ chondrocytes 3.5.1.4.2
Chondrocytes displayed marked shape changes in grade-1 as compared to grade-0 
cartilage (Fig. 3.10). In this section the morphological characteristics of chondrocytes 
were quantified in more detail, by determining the percentage of chondrocytes with 
processes, number of processes per cell and the length of cytoplasmic processes in all 
the three zones (in coronal views) and compared in grade-0 and grade-1 cartilage 
explants.   
3.5.1.4.2.1 Chondrocytes with cytoplasmic processes 
In grade-0 cartilage, overall in all the zones of cartilage, 17±2% chondrocytes 
exhibited cytoplasmic processes and no significant difference existed between the 
percentages of chondrocytes with processes between the three zones of cartilage 
(Fig. 3.13a). However, in grade-1 cartilage throughout the whole thickness of 
cartilage, a significantly higher percentage of chondrocytes had cytoplasmic 
processes (35±5%) as compared to grade-0 cartilage (P=0.0007; Fig. 3.13b). The 
zone-wise analysis of chondrocyte morphology revealed that in the SZ of grade-1 
cartilage, a significantly higher percentage of chondrocytes had cytoplasmic 
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processes (47±11%) as compared to grade-0 cartilage (17±4%; P=0.004; Fig. 3.13b). 
In the MZ and DZ no significant difference existed between the percentages of 
chondrocytes having processes (Fig. 3.13b).  
3.5.1.4.2.2 Number of processes per cell 
The number of processes per cell varied considerably across the various zones of 
grade-0 and grade-1 cartilage. In grade-0 cartilage the number of processes per cell 
was not significantly different in the three zones ranging from one (commonly) to 
four (rarely) processes per cell (Fig. 3.13c). However, in the grade-1 cartilage the 
number of processes per cell was significantly higher in the SZ as compared to MZ 
and DZ chondrocytes (P<0.01 and 0.05; ANOVA for the three zones; Fig. 3.13d). 
Additionally, the number of processes per cell was significantly higher in the SZ, 
ranging from one (commonly) to seven (rarely) processes per cell in grade-1 
cartilage as compared to grade-0 cartilage (P=0.008; Fig. 3.13d). 
3.5.1.4.2.3 Average length of cytoplasmic processes 
The length of the cytoplasmic processes was quite variable within various zones of 
cartilage. In grade-0 cartilage the average length of cytoplasmic processes in the SZ 
and MZ was 5±0.2 µm [N(nʹ)=8(89) and 8(79) for SZ and MZ respectively] and was 
significantly greater than the average length of cytoplasmic processes in the DZ 
[3±0.2 µm; N(nʹ)=8(28); P<0.001 for both; ANOVA for the three zones; Fig. 3.13e]. 
In grade-1 cartilage the average length of processes in the SZ was (15.6±2 µm) 
significantly longer than length of processes in MZ (6±0.5 µm) and DZ (4±0.5 µm; 
P<0.01 for both; ANOVA for the three zones; Fig. 3.13f). Moreover, the average 
length of the cytoplasmic processes was significantly longer in the SZ, MZ and DZ 
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of grade-1 cartilage as compared to these three zones of grade-0 cartilage (P<0.0001; 
P=0.01 and P=0.03 for the SZ, MZ and DZ respectively; Fig. 3.13f). These results 
suggested that the length of cytoplasmic processes increased in the various zones 
with cartilage degeneration. 
3.5.1.4.2.4 Percentage of chondrocytes with processes of various lengths  
The length of the cytoplasmic process was fairly variable and the range was 
extensive. Keeping in mind the complex nature of these results, the cells with 
processes were further categorised into 4 groups with length (L) 1-4 (length 
categories). Based on the length of the processes these groups were defined as 
L1<5µm, 5<L2≤10µm, 10<L3≤15µm and L4>15µm. The percentage of cells having 
cytoplasmic processes of specific length category was determined (section 3.4.6) and 
compared in grade-0 and grade-1 cartilage explants.  
In grade-0 cartilage, throughout the whole thickness of cartilage, a significantly 
higher percentage of chondrocytes had cytoplasmic processes within L1 category as 
compared to L2, L3 and L4 categories (P<0.001; ANOVA; Fig. 3.14a). However, in 
grade-1 cartilage, chondrocytes had processes ranging from L1-L4 categories in 
length and no difference existed between the percentages of chondrocytes having 
cytoplasmic processes with L1-L4 categories. In grade-0 and grade-1 cartilage there 
was no significant difference between processes within L1 category. However, 
processes within L2, L3 and L4 categories were significantly higher in grade-1 
cartilage as compared to grade-0 cartilage (P=0.001, P=0.004 and P=0.04 




Figure 3.13: Morphological characteristics of chondrocytes in grade-0 and 
grade-1 human femoral head articular cartilage. 
Graphs show pooled data regarding (a, b) percentage of cells with cytoplasmic 
processes, (c, d) number of processes per cell and (e, f) average length of 
cytoplasmic processes (µm) in grade-0 and grade-1 cartilage respectively. Data were 
from [N(nʹ)=8(1154) and 3(360)] for grade-0 and grade-1 cartilage explants 
respectively. # indicated a significant difference according to one-way ANOVA 
followed by Tukey’s multiple comparison post-hoc test. + showed a significant 
difference between grade-0 and grade-1 cartilage explants according to Student’s t-
test. The single, double and triple symbols showed the level of significance for 




Figure 3.14: Percentages of chondrocytes with processes within various zones of 
cartilage. 
Graphs show pooled data for the percentage of chondrocytes with cytoplasmic 
processes of various lengths in (a) grade-0 and (b) grade-1 human femoral head 
articular cartilage. Data were from [N(nʹ)=8(1154) and 3(360)] for grade-0 and 
garde-1 cartilage explants respectively. # indicated a significant difference according 
to one-way ANOVA followed by Tukey’s multiple comparison post-hoc test. + 
showed a significant difference between grade-0 and grade-1 cartilage explants 
according to Student’s t-test. The single, double and triple symbols showed the level 
of significance for P<0.05, 0.01 and 0.001 respectively. 
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3.5.1.4.2.4.1 Superficial Zone 
In grade-0 cartilage in the SZ, a significantly higher percentage of chondrocytes had 
processes in L1 category (11±3%) as compared to L3 category (1±0.3%; P<0.001; 
Fig. 3.14a), 5±1% cells had processes in L2 category which were not significantly 
different from the percentage of cells with L1 category and no cell had processes in 
the L4 category. In grade-1 cartilage in the SZ, chondrocytes had processes 
belonging to all the four length categories (L1-L4) and statistically no difference 
existed in the percentage of chondrocytes having processes of different length 
categories (P>0.05). However, when the SZ chondrocytes of grade-0 and grade-1 
cartilage explants were compared, a significantly higher percentage of chondrocytes 
had processes of length categories L2, L3 and L4 in grade-1 cartilage as compared to 
grade-0 cartilage (P=0.03, P=0.02 and P=0.03 respectively; Fig. 3.14a & b). 
Moreover, no difference was found between the percentages of chondrocytes having 
processes with L1 length category. In summary, in the SZ the percentage of 
chondrocytes with cytoplasmic processes having L2-L4 length categories, increased 
in grade-1 as compared to grade-0 cartilage. 
3.5.1.4.2.4.2 Mid-zone 
In the MZ of grade-0 and grade-1 cartilage, the length of cytoplasmic processes 
varied between L1 and L3 categories and no processes within L4 category were 
found. In the MZ of grade-0 cartilage a significantly higher percentage of 
chondrocytes had processes with L1 length category as compared to L2, L3 and L4 
categories (P<0.001; ANOVA; Fig. 3.14a). In the MZ of grade-1 cartilage the length 
of processes ranged between L1-L3 categories and no processes with L4 category 
were present. There was statistically no difference between the percentages of 
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chondrocytes having processes with L1 and L2 length categories (P>0.05). However, 
a significantly higher percentage of chondrocytes had L1 length category processes 
as compared to those with L3 and L4 categories (P<0.05 and P<0.01 respectively; 
Fig. 3.14b). When grade-0 and grade-1 cartilage explants were compared, it was 
observed that in the MZ no difference existed between percentages of cells with 
processes in L1 length category. Additionally, a significantly higher percentage of 
chondrocytes had processes with L2 and L3 categories in grade-1 cartilage as 
compared to grade-0 cartilage (P=0.04 and P=0.03 respectively; Fig. 3.14b). In 
summary, in the MZ the percentage of chondrocytes with cytoplasmic processes 
having L2 and L3 categories increased in grade-1 as compared to grade-0 cartilage. 
3.5.1.4.2.4.3 Deep Zone 
 In grade-0 cartilage within the DZ, chondrocytes had processes only L1 in length 
category and processes with length ranging from L2-L4 categories were not observed 
(Fig. 3.14a). In grade-1 cartilage in the DZ, chondrocytes had processes with L1 and 
L2 length categories but L3 and L4 categories were absent. In grade-1 cartilage a 
significantly higher percentage of chondrocytes had processes with L1 category as 
compared to L2 (P<0.001; ANOVA; Fig. 3.14b). When the DZ of grade-0 and grade-
1 cartilage was compared, there was no significant difference between the 
percentages of chondrocytes with processes in L1 length category (P>0.05). 
However, a significantly higher percentage of chondrocytes had processes with L2 
category in grade-1 as compared to grade-0 cartilage (P<0.0001; Student’s t-test; Fig. 
3.14b). In summary, in the DZ the percentage of chondrocytes having processes 




To summarise this section on the abnormal morphology of chondrocytes, in grade-0 
as compared to grade-1 cartilage fewer, fine cytoplasmic processes with an average 
length of 5µm were present within cells of all zones. However, in grade-1 cartilage 
numerous chondrocytes had cytoplasmic processes of variable lengths. There existed 
a general trend regarding the presence of cells with processes, in relation to depth of 
the cartilage which suggested that they were seen mostly in the SZ, less in the MZ 
and least in the DZ. Moreover, the number of processes per cell and the length of 
these cytoplasmic processes also decreased with increasing depth of cartilage. 
3.5.2 Viability and morphology of chondrocytes in human articular cartilage 
obtained from various clinical conditions 
Marked changes to chondrocyte morphology were observed in osteochondral 
explants obtained from patients with different clinical conditions. Five human 
cartilage samples from various joints under different clinical conditions were 
obtained and cell viability and morphology of fluorescently-labelled chondrocytes 
was visualised by CLSM. Four of these samples were small fragments of cartilage 
and bone whereas only one was a complete femoral head, all obtained post-
operatively. Three osteochondral fragments were obtained from patients suffering 
from osteochondritis dissecans (OCD) and fourth one from a patient having fracture 
of the ankle joint. The osteochondral explants from femoral head were obtained after 
dissection with the similar protocol as that performed for the explants in the earlier 
section of this chapter. However, the osteochondral fragments were simply trimmed 
and rectangular pieces were obtained for CLSM. The samples were incubated with 
CMFDA and PI (live and dead chondrocytes respectively) and prepared for CLSM. 
The samples were imaged at low and high magnification for axial view (all samples) 
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and coronal views (where possible). The details of the methodology for cartilage 
preparation and imaging can be viewed in the Materials and Methods (sections 3.4.3 
and 3.4.4).  
  Human osteochondral fragment (knee joint) (OCD) 3.5.2.1
An osteochondral fragment of the knee joint with the dimensions of 1.3 cm x 0.5 cm 
(Fig. 3.15) was obtained from 18 yrs. old male diagnosed as suffering from the OCD 
and consisted of cartilage with some underlying bone. Chondrocytes were labelled 
with CMFDA and PI (for live and dead cells respectively) and imaged with CLSM. 
The areas of hypo-cellularity were present and chondrocyte morphology was typical 
of grade-1 cartilage (Figs. 3.6b & 3.7b). Chondrocytes were present in clusters and 
had multiple cytoplasmic processes (Fig. 3.16). There were no PI-labelled 




Figure 3.15: Photograph of osteochondral fragment of knee joint. 




Figure 3.16: Axial CLSM reconstructed images of chondrocytes of human knee 
articular cartilage of a patient suffering from OCD. 
CLSM reconstructions of (a) low (x10) and (b) high (x40 DW) magnification images 
of CMFDA and PI labelled chondrocytes (live and dead cells respectively). The solid 
arrows indicated examples of cytoplasmic processes, broken arrows indicated 
examples of clusters present and two headed arrows indicated areas of hypo-
cellularity. Scale bar for left and right panels = 100µm and 25µm respectively.  
 
 Human osteochondral fragment of talus (ankle joint) (OCD) 3.5.2.2
An osteochondral fragment from talus bone of ankle joint was obtained after surgery 
from a 30 yrs. old male patient suffering from OCD. The dimensions of the sample 
were 1cm x 1cm and it comprised of thin cartilage with some underlying bone (Fig. 
3.17). The low and high power CLSM images showed presence of numerous PI-
labelled chondrocytes in the axial and coronal views of the cartilage sample as 
compared to the OCD knee joint sample (Fig. 3.16). Chondrocyte morphology 
displayed marked heterogeneity and areas of hypo-cellularity were present. 
Morphology of chondrocytes was altered in terms of cell proliferation and shape of 
cells. Chondrocytes were no more spheroidal in morphology, were present in clusters 
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and had multiple cytoplasmic processes emanating from their cell bodies (Figs. 3.18 
& 3.19).   
 
Figure 3.17: Photograph of osteochondral fragment of talus from human ankle 
joint. 
Arrows indicate cartilage and subchondral bone. 
 
Figure 3.18: Axial CLSM reconstructed images of human ankle joint cartilage 
of a patient suffering from OCD. 
CLSM reconstructions of (a) low (x10) and (b) high (x40 DW) magnification images 
of CMFDA and PI-labelled chondrocytes (live and dead cells respectively) in human 
cartilage from talus bone (ankle joint). The solid arrows indicated examples of 
cytoplasmic processes, broken arrows indicated examples of clusters and two headed 
arrows indicated areas of hypo-cellularity. Scale bar for left and right panels = 




Figure 3.19: Coronal CLSM reconstructed images of human ankle joint 
cartilage of a patient suffering from OCD. 
CLSM reconstructions of (a) low (x10) and (b) high (x40 DW) magnification images 
of CMFDA and PI labelled chondrocytes (live and dead cells respectively) in human 
cartilage from talus bone (ankle joint). The solid arrows indicated examples of 
cytoplasmic processes, broken arrows indicated examples of clusters present and two 
headed arrows indicated areas of hypo-cellularity. The subchondral bone has been 
labelled with PI. Scale bar for left and right panels = 100µm and 25µm respectively.  
 
 Human osteochondral fragment of talus (ankle joint) (OCD) 3.5.2.3
The sample was acquired from talus bone of ankle joint of 26 yrs. old female patient 
diagnosed as OCD since months. The dimensions of the osteochondral fragment 
obtained were 1cm x 0.5cm and comprised of cartilage from talus bone with some 
underlying bone (Fig. 3.20). When the cartilage was viewed with the low and high 
power magnification objectives, some PI-labelled chondrocytes and areas of hypo 
cellularity were seen. Moreover, chondrocytes showed marked heterogeneity in 
morphology characterised by the presence of clusters and multiple long cytoplasmic 
processes (Fig. 3.21). The cartilage was examined in the coronal view and both low 
and high magnification images displayed areas of hypo-cellularity and the PI-
labelled chondrocytes were numerous in the SZ as compared to MZ and DZ. 
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Chondrocytes in the SZ and MZ displayed morphological changes with the presence 
of multiple cytoplasmic processes. However, in the DZ chondrocytes were relatively 
spheroidal in morphology as compared to SZ and MZ chondrocytes (Fig. 3.22). 
 
Figure 3.20: Photograph of osteochondral fragment of talus from human ankle 
joint. 
Arrow indicates the cartilage but the underlying bone is not visible in the 
photograph.  
 
Figure 3.21: Axial CLSM reconstructed images of human ankle joint cartilage. 
CLSM reconstructions of (a) low (x10) and (b) high (x40 DW) magnification images 
of CMFDA and PI labelled chondrocytes (live and dead cells respectively) in human 
cartilage from the talus bone (ankle joint). The solid arrows indicated examples of 
cytoplasmic processes, broken arrows indicated examples of clusters and two headed 
arrows indicated areas of hypo-cellularity. Scale bar for left and right panels = 




Figure 3.22: Coronal CLSM reconstructed images of human ankle joint 
cartilage. 
CLSM reconstructions of (a, c, e) low (x10) and (b, d, f) high (x40 DW) 
magnification images of CMFDA and PI labelled chondrocytes (live and dead cells 
respectively) in human cartilage from talus bone (ankle joint) within the various 
zones of cartilage. The solid arrows indicated examples of cytoplasmic processes, 
broken arrows indicated examples of clusters present and two headed arrows 
indicated areas of hypo-cellularity. Scale bar for left and right panels = 100µm and 
25µm respectively.  
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 Human femoral head articular cartilage (hip joint) (AVN) 3.5.2.4
 
Human femoral head was obtained from 36 yrs. old female patient suffering from 
AVN since months. When the femoral head was viewed for its general appearance it 
was grossly abnormal. The femoral head was shrunken and its shape was non-
spheroidal with several raised and depressed areas of cartilage (Fig. 3.23). The 
osteochondral explants were obtained from the femoral head from the area indicated 
on the photograph (Fig. 3.23). 
The low and high power axial images of the fluorescently-labelled chondrocytes 
showed irregular cartilage surface and extensive cell death as indicated by the 
presence of PI-labelled chondrocytes. Marked areas of hypo cellularity were obvious 
and chondrocyte morphology was strikingly abnormal. Chondrocytes were flattened 
in shape and were present in clusters and had multiple cytoplasmic processes (Fig. 
3.24). In the low and high power coronal images of the cartilage the morphologically 
abnormal chondrocytes were present in the SZ and MZ. However, chondrocytes in 







Figure 3.23: Photograph of human femoral head of a patient suffering from 
avascular necrosis. 
The solid arrow indicated raised areas and the broken arrow indicated depressed 
areas of cartilage still attached to the underlying subchondral bone. The white box 
showed the area from where sample was obtained. The fovea is labelled on the 
photograph. 
 
Figure 3.24: Axial CLSM reconstructed images of human femoral head 
cartilage of a patient suffering from avascular necrosis. 
CLSM reconstructions of (a) low (x10) and (b) high (x40 DW) magnification images 
of CMFDA and PI labelled chondrocytes (live and dead cells respectively) in human 
femoral head cartilage. The solid arrows indicated examples of cytoplasmic 
processes, broken arrows indicated examples of clusters and two headed arrows 
indicated areas of hypo-cellularity. Scale bar for left and right panels = 100µm and 






Figure 3.25: Coronal CLSM reconstructed images of human femoral head 
cartilage from a patient of avascular necrosis. 
CLSM reconstructions of (a, b) low (x10) and (c, d & e) high (x40 DW) 
magnification images of CMFDA and PI labelled chondrocytes (live and dead cells 
respectively) within various zones in human femoral head cartilage. The solid arrows 
indicated examples of cytoplasmic processes; broken arrows indicated examples of 





 Osteochondral fragment of calcaneus bone (subtalar joint) 3.5.2.5
 
This sample was obtained from the calcaneus bone of a 55 yrs. old male who had 
suffered from acute trauma with fracture dislocation of subtalar joint a few days 
before the sample was obtained. The sample was 1.3 cm x 1 cm in dimensions and 
consisted of the cartilage grade-0 and underlying bone (Fig. 3.26). Fluorescently-
labelled chondrocytes were imaged and both low and high power axial images 
showed no chondrocyte death in the sample. Additionally, chondrocytes were normal 
(elliptical/spheroidal) in morphology and there was no clustering present (Fig. 3.27). 
In the low and high power coronal images, the cartilage surface was regular and only 
few dead chondrocytes were present in the SZ as compared to MZ and DZ. The 
morphology of chondrocytes was normal (elliptical/spheroidal in shape with no 
cytoplasmic processes) throughout the whole thickness of cartilage. In addition to 
this chondrocytes were not present in the form of clusters in any of the zones of 
cartilage (Fig. 3.28). 
 
Figure 3.26: Photograph of osteochondral fragment of calcaneus from human 
subtalar joint. 








Figure 3.27: Axial CLSM reconstructed images of human subtalar joint 
cartilage. 
CLSM reconstructions of (a) low (x10) and (b) high (x40 DW) magnification images 
of CMFDA and PI-labelled chondrocytes (live and dead cells respectively) in human 
cartilage from the calcaneus bone (subtalar joint). Scale bar for left and right panels = 




Figure 3.28: Coronal CLSM reconstructed images of human subtalar joint 
cartilage. 
CLSM reconstructions of (a, b) low (x10) and (c, d, e) high (x40 DW) magnification 
images of CMFDA and PI-labelled chondrocytes (live and dead cells respectively) in 
human cartilage obtained from calcaneus bone (subtalar joint) within the various 
zones of cartilage. Scale bar for left and right panels = 100µm and 25µm 
respectively.  
To summarise this section, in the cartilage of patients suffering from two clinical 
conditions namely OCD and AVN certain features of cartilage degeneration were 
present. The surface of the cartilage was irregular and chondrocyte morphology was 
strikingly altered. These abnormal chondrocytes had elongated cell bodies with 
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multiple cytoplasmic processes and chondrocyte clusters were also present. These 
morphological changes (clusters/processes) appeared to be present mostly in the SZ 
extending into the MZ. However, DZ chondrocytes were mostly normal in 
morphology.  
3.6 DISCUSSION 
This study utilised fluorescent-mode CLSM to visualise in situ chondrocyte 
morphology in grade-0 and grade-1 human femoral articular cartilage and cartilage 
obtained from various clinical conditions. The main aims of this work were to study 
human femoral head cartilage samples obtained from patients after hip replacement 
surgery to determine morphology of chondrocytes in non-OA cartilage and to 
compare the morphological characteristics of human femoral articular chondrocytes 
with other human cartilage samples studied. These human femoral head articular 
cartilage samples were a valuable biological material to study chondrocyte 
morphology and the CLSM technique used in this study was a suitable method to 
determine the morphological characteristics of chondrocytes due to several reasons: 
Firstly, the human femoral heads were obtained from patients undergoing surgery 
for fracture and had no known diseases of the joints which assured that grade-0 
cartilage was healthy and was an appropriate control for the study. Secondly, grade-1 
cartilage was obtained from the same joint from which grade-0 cartilage was 
obtained and the importance of this was twofold (a) chondrocyte morphology of non-
degenerated and mildly-degenerated cartilage could be fairly compared and (b) early 
morphological changes in cartilage degeneration could be studied. Thirdly, the 
results from these human samples were directly applicable to the human disease OA 
because of similar mechanical and biochemical environment. Fourthly, the 
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volume/morphological data obtained from femoral articular cartilage could be 
directly compared with already available data on volume/morphology of 
chondrocytes from other joints such as knee joint. Lastly, the changes to morphology 
of chondrocytes in grade-1 human cartilage could be compared with morphological 
changes observed in bovine chondrocytes cultured in weak gels (chapter 4) to 
determine similarities and differences. 
However, the concerns with the use of these samples and CLSM technique were (a) 
possibly the dissection of samples could induce morphological changes but the 
chances were less. If shape changes were the cutting artefact then the presence of 
heterogeneous chondrocytes in the axial sections was not possible (b) the removal of 
explants from the femoral heads might lead to cartilage swelling (Maroudas and 
Venn, 1977). This was minimised by dissecting explants along with underlying bone 
because the lack of bone leads to cartilage swelling due to imbibition of fluid 
(Maroudas, 1990) and (c) these samples were rarely obtained and therefore, data 
could be obtained from a very limited number of samples.  
In this study the volume/morphology of chondrocytes in situ in grade-0 grade-1 were 
studied in human femoral cartilage and in various clinical conditions. The cartilage 
was obtained from patients undergoing hip replacement surgery for fracture neck of 
femur and graded according to the macroscopic and microscopic characteristics of 
author’s own criteria given in Table 3.2. Although 3 samples of grade-0 human 
cartilage were obtained from the femoral heads which contained areas of grade-1 
cartilage also, the results indicated that there was no significant difference between 
these cartilage samples and the grade-0 samples obtained from heads containing no 
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grade-1 areas, therefore, the data obtained were grouped together. The grading 
criteria used in this study is comparable for the macroscopic appearance of cartilage 
with the previously published grading system (Pritzker et al., 2006). However, 
microscopic changes presented here cannot be directly compared with the previously 
published grading system for degenerating cartilage such as (Pritzker et al., 2006) 
because in the present study the grading has been done on the basis of CLSM 
microscopic examination of chondrocyte morphology but in previous study histology 
was performed. Several features to be considered between previous grading systems 
and our criteria were (a) macroscopically cartilage was intact in grades-0/1 according 
to previous grading system and observed to be intact in grade-0 and roughened in 
grade-1 cartilage samples in this study (b) the tissue is uninvolved in grade-0 
according to the previous grading system but slight morphological changes were 
observed in grade-0 cartilage in this study in terms of presence of few small clusters 
and few fine cytoplasmic processes (c) the tissue changes included cluster formation 
in grade-1 cartilage in both previously reported and grading criteria used in this study 
(d) in the previous grading system there is sub-grading also which states that the 
grades of cartilage can be like 1.5, 2.5, & 3.5 and so on in between 1, 2, 3 & 4. 
Therefore, comparison of the two grading methodologies suggested that 
macroscopically grade-0 in the present study is equivalent to grade-0 or between 0 
and 1 according to the previous grading system. Microscopic examination revealed 
presence of some morphological changes in grade-0 cartilage in the present study 
suggesting the possibility of these morphological changes as the very initial events in 
degenerating cartilage. The grade-1 in the present study appears to be between grade-
1 and grade-2 according to the previous system based upon the macroscopic and 
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microscopic features. The additional morphological feature reported in the present 
study which can possibly become an important additional feature of grading system 
is the presence of cytoplasmic processes. Therefore the fine morphological details of 
grade-0 and grade-1 cartilage presented in this study provided new insights into the 









 No visible changes 




 Pale in colour 
 Smooth and even surface 
 Chondrocytes present in a pattern 
within the various zones of cartilage 
 Few chondrocytes present in the form 
of small clusters 
 85% chondrocytes were normal  
 17±2% chondrocytes had cytoplasmic 
processes 
 The average length of cytoplasmic 
processes was ≤5µm 
Grade-1  Uneven surface 
 Rough surface 
 Discolouration of 
cartilage 





 Rough/eroded surface 
 Chondrocyte orientation pattern was 
disturbed 
 Large clusters present with greater 
number of cells per cluster 
 65% chondrocytes were normal 
 35±5% chondrocytes had cytoplasmic 
processes 
 The percentage of abnormal cells, 
number of processes per cell and 
length of processes followed a trend 
throughout cartilage depth, having 
greatest values in SZ, lesser in MZ 
and least in the DZ. 
 
Table 3.2: Characteristics of grade-0 and grade-1 human femoral head articular 
cartilage. 
The surface properties of cartilage and chondrocyte morphology taken into 




Chondrocyte cell death is common feature of cartilage degeneration in OA (Kim et 
al., 2000); in this chapter PI-labelled chondrocytes were hardly visible in the axial 
low and high power CLSM images of grade-0 and grade-1 human femoral cartilage 
(Figs. 3.6 & 3.7). In the coronal CLSM images of grade-0 and grade-1 cartilage PI-
labelled chondrocytes were present (Figs. 3.9 & 3.10). The possible explanation 
could be that the DNA degrading enzymes in synovial fluid similar to FCS could 
have digested the DNA of dead cells thus rendering PI-labelling impossible in axial 
images (Zhou et al., 2011). In the coronal sections the cut edges were imaged and the 
cell death was a result of cartilage trimming during preparation of osteochondral 
explants as reported by others (Amin et al., 2008a).   
CLSM with fluorescent-mode is a powerful technique which rendered the 
determination of three-dimensional living in situ chondrocyte volume possible in 
relatively unperturbed ECM (Errington et al., 1997, Bush and Hall, 2001a, Bush and 
Hall, 2001b). The details of the volume measurement protocol by using 3D image 
analysis software and the correction factor applied have been discussed in detail in 
Materials and Methods section of chapter 4 in this thesis. The correction factor 
utilised for calculation of volume of chondrocytes in human and bovine chondrocytes 
was identical. The results showed variable but reproducible values of chondrocyte 
volume in the various zones of human femoral cartilage. In the SZ, MZ and DZ the 
volume of chondrocytes ranged from 254 to 2079 µm
3
, from 272 to 2686 µm
3
 and 
from 255 to 2080 µm
3
 respectively (Figs. 3.8a-c). The mean and ranges of volumes 
of chondrocytes in various zones in human tibia plateau and human femoral head 
cartilage were compared (Table 3.3). The values were different from the volume of 
cells from tibia plateau cartilage ranging from 193 to 903 μm
3





and from 273 to 1703 μm
3 
for MZ and DZ, respectively as reported already 
(Bush and Hall, 2003). There was marked heterogeneity in the volumes of 
chondrocytes in each zone both in tibia plateau and human femoral head cartilage 
with the greatest in MZ. In the tibia plateau cartilage the mean volume of 
chondrocytes was greatest in the DZ but was greatest in the MZ in femoral head 
cartilage in this study. These differences in the volumes of chondrocytes in different 
joints were possibly due to (a) differences in experimental techniques used in the 
present and previous study (b) differences in loading patterns and biomechanics of 
knee and hip joints.  
Source of 
cartilage 
Volume of chondrocytes (μm
3
) 
Mean and range 
SZ MZ DZ 
Tibia plateau 396 
193 to 903 
522 
135 to 2093 
590 
273 to 1703 
Femoral head 912 
254 to 2079 
1113 
272 to 2686 
927 
255 to 2080 
 
Table 3.3: Comparison of chondrocyte volume in various zones of grade-0 
human tibia plateau (Bush and Hall, 2003) and femoral head articular cartilage 
(author’s results). 
Values are given as mean and the range of volume in SZ, MZ and DZ of cartilage. 
 
The results in this chapter showed that in the grade-0 and grade-1 human femoral 
cartilage there were two key findings regarding the morphology of chondrocytes. 
Firstly, in grade-1 cartilage numerous large clusters were present as compared to 
grade-0 where few small sized clusters were observed. Additionally, clustering was 
more pronounced in SZ of grade-1 cartilage as compared to grade-0 (Fig. 3.12). 
Secondly, in grade-0 cartilage fewer, short cytoplasmic processes were present 
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within chondrocytes of all zones. In grade-1 cartilage these cytoplasmic processes 
were present mostly in the SZ, less in the MZ and least in the DZ. The number of 
processes per cell and the length of processes followed similar trend (Fig. 3.13).  
Chondrocyte clustering was routinely seen in the grade-1 cartilage as described by 
others as a hallmark of degeneration in OA (Mitchell et al., 1992, Lotz et al., 2010) 
but was evident in the SZ (Fig. 3.9). The occurrence of clusters in the SZ might be 
due to the enhanced access of proliferative/growth factors from synovial fluid to 
these cells due to loosening of matrix (Meachim and Collins, 1962). Additionally, the 
compromised integrity of the collagen matrix in the SZ might lead to the enhanced 
proliferative activity of chondrocytes in degenerate cartilage (Hollander et al., 1995).  
Another key finding was the presence of cytoplasmic processes emanating from 
chondrocyte cell bodies within both non-degenerate and mildly degenerate cartilage 
explants. CLSM technique used here rendered it possible to visualise these fine 
morphological structures and by using the 3D software Volocity
TM 
these processes 
were traced in 3D and measured accurately. It is unlikely that these cytoplasmic 
processes were a cutting artefact as they were clearly visible in the axial images also. 
The possibility that the cytoplasmic processes were dye labelling or imaging artefacts 
was negligible because CMFDA labels the cytoplasm of living cells specifically and 
CLSM causes minimal disturbances to tissue architecture (Brakenhoff et al., 1990). 
The presence of these processes in the non-degenerate cartilage raised the possibility 
of having these processes as an early change in chondrocyte morphology during 
degeneration. Moreover, the cartilage samples used in this study were from elderly 
patients suggesting that these cytoplasmic processes might be the result of normal 
142 
 
aging process. Another evidence to support this theory is the absence of these 
processes in a single human cartilage sample obtained from a relatively younger 
patient in this study (Fig. 3.26). The age of the patient was 55 yrs. operated for acute 
fracture of subtalar joint. The chondrocyte morphology was normal with no 
cytoplasmic processes present both in the axial and CLSM views of sample (Figs. 
3.27 & 3.28). This theory can be further supported by stating that bovine 
chondrocytes showed no evidence of presence of these processes and were obtained 
from 3 yr. old cows (Chapter 6). It is also possible that the grading system employed 
in this study was slightly different, due to which the cartilage categorized as grade-0 
might not be grade-0 strictly and can be grade-0.5 instead. This can possibly explain 
the presence of cytoplasmic processes in non-degenerate cartilage. 
There is existing evidence that in several previous studies presence of cytoplasmic 
processes was observed but they were not comprehensively studied (Stockwell, 
1978, Kouri et al., 1996b, Lee and Loeser, 1998, Kouri and Abbud-Lozoya, 2002). In 
the study by Kouri and co-workers these cytoplasmic extensions were named as 
filopodia and they suggested that these structures have a possible role in cell 
migration and grouping to form clusters. One possible reason why these cytoplasmic 
processes were not studied extensively in the previous studies could be the 
limitations of the techniques utilised. In most of these studies histological techniques 
were applied and it is possible that dehydration and fixation steps involved in 
histology caused cell shrinkage and thus obscured these fine morphological details. 
The presence of these cytoplasmic processes was first reported in a study done on 
tibia plateau cartilage by using fluorescent-mode CLSM and reported that even in 
non-degenerate cartilage 40% of chondrocytes had these cytoplasmic processes 
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(Bush and Hall, 2003). In this previous study the authors also suggested two possible 
theories i.e. active and passive theories for the production of these processes. These 
tibia plateau cartilage samples were obtained from patients undergoing total knee 
replacement (TKR) therefore it is difficult to obtain non-degenerate cartilage from an 
OA failing joint. In comparison to these samples the human femoral head samples 
used in the present study were obtained from patients undergoing hip replacement 
surgery without known degenerative disease of joint. Therefore grade-0 cartilage 
samples utilised in this study are more likely to be actually non-degenerate. This may 
also possibly explain the presence of these cytoplasmic processes on 17% 
chondrocytes as compared to 40% reported in the previous study.   
In the present study several findings regarding the existence of these cytoplasmic 
processes potentially added to already existing knowledge about this morphological 
structure. Firstly, presence of cytoplasmic processes in human femoral non-
degenerate cartilage, secondly, with cartilage degeneration number and length of the 
processes increased and lastly, these processes were most numerous in the SZ of 
cartilage. The possible explanation for the existence of these processes in cartilage 
degeneration could be attributed to the damage to the PCM either due to loss of PGs 
or due to disruption of collagen Type VI. This weakened immediate micro-
environment of chondrocytes could allow cytoplasm to protrude out and form 
processes.  PCM plays a vital role in transducing chemical and mechanical signals in 
articular cartilage (Guilak et al., 2006) and therefore regulates structure and functions 
of chondrocytes. These abnormal chondrocytes will possibly produce altered matrix 
causing further destruction of ECM. However, the exact mechanism for initiating this 
process is unknown. The possible explanation for the presence of greatest 
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heterogeneity of chondrocyte morphology in the SZ could be due to greater access of 
proliferative/growth factors to these chondrocytes caused by cartilage loosening 
(Hollander et al., 1995).  
The samples from five different patients were also obtained suffering from other 
clinical conditions, such that three samples were from OCD patients, one from AVN 
and one from an acute fracture trauma. The grading of the cartilage samples suffering 
from OCD was not possible because they were small samples but grossly the 
cartilage surface was intact which suggested they were macroscopically normal 
(Figs. 3.15, 3.17 & 3.20). In the AVN sample the whole femoral head was abnormal 
in shape and there were raised and depressed areas but the cartilage did not show any 
surface fibrillations (Fig. 3.23). The cartilage sample obtained from the fractured 
subtalar joint was very small and grading of cartilage was difficult but cartilage 
surface appeared to be intact and healthy (Fig. 3.26). These clinical samples 
belonged to younger patients as compared to the femoral head grade-0 and grade-1 
discussed earlier in this study. The patients were suffering from OCD and AVN for 
few months before these samples were obtained but the one obtained from fractured 
subtalar joint was obtained within days after fracture. The results showed that in the 
cartilage samples obtained from patients who suffered from OCD and AVN 
chondrocytes displayed obvious morphological changes (clusters/processes). 
However, the sample obtained after fracture showed that chondrocytes in all the 
zones of cartilage had normal morphology with no evidence of clusters/cytoplasmic 
processes (Figs. 3.27 & 3.28). Moreover, the clusters and processes were present 
mostly within SZ and MZ but the cells in the DZ were relatively normal in 
morphology. The possible explanation for the presence of cytoplasmic processes in 
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OCD could be due to absence of weight bearing on these loose bodies. These 
fragments were possibly detached and floating in the joint space for months without 
weight bearing which may lead to the cartilage destruction and appearance of 
cytoplasmic processes. In AVN the presence of morphologically abnormal 
chondrocytes is possibly related to cartilage degeneration due to decreased blood 
supply/nutrition and necrosis of the bone. The presence of cytoplasmic processes in 
OCD and AVN samples and in human femoral head grade-0 cartilage suggested that 
this may be a key morphological feature of cartilage degeneration. In a previous 
study the histological evaluation of OCD samples revealed the presence of bone 
necrosis and cartilage degeneration (Yonetani et al., 2010). In this previous study 
irregularity and fibrosis in the superficial layers and normal deep layers were 
reported. In the present study chondrocytes in the deep layers of OCD cartilage were 
normal and this is in agreement with the previous study. However, in the present 
study the fine details of chondrocyte morphology have been presented in the CLSM 
axial and coronal images thereby increasing our knowledge regarding the irregularity 
in superficial layers mentioned in the previous study. Our findings regarding the 
presence of cytoplasmic processes is in agreement with a previous morphological 
and molecular study conducted on OCD fragments where cytoplasmic extensions of 
chondrocytes were observed (Skagen et al., 2011). However, in the previous study 
the morphological analysis was performed on the histological sections whereas, in 
the present study fluorescent-mode CLSM has been performed to obtain 3D images 
of chondrocyte morphology in OCD.  
Further, investigations are required in order to explore the role of cytoplasmic 
processes in cartilage degeneration.  
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4 CHAPTER 4: RESULTS                                                                                 
THE EFFECTS OF VARYING GEL STRENGTH AND FCS 
CONCENTRATION ON THE MORPHOLOGICAL 
CHARACTERISTICS OF BOVINE CHONDROCYTES 





4.1 CHAPTER SUMMARY 
 
Chondrocyte morphology has a strong influence on the metabolism of extracellular 
matrix (ECM). As a first step towards understanding this relationship a 3D agarose 
gel model was utilised to study changes in chondrocyte morphology. Chondrocyte 
shape can be altered by using strong/weak gels and this is a model to study the effect 
of gel strength and increasing concentrations of FCS on chondrocyte properties. 
Chondrocytes were isolated from bovine metacarpal-phalangeal joints using 
collagenase. Gels were prepared with variable agarose concentration as strong or 
weak (2% or 0.2% (v/v) to determine the effect of gel strength on chondrocyte 
morphology and cultured for 14 days in DMEM (380mOsm; with added NaCl, 10% 
FCS and 50µg/ml ascorbic acid) at 37
o
C; 5%CO2; pH 7.4. In some of the 
experiments varying concentrations of FCS 1-10% were added to the culture medium 
and cells were cultured for 7 days. Chondrocytes were fluorescently-labelled with 
CMFDA and PI (for live and dead cells at day 1 of culture), with CMFDA and 
DRAQ5 (at days 3 and 7) and volume/morphology examined by confocal 
microscopy at distinct time points and data were presented as Mean±S.E.M. After 
one week of culture, chondrocyte density in strong gels remained unaffected and 
chondrocytes were mostly spheroidal; 18.5±1% chondrocytes exhibited fine 
processes and 42.5±0.1% of the chondrocytes in defined region of interest formed 
small clusters with average number of 3.9±0.2 cells/cluster. However, in weak gels, 
chondrocyte density increased significantly as compared to strong gels (P=0.03), and 
66.9±1.3% (P=0.006) of chondrocytes had processes with lengths 7-63µm and 
76±5% of the cell population (P=0.001) were present in large clusters with average 
number of 6.3±0.5 cells/cluster (P=0.002). In the weak gel after seven days, 
148 
 
increasing FCS concentration markedly elevated the %age of chondrocytes in 
clusters from 31.1±0.2% in 1% FCS, to 87.3±0.23% in 10% FCS (P<0.05). 
Additionally, the percentage of chondrocytes with processes increased with 
increasing concentration of FCS from 14.4±0.2% in 1% FCS, to 88.7±1.6% in 10% 
FCS (P<0.001). In summary chondrocytes cultured in weak 3D gels and with high 
concentrations of FCS displayed morphological changes (clusters/processes) as 
compared to those in the strong gels and with low concentrations of FCS. 
Chondrocyte morphology changed in the weak agarose gels, suggesting that these 
morphological changes might play a role in changes to matrix metabolism.  
4.2 INTRODUCTION 
 
In OA, the chondrocytes produce changes in matrix metabolism leading to cartilage 
degeneration (Aigner et al., 2007). Various biomechanical, biochemical and genetic 
factors lead to an imbalance in the normal turnover of articular cartilage by 
disrupting cell-matrix associations (Goldring, 2000a). As a generally accepted view 
in OA these disturbances include loss of proteoglycans and disorganization/loosening 
of collagen network which begins near the surface of the cartilage (Desrochers et al., 
2012). The loosening of collagen network leads to softening and swelling of the 
cartilage (Aigner and McKenna, 2002). The disease process is generally thought to 
occur in two phases: (a) biosynthetic phase in which the chondrocytes attempt to 
repair the damaged cartilage and (b) degenerative phase during which the enzymes 
produced from these cells destroy the matrix. These changes reduce the load bearing 
capacity of cartilage thus making it mechanically fragile and resulting in its 
progressive loss (Howell, 1986). 
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In early OA, chondrocytes attempt to restore the damaged cartilage by enhanced 
synthesis of aggrecans and collagen type II in response to these biochemical changes 
in the matrix properties (Lippiello et al., 1977, Eyre et al., 1980, Aigner et al., 1992). 
Various growth factors play a significant role in the cartilage repair by stimulating 
synthetic activity of chondrocytes (Fortier et al., 2011). The reaction pattern of 
chondrocytes includes rapid proliferation, increased synthesis of collagens and 
proteoglycans and enhanced production of matrix degrading enzymes (Goldring, 
2000a). Various studies conducted to study the osteoarthritic changes in human 
articular cartilage reported that the chondrocytes making an inappropriate and 
mechanically weak cartilage became hyperactive and proliferated forming clusters of 
cells, a hallmark of OA (Weiss and Mirow, 1972, Rothwell and Bentley, 1973, 
Mitchell et al., 1992, Kouri et al., 1996b, Pfander et al., 2001). It has been suggested 
that this cluster formation could be due to an enhanced access to the growth and 
proliferative factors from the synovial fluid due to loosening of the cartilage matrix 
(Meachim and Collins, 1962).  
Although changes in the biochemical environment of the cartilage in OA have been 
studied in detail the biosynthetic response of chondrocytes to these degenerative 
changes associated with morphology of these cells has not been comprehensively 
studied. In several studies conducted on OA cartilage the morphologically abnormal 
chondrocytes were observed but they were not studied comprehensively in 
association with the cartilage degeneration (Stockwell, 1978, Lee and Loeser, 1998, 
Tesche and Miosge, 2004). The possible reason could be the histological techniques 
used in these studies resulted in the cell shrinkage and masking of these cytoplasmic 
processes. As an example in a previous study conducted on bacteria the scientists 
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noticed considerable cell shrinkage due to dehydration during histological procedure 
(Woldringh et al., 1977). Therefore, the conventional histological methods rendered 
it impossible to study chondrocytes without alteration in their morphology. However, 
in this work fluorescent-mode CLSM was utilised to study the morphological 
properties of chondrocytes in thick gel moulds (Brakenhoff et al., 1990) in a 
relatively unperturbed environment. Additionally, by using CLSM 3D morphology 
of chondrocytes has been determined in this study as compared to the previous 
studies with 2D image analysis of chondrocyte morphology. Therefore, CLSM 
rendered it possible to study fine morphological details of chondrocytes in 3D 
(cytoplasmic processes) thereby providing new insights into changes to chondrocyte 
morphology.  
Few studies conducted on chondrocyte volume and morphology in OA demonstrated 
abnormal chondrocyte morphology in this disorder (Kouri et al., 1998, Bush and 
Hall, 2003). When the morphology of chondrocytes was studied using vital 
fluorescent stains and CLSM imaging technique in both normal and degenerate 
cartilage, 40% cells had cytoplasmic processes as shown in Figure 4.1 (Bush and 
Hall, 2003). In this previous study morphologically abnormal superficial zone 
chondrocytes were even observed in macroscopically normal cartilage suggesting a 
paradox that even the cartilage was macroscopically normal but microscopically 
there were signs of early OA. Another possibility for the presence of these abnormal 
cells in macroscopically normal cartilage could be that the occurrence of processes 
on cells is a result of normal aging process. An evidence to support this theory is that 
in bovine chondrocytes (obtained from young 3 yr. old cows) these cytoplasmic 
processes were never observed. In osteoarthritic femoral head cartilage with pannus 
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cells with multiple elongated cytoplasmic processes were observed (Holloway et al., 
2004). Furthermore, there exists a relationship between chondrocyte morphology and 
its biosynthetic activity. It was reported in a study that the abnormal chondrocytes in 






Figure 4.1: Examples of morphologically abnormal human articular mid zone 
chondrocytes. 
This figure illustrates features that were used to describe in situ mid zone 
chondrocytes with varying morphologies. The chondrocytes in this zone were (a) 
‘morphologically normal’ and spheroidal with a relatively smooth surface. Some 
cells as illustrated in (b), had a single small (<8 μm) cytoplasmic processes, whereas 
in others as shown in (c), the single process from one chondrocyte extended by more 
than 8 μm. Occasionally, as shown in the example in (d), a single chondrocyte had 
multiple processes, some of which were greater than 8 μm. (Adapted from Bush and 
Hall, 2003). Scale bar = 10µm. 
 
In order to study chondrocyte morphology, cell isolation and in vitro culture 
techniques give a wide range of flexibility for altering the culture conditions and also 
changes in morphology can be studied over a time course by keeping the cells alive 
for several weeks. It has been reported previously that chondrocytes de-differentiate 
(flattened fibroblast-like shape) when cultured in 2D and also accompanied by 
altered expression of the ECM (type I collagen) because of the phenotypic changes 
(Mark et al., 1977, Marlovits et al., 2004). However, these de-differentiated cells 
could be differentiated (rounded shape) back to their normal phenotype with the re-
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expression of functional matrix (type II collagen) when cultured back in 0.5% 3D 
agarose gels (Benya and Shaffer, 1982). The cellular morphology and cell-matrix 
interactions differed in 2D and 3D environments significantly (Cukierman et al., 
2001). Therefore, providing a 3D environment for chondrocyte culture may enable 
the cells to overcome the phenotypic problems associated with 2D cultures as 3D 
system mimics the in vivo conditions (Schuh et al., 2012a). Moreover, chondrocytes 
cultured in 3D agarose cultures produce mechanically functional ECM (Buschmann 
et al., 1992).  
In the present study 3D agarose gels with two different gel strengths (strong and 
weak) were used to culture chondrocytes to study their morphology. The strong gels 
were used as a control to compare intact cartilage and weak gels as experimental 
condition to compare weakened matrix in cartilage degeneration. The purpose of 
using these gel strengths was to use gel stiffness as a tool to control chondrocyte 
shape. The agarose gels were considered a suitable model to culture chondrocytes 
because they can maintain their phenotype in agarose gels during long term culture 
(Benya and Shaffer, 1982, An et al., 2001) and also because chondrocytes produce 
mechanically functional matrix when cultured in 2% agarose gels (Buschmann et al., 
1992).  
Gel stiffness influences chondrocyte proliferation and rate of production of ECM as 
reported previously (Schuh et al., 2012b). Chondrocytes when cultured in weak gels 
(0.75%) as compared to stiff gels (1.5%) had a greater cell density and amount of 
ECM after two weeks (Schuh et al., 2012b). Although effect of gel stiffness on 
chondrocyte biosynthetic properties was studied the effect of gel strength on 
chondrocyte morphology was not studied in detail previously.  
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The increasing concentration of agarose decreases penetration of serum factors 
(Johnson et al., 1996) and the response of bovine chondrocytes to growth factors has 
been studied to be affected by the culture conditions (van Susante et al., 2000). 
Therefore, in the present study FCS concentration was varied to determine its effect 
on chondrocyte morphology. Cell tracker green (CMFDA) fluorescent molecular and 
DRAQ5-DNA dyes were used to label the cytoplasm and nuclei respectively, when 
imaged by CLSM provided 3D information about the morphology and density of 
cells.  
The main aims of this chapter were (a) to develop a model to determine at what stage 
of culture chondrocytes change shape (b) to study the effect of gel strength on 
chondrocyte morphology and (c) to study the effect of increasing concentrations of 




4.3.1 Primary hypothesis 
Bovine chondrocytes cultured in weak 3D agarose gels show increased volume and 
abnormal morphology (clusters/cytoplasmic processes) as compared to strong gels. 
4.3.2 Secondary hypothesis 
Increasing concentrations of FCS accelerate changes in the volume and morphology 





4.4 MATERIALS AND METHODS 
 
4.4.1 3D agarose gel model to culture isolated bovine chondrocytes 
 Isolated bovine chondrocytes 4.4.1.1
 Bovine joint dissection and cartilage removal  4.4.1.2
Bovine metacarpal-phalangeal joints of 3 yr. old cows were obtained from a local 
abattoir and washed to remove mud and faeces. The skin and hoof were removed 
using a number 24 scalpel blade. The joint was then sprayed with 70% (v/v) alcohol 
and under aseptic conditions dissected in a class 1-flow hood by using a number 24 
blade to cut open the joint. The joint was examined carefully to ensure the joint 
capsule had not been punctured and whether cartilage was non-degenerate or 
degenerate in appearance. Non-degenerate joints had healthy cartilage with smooth 
surface and without fissures whereas, joints with irregular cartilage surface and 
discoloration were considered degenerated/unhealthy. The macroscopic appearance 
of joints for healthy and degenerate was assessed in this study according to the 
criteria mentioned in a study performed on human knee joints (Musumeci et al., 
2013). The degenerate and punctured joints were discarded and only non-degenerate 
un-punctured joints were included in the study. Healthy full depth (FD) explants of 
cartilage down to and including small sections of subchondral bone were removed 
carefully with a number 11 scalpel blade from load-bearing areas of this hinge joint 
(Fig. 4.2). The cartilage explants (approximately 0.35 g) obtained from one joint 
were washed twice with DMEM 380mOsm (section 2.1.1) to remove synovial fluid 
and then transferred to 380mOsm DMEM (20ml) and cultured at 37˚C, 5% CO2 (pH 




Figure 4.2: Bovine joint dissection and cartilage removal. 
Bovine feet (a) washed, (b) skin and hoofs removed, (c) metacarpophalangeal joint 
dissected out and cartilage removed. Scale bar for all panels = 10cm. Photographs 
kindly provided by Dr. Innes D M Smith, Centre for Integrative Physiology, 
University of Edinburgh. 
 
 Isolation of chondrocytes from bovine articular cartilage 4.4.1.3
The cartilage obtained was incubated with collagenase (0.8mg/ml) for approximately 
18 hrs at 37˚C, 5% CO2 (pH 7.4) for the enzyme to weaken the ECM of the cartilage 
samples, thus releasing the chondrocytes (Kuettner et al., 1982). The flask was then 
gently mixed to loosen undigested cartilage. Under strict aseptic conditions in the 
flow hood, the sample was filtered initially through a tea strainer and flushed through 
with excess 380mOsm DMEM. Later the filtrate was again filtered through a nylon 
cloth filter (Monodur®) with a pore of 200µm. The filtrate was topped up with 
380mOsm DMEM to 50 ml and centrifuged (Hettich Zentrifugen Universal 32 R) at 
21˚C, 1500 RPM for 10 min with an accelerating and decelerating setting of 9. The 
supernatant was pipetted off carefully and the remaining cell pellet gently re-
suspended in 380mOsm DMEM. This was repeated once again until a clear pellet 
was obtained and was then re-suspended in approximately 2ml of DMEM. A 1:1 
preparation of the chondrocyte solution with 1% trypan blue stain (Thermo Fisher 
Scientific, UK) was prepared by mixing 5µl of each. A haemocytometer was charged 
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with this cell suspension and the cells were counted. There were few dead cells and 
the cell viability was ~99%. The samples with cell viability below 95% were 
discarded. Samples with a count of approximately 30 x 10
6 
cells /ml were used and 
the final cell density in the gels was approximately 15 x 10
6 
cells /ml for culture 
similar to seeding densities previously utilised (Buschmann et al., 1995, Mauck et al., 
2002). Isolated chondrocytes in 380mOsm DMEM were kept at 37˚C in the water 
bath inside the flow hood until required. 
 Chondrocyte culture in strong and weak agarose gels 4.4.1.4
Gels were prepared 4% w/v by mixing 4g low melting point (LMP) agarose 
thoroughly in 100 ml of PBS and heated in the microwave (180°C) for about 30 
seconds. The small volume of PBS evaporated during heating was restored and 
stirred thoroughly. The agarose solution was incubated in a water bath to bring the 
temperature to 37˚C before being poured in the rectangular gel cast (124mm x 
88mm) and 7mm deep (Fig. 4.3a). The gel cast was placed on ice in a box to cause 
rapid cooling of the agarose solution to set the gel promptly. After about 15 min, the 
gel mixture was poured in the cast while still on the ice. A Perspex sheet with 5mm 
long rods was placed on the cast and kept at approx. 8°C for 15 min to obtain 
properly formed wells in the gel mould (Fig. 4.3b). The chondrocyte cell suspension 
was divided into equal parts in order to culture them in the gels of two different 
strengths of 0.2% and 2% w/v agarose solutions (section 4.2), prepared by mixing 
0.04 and 0.4 g of agarose powder in 10 ml of PBS respectively. Some pilot 
experiments were performed using three different concentrations of agarose (2%, 
0.5% and 0.2% w/v) in order to determine appropriate concentrations of agarose for 
strong and weak gels. Based upon the results of these pilot experiments it was 
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observed that after 1 week chondrocytes cultured in 0.5% gels displayed less shape 
changes as compared to 0.2% gels. Therefore, 2% and 0.2% w/v agarose 
concentrations were used as strong and weak gels in this study. The agarose was 
mixed thoroughly in PBS by heating in the microwave and the volume kept at 10ml 
for each solution, then incubated for 15min (37˚C). The agarose solutions were 
mixed in the chondrocyte cell suspensions 1:1, mixed thoroughly but gently and 
pipetted into pre-formed wells in the gel by using pre-warmed pipette tips 
throughout. The gel cast was placed on the ice box to cause the rapid cooling of the 
chondrocyte-gel solutions especially for the weak gels. Each solution was pipetted 
with fresh pipette tips in the wells of the gel cast. The gel was placed in the fridge for 
2hr to set. Blocks of gel were then cut with a sterile scalpel blade and placed in 6 
well culture plates with 9 ml of DMEM 380mOsm pipetted in each well and 
incubated at 37˚C with 5% CO2 (pH 7.4) until required (Fig. 4.3c). The culture 
medium was changed with freshly prepared culture medium on alternate days during 
the culture period. 
In the experiments where the effect of gel strength on chondrocyte morphology was 
studied, the culture medium contained the same concentration of FCS (10%). 
However, in experiments performed to investigate the effect of increasing 
concentrations of FCS on chondrocyte morphology, the composition of the culture 
medium was altered, by culturing these chondrocytes in different concentrations of 
FCS (1%, 2%, 5% and 10%) both for strong (2%) and weak (0.2%) gels. The 
solutions with 1%, 2%, 5% and 10% FCS were prepared by adding 5ml, 10ml, 25ml 
and 50ml respectively to 500ml of culture medium and then pipetted into the culture 
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plates. Apart from the concentration of FCS in the serum the remaining methodology 
of these experiments was same as already described.  
 
Figure 4.3: Chondrocyte culture in 3D agarose gels. 
The gel mould prepared in (a) the rectangular gel cast with dimensions L=124mm, 
B=88mm and depth=7mm, (b) Perspex sheet with 5mm long rods to make wells in 
the gel mould and (c) 6-well culture plate for keeping the gels in culture in the 
incubator.  
 
 Preparation of cultured chondrocytes for microscopy 4.4.1.5
 
Isolated bovine chondrocytes were cultured in strong and weak agarose gels and kept 
in the incubator under controlled conditions up to 7 days. During the course of 
culture chondrocytes were viewed by CLSM at three time points. At day 1 
chondrocytes were incubated with CMFDA (12.5µM) and PI (5 µM) and at days 3 
and 7 with CMFDA (12.5µM) and DRAQ5 (18 µM) as final concentrations in the 
well during the last hour of incubation, to label the cytoplasm (green) and nuclei 
(red) respectively. DRAQ5 is a far-red fluorescent DNA dye which stained the nuclei 
of chondrocytes (Martin et al., 2005) and rendered counting of the cells possible in 
the clusters (section 2.1.2). The gels were then washed in PBS to remove excess of 
dye, fixed in 4% formaldehyde for 30mins and mounted in small cell culture dishes 
(Cellstar
®
; 35x10mm) with Super Glue gel (Loctite). A pin-head size drop of glue 
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was applied to the base of the dish and one of the edges of the gel block was gently 
placed on it and allowed to attach. The chondrocytes cultured in wells were 
considerably distant from the point of attachment of gel and were imaged within ~30 
min by confocal laser scanning microscopy (CLSM) and the samples were stored in 
PBS at 4°C (in dark) prior to imaging. 
 
 Acquisition of images of chondrocytes cultured in 3D agarose gel by 4.4.1.6
CLSM 
The fluorescent images of the chondrocytes cultured in different gel concentrations 
were obtained using a Zeiss Askioskop LMS510 confocal microscope with x10 
(dry), or x40 Dipping Water (DW) and x63 DW lenses having numerical apertures 
(NA) of 0.3, 0.8 and 0.95 respectively. Argon/2 laser with the excitation wavelength 
(EXλ ) of  488 nm and HeNe2 laser with EXλ = 633 nm or 543nm were used to excite 
the fluorophores CMFDA and DRAQ5 or PI respectively and the emission then 
measured through a band pass filter of 505-530 nm and a long pass filter of 650 nm 
respectively. The images were optimized by adjusting detector gain and offset slider 
to minimise pixel saturation and background intensity respectively. The Z stack 
images acquired were 5.8µm steps typically 100µm deep for the x10, 1µm steps 
typically 100µm deep for the x40 DW and 1µm steps typically 50µm deep for x63 
DW objectives respectively, with a frame size of 1024 x 1024 pixels. The scanning 
speed for the images was 9 frames/sec with 8-bit (data depth) having a pinhole 




 Analysis of images using VolocityTM 3D image analysis software  4.4.1.7
 
The 3D images obtained from CLSM by x40 DW objective were then analysed by 
Volocity
TM 
software version 5.4.1 (Improvision, Coventry, UK). The three 
dimensional information acquired from CLSM images was visualised and analysed 
using Volocity
TM
 software to obtain quantitative data. A 3D region of interest (ROI) 
was applied to the images with the dimensions of x, y, z 230, 230 and 100µm 
respectively and the number of cells were counted in these specified ROIs. Cell 




 by the formula (total no. of 
CMFDA and DRAD5 labelled cells/ volume of gel imaged). 
  Volume measurement protocol by VolocityTM 4.4.1.7.1.
 
A measurement protocol was developed on Volocity
TM
 to determine the volume of 
individual, pairs and clusters of chondrocytes in the high power magnification (x40 
DW) images. In order to determine the volume accurately, it was essential to 
determine the edge of the cell precisely and this was achieved by using the threshold 
segmentation method. By this approach the edge between the cell and the matrix was 
defined and volume calculated by using the Volocity
TM
 measurement protocol. This 
measuring protocol determined single cells as separate items but the clusters were 
identified as a whole unit. The volume of the clusters was measured by the same 
methodology as explained for individual cells thus by measuring the whole unit as a 
cluster. This was because the threshold of intensity was similar for all the cells in the 
cluster and the segmentation of individual cells in the cluster was not possible (Fig. 





by counting the DRAQ5 labelled nuclei. The volume of individual cells in a cluster 
was determined by the formula (total volume of cluster in µm
3
/total number of cells 
in cluster). The percentage of chondrocytes forming clusters was calculated with the 
formula 100 × (number of cells forming clusters/total number of cells) %. 
Chondrocytes exist typically as pairs in healthy bovine cartilage (Sasazaki et al., 
2008) termed as chondron (“chondron” see foot note
1
), possibly can be isolated as 
pair during cell isolation step and therefore were not considered clusters in this study.  







Figure 4.4:  Volocity
TM 
measurement protocol. 
Examples of confocal microscopy x40 (DW) image of CMFDA labelled 
chondrocytes. A chondrocyte (solid white arrow) and a cluster (broken white arrow) 
segmented by Volocity
TM
 measurement protocol identifying objects by intensity and 
calculating their volumes (µm
3




“A chondron is defined as the chondrocyte and its pericellular microenvironment” and can exist in single, double 
or linear column arrangement (Poole, 1997). 
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 Calibration of Volume measurement protocol 4.4.1.7.2.
 
The measurement protocol was calibrated by the fluorescent latex beads. 
Fluoresbrite
TM 
(Polyscience Inc., Warrington) of known diameter (10.16 µm) and 
volume (549 µm
3
) were imaged under conditions identical to those used for bovine 
chondrocytes. The diameter of the calibration beads was checked in both planar and 
axial axes to confirm spherical geometry. The baseline threshold was adjusted to 
identify edges of the beads and then volume measured. The volumes of the beads 
both in the strong and weak gels were determined and the values obtained (mean ± 
SEM) were 762.25 ± 8.21 µm
3 
(n=12) and 763.6 ± 15.05 µm
3 
(n=8) as shown in Figs. 
4.5a & b. There was slight overestimation of volume by this protocol due to 
diffraction of light and thus the correction factor of 0.72 was determined. The 
volume measured for chondrocytes were multiplied by this factor to determine the 
corrected volume and this was in good agreement with a correction factor of 0.7 
which was applied by Bush & Hall (2001). The method used to acquire quantitative 




                 
Figure 4.5: Volume measurement of fluorescent latex beads. 
CLSM images of fluorescently labelled beads with x40 (DW) objective in (a) 2% and 
(b) 0.2% gel strengths. 
 
Figure 4.6: A flow diagram demonstrating analysis of images. 
The key steps concerned in the analysis of 3D images acquired by CLSM using 
Volocity
TM









The length of the cytoplasmic processes in the images was determined by using 
Volocity
TM
 software as it enabled the measurement of the length in 3D by tracing the 
process in the z direction. The methodology utilised is shown in the example of an 
image with cell having processes (Fig. 4.7). The measurement of the cytoplasmic 
process was started at its origin from the cell body and then traced throughout its 
whole length until termination (Fig. 4.7). The length of cytoplasmic processes was 
categorised into three groups as small (0-29.9 µm), medium (30-59.9 µm) and large 
(≥60 µm) taking into consideration the minimum and maximum length of 
cytoplasmic processes in these experiments. The percentage of abnormal 
chondrocytes was calculated with the formula 100 × (number of abnormal cells/total 
number of all normal and abnormal cells) %. 
 




Example of a x40 (DW) CLSM image of CMFDA and DRAQ5 labelled chondrocyte 
with cytoplasmic processes demonstrating the methodology to measure the length of 
the process (as indicated by arrow) in 3D by tracking the process in z direction. 




4.5.1 Effect of agarose gel strength on bovine chondrocyte density and 
morphology cultured in 3D agarose gels with 10% FCS 
In the strong gels chondrocyte density remained unaffected and few morphological 
changes were observed. However, chondrocyte density and morphology changed 
markedly in the weak strength of agarose gels during the progression of the culture 
and complex changes were observed (Fig. 4.20). Freshly isolated bovine articular 
chondrocytes were cultured in strong or weak gel strengths over 14 days and images 









 day in vitro. PI was used to label nuclei of dead cells at day1 and 
DRAQ5 was used to label the nuclei of live cells (at days 3 and 7) to count the cells 
involved in forming the clusters (section 4.4.1.5). PI was used at day 1 to assess 
chondrocyte viability at the beginning of culture and DRAQ5 at later time points 
because clusters were not present at day 1 and developed later on during culture. 
Nuclei of the live cells were counted in the specified ROI which enabled 
measurement of cell density. Quantitative analysis of the cell density, volume and 
morphology of chondrocytes was performed as described (section 4.4.1.7). The 
results at distinct time points were presented in the following sections. 
 Changes to chondrocyte density during 7 days of culture in strong and 4.5.1.1
weak agarose gels 
Quantitative data regarding chondrocyte density were obtained from high power 






 day of culture in both 
strong and weak gel strengths (Figs. 4.10, 4.14 & 4.21). Cell density was unaffected 
during the course of culture in the strong gel cultures (Fig. 4.8). However, cell 
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density increased significantly in the weak gels as compared to strong gels by day 7 




[N(nʹ)=6(525) and 6(313) respectively]; P=0.03; 
Fig. 4.8). Moreover, the cell density increased significantly in the weak gels by day 7 
in comparison with day 1 and day 3 in the same gel strength (P<0.05 and P<0.001 
respectively; Fig. 4.8). 
 
Figure 4.8: Chondrocyte density in the strong and weak gels over 7 days of 
culture. 
Graph shows pooled data on cell density at various time points in strong and weak 
gels respectively. Data were from [N(nʹ)=6(175, 228, 313) in strong gels and 6(111, 
491, 525) in the weak gels at days 1, 3 and 7 respectively. * indicated a significant 
difference according to unpaired student’s t-test. # indicated a significant difference 
according to one-way ANOVA followed by Tukey’s multiple comparison post-hoc 
test. The single, double and triple symbols showed the level of significance for 
P<0.05, 0.01 and 0.001 respectively. 
 Changes to chondrocyte volume at day 1  4.5.1.2
The volume of chondrocytes changed considerably when cultured in two agarose gel 
strengths but chondrocyte morphology remained unaffected and very few 
cytoplasmic processes were observed. The low (x10) and high (x40) power images of 
chondrocytes on day 1 showed relatively normal spheroidal morphology of 
chondrocytes with heterogeneity in cell size in both concentrations of agarose (Figs. 




Figure 4.9: Axial CLSM reconstructions of isolated chondrocytes cultured in 3D 
strong and weak gel cultures. 
Confocal microscope low power (x10 objective) images of chondrocytes incubated 
with CMFDA and PI from day 1 of culture in strong and weak gel strengths. Scale 
bar = 100µm. 
 
Figure 4.10: Axial CLSM reconstructions of isolated chondrocytes cultured in 
3D strong and weak gel cultures. 
Confocal microscope high power (x40 DW objective) images of chondrocytes 
incubated with CMFDA and PI from day 1 of culture in strong and weak gel 
strengths. Solid arrows indicate examples of pairs of cells and broken arrows indicate 




Data regarding the distribution of volume measurements of chondrocytes on day 1 of 
culture in strong and weak gels were shown in Fig. 4.11. The range for volume of 









. The highest frequency of chondrocytes in the strong gels 
had volumes in the range of 700-800 µm
3
 whereas in the weak gels the majority of 
cells had volume in the range of 900-1100 µm
3
. The volume of isolated chondrocytes 
increased significantly on day 1 when cultured in weak gels as compared to the 
strong gels (P=0.005; Fig. 4.12) suggesting that volume changed after one day of 
culture. 
 
Figure 4.11: Frequency distribution of chondrocyte volume (µm
3
) in different 
gel strengths on day 1 of culture. 
Cells were ranked into 100 (µm
3
) bands and the values obtained from [N(nʹ)=6(91) 





Figure 4.12: Chondrocyte volume increased in the weak gel cultures at day 1. 
Pooled data regarding the volume of isolated chondrocytes (µm
3
) cultured in strong 
and weak gel strengths at day 1. Values obtained from [N(nʹ)=6(91) and 6(69)] 
samples in strong and weak gels respectively. * indicated a significant difference 
according to unpaired student’s t-test. The single, double and triple symbols showed 
the level of significance for P<0.05, 0.01 and 0.001 respectively. 
 
However, cluster formation and presence of cytoplasmic processes studied in these 
cultured chondrocytes were not found to be significantly different between both the 
concentrations of gel (Tables 4.1 & 4.2) at day 1. Very few chondrocytes were 
present in small sized clusters with an average of 3 cells/cluster. There existed no 
significant difference between various parameters of clusters present in strong and 
weak gels at day 1 (Table 4.1). Only 1-2% of the cells had a single fine small 
cytoplasmic process cultured in both concentrations of gel. One finding worth 
mentioning is that at day 1 the average length of the processes in weak gels was 
greater than in strong gel but the difference at this early stage of culture was not 
statistically significant (Table 4.2). This suggested that although the volume of 
chondrocytes increased in the weak gels after day 1 of culture, the morphology of the 
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cells remained virtually unchanged and very few abnormal cells with cytoplasmic 




Strong (2%) gel Weak (0.2%) gel P value* 
No. of clusters 
per field of view 
2.6 ± 0.5 1.3 ± 0.3 0.1 
No. of 
cells/cluster 
3.4 ± 0.3 3.7 ± 0.3 0.5 




2726.1 ± 357.1 2785.3 ± 666.5 0.9 
Av. Volume of 









17.8 ± 6.3 13.6 ± 3.9 
0.6 
 
Table 4.1: Characteristics of clusters present in strong and weak gel strengths at 
day 1 of culture. 
Data were presented regarding the number of clusters, number of cells/cluster, 
volume of clusters, volume of individual cell in a cluster and % of chondrocytes 
present in clusters on day 1 in strong and weak gels. Data shown as mean ± standard 
















% of chondrocytes with 
processes 
1.7 ± 0.4 2.7 ± 0.4 0.4 




Small 4.2 ± 0.1 19.5 ± 4.5 0.07 
Medium 0 0 0 








Small 1.7 ± 0.4 2.7 ± 0.4 0.4 
Medium 0 0 0 
Long 0 0 0 
 
Table 4.2: Chondrocytes with cytoplasmic processes present in strong and weak 
gels at day 1 of culture. 
Data were presented regarding the % of chondrocytes with processes, number of 
processes/cell, length of processes and the % of chondrocytes with processes 
according to length categories on day 1 in strong and weak gels. Data shown as mean 
± standard error, * indicated probability value result from un-paired Student’s t-test 
with P<0.05.  
 
 Development of abnormal chondrocyte morphology by day 3 4.5.1.3
 
Chondrocytes cultured in weak gels displayed marked changes in morphology by day 
3 and had cytoplasmic processes emanating from the cell body as compared to the 
chondrocytes in strong gels (Fig. 4.14). The mean volume of isolated cells cultured 
in weak gels was significantly 13% greater (P=0.03) than those in the strong gels 
(Fig. 4.15). However, the volume of chondrocytes in weak gels at day 3 when 
172 
 
compared to the volume at day 1 showed no significant difference (P>0.05), 
suggesting that the chondrocytes by day 3 did not change volume significantly but 
started producing cytoplasmic processes. The volume measurements of abnormal 
chondrocytes with processes did not include the volume of processes because when 
the threshold was applied the processes were not segmented along with the cells. 
However, the volume of processes appeared to be very small and did not affect the 
volume measurements of individual cells. 
 
Figure 4.13: Axial CLSM reconstructions of isolated chondrocytes cultured in 
3D strong and weak gel cultures. 
Confocal microscope low power (x10 objective) images of chondrocytes incubated 
with CMFDA and DRAQ5 from day 3 of culture in strong and weak gel strengths. 





Figure 4.14: Axial CLSM reconstructions of isolated chondrocytes cultured in 
3D strong and weak gel cultures. 
Confocal microscope high power (x40 DW objective) images of chondrocytes 
labelled with CMFDA and DRAQ5 from day 3 of culture in strong and weak gel 
strengths. Solid arrows point to the examples of cells with cytoplasmic processes and 
the broken arrows indicate examples of cell clusters. Few red cells in 2% gel indicate 
dead cells. Scale bar = 25µm. 
 
Figure 4.15: Chondrocyte volume increased in the weak gel cultures at day 3. 
Pooled data regarding the volume of isolated chondrocytes (µm
3
) cultured in strong 
and weak gel strengths at day 3. Values obtained from [N(nʹ)=6(84) and 6(169)] 
samples in strong and weak gels respectively. * indicated a significant difference 
according to unpaired student’s t-test. The single, double and triple symbols showed 




At day 1, chondrocyte morphology remained unaffected in strong and weak gels. By 
day 3, a significantly higher % age of chondrocytes cultured in the weak gels 
produced cytoplasmic processes in comparison to those in strong gels (P=0.015; Fig. 
4.16) where cells were mostly rounded in shape. The average number of processes 
per chondrocyte was greater in weak concentration of agarose but the difference 
from strong gels was not statistically significant (P=0.2; Fig. 4.17). Some of the 
chondrocytes cultured in weak gels developed single or multiple cytoplasmic 
processes of smaller, medium and longer lengths (section 4.4.1.7.3. for length 
categories) as compared to the chondrocytes in strong gels which demonstrated only 
small and medium sized processes (Fig. 4.18).  
The average length of small and medium sized processes did not differ in both strong 
and weak gels but a significantly higher percentage of chondrocytes showed the 
presence of small, medium and long processes in the weak gels as compared to 
strong gels (P=0.02; P=0.04 and P=0.03 respectively; Fig. 4.19). Moreover, in the 
weak gels, the percentage of chondrocytes having smaller processes was significantly 






Figure 4.16: Percentage of chondrocytes with cytoplasmic processes increased in 
weak gel cultures as compared to strong gels at day 3. 
Values obtained from [N(nʹ)=6(228) and 6(491)] samples in strong and weak gels 
respectively. * indicated a significant difference according to unpaired student’s t-
test. The single, double and triple symbols showed the level of significance for 
P<0.05, 0.01 and 0.001 respectively. 
 
Figure 4.17: Number of processes per chondrocyte in weak gel cultures as 
compared to strong gels at day 3. 
The difference between the number of processes/cell was statistically not significant 
between the strong and weak gel cultures. Values obtained from [N(nʹ)=6(228) and 






Figure 4.18: Various categories of length of processes in strong and weak gel 
cultures. 
Chondrocytes cultured in weak gels displayed small, medium and long processes as 
compared to strong gels where only small and medium sized processes were present 
at day 3. Values were from [N(nʹ)=6(228) and 6(491)] in strong and weak gels 
respectively. 
 
Figure 4.19: The percentage of chondrocytes with various lengths of cytoplasmic 
processes increased in the weak gels. 
The percentage of chondrocytes with small, medium and long processes was higher 
in the weak gels as compared to the strong gels at day 3 of culture. Values displayed 
for a sample size [N(nʹ)=6(228) and 6(491)] in strong and weak gels respectively. * 
indicated a significant difference according to unpaired student’s t-test. # indicated a 
significant difference according to one-way ANOVA followed by Tukey’s multiple 
comparison post-hoc test. The single, double and triple symbols showed the level of 




At day 3, there was no effect on cultured chondrocytes in terms of cluster formation 
and various characteristics of clusters did not differ significantly in both the gel 
strengths (Table 4.3). This suggested that cytoplasmic processes developed before 
chondrocyte cluster formation. 
Characteristics of 
clusters formed 
Strong (2%) gel Weak (0.2%) gel P value* 
No. of clusters per 
field of view 
2.5 ± 1 2.6 ± 0.6 0.9 
No. of cells/cluster 
4 ± 0.2 4 ± 0.2 0.6 




3746.6 ± 466.7 3789.9 ± 312.1 0.9 
Av. Volume of 




966.8 ± 70.1 969.1 ± 59.1 
0.9 
% of chondrocytes 
forming clusters 
20.7 ± 6.6 24.1 ± 5.5 
0.7 
 
Table 4.3: Characteristics of clusters present in strong and weak gel strengths at 
day 3 of culture. 
There existed no significant difference between various parameters of clusters 
present in strong and weak gels at day 3. Data were presented regarding the number 
of clusters, number of cells/cluster, volume of clusters, volume of individual cell in 
cluster and % of chondrocytes forming clusters on day 3 in strong and weak gels. 
Data shown as mean ± standard error, * indicated probability value result from un-
paired Student’s t-test with P<0.05. 
 
To summarise the results of this section by day 3 of culture the chondrocytes were 
larger in volume and showed higher percentage of cytoplasmic processes when 
cultured in weak agarose gels compared with strong gels. There was no significant 
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difference between any of the characteristics of the clusters formed in strong and 
weak gels by day 3. 
 Chondrocyte cluster formation and development of abnormal morphology 4.5.1.4
by day 7 of culture in weak gels  
Cultured chondrocytes displayed striking changes in the cell morphology within 
weak agarose gels after 7 days even in the images obtained by using low power (x10 
dry) objective (Fig. 4.20). In the weak agarose gels, chondrocytes showed dramatic 
changes to morphology characterised by cluster formation and development of 
cytoplasmic processes (Fig. 4.21 & 4.22). The volume of isolated chondrocytes was 
significantly higher in weak gels as compared to the cells cultured in strong gels 
(P=0.02; Fig. 4.23).  
 
Figure 4.20: Axial CLSM reconstructions of low power images showing cluster 
formation and development of cytoplasmic processes in the weak gels. 
Confocal microscope x10 objective images of isolated chondrocytes incubated with 
CMFDA and DRAQ5 at day 7 of culture in strong and weak gel strengths. Solid 
arrows identify examples of cells developing cytoplasmic processes and examples of 




Figure 4.21: Axial CLSM reconstructions of high power images indicating 
cluster formation and development of cytoplasmic processes in the weak gels. 
Examples of confocal microscope x40 objective images of isolated chondrocytes 
incubated with CMFDA and DRAQ5 at day 7 of culture in strong and weak gel 
strengths. Chondrocytes in weak gels developed abnormal morphology by day 7 and 
those in the strong gels remained unaffected. Solid arrows indicate examples of cells 
developing cytoplasmic processes and the examples of cell clusters indicated with 
broken line arrows. Scale bar = 25µm. 
 
Figure 4.22: Axial CLSM reconstructions of high power images demonstrating 
abnormal morphology of chondrocytes in weak gels. 
Confocal microscope x63DW objective images of fluorescently-labelled isolated 
chondrocytes at day 7 of culture in strong and weak gel strengths. Solid arrows point 
to the examples of cells demonstrating cytoplasmic processes and the broken arrows 




Figure 4.23: Chondrocyte volume increased in the weak gel cultures. 
The volume of isolated chondrocytes (µm
3
) cultured in strong and weak gels at day 7 
displayed in the graph were from [N(nʹ)=6(66) and 6(41)] chondrocytes cultured in 
strong and weak gels respectively. * indicated a significant difference according to 
unpaired student’s t-test. The single, double and triple symbols showed the level of 
significance for P<0.05, 0.01 and 0.001 respectively. 
 
 Chondrocyte clustering  4.5.1.4.1
An obvious morphological feature of chondrocytes observed routinely when cultured 
in weak gels was the formation of clusters. Quantitative data regarding the number of 
clusters, number of cells/cluster, percentage of cells forming clusters, the volume of 
clusters and volume of individual cells in a cluster was obtained at day 7 of culture 
(section 4.4.1.7.1). The number of clusters and number of cells per cluster in the 
weak gels were significantly higher as compared to those in strong gels (P<0.05 and 
P=0.002 respectively; Figs. 4.24a & b). In the weak gel cultures a significantly 
higher percentage of chondrocytes formed clusters (76±5% [N(nʹ)]=[6(525)]) as 
compared to those in strong gels (41±5% [N(nʹ)]=[6(313); P=0.001; Fig. 4.24c]). At 
day 7 of culture chondrocytes in weak gels formed large clusters having on the 
average 6-7 cells per cluster (P=0.0007) as compared to strong gels comprising of 
average 3-4 cells per cluster (Fig. 4.24d). The volume of individual chondrocytes in a 
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cluster showed no significant difference after 7 days of culture in both the gel 
strengths (Fig. 4.24e). Moreover, the volume of isolated chondrocytes and of the 
individual chondrocytes in the culture appeared to be similar in both gel strengths. 
 
Figure 4.24: Characteristics of chondrocyte clusters present in strong and weak 
gels at day 7. 
Values displayed for (a) average number of clusters formed (b) average number of 
cells/cluster (c) % of chondrocytes present in clusters (d) average volume of the 
clusters (µm
3
) and (e) average volume of individual chondrocyte in a cluster (µm
3
). 
Data obtained from [N(nʹ)]=[6(313) and 6(525)] in strong and weak gels 
respectively. * indicated a significant difference according to unpaired student’s t-
test. The single, double and triple symbols showed the level of significance for 
P<0.05, 0.01 and 0.001 respectively. 
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 Chondrocyte morphology 4.5.1.4.2
Chondrocytes cultured in weak gels displayed marked shape changes by day 7 
characterised by the appearance of cytoplasmic processes (Figs. 4.21 & 4.22). A 
significantly higher percentage of chondrocytes, (67±1%; [N(nʹ)]=[6(525)]; section 
4.4.1.7.3.) in weak gel cultures had cytoplasmic processes emanating from their cell  
bodies after 7 days of in vitro culture as compared to 18±1% [N(nʹ)]=[6(313)] cells in 
strong gels (Fig. 4.25; P=0.006). The number of processes/cell was also significantly 
higher in the weak gels as compared to strong gels (Fig. 4.26; P=0.0002). The 
analysis of the length categories of processes (section 4.4.1.7.3.) revealed the 
presence of small, medium and long processes emanating from the chondrocytes in 
weak gels and only small and medium sized processes present at the chondrocytes in 
the strong gel. Chondrocytes cultured in weak gels displayed long processes as 
compared to strong gels where no long processes were observed (Fig. 4.27). A 
significantly higher percentage of chondrocytes had small, medium and long 
processes in the weak gels as compared to strong gels (P<0.0001; P=0.0009 and 
P=0.03 respectively; Fig. 4.28). Moreover, a higher percentage of chondrocytes had 
smaller processes (0-29.9 µm) as compared to medium (30-59.9 µm) and long (≥60 
µm) processes in the weak gels (P<0.001 for all conditions). Additionally, the % of 
chondrocytes having medium processes were more numerous than the ones with long 




Figure 4.25: A higher percentage of chondrocytes had cytoplasmic processes in 
the weak gels at day 7. 
The percentage of chondrocytes producing cytoplasmic processes increased 
significantly in the weak gels as compared to the strong gels at day 7. Pooled data 
obtained from [N(nʹ)=6(313) and 6(525)] samples in strong and weak gels 
respectively. * indicated a significant difference according to unpaired student’s t-
test. The single, double and triple symbols showed the level of significance for 
P<0.05, 0.01 and 0.001 respectively. 
 
Figure 4.26: Number of processes per cell increased in the weak gels at day 7. 
Chondrocytes cultured in weak gels had a higher number of processes per cell as 
compared to the strong gels. Values obtained from [N(nʹ)=6(313) and 6(525)] 
samples in strong and weak gels respectively. * indicated a significant difference 
according to unpaired student’s t-test. The single, double and triple symbols showed 





Figure 4.27: Various categories of length of processes in strong and weak gel 
cultures. 
Chondrocytes cultured in weak gels displayed small, medium and long processes as 
compared to strong gels where only small and medium sized processes were present 
at day 7. Values regarding the average length of these processes was displayed with 
sample size [N(nʹ)=6(313) and 6(525)] in strong and weak gels respectively. 
 
 
Figure 4.28: The percentage of chondrocytes with various lengths of cytoplasmic 
processes increased in the weak gels. 
The percentage of chondrocytes with small, medium and long processes was higher 
in the weak gels as compared to the strong gels at day 7 of culture. Values displayed 
for a sample size [N(nʹ)=6(313) and 6(525)] in strong and weak gels respectively. * 
indicated a significant difference according to unpaired student’s t-test. # indicated a 
significant difference according to one-way ANOVA followed by Tukey’s multiple 
comparison post-hoc test. The single, double and triple symbols showed the level of 




To summarise the results, the differences in the development of morphological 
changes in both strengths of agarose gels were strikingly obvious. By day 7 of 
culture bovine chondrocytes cultured in weak agarose gels demonstrated marked 
heterogeneity of chondrocyte morphology in terms of enlargement of cells, cluster 
formation and development of cytoplasmic processes. Chondrocytes cultured in 
strong agarose gels displayed similar type of morphological changes as seen in the 
weak gels but statistically less in quantity.  
 Images of chondrocytes cultured in 3D gels with different strengths of 4.5.1.5
agarose after 14 days of culture 
Chondrocytes isolated from bovine cartilage were kept in culture for 14 days in 
strong and weak gels and imaged with low (x10) and high (x40 DW) power 
objectives to observe any changes to the morphology of chondrocytes. The images 
obtained (Figs. 4.29 & 4.30) displayed complex morphological changes in the weak 
gels with the production of large-sized clusters and numerous cytoplasmic processes. 
However, chondrocytes cultured in the strong gels maintained their morphology 
relatively unchanged even after 14 days of in vitro culture. A very detailed analysis 
of chondrocyte morphological changes observed in strong and weak gels was 
performed in this study by day 7 of culture. However, by day 14 the morphology of 
chondrocytes became complicated and huge clusters of abnormal cells were formed. 
Volume of single cell within strong gels could be determined but in the weak gels 
there were no single cells present (Fig. 4.30) therefore, data analysis was not 
possible. Thus it was almost impossible to analyse volume/morphology of cells at 




Figure 4.29: Axial CLSM reconstructions of low power images showing cluster 
formation and development of cytoplasmic processes in the weak gels. 
Confocal microscope x10 objective images of isolated chondrocytes incubated with 
CMFDA and PI at day 14 of culture in strong and weak gel strengths. Solid arrows 
indicate the examples of cells developing cytoplasmic processes and the examples of 
cell clusters indicated with broken line arrows. Scale bar = 100µm. 
 
Figure 4.30: Axial CLSM reconstructions of isolated chondrocytes cultured in 
3D strong and weak gel cultures. 
Confocal microscope high power (x40 DW objective) images of chondrocytes 
labelled with CMFDA and PI from day 14 of culture in strong and weak gel 
strengths. Solid arrows point to the examples of cells developing cytoplasmic 





To summarise this section, chondrocytes cultured in weak agarose gels showed an 
increase in volume and marked changes in morphology in terms of cluster formation 
and abnormal shapes with cytoplasmic processes as compared to strong gels. 
However, the changes in volume and morphology were also seen in the chondrocytes 
cultured in strong gels but these developed more slowly as compared to those in the 
weak gels. The results suggested that the changes were basically similar between 
strong and weak gels but were simply more rapid in the weak gels.  
 
4.5.2 Effect of increasing concentrations of FCS on the morphology of bovine 
chondrocytes cultured in strong and weak 3D agarose gels 
In the previous section in this chapter, regarding the effect of gel strength on 
chondrocyte morphology 10% FCS was used in the culture medium. It was possible 
that the morphological changes observed in the weak gels were due to increased 
penetration of FCS into the gels. To investigate this effect, in the present section 
varying concentrations of FCS were used (1%-10%). However, in these experiments 
serum-free/0% FCS was not utilised as a culture condition because FCS-
supplemented medium is required for the chondrocyte growth and maintenance of 
phenotype in cultures as reported already (Glaser and Conrad, 1984). Freshly isolated 
bovine chondrocytes were cultured over 7 days in strong and weak gels with FCS 





 day of culture by obtaining low and high power CLSM images and quantitative 




 Changes to chondrocyte volume at day 1 4.5.2.1
 
The volume of chondrocytes increased in the weak gel strengths with the increasing 
concentrations of FCS but no abnormal chondrocytes with processes were present. 
When visualised on day 1 of culture with x10 objective, chondrocyte density 
appeared to be broadly similar and there was little evidence of clustering in either 
strong or weak gels in the four different concentrations of FCS (Fig. 4.31). 
Chondrocytes cultured in either strong or weak agarose gels in the four different 
concentrations of FCS imaged with x40 objective, were spheroidal in shape (Fig. 
4.32). Occasionally, pairs of chondrocytes could be seen in both the gel strengths 
(examples shown in Fig. 4.32). Heterogeneity in cell sizes was discernible but no 
obvious morphological changes (cytoplasmic processes/clusters) were present in 
either gel strengths cultured with 1%, 2%, 5% or 10% FCS (Fig. 4.32). The cell 
density was calculated from x40 magnification images of chondrocytes in strong and 
weak gels at day 1 as previously described (section 4.4.1.7). Cell density was not 
markedly different in strong and weak agarose gels with 1%, 2%, 5% or 10% FCS 




 in weak gels 
respectively; data obtained from a single experiment). It was noticed that cell density 




 which suggested that 
possibly a certain level of FCS is required for chondrocyte culture. However, in the 
weak gels with 1% FCS this was not observed because the penetrability of serum in 





The volume of isolated chondrocytes in weak gels was higher as compared to the 
volume of chondrocytes in strong gels cultured in 2%, 5% and 10% FCS (P<0.05 for 
the three higher concentrations of FCS) but not with very low (1%) concentration of 
FCS as shown in Fig. 4.33. Chondrocytes cultured in both gel strengths with 
increasing concentrations of FCS showed no cytoplasmic processes by day 1 of 
culture. Rarely (1-2) small clusters involving 3-4 cells per cluster were observed in 
both gel strengths with 1%, 2%, 5% and 10% FCS concentrations on day 1 of culture 
(Table 4.4; data obtained from a single experiment). The average volume of clusters 
and the volume of individual cells in a cluster appeared to be unaffected in both gel 
strengths with all the four concentrations of FCS (Table 4.4). These results suggested 
that the volume of chondrocytes increased in the weak gel cultures with higher 
concentrations of FCS after 1 day but the morphology of cells was unaffected by gel 












Figure 4.31: Axial CLSM reconstructions of isolated chondrocytes cultured in 
strong and weak gels with varying concentrations of FCS. 
Confocal microscope low power (x10 objective) magnification images of 
chondrocytes incubated with CMFDA and PI from day 1 of culture in (a, c, e, g) 
strong and (b, d, f, h) weak gel strengths with (a, b) 1%, (c, d) 2%, (e, f) 5% and (g, 




Figure 4.32: Axial CLSM reconstructions of images of isolated chondrocytes in 
strong and weak gels cultured with varying concentrations of FCS. 
Confocal microscope high power (x40 objective) magnification images of 
chondrocytes incubated with CMFDA and PI from day 1 of culture in (a, c, e, g) 
strong and (b, d, f, h) weak gel strengths with (a, b) 1%, (c, d) 2%, (e, f) 5% and (g, 
h) 10% concentrations of FCS. The solid arrows indicate examples of chondrocyte 
pairs and broken arrows indicate examples of swollen chondrocytes displaying 
heterogeneity in cell sizes. In the weak gels numerous swollen cells present and in 
strong gels only in 10% FCS few swollen chondrocytes observed. Scale bar for all 




Figure 4.33: Chondrocyte volume increased in the weak gels as compared to 
strong gels at higher concentrations (2%, 5% and 10%) of FCS. 
Data regarding the volume of isolated chondrocytes (µm
3
) cultured in strong and 
weak gel strengths at day 1 with increasing concentrations of FCS. Values obtained 
from [N(nʹ)= 2(10, 6, 11, 4) in strong gels and 2(16, 12, 5, 18)] in weak gels cultured 
with 1%, 2%, 5% and 10% FCS concentrations respectively. * indicated a significant 
difference according to unpaired student’s t-test. The single, double and triple 


















































3 4 4.5 3 4 0 3 3 





















Vol. of ind. 




























Table 4.4: Characteristics of clusters present in strong and weak gel strengths in 
different concentrations of FCS at day 1 of culture. 
Data were presented regarding the number of clusters, number of cells/cluster, 
volume of clusters and volume of individual cell in a cluster on day 1 in strong and 
weak gels. Data were shown from a single experiment. 0 values in the table indicated 




 Changes to chondrocyte density during 7 days of culture in strong and 4.5.2.2
weak agarose gel cultures 
Chondrocyte density was determined by analysing the CLSM images obtained by 
using high power magnification (x40DW) objective. Fluorescently-labelled nuclei of 
cells were counted and the cell density determined by the formula detailed previously 
(section 4.4.1.7). After 7 days of in vitro culture cell density remained unaffected in 
the strong gel cultures with increasing concentrations of FCS (Fig. 4.34; P>0.05; 
ANOVA). In the weak gel cultures, chondrocyte density increased significantly in 
the presence of 10% FCS as compared to 1% and 2% FCS (Fig. 4.34; P<0.05; 
ANOVA for both conditions). These results suggested proliferation of cells in the 
clusters in the weak gels with increasing concentrations of FCS. 
 
Figure 4.34: Chondrocyte density increased in the weak gels over 7 days of 
culture with higher concentrations of FCS. 
Graph shows pooled data on cell density at day 7 in the weak gels as compared to 
strong gels. Values were from [N(nʹ)=6(35, 34, 180, 98) in strong gels and 6(222, 
334, 389, 569) in the weak gels with 1%, 2%, 5% and 10% FCS respectively]. # 
indicated a significant difference according to one-way ANOVA followed by 
Tukey’s multiple comparison post-hoc test. The single, double and triple symbols 
showed the level of significance for P<0.05, 0.01 and 0.001 respectively. 
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 Formation of clusters and development of abnormal chondrocyte 4.5.2.3
morphology in weak gels compared to strong gels in the presence of 
higher concentrations of FCS by day 7 
 
Chondrocytes cultured in weak gels showed marked changes in morphology 
compared to those in strong gels. Moreover, the morphological changes observed in 
weak gels which were characterised by cluster formation and presence of 
cytoplasmic processes appeared to be intensified with increasing concentrations of 
FCS (Fig. 4.35). The CLSM images acquired on day 7 by x40 objective of 
chondrocytes cultured in strong and weak gels with different concentrations of FCS 
(Fig. 4.36) were analysed for chondrocyte morphology. Quantitative data regarding 
morphology of chondrocytes (volume/clusters/processes) were obtained and 




Figure 4.35: Axial CLSM reconstructions of isolated chondrocytes showing 
evidence of abnormal chondrocyte morphology (clusters/processes) in the weak 
gels with high concentrations of FCS. 
Confocal microscope low power magnification images of chondrocytes incubated 
with CMFDA and DRAQ5 from day 7 of culture in (a, c, e, g) strong and (b, d, f, h) 
weak gel strengths with (a, b) 1%, (c, d) 2%, (e, f) 5% and (g, h) 10% concentrations 
of FCS. The solid arrows indicate examples of chondrocytes with processes and 
broken arrows indicate examples of clusters formed. Inset images show three times 





Figure 4.36: Axial CLSM reconstructions of isolated chondrocytes showing 
increasing evidence of clusters and abnormal chondrocyte morphology with 
processes in weak gels with high concentrations of FCS. 
Confocal microscope high power magnification images of chondrocytes incubated 
with CMFDA and DRAQ5 from day 7 of culture in (a, c, e, g) 2% and (b, d, f, h) 
0.2% gel strengths with (a, b) 1%, (c, d) 2%, (e, f) 5% and (g, h) 10% concentrations 
of FCS. The solid arrows indicate examples of cytoplasmic processes and broken 
arrows indicate examples of cell clusters. Scale bar for all panels = 25µm. 
197 
 
The volume of chondrocytes cultured in strong and weak gels was not affected with 
higher (5% and 10%) concentrations of FCS by day 7 but the volume was 
significantly higher in weak gels cultured in the presence of 1% and 2% FCS 
concentrations (P=0.02 in both conditions; Fig. 4.37). This suggested that basically 
the reduced chondrocyte volume in the strong gels could be overcome by raising the 
FCS concentration. 
 
Figure 4.37: Chondrocyte volume was higher in the weak gels as compared to 
strong gels in the lower concentrations of FCS by day 7. 
Data regarding the volume of isolated chondrocytes (µm
3
) cultured in strong and 
weak gel strengths at day 7 in increasing concentrations of FCS. Values obtained 
from [N(nʹ)=6(8, 12, 21, 21)] in strong gels and 6(66, 60, 43, 19)] in weak gels 
cultured with 1%, 2%, 5% and 10% FCS concentrations respectively. * indicated a 
significant difference according to unpaired student’s t-test. The single, double and 
triple symbols showed the level of significance for P<0.05, 0.01 and 0.001 
respectively. 
 
 Chondrocyte clustering 4.5.2.3.1
A significantly higher number of clusters/field of view was seen in chondrocytes 
cultured in weak gels with higher concentrations (5% and 10%) of FCS as compared 
to those in strong gels (P=0.04 in both conditions). However, the number of clusters 
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formed in the presence of lower concentrations (1% and 2%) of FCS remained 
unaffected in both gel strengths. Additionally, a significantly higher number of 
clusters was formed in the weak gels in the presence of 5% and 10% as compared to 
the cells in weak gels with 1% FCS (P<0.01 for both conditions; Fig. 4.38a). There 
was no significant difference regarding the number of clusters formed in the strong 
gels with all the four concentrations of FCS (P>0.05; ANOVA). 
The number of cells per cluster was significantly higher in the weak gels as 
compared to strong gels cultured with 10% FCS (P=0.01; Fig. 4.38b). Chondrocytes 
cultured in weak gel strengths with highest concentration (10%) of FCS displayed a 
higher number of cells per cluster as compared to the lower concentrations (1%, 2% 
and 5%) of FCS in the same gel strength (P<0.05, P<0.001 and P<0.01 respectively; 
Fig. 4.38b). However, no significant difference existed regarding the number of cells 
per cluster amongst the chondrocytes cultured in strong gels with all the four 
concentrations of FCS (P>0.05; ANOVA). 
The percentage of chondrocytes present in clusters increased significantly by day 7 
in the weak gels as compared to strong gels with 10% FCS (P=0.01). In the weak 
gels, a very high percentage of cells were present in clusters as compared to those in 
strong gels [80±7%; 53±11; N(nʹ)=6(98) and 6(569) for strong and weak gels 
respectively]. Moreover, in the weak gels a significantly higher percentage of 
chondrocytes were present in clusters in the presence of 5% and 10% FCS as 
compared to chondrocytes cultured in the presence of 1% FCS in the same gel 
strength (P<0.05 and P<0.001 respectively; Fig. 4.38c). Additionally, a higher 
percentage of chondrocytes were present in clusters in weak gels with 10% FCS as 
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compared to those in 2% FCS in the same gel strength (P<0.01). However, the 
percentage of cells present in clusters remained unaffected in the strong gels with all 
the four concentrations of FCS (P>0.05; ANOVA). 
The volume of clusters present in the weak gels with 10% FCS was significantly 
higher than the volume of clusters present in 1% and 2% FCS in the same strength of 
gel (P<0.05 and P<0.01 respectively). When the volume of clusters present in both 
the gel strengths was compared (Fig. 4.38d) significantly higher values were 
observed in the cells cultured in the weak gels with 10% FCS (P=0.009) and no 
difference was observed in the lower concentrations of FCS (1%, 2% and 5%). 
Moreover, the volume of clusters present in strong gels showed no significant 
difference in all concentrations of FCS (Fig. 4.38d; P>0.05; ANOVA). The mean 
volume of individual cells present in the cluster was found to be approximately the 
same in all the culture conditions (Fig. 4.38e).  
These results strongly suggested that the cell density increased significantly possibly 
due to cell proliferation in the weak gels with increasing concentrations of FCS. A 
very high percentage of chondrocytes in weak gels in the presence of 10% FCS 
formed clusters as compared to strong gels with the same concentration of FCS. 
Moreover, these clusters in weak gels were large-sized with many cells per cluster as 
compared to those in strong gels. The results suggested that increasing the 
concentrations of FCS accelerated formation of clusters in the weak gels but not in 




Figure 4.38: Characteristics of clusters present in the strong and weak gels with 
varying concentrations of FCS at day 7. 
Values displayed for (a) average number of clusters present, (b) average number of 
cells/cluster, (c) % of chondrocytes present in clusters, (d) average volume of the 
clusters (µm
3
) and (e) average volume of individual chondrocyte in a cluster (µm
3
). 
Data obtained from [N(nʹ)=6(35, 34, 180, 98) in strong gels and 6(222, 334, 389, 
569)] in weak gels cultured with 1%, 2%, 5% and 10% concentrations of FCS 
respectively. * indicated a significant difference according to unpaired student’s t-
test. # indicated a significant difference according to one-way ANOVA followed by 
Tukey’s multiple comparison post-hoc test. The single, double and triple symbols 
showed the level of significance for P<0.05, 0.01 and 0.001 respectively. 
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 Chondrocyte morphology 4.5.2.3.2
Chondrocytes cultured in weak gels after 7 days demonstrated a significantly higher 
percentage of chondrocytes with cytoplasmic processes in the presence of higher 
concentrations of FCS (5 and 10%) as compared to those in strong gels (P=0.0006 
and P<0.0001 respectively; Fig. 4.39). In the weak gels, chondrocytes cultured with 
2% and 5% of FCS had a significantly higher percentage of cells with processes as 
compared to those with 1% FCS in the same gel strength (P<0.01 and P<0.05 
respectively). Moreover, chondrocytes cultured in the weak gels with 10% FCS had a 
significantly higher percentage of these abnormal cells with processes as compared 
to all the three lower concentrations (1%, 2% and 5%) of FCS (P<0.001; for all the 
conditions). However, the percentage of chondrocytes with cytoplasmic processes 
was not affected with increasing the concentrations of FCS for the cells cultured in 
strong gels. Thus, these results suggested that FCS and gel strength were related 
factors and the penetration of FCS into the gels was controlled by gel strength. Both 
these factors appeared to work in a similar manner and altered the same 





Figure 4.39: A higher percentage of chondrocytes had cytoplasmic processes in 
the weak gels with higher concentrations of FCS at day 7. 
Pooled data obtained from [N(nʹ)=6(35, 34, 180, 98) in strong gels and 6(222, 334, 
389, 569)] in weak gels cultured with 1%, 2%, 5% and 10% concentrations of FCS 
respectively. * indicated a significant difference according to unpaired student’s t-
test. # indicated a significant difference according to one-way ANOVA followed by 
Tukey’s multiple comparison post-hoc test. The single, double and triple symbols 
showed the level of significance for P<0.05, 0.01 and 0.001 respectively. 
 
 
The number of processes per cell was significantly higher  in chondrocytes cultured 
in weak gels in the presence of higher concentrations (5% and 10%) of FCS as 
compared to those in strong gels (P<0.0001 and P=0.0002 respectively). In the weak 
gels, a significantly higher number of processes per cell were seen in the presence of 
10% FCS as compared to those in 1%, 2% and 5% FCS (P<0.001, P<0.001 and 
P<0.01 respectively) at the same gel strength. Moreover, chondrocytes cultured in 
weak gels with 5% FCS had higher numbers of processes per cell as compared to 
those cultured in the presence of 1% and 2% FCS in the same gel strength (P<0.001 
for both conditions; Fig. 4.40). However, the number of cytoplasmic processes per 
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cell remained unaffected by increasing the concentrations of FCS in the strong gels 
after 7 days of in vitro culture. 
 
Figure 4.40: Number of processes per cell increased in the weak gels with higher 
concentrations of FCS at day 7. 
Pooled data obtained from [N(nʹ)=6(35, 34, 180, 98) in strong gels and 6(222, 334, 
389, 569) in weak gels cultured with 1%, 2%, 5% and 10% concentrations of FCS 
respectively. * indicated a significant difference according to unpaired student’s t-
test. # indicated a significant difference according to one-way ANOVA followed by 
Tukey’s multiple comparison post-hoc test. The single, double and triple symbols 
showed the level of significance for P<0.05, 0.01 and 0.001 respectively. 
 
 
To summarise this section, when bovine chondrocytes were cultured in weak agarose 
gels with high concentrations of FCS cell density increased and displayed marked 
changes in morphology characterised by cluster formation and production of 
cytoplasmic processes as compared to cells cultured in strong gels. Moreover, 
increasing the concentration of FCS accelerated these morphological changes in 
weak gels but had no effect in strong gels. These results suggested that the factors 
present in FCS augmented cell proliferation and the morphological changes 
(clusters/cytoplasmic processes). Therefore, quantitatively both FCS and strength of 
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gels had the same effect on characteristics of chondrocytes and they appeared to be 
related in controlling chondrocyte morphology. The penetration of FCS was 




This study aimed at developing a reproducible in vitro 3D agarose gel culture model 
to study the morphological and volume changes in chondrocytes. The results 
supported the hypotheses such that chondrocytes cultured in weak agarose gels and 
with high concentrations of FCS displayed striking changes in volume and 
morphology (clusters/cytoplasmic processes) as compared to strong gels and with 
low concentrations of FCS. An obvious striking increase in density, volume and 
production of abnormal morphology (clusters/processes) was observed in the cells 
cultured in weak compared to the strong agarose gels (Figs. 4.21 & 4.22). Similar 
morphological changes were also observed in strong gels but the effect was mild. In 
other words strong gels appeared to slow down the changes to chondrocyte 
morphology. Additionally, chondrocytes cultured in weak gels over one week with 
high concentration of FCS displayed marked increase in chondrocyte density and 
altered morphology (clusters/processes) as compared to the low concentration of 
FCS (Fig. 4.36) where lower cell density and lesser clusters/processes were 
observed.   
Various difficulties were encountered to establish this culture model and were 
minimised by taking great care and sometimes altering the methodology. The 
production of successful sterile cell cultures was the greatest problem and was 
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overcome by using rigorous aseptic experimental conditions. All the instruments 
used in these experiments were autoclaved, the joints were dissected under strict 
aseptic sterile conditions in class I-flow hood, freshly-prepared culture medium with 
antibiotics was used and medium changed on alternate days during the culture 
period. A specific type of agarose was used in these experiments, having a low 
melting point, was very sensitive to temperature changes therefore, 2% gel-
chondrocyte suspension tended to set prematurely before getting thoroughly mixed 
and pipetted into the gel mould. This problem was solved by keeping the suspension 
warm in a water bath at 37˚C inside the flow hood and also by using pre-warmed 
pipette tips. The weak agarose gels took more time to set and were difficult to handle 
as they would often fall out of the 3D gel mould. This was overcome by cooling the 
gel mould to 4°C before pipetting the weak gel-chondrocyte suspension. This would 
let the temperature of the suspension fall quickly when pipetted in the wells causing 
the weak gels to set at once and firmly in the wells. The CLSM image acquisition 
was also problematic due to thickness of the gel blocks and it was optimized by 
cutting the base of the gel blocks carefully with a sharp sterile scalpel blade. 
However, the methodology finally used for obtaining these results was quite 
reproducible and allowed the successful culture of chondrocytes in different 
concentrations of agarose over a period of two weeks, thereby, promoting the 
maintenance of chondrocyte phenotype over the culture period. Use of bovine 
chondrocytes for orthopaedic research is well established as they can be obtained in 
adequate number and the cost effect is minimal and the findings from these cells may 
be relevant in the human condition (OA) by carrying out similar experiments on 
human tissue. As a general observation the changes in chondrocyte morphology were 
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more numerous on the gel surface and in the superficial layers of the gels but were 
easily seen until 100µm depth; below this point the fluorescent signals were very 
weak. Chondrocytes were occasionally present in pairs (Fig. 4.32) and this 
bichondral configuration is often present in intact bovine cartilage as previously 
reported by (Sasazaki et al., 2008). The chondrocyte pairs in situ were therefore 
possibly isolated as pairs following incubation with collagenase.  
The volume of isolated bovine chondrocytes when cultured in weak gels increased 
significantly even after 1 day during in vitro culture as compared to the strong gels 
(Fig. 4.12). In a previous study it has been reported that the volume changes due to a 
change in medium osmolarity of in situ and isolated articular chondrocytes from 
280mOsm to 380mOsm were similar (chondrocyte volume = 668 ± 31.7 µm
3   
and
  
646 ± 54.6 µm
3  
respectively) (Bush and Hall, 2001a). In the present experiments as 
DMEM with osmolarity raised to 380 mOsm (by adding NaCl) was used we believed 
that the isolated cells would maintain their in situ volume (Bush and Hall, 2001a). 
However, the likely explanation for increase in volume noticed in weak gels as 
compared to strong gels may be that chondrocytes have a tendency to swell and they 
can do this more easily in the weak gels as compared to strong gels.  
Abnormal chondrocytes with processes developed in weak gels due to enhanced 
penetration of FCS therefore, both the factors appeared to be related such that FCS 
penetrability was enhanced in weak gel strength. Chondrocytes cultured in weak 
agarose gels started developing cytoplasmic processes in the early days of in vitro 
culture compared to strong gels (Fig. 4.14) and there could be several possible 
theories to explain these morphological changes. Since the penetrability of serum 
factors has been shown to decrease with increasing concentration of agarose 
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(Johnson et al., 1996), decreased stiffness of hydrogel could increase the availability 
of nutritive factors to the chondrocytes cultured in weak gels. Therefore, one possible 
explanation for morphological changes of these chondrocytes cultured in weak 
concentration of agarose gels is possibly due to increased rate of penetration of FCS 
into the weak gels. These serum morphogenic factors such as growth hormone, 
thyroid hormones T3/T4 and insulin possibly stimulated chondrocytes and promoted 
their synthetic activity. As a result, enhanced production of catabolic cytokines such 
as IL-1ß and TNFα caused destruction of the pericellular matrix of chondrocytes 
possibly collagen type VI and thus cytoplasmic extensions protruded out. This 
mechanism can be explained in the light of a study which stated that the abnormal 
chondrocytes with processes were associated with high levels of IL-1ß and disrupted 
pericellular collagen type VI (Murray et al., 2010). The previous and present studies 
cannot be directly compared because the previous study was performed on in situ 
chondrocytes and the results of present study are based on cultured chondrocytes. 
Although IL-1ß levels and type VI was beyond the scope of this work it can be 
speculated that abnormal cultured chondrocytes with processes may also produce 
high levels of IL-1ß thereby causing disruption of collagen type VI. Second possible 
explanation could be that the cells respond by sensing the stiffness of the culture 
material (Schuh et al., 2010). This can be well explained with a recent study 
highlighting the influence of substrate stiffness on mechanical properties of 
chondrocytes regulated by changes in actin cytoskeleton, focal adhesions and altered 
ECM synthesised (Chen et al., 2014). Therefore, it is possible that in the present 
study the ability of chondrocytes to sense the stiffness of their environment led to 
different morphological responses in different gel strengths. Third possibility could 
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be that the structural macromolecules such as PGs produced by chondrocytes in 
weak concentration of agarose gel were diffused through the gels possibly due to 
lack of an effective scaffold and enough attachment sites. However, the strong gels 
were dense enough to provide a scaffold for attachment and thus the ECM remained 
localised to the chondrocytes rather than getting diffused and assisted them in 
maintaining their spheroid morphology (Buschmann et al., 1992). Therefore, these 
reduced cell-matrix interactions in the weak gels could be a possible cause of 
abnormal shapes and development of processes.  
In a very recent study it was reported that matrix stiffness does not influence the 
maintenance of chondrocytic phenotype (Schuh et al., 2012b) but increased cluster 
formation, enhanced expression of DNA and ECM formation by chondrocytes 
cultured in softer gels as compared to the stiffer gels was observed. Moreover, they 
measured expression of type II collagen and observed no effect of gel strength on 
expression of type II collagen. On the other hand the study presented here 
highlighted the detailed analysis of changes to chondrocyte morphology with varying 
gel strength. The common feature between previous and present study was 
chondrocyte cluster formation in weak/soft gels as compared to strong/stiff gels. 
There can be several reasons why morphological changes were not observed by 
Schuh and co-workers but the few main ones will be discussed here. One possibility 
is the difference in culture conditions as the minimum concentration of agarose used 
in their experiments was 0.75% and in the present study very weak gel strength 
(0.2%) was used and this might be the cause of altered morphology. However, an 
interesting future experiment could be culturing chondrocytes in 0.75% gel strength 
and studying their morphology as this can give a better insight as to whether 
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chondrocytes change shape at 0.75% gel strength or not. The other likely possibility 
is that in the previous study, immunohistochemistry (IHC) was used to study 
expression of collagen types I and II whereas in the present study chondrocytes were 
labelled with CMFDA. It was unlikely to visualise chondrocyte shape changes with 
the fluorescent markers labelling matrix in the previous study whereas labelling 
chondrocytes with CMFDA rendered it possible to visualise cytoplasmic processes 
as it labelled the cytoplasm.  
We have also frequently observed cluster formation later during in vitro culture. 
Large sized clusters having more number of cells/cluster were present in weak gels 
as compared to strong gels (Fig. 4.21) and the number of clusters formed was 
significantly higher in weak gels with higher concentration of FCS as compared to 
the lesser concentrations of FCS (Fig. 4.36). An explanation could be the greater 
access of growth and proliferative factors present in the serum to the chondrocytes 
cultured in weak gels and to those within weak gels with higher concentrations of 
FCS. These growth factors might have stimulated the cells leading to proliferation 
and clusters were formed (van Susante et al., 2000). However, the chondrocytes 
cultured in strong gels with lower levels of penetration of FCS displayed low 
proliferative activity and lesser cluster formation (Johnson et al., 1996). Previous 
studies done on the degenerated osteoarthritic human cartilage (Weiss and Mirow, 
1972, Bush and Hall, 2003) also observed cluster formation. Cluster formation is 
considered the hallmark of OA and the weak gels used in this study as an in vitro 
model for OA also displayed this change in cultured bovine chondrocytes (Figs. 4.24 
& 4.38). Furthermore, the occurrence of chondrocyte clusters in the 
degenerate/weakened matrix in the superficial layers of cartilage have been related to 
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the enhanced access of growth factors present in synovial fluid (Meachim and 
Collins, 1962). The detailed quantitative analysis of data regarding cluster formation 
revealed that the volume of individual chondrocytes in the clusters remained 
unaffected but the total volume of clusters and number of cells per cluster increased 
significantly (Fig. 4.24). These findings suggested that in the weak gels under the 
effect of certain proliferative factors such as growth hormone present in FCS 
chondrocyte proliferation was triggered in forming clusters rather than increasing in 
volume. 
This study has provided new insights regarding the effect of gel strength and 
morphogenic factors present in serum on chondrocyte morphology. In conclusion, 
both factors i.e. FCS and gel strength appeared to be related in controlling 
chondrocyte morphology as penetrability of FCS increased due to weak gel strength. 
In contrast, in the strong gels the penetration of FCS was reduced. Whether 3D 
agarose gel model developed in this study can be utilised to study chondrocyte 
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5.1 CHAPTER SUMMARY 
 
Chondrocyte morphology strongly influences the metabolism of ECM. This chapter 
aimed to assess the matrix produced by isolated bovine chondrocytes cultured in 
strong (2%) or weak (0.2%) agarose gel concentrations at days 1, 3 and 7 of culture. 
Haematoxylin and eosin (H&E), Alcian blue and Masson’s trichrome stainings were 
performed by histology for chondrocyte morphology, proteoglycans (PGs) and 
collagen respectively. The H&E staining showed presence of chondrocyte clusters in 
weak gels by days 3 and 7 of culture as compared to strong gel strength. By days 3 
and 7 of culture the percentage of Alcian blue staining was significantly higher in the 
cryosections of strong gels as compared to weak gels (P<0.001). However, Masson’s 
trichrome staining results were inconclusive in these strong or weak gel sections. The 
abnormal chondrocytes in weak agarose gels produced altered matrix.  
5.2 INTRODUCTION 
 
In articular cartilage, chondrocytes are responsible for the production of matrix 
macromolecules thereby maintaining the normal tissue architecture and providing 
load-bearing properties to cartilage for its normal functioning. The major 
components of cartilage matrix are PGs (mainly aggrecan) and collagens (McDevitt, 
1973). Matrix synthesis and breakdown are controlled by the anabolic and catabolic 
activities of chondrocytes thereby, maintained at a steady state level (Pearle et al., 
2005). In OA, this balance is disturbed and chondrocyte catabolic activities exceed 
anabolic activities leading to cartilage degeneration (Goldring and Goldring, 2004). 
Therefore, in the pathophysiology of OA, altered chondrocyte metabolism is one of 
the mechanisms involved in cartilage degeneration. This altered chondrocyte 
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metabolism leads to loss of PGs and loosening of matrix as early events of OA 
(Malemud, 1991). The loss of PGs leads to matrix weakening, increased permeability 
and swelling of the cartilage (Wang et al., 2013a) thereby reducing stiffness 
(Maroudas, 1976) and mechanical resilience of the tissue. This weakened matrix 
increases access of proliferative factors from the synovial fluid to the chondrocytes 
thus stimulating them and producing clusters especially in the superficial layers of 
cartilage (Schumacher et al., 2002, Lotz et al., 2010).  
Cell metabolism has already been associated to changes in cell shape and volume in 
several other types of cells (D'Anselmi et al., 2011). Few studies conducted on the 
morphology of chondrocytes in OA have reported abnormal chondrocyte 
morphology in this disorder (Kouri et al., 1998, Bush and Hall, 2003). There exists a 
strong relationship between chondrocyte morphology and the biosynthetic activity as 
reported in a study where fibroblast-like chondrocytes were seen in late stages of OA 
and were associated with the expression of abnormal matrix rich in type I collagen 
and small molecular weight PGs (Tesche and Miosge, 2005). Additionally, in a 
recent study, abnormal chondrocyte morphology has been related to increased levels 
of IL-1ß and decreased pericellular type VI collagen levels (Murray et al., 2010). To 
determine the effect of abnormal chondrocyte morphology on matrix metabolism 3D 
agarose gel model has been utilised in this study. 
As explained in the previous chapter (chapter 4) a 3D agarose gel model was 
developed and utilised as a tool to control chondrocyte shape, therefore, strong and 
weak gels were used as control and experimental conditions. The strong gels were 
used to compare healthy intact matrix whereas, weak gels to compare 
damaged/weakened matrix. The importance of using agarose gel cultures could be 
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due to two main reasons: Firstly, chondrocytes when isolated from their native 
environment by cell isolation technique using enzymatic digestion of ECM and 
cultured in 3D agarose gels have shown to maintain their phenotype during long-
term culture (Benya and Shaffer, 1982). Secondly, chondrocytes synthesize 
mechanically functional proteoglycan-collagen matrix when cultured in agarose gels 
(Buschmann et al., 1992) and have been reported most suitable for chondrocyte 
culture (Schuh et al., 2012a).  
In the preliminary work presented in this thesis by using fluorescent-mode CLSM 
chondrocytes displayed marked changes to morphology (clusters/processes) when 
cultured in weak gels as compared to strong gels (section 4.6). Whether these 
chondrocytes with abnormal morphology produced altered matrix in comparison to 
morphologically normal chondrocytes, histological examination was performed and 
results presented in this chapter. 
5.3 HYPOTHESIS 
 
The abnormal chondrocytes with cytoplasmic processes in weak agarose gels 
produced altered matrix in comparison to normal chondrocytes cultured in strong 
gels. 
5.4 MATERIALS AND METHODS 
 
5.4.1 Tissue processing for histology of isolated chondrocytes cultured in 3D 
agarose gel moulds 
Freshly isolated bovine chondrocytes were cultured in two different gel strengths 
(2% and 0.2%) i.e. strong and weak according to the methodology already described 
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(section 4.4). At three time points (days 1, 3 and 7) the strong and weak gels 
containing cultured bovine chondrocytes were snap frozen and sectioned to prepare 
for the histological staining. 
5.4.2 Snap freezing and sectioning of gels 
 
A beaker containing hexane was placed in dry ice one hour prior to snap freezing to 
cool hexane to approx. -70°C. The strong and weak gels were placed in aluminium 
foil boats and immersed in the pre-cooled hexane to snap freeze. Snap freezing is a 
technique for rapid cooling of samples to maintain tissue integrity at molecular level 
as much as possible by avoiding dehydration of samples. In a previous study it has 
been reported that rapid cooling caused very little damage to the cartilage matrix 
(Guan et al., 2006). After freezing, the gel blocks were wrapped in aluminium foil 
separately, labelled and stored at -80°C until required. The gels were taken out from -
80° freezers and kept in -20° freezers a night before cutting in order to equilibrate 
them to the cutting temperature. A few drops of OCT (optimal cutting temperature, 
Bright Instrument Company, UK) were poured on the chuck of the cryostat (Leica 
CM3050S, Leica Microsystems Ltd., UK) and the gel blocks were submerged almost 
one-third in the OCT in such a way that it covered the base of the gel block and just 
lower one-third of the sides of block. The gel block was left in OCT for 5 min until it 
was frozen and the gel was fixed properly to the chuck. The chuck was placed in the 
cutting position and oriented at an angle to cut the block symmetrically. The samples 
were then sectioned (10 µm thick) by adjusting temperature between -23°C and -
26°C. The sections were cut slowly and cautiously to avoid any wrinkling of the 
tissue and collected onto Superfrost microscopy slides (Thermo Scientific, UK). 
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Slides were labelled, individually wrapped in aluminium foil, kept in boxes and 
stored at -80°C until used. The slides were left at room temperature before being 
unwrapped and used for histology. 
5.4.3 Histological staining 
 
The sections were stained with H&E, Alcian blue and Masson’s trichrome staining 
techniques in a single large-batch in order to limit artefact introduced discrepancies 
in the staining intensity. The details of histological staining steps were given in 
following sections. 
 H&E staining of frozen sections 5.4.3.1
 
The H&E staining was performed to visualise the morphology of chondrocytes 
cultured in strong and weak gels at three time points during the culture. The frozen 
sections were fixed in 4% PFA for 20 min at room temperature, rinsed gently in tap 
water. The slides were then placed in jars containing filtered Harris’ haematoxylin 
(Avwioro, 2011) composed of 1 g haematoxylin, 10 ml absolute alcohol, 20 g 
potassium alum, 200 ml distilled water (D/W), 0.5 g mercuric oxide and 8 ml glacial 
acetic acid added once solution is cooled (Sigma-Aldrich, Poole, U.K.) for 5 min, 
and then washed in running water. The slides were placed in STWS (Scott’s tap 
water substitute) composed of 20 g magnesium sulphate, 3.5 g sodium bicarbonate 
(Sigma-Aldrich Co. Ltd., Poole, UK) and 1 L D/W as this blues the haematoxylin; for 3 
min and then washed in water for 3 min. The staining was checked under the 
microscope and the slides were placed in 1% water based filtered eosin composed of 
1 g eosin in 100 ml (Sigma-Aldrich, Poole, U.K.) for 2 min. The slides were rinsed 
briefly in water and placed in 5% Potassium alum composed of 5 g potassium 
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aluminium sulphate in 100 ml of D/W, for 2 min and rinsed in water again. The 
slides were placed on racks and left to air dry overnight inside the flow hood and the 
flow hood was left on. The next day, slides were mounted directly in organic solvent 
soluble DPX mounting medium distyrene plasticizer xylene (DPX, Sigma-Aldrich 
Co. Ltd., Poole, UK) a mixture of distyrene, plasticizer and xylene, cover slipped and 
left in the flow hood overnight. After drying, the slides were placed in slide boxes 
and stored at room temperature until used. 
 Alcian blue staining of frozen sections 5.4.3.2
 
Proteoglycans (PGs) are composed of glycosaminoglycans (GAGs) covalently 
attached to the core protein. These highly sulphated negatively charged PGs in the 
cultured chondrocytes were stained with 1% Alcian blue 8GX (Sigma-Aldrich, 
Poole, U.K.); pH1.0. 1 g of Alcian blue 8GX dissolved thoroughly on a magnetic 
stirrer in 100 ml of 0.1M HCl at room temperature; solution filtered and stored at 
room temperature. The sections were fixed with 4% PFA, washed with PBS (x3) and 
then stained in filtered Alcian blue solution overnight. The slides were rinsed once 
with 0.1M HCl (0.36 ml of HCl was dissolved in 100 ml of D/W to prepare 0.1M 
HCl), then with PBS (x2) and then with water. The sections were counterstained in 
Nuclear fast red solution composed of 12.5 g of aluminium sulphate dissolved in 250 
ml of D/W; 0.25 g of nuclear fast red was added and slowly heated to boil and cool; 
solution filtered and a grain of thymol (Sigma-Aldrich, Poole, U.K.) was added as a 
preservative, for 5 min to stain the nuclei pink and washed in running tap water for 1 
min and finally rinsed in D/W once for 2 min. The slides were then dehydrated in 
ascending grades of ethanol (70%, 95% and 100% for 2 min each), cleared in xylene 
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(5 min), mounted and cover-slipped in DPX and stored as previously described 
(section 5.4.3.1). 
 Masson’s trichrome staining of frozen sections 5.4.3.3
 
To stain the collagen amongst the cultured chondrocytes in strong and weak gels, the 
frozen sections were stained with a Masson’s trichrome staining technique (Suvik 
and Effendy, 2012). Masson’s trichrome does not selectively stain any particular type 
of collagen rather collectively stains the overall collagen present within the tissue. In 
a recent study the histological evaluation of overall cartilage repair was performed by 
Masson’s trichrome and type II collagen was detected by immunohistochemistry 
(Chung et al., 2014). The sections were fixed with 4% PFA, washed in D/W and 
stained in Weigert’s iron Hematoxylin working solution (Stock solution A: 1g 
Hematoxylin was dissolved in 100 ml of 95% alcohol; Stock solution B: 4 ml of 29% 
ferric chloride and 1 ml of concentrated HCl was added to 95 ml of D/W; equal parts 
of stock solution A and B were mixed) for 5 min. The slides were then rinsed in 
running warm tap water for 10 min and then washed in D/W. The slides were then 
placed in jars containing Biebrich scarlet-acid fuchsin solution (90 ml of 1% aqueous 
Biebrich scarlet, 10 ml of 1% aqueous acid fuchsin and 1 ml of glacial acetic acid 
were dissolved) for 10 min and then washed in D/W. The sections were then 
differentiated in phosphomolybdic-phosphotungstic acid solution (25 ml of 5% 
phosphomolybdic acid solution was added to 25 ml of 5% phosphotungstic acid 
solution) for 15 min. The sections were transferred directly (without rinse) to Aniline 
blue solution (2.5 g aniline blue was dissolved in 2 ml of glacial acetic acid and 100 
ml of D/W) and stained for 15 min, rinsed briefly in D/W and differentiated in 1% 
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acetic acid solution (1 ml of glacial acetic acid was added to 99 ml of D/W) for 3 min 
and finally washed in D/W. The slides were dehydrated very quickly through 
absolute ethyl alcohol, cleared in xylene, mounted, dried and stored as previously 
described.  
5.4.4 Acquisition of photomicrographs of stained sections of cultured bovine 
chondrocytes 
The photomicrographs of the stained sections of chondrocytes cultured in different 
gel concentrations were obtained using Leica DMRE 35578 upright microscope 
(Leica Microsystems GmbH, Wetzlar, Germany) with 12V 100W halogen bulb for 
bright field (BF) illumination and during imaging the condenser disc was adjusted 
for bright field position. The images were obtained with x10 PL Fluotar or x20 PL 
Apo/oil lenses with NA of 0.30 and 0.70 respectively and captured with mounted 
digital QImaging Retiga 2000R-monochrome cooled CCD camera (Photometrics, 
Tucson, U.S.A.). An RGB (red green blue) filter placed in front of the camera 
allowed capture of colour images. The coloured images were then viewed and 
captured by using QCapture Pro v6.0 software (Photometrics, Tucson, U.S.A.) after 
adjusting the appropriate light intensity. On all the slides various sections were 
imaged randomly and in one session with similar microscopic adjustments in order to 
avoid discrepancies in the measurement of intensity of staining colour due to 
variability in the intensity of light.  
5.4.5 Analysis of images by using ImageJ analysis software 
 
The photomicrographs of stained histological sections were then analysed by Java-
based image processing software ImageJ
 
version 1.46h (ImageJ, NIH, Bethesda, MD, 
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U.S.A.). The images acquired provided information regarding the staining intensity 
which was visualised and analysed to obtain quantitative data. H&E stained 
photomicrographs were visualised to compare the density and morphology of 
cultured chondrocytes in the strong and weak gels. 
The high power (x20 oil immersion) magnification images were used for 
determination of staining pattern of the cultured chondrocytes at days 1, 3 and 7 of 
culture and compared in both concentrations of agarose gel.  A specified ROI was 
applied with dimensions of x, y, z 178, 192 and 10 µm respectively around the 
cells/clusters and not taking into account the background staining of gels. Firstly, 
after applying the ROI the image was cropped and the area of the whole ROI was 
measured. Secondly, colour threshold was adjusted and blue stained area around 
cell/cluster was measured. Lastly, a percentage of Alcian blue staining was 
determined with the formula 100 x (Blue stained area around cell/cluster/total area of 
ROI applied) %. It was possible to determine percentage of Alcian blue staining 
between single cells. However, in order to determine percentage staining of 
individual chondrocytes within a cluster, the staining of the cluster was determined 
initially. This was because the threshold of intensity of blue colour was similar for all 
the cells in the cluster and the segmentation of staining around individual cells in the 
cluster was not possible (Fig. 5.1). The number of cells in the clusters was counted 
by eye on ImageJ by counting the nuclei stained with Nuclear fast red dye. 
Therefore, the average Alcian blue staining around individual cells in a cluster was 
determined with the formula (percentage of Alcian blue staining in cluster (%)/total 




Figure 5.1: Determination of staining intensity of images by ImageJ analysis 
software. 
Examples of determination of Alcian blue stained area for (A) single cell in the 
strong gel and (B) cluster in the weak gel. The left panel shows full image with the 
application of specified ROI, centre panel contains cropped images within ROI and 
right panel comprises of images outlining the blue area determined after adjusting for 




5.5.1 Histological evaluation of matrix produced by isolated bovine 
chondrocytes cultured in strong or weak agarose gels 
 
In order to investigate and compare the differences in matrix produced by 
chondrocytes with altered morphology (clusters/cytoplasmic processes) and 
morphologically normal chondrocytes, histology was performed. As a first step, it 
was observed that the strong gels had higher intensity of background staining with 
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Alcian blue caused by the staining of agarose gel molecules as compared to weak 
gels throughout the culture (Fig. 5.2; P<0.002). Therefore, a region of interest (ROI) 
was determined to encompass the staining intensity around individual cells/clusters 
rather than taking into account the whole image in order to avoid the discrepancies 
produced due to background staining. Therefore, this background staining had no 
impact on the results. An alternative method could have been to subtract the 
background staining value in both strong and weak gels. However, to be more 
accurate chondrocytes and clusters were analysed individually.   
 
Figure 5.2: Percentage intensity of background staining of Alcian blue in strong 
and weak gels. 
Graph shows pooled data with a significantly less background staining of Alcian blue 
in weak gels as compared to strong gels. Data were from [N(n) = 3(8)]. * indicated a 
significant difference according to unpaired student’s t-test. The single, double and 
triple symbols showed the level of significance for P<0.05, 0.01 and 0.001 
respectively. 
 
 Alcian blue staining 5.5.1.1
 
The histology sections of isolated chondrocytes cultured in strong and weak gels 
were stained with Alcian blue to stain PGs present at three time points. The specified 
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ROI (section 5.4.5) was selected and applied to all the images and in both strengths 
of agarose gels. The percentage staining was calculated by applying the specified 
ROI to all the images without any alteration in the dimensions of ROI. The data 
seemed to be complicated by days 3 and 7 of culture because of the presence of 
clusters therefore; average percentage staining around individual cells in the cluster 
was calculated (section 5.4.5). At day 1, slight Alcian blue staining was observed 
around chondrocytes but there was background staining in the sections having 
chondrocytes cultured in both strengths of gel and nuclei could be seen (Figs. 5.3a, b 
& 5.4a, b). At days 3 and 7 of culture the Alcian blue stain was less in the 
chondrocytes cultured in weak as compared to strong gels (Figs. 5.3 & 5.4). The 
Alcian blue staining was not easily visible at low power magnification hence high 
power images were analysed to study the different staining pattern in both gel 
strengths.  
The quantitative data regarding percentage of Alcian blue staining varied in the two 
strengths of gel. At day 1, chondrocytes cultured in strong and weak gels showed 
almost no staining with Alcian blue (Fig. 5.5). The chondrocytes cultured in both gel 
strengths showed a significant increase in the percentages of Alcian blue staining by 
days 3 and 7 of culture as compared to day 1 (Fig. 5.5; P<0.001; one-way ANOVA 
for the two time points and in both strengths of gel). Alcian blue staining appeared 
more intense and structured around chondrocytes in the strong as compared to weak 
gels where staining was less in intensity and diffused in appearance (Fig. 5.4e&f).  
Percentages of Alcian blue staining were compared in both strengths of agarose gel 
and was observed that at day 3, percentage of Alcian blue staining was significantly 
higher in the chondrocytes cultured in strong gels (4.9±0.4%) as compared to weak 
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gels (2±0.1%; Fig. 5.5; P<0.001; student’s t-test). Similarly, at day 7 the percentage 
of Alcian blue staining was also found to be significantly higher in the strong gels 
(6.5±0.4%) as compared to weak gels (1.7±0.2%; Fig. 5.5; P<0.001; student’s t-test). 
Additionally, the percentage of Alcian blue staining around chondrocytes increased 
significantly at day 7 as compared to day 3 (P<0.05). However, the percentage of 
Alcian blue staining by day 7 remained unaffected in weak agarose gels as compared 
to day 3, but they appeared to stain positively for Alcian blue after day 3. 
 
Figure 5.3: Photomicrographs of Alcian blue stained sections of chondrocytes 
cultured in different gel strengths at low power magnification. 
The histological sections of cultured chondrocytes stained with Alcian blue and 
imaged at low power (x10) at (a, b) day 1, (c, d) day 3 and (e, f) day 7 of culture in 
strong (left panel) and weak (right panel) agarose gels. Section (a) shows artefact in 




Figure 5.4: Photomicrographs of Alcian blue stained sections of chondrocytes 
cultured in different gel strengths at high power magnification. 
The histological sections of cultured chondrocytes stained with Alcian blue and 
imaged at high power (x20 oil immersion) at (a, b) day 1, (c, d) day 3 and (e, f) day 7 
of culture in strong (left panel) and weak (right panel) agarose gels. Scale bar for 
both panels = 25µm. 
 
To summarise this section, percentage of Alcian blue staining increased 
progressively during the course of culture in the strong gels. In the weak gels 
percentage of Alcian blue staining increased significantly by day 3 but no further 
increase was detected by day 7. At days 3 and 7 of culture percentages of Alcian blue 





Figure 5.5: The percentage of Alcian blue staining of isolated bovine 
chondrocytes cultured in strong and weak gels. 
Graph shows pooled data regarding percentage of Alcian blue staining of cultured 
chondrocytes at days 1, 3 and 7 of culture in different gel strengths. Data were from 
[N(nʹ) = 6(10,10), (27, 42) and (43, 54) cells at days 1, 3 and 7 strong and weak gels 
respectively]. * indicated a significant difference according to unpaired student’s t-
test. # indicated a significant difference according to one-way ANOVA followed by 
Tukey’s multiple comparison post-hoc test. The single, double and triple symbols 
showed the level of significance for P<0.05, 0.01 and 0.001 respectively. 
 
 
 H&E staining 5.5.1.2
 
The H&E stain the nuclei and cytoplasm of the cells as purple and pink respectively, 
haematoxylin is a powerful and selective nuclear stain giving sharp outline of nuclear 
structure (Avwioro, 2011). The low and high power  images of H&E stained sections 
of cultured chondrocytes (Figs. 5.6 & 5.7) showed cluster formation in the weak as 
compared to strong gels by days 3 and 7 of culture. In the preliminary experiments, 
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with the use of fluorescent mode CLSM, chondrocytes cultured in weak gels showed 
cytoplasmic processes emanating from the cell bodies as compared to the 
chondrocytes cultured in strong gels (section 4.5). These results suggested that 
chondrocytes changed shape dramatically in the weak gels. However, it was not 
possible to visualise these fine morphological details by the routine histological 
techniques. With H&E histological staining, at day 7 of culture the cell density also 
appeared to increase in the weak gels as compared to strong gels (Figs. 5.6 & 5.7). 
Quantitative data regarding cell density could not be acquired with H&E staining 
because of the clusters present and it was not possible to count number of cells in a 
cluster in a 2D image. Moreover, the non-specific H&E staining of the background 
was more in the strong gels as compared to the weak gels (Figs. 5.6 & 5.7). The 
explanation for this background staining can be due to haematoxylin binding to the 

















Figure 5.6: Photomicrographs of H&E stained sections of isolated chondrocytes 
cultured in different gel strengths at low power. 
The histological images (x10) of cultured chondrocytes at (a, b) day 1, (c, d) day 3 
and (e, f) day 7 of culture in strong (left panel) and weak (right panel) gels. The inset 
images show twice zoomed in areas and indicates to the examples of chondrocyte 
clusters present in the weak gels. Scale bar for all panels and for inset images = 





Figure 5.7: Photomicrographs of H&E stained sections of isolated chondrocytes 
cultured in different gel strengths at high power. 
The histological images (x20 oil immersion) of cultured chondrocytes at (a, b) day 1, 
(c, d) day 3 and (e, f) day 7 of culture in strong (left panel) and weak (right panel) 
gels. Solid arrows indicate to the examples of chondrocyte clusters present in the 





 Masson’s trichrome staining 5.5.1.3
 
The histology sections of cultured chondrocytes in strong and weak gels were stained 
with Masson’s trichrome stain to roughly estimate the presence of collagen produced 
by cultured cells. This technique stains nuclei black, cytoplasm/muscle red and 
collagen blue (Kiernan, 2008). The Masson’s trichrome staining technique stained 
the collagen present as shown in a representative control image of cartilage section 
with blue (Fig. 5.8B). The low and high power magnification images of Masson’s 
trichrome showed weak staining (Figs. 5.8 & 5.9) during the course of culture. The 
positive staining in the control samples and weak staining observed in the 
experimental sections indicated two possibilities. The first one was that the technique 
was not successful for detecting collagen within chondrocytes cultured in agarose 
gels. Second possibility was that in such a short time no significant levels of collagen 
were produced by chondrocytes. In summary this staining method couldn’t stain 
collagen if produced by these cultured chondrocytes at days 3 and 7 of culture in 
















Figure 5.8: Low power photomicrographs of Masson’s trichrome stained 
sections of chondrocytes cultured in strong and weak gels. 
 (A) The histological sections of cultured bovine chondrocytes stained with Masson’s 
trichrome and imaged at low power (x10) at (a, b) day 1, (c, d) day 3 and (e, f) day 7 
of culture in strong (left panel) and weak (right panel) gels. (B) The representative 
image of positive control for collagen staining with Masson’s trichrome stain in 
bovine articular cartilage showing presence of collagen in all the zones of cartilage. 






Figure 5.9: High power photomicrographs of Masson’s trichrome stained 
sections of chondrocytes cultured in strong and weak gels. 
The histological sections of cultured bovine chondrocytes stained with Masson’s 
trichrome and imaged at high power (x20 oil immersion) at (a, b) day 1, (c, d) day 3 
and (e, f) day 7 of culture in strong (left panel) and weak (right panel) gels. Scale bar 








The results partially supported the main hypothesis of the study such that Alcian blue 
staining was significantly less in the chondrocytes cultured in weak gels but the 
results for the Masson’s trichrome staining were unconvincing. The histology with 
H&E revealed the presence of chondrocyte clusters in the weak gels but not in strong 
gels (Figs. 5.6 & 5.7). The Alcian blue staining pattern might indicate higher levels 
of PGs in strong versus weak gels (Fig. 5.5). However, Masson’s trichrome staining 
results were indecisive and collagen if produced by these cultured chondrocytes 
could not be successfully detected in strong and weak gels by day 7.  
Some technical difficulties encountered during staining procedure and data 
acquisition were attempted to be minimised. Firstly, in the Alcian blue stained 
sections there was non-specific background staining because of binding of dye to the 
agarose molecules due to its ability to bind polysaccharides (Terry et al., 2000). This 
background staining was more intense in strong gels as compared to weak gels (Fig. 
5.2). During culture this background Alcian blue staining intensity did not increase in 
either strengths of gel (Fig. 5.4) but the staining intensity around chondrocytes 
increased in the strong gels (Fig. 5.5). This suggested that may be the background 
staining was not due to binding of dye to the PGs rather it was due to binding to 
agarose molecules. Secondly, in the Masson’s trichrome staining technique with the 
protocol published by others (Suvik and Effendy, 2012) showed inconclusive results 
(Figs. 5.8A & 5.9). Although by the same protocol cartilage samples (positive 
control) were stained successfully for the presence of collagen (Fig. 5.8B). These 
technical staining issues are now discussed in detail. 
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In this study the fine morphological details (cytoplasmic processes) were possibly 
masked because of the histological techniques performed and changes to 
chondrocyte morphology were not visible (Fig. 5.7). To author’s knowledge there is 
no reported evidence of presence of cytoplasmic processes with routine histology and 
light microscopy. The few studies done on OA tissue reporting the presence of these 
cytoplasmic processes in this disorder utilised CLSM to visualise this morphological 
feature of chondrocytes (Kouri et al., 1998, Bush and Hall, 2003).  
Cluster formation is a characteristic feature of OA (Lotz et al., 2010) and was 
observed routinely in H&E stained sections in this study at days 3 and 7 in the weak 
gels as compared to strong gels (Figs. 5.6 & 5.7). These findings are in agreement 
with previous studies where cluster formation was observed in chondrocytes cultured 
in agarose gels (Buschmann et al., 1992, Ross et al., 2006, Schuh et al., 2012b). The 
presence of these clusters could be possibly due to the greater access of 
proliferative/growth factors present in serum to the chondrocytes cultured in weak 
gels as compared to strong gels (Schuh et al., 2012b). This can be well explained by 
considering a study reporting the greater diffusive hindrance in the gels with higher 
concentration of agarose (Johnson et al., 1996). In this previous study it was reported 
that in the dilute gels with low concentration of agarose there was less hindrance to 
diffusion and therefore greater diffusivity. This previous study also suggested that in 
more concentrated gels the diffusion was hindered. Therefore, in the present study 
possibly growth/proliferative factors such as growth hormone and insulin present in 
the FCS could diffuse more in the weak gels as compared to the strong gels. These 
factors could possibly trigger chondrocytes to proliferate and form clusters.  
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Masson’s trichrome staining for the cultured chondrocytes in strong and weak gels 
results were indecisive (Figs. 5.8 & 5.9). A possible explanation could be that these 
chondrocytes were cultured over a period of just 7 days and this time period was not 
enough to produce a quantity of collagen detectable by this histological technique. 
However, in a previous study production of small amounts of type II collagen by 
chondrocytes was detected at day 6 of culture in 2% agarose gels but the technique 
used was IHC to detect collagen (Bougault et al., 2008). Masson’s trichrome is a 
very crude method for staining collagen in comparison to IHC which is quite a 
sensitive method of collagen staining. Therefore, possible explanation of these 
indecisive results can be either insufficient production of collagen by cultured 
chondrocytes or the insensitivity of the technique utilised. 
Alcian blue staining is considered a standard histological staining method and has 
been successfully used to stain PGs amongst the chondrocytes cultured in agarose 
gels (An et al., 2001). In order to minimise the error produced by background 
staining, the ROI was created and applied in the vicinity of chondrocytes and the 
percentage staining was calculated for individual cells (section 5.4.5). In the Alcian 
blue stained sections at days 3 and 7, the percentage of Alcian blue staining was 
significantly less around chondrocytes in the weak gels as compared to strong gels 
(Fig. 5.5). This decreased Alcian blue staining intensity in weak gels led to the notion 
that chondrocytes possibly produced lesser amount of PGs as compared to strong 
gels and there may be several possible explanations for this observation. Firstly, it is 
possible that the chondrocytes in weak gels with altered morphology were 
synthesizing lesser amounts of PGs as compared to the chondrocytes with normal 
morphology in the strong gels. This possibility could be explained keeping in view 
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the previous work which suggested that loss of chondrocytic phenotype was 
associated with decreased synthesis of PGs (Benya and Shaffer, 1982). Secondly, 
possibly chondrocytes in weak gels were metabolically activated by the factors in the 
serum and this led to the destruction and loss of PGs synthesized. This can be 
explained on the basis of already reported enhanced synthetic/proliferative activity of 
chondrocytes causing destruction of PGs in OA (Sandell, 2007, Goldring et al., 
2008). Thirdly, these abnormal chondrocytes were possibly synthesizing low 
molecular weight PGs rather than aggrecan which stained less intensely with Alcian 
blue (Tesche and Miosge, 2005). The low molecular weight PGs such as decorin and 
biglycan have been stated to be up regulated in the late stages of OA in human 
articular cartilage and exhibited reduced staining with Alcian blue (Bock et al., 
2001). Lastly, it can be speculated that due to the absence of effective scaffold 
around chondrocytes in weak gels the PGs produced were possibly diffused through 
the gels. This may also give rise to the possibility that some of the background 
staining in the weak gels was due to the PGs diffusing through weak gels and stained 
with Alcian blue. 
The results presented here also showed that chondrocytes cultured in strong gels 
displayed progressive increase in the Alcian blue staining throughout the course of 
culture (Fig. 5.5). This observation is quite obvious due to a previous study which 
stated increase in production of PGs with time when cultured in agarose gels (Schuh 
et al., 2012b). Chondrocytes cultured in weak gels showed an initial increase in 
Alcian blue staining by day 3 but then no further increase was present at the later 
time point (Fig. 5.5). Therefore, it is possible that chondrocytes cultured in weak gels 
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in this study underwent morphological changes, thereby, producing catabolic 
cytokines causing enhanced destruction of PGs.  
In conclusion, the histological examination of chondrocytes cultured in weak gels 
showed cluster formation with H&E, reduced Alcian blue staining and inconclusive 
results with Masson’s trichrome staining. Therefore, this study provided some new 
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6.1 CHAPTER SUMMARY 
 
In degenerate cartilage, chondrocytes often exhibit increased volume, abnormal 
morphology, enhanced proliferation/cluster formation and loss of viability. These 
changes may lead to abnormal matrix production/poor repair, enhancing 
susceptibility to secondary osteoarthritis (OA). This chapter aimed to develop an in 
vitro model of mechanically-injured cartilage, to study changes in chondrocyte 
viability and morphology at the injured site. Full-depth cartilage explants obtained 
from bovine metacarpal-phalangeal joints were divided into four experimental 
groups. Group 1: Osteochondral explants with partial-thickness injury i.e. did not 
breach the subchondral bone with a single standardised scalpel cut and viewed 
axially, Group 2: Osteochondral explants viewed coronally at the cut edge, Group 
3: Cartilage explants without subchondral bone injured and viewed axially and 
Group 4: Cartilage explants with the superficial zone removed, injured and viewed 
axially. These explants were then cultured over 14d in (a) standard-DMEM, (b) 10% 
FCS-DMEM or (c) 10% SF-DMEM (37
o
C, pH 7.4). At various time points, 
chondrocytes were fluorescently-labelled with CMFDA and PI to identify living and 
dead cells respectively, examined by confocal microscopy and analysed by 
Volocity
TM 
software. In group 1, at day 0, at the injury 18±0.5% chondrocytes were 
PI-labelled; the volume of chondrocytes was 711±24µm
3 
and morphology was 
relatively normal. The % PI-labelled chondrocytes decreased ~80-90% in SF-DMEM 
and FCS-DMEM in comparison with standard-DMEM throughout the culture period. 
At day 3, chondrocyte volume at the injury increased in SF-DMEM and FCS-DMEM 
by ~55% as compared to standard-DMEM (P<0.0001 for both). At day 7, at the 





) and FCS-DMEM (3839±190µm
3
) as compared to standard-DMEM 
(2802±96µm
3
; P<0.0001; P=0.0003 respectively). At day 14, chondrocytes at the 
injury in standard-DMEM were mostly spheroidal. However, 15±3% cells in SF-
DMEM and 31±5% cells in FCS-DMEM showed significant morphological changes 
(P=0.0013; P<0.0001 respectively) which included cellular enlargement, elongation 
of cell body and formation of cytoplasmic processes restricted to the superficial 
layers of cartilage. In the injured explants from group 2, chondrocytes changed 
morphology in the presence of SF-DMEM and FCS-DMEM as compared to 
standard-DMEM and the changes started in the deeper layers of cartilage extending 
upwards progressively. In group 3, the sequence of changes regarding the width of 
injury, chondrocyte viability, volume and morphology (clusters/processes) in the 
presence of SF-DMEM and FCS-DMEM as compared to standard-DMEM was 
similar to explants in group 1. In group 4, at day 0, 53±5% chondrocytes were PI-
labelled, chondrocytes were relatively normal in morphology with a volume of 
1117.8±82.9 µm
3
. During culture PI-labelled chondrocytes decreased by 96% in the 
presence of FCS as compared to standard-DMEM. At day 7, the volume of 
chondrocytes remained unaffected in both culture conditions. However, 
chondrocytes were present in large clusters in the presence of FCS-DMEM as 
compared to standard-DMEM and the volume of clusters in both conditions was 
significantly different (P=0.01). At day 14, chondrocytes at, and distant from, the 
injury in standard-DMEM were mostly spheroidal. The percentage of abnormal 
chondrocytes at and distant from the injury was higher in the FCS-DMEM as 
compared to standard-DMEM (P=0.0002; P<0.0001 respectively). These results 
suggested that the factors present in SF/FCS and strength/damage to matrix are 
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related factors such that the strength of matrix controls penetration of SF/FCS. 
Chondrocyte morphology markedly changed at the injury, suggesting that these 
morphological changes play a role in changes to matrix metabolism. 
6.2 INTRODUCTION 
 
Mechanical partial thickness injuries which don’t penetrate the subchondral bone 
may lead to post-traumatic Osteoarthritis (PTOA), due to poor regenerative/repair 
capacity of chondrocytes (Campbell, 1969, Buckwalter, 1998, Newman, 1998, 
Hunziker, 2001). However, in full-thickness osteochondral defects where injury 
penetrates the subchondral bone the repair consists of formation of fibro-cartilage at 
the injured site. The mesenchymal stem cells in the bone marrow have the ability to 
differentiate into various cell types such as chondrocytes, osteocytes, fibroblasts etc. 
These stem cells play a vital role in repairing the full-thickness defects of articular 
cartilage (Shapiro et al., 1993). PTOA is secondary OA occurring as a consequence 
of trauma/injury and chiefly characterised by pain and disability (Brown et al., 2006). 
However, the mechanisms underlying this condition are partially understood so far. 
Loss of chondrocyte viability following injury as an early event is believed to be 
involved in the development of PTOA (Kramer et al., 2011). Chondrocytes’ death 
associated with the trauma has been categorised as necrosis in the acute phase 
followed by apoptosis at later stages which leads to widespread degeneration of 
cartilage (Tew et al., 2000, D’Lima et al., 2001a, Otsuki et al., 2008). Necrotic cell 
death associated with trauma has been recently reported to produce chemotactic 
factors which attract the chondrogenic progenitor cells to the site of damage for 
regeneration and repair of the damaged tissue (Seol et al., 2012). Moreover, the 
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extracellular matrix (ECM) disruption as a result of trauma leads to the loss of 
proteoglycans (Quinn et al., 1998, Kurz et al., 2001, Patwari et al., 2003) and 
production of degrading enzymes (Kurz et al., 2005), this imbalance in ECM 
metabolism causes degeneration of the cartilage thereby, increasing susceptibility to 
PTOA (Lee et al., 2005). 
The response of chondrocytes in the pathogenesis of PTOA is crucial. Under normal 
circumstances chondrocytes are spheroidal/ellipsoidal in shape, surrounded by PCM, 
do not migrate and hardly exhibit any mitotic activity (Mankin, 1982). Adjacent to 
the zone of dead necrotic tissue, in response to injury chondrocytes become 
hyperactive and try to ‘repair’ the defect. It has been suggested that in an attempt to 
‘repair’ the cartilage, chondrocytes undergo proliferation/cluster formation and an 
over-production of ECM (Redman et al., 2004). However, it is thought that the role 
of chondrocytes in the repair of partial thickness defects is not effective and 
ultimately leads to improper wound healing. Recently, in injured cartilage in 
response to injury, chondrocytes have been reported to produce cytoplasmic 
processes (Lyman et al., 2012). In two recent studies the emerging role of 
chondrogenic progenitor cells in cartilage ‘repair’ has been studied (Seol et al., 2012, 
Seol et al., 2014) suggesting potential of chondrocytes to ‘repair’ the cartilage. How 
the present work builds up on the current knowledge of response of chondrocytes to 
injury has been discussed in the later part of this chapter (section 6.6). 
In articular cartilage the ECM creates a unique environment for the chondrocytes and 
regulates their structure and functions via cell-matrix interactions (Gao et al., 2014). 
Therefore, it is crucial to study chondrocyte morphology in the relatively intact ECM 
environment to avoid any perturbations. CLSM is a relatively novel methodology 
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which has rendered the morphological analysis of chondrocytes in a relatively 
undisturbed and complicated ECM environment possible. This technique allows 
multiple optical sections to be obtained and thus the three-dimensional morphology 
and volume of in situ chondrocytes can be determined (Jones et al., 2005). Moreover, 
by the use of confocal microscope, minute details about morphology as e.g. 
cytoplasmic processes emanating from cell bodies can be visualised in 3-D as this 
delicate morphological feature may get masked due to shrinkage effect with the 
fixation techniques used for histology as reported in a study on bacteria (Woldringh 
et al., 1977).  
Several in vitro studies have been done in the past using different methods to 
produce trauma to the cartilage (Quinn et al., 1998, Tew et al., 2000, D’Lima et al., 
2001b, Kurz et al., 2005) and study its consequences. In the present study partial-
thickness scalpel injured osteochondral explants were utilised to develop an in vitro 
injured cartilage model to determine chondrocyte reaction at injury. Osteochondral 
explants served an excellent model to study chondrocyte response in cartilage 
because (a) it is a relatively reproducible model (b) partial thickness injuries could be 
produced with ease because of intact bone (c) there was possibility although remote 
of synovial cells to interfere in results (d) in the uninjured areas of explants the 
chondrocytes remained alive (e) culture conditions could be altered and modified 
according to the experimental demands (f) in ‘off the bone’ injured explants, any 
interference of osteocytes and bone factors in the response of cells to injury could be 
ruled out (g) in explants without superficial layers response of deeper cells to injury 
could also be studied.  
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Most of the previous studies performed on traumatised cartilage utilised blunt trauma 
and injurious compression injuries, and thus was difficult to precisely define the 
extent of injury and ultimately the damage produced was widespread (Clements et 
al., 2004). The sharp mechanical trauma model used in this work has been utilised 
successfully in the past to study the chondroprotective effects of various solutions 
(Amin et al., 2008a, Amin et al., 2008b). This model was a preferable method to 
study cell viability and morphology of chondrocytes in response to injury due to 
various reasons: Firstly, the sharp scalpel cut applied in the single plane of cartilage 
avoided the variability in death and extent of matrix damage ascribed to the 
anisotropic property of cartilage structure (Jeffery et al., 1991). Secondly, 
standardization of the injury was ensured by (a) producing it with a ‘push-through 
mode’ as this enabled the application of constant amount of force on the scalpel at 
the site of injury which avoided variations in the percentage cell death (PCD), 
because the amount of cell death would be expected to vary with the extent of 
injurious force applied (Huntley et al., 2005) (b) applying specified ROIs at  the site 
of injury and distant from the injury on all the images to determine PCD. Thirdly, 
sharp trauma led to less chondrocyte death as compared to blunt trauma (Redman et 
al., 2004) and this would cause less disruption of matrix components (Tew et al., 
2000, D’Lima et al., 2001b, Quinn et al., 2001) and less release of intracellular 
components (Kuhn et al., 2004). Fourthly, this model allowed a wide range of 
experiments (a) to study the effect of presence or absence of subchondral bone on 
chondrocyte morphology in response to injury (b) to investigate whether the 
superficial cells alone are responsible for changes to morphology or the deep layered 
calls also respond similarly. Lastly, this was a reasonable model to study sharp 
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scalpel induced mechanical injury and then to compare with the cartilage distant 
from the injury as the changes would be confined to the site of injury (Redman et al., 
2004). These injured cartilage explants had an uninjured control area outside the 
region of interest (ROI) i.e. distant from the injury. It allows a direct comparison of 
injured and uninjured cartilage areas in the same explant and this comparison is not 
possible with the blunt trauma and injurious compression injuries. Therefore, this in 
vitro model of sharp mechanical injury is a highly reliable, controlled and 
reproducible one. 
Various studies conducted in the past on degenerate cartilage found chondrocytes to 
change phenotype thereby leading to alterations in their biosynthetic activity (Kouri 
et al., 1996a, Darling and Athanasiou, 2005, Tesche and Miosge, 2005, Yagi et al., 
2005, Murray et al., 2010). Furthermore, several studies have investigated the 
biochemical changes produced by chondrocytes in the damaged/traumatised cartilage 
and cartilage remodelling as a consequence of trauma (Grodzinsky et al., 2000, 
Patwari et al., 2001, Milentijevic et al., 2005). Although biochemical response of 
chondrocytes to trauma has been studied extensively but morphology of 
chondrocytes in response to injury was not comprehensively studied. Therefore, in 
the present study, cartilage was injured as a mechanism to increase the likelihood 
that factors present in synovial fluid (SF)/foetal calf serum (FCS) could interact with 
the in situ chondrocytes and thus morphology of chondrocytes in response to injury 







6.3.1 Primary hypothesis 
 
Chondrocytes near injury produce morphological changes in response to some 
factors present in SF and FCS.  
6.3.2 Secondary hypothesis 
 
Chondrocytes throughout cartilage are susceptible to morphological changes in 
response to injury in the presence of SF and FCS.  
6.3.3 Tertiary hypothesis 
 
Chondrocytes produce morphological changes in the presence of SF and FCS even in 
the absence of subchondral bone.  
 
6.4 MATERIALS AND METHODS 
6.4.1 In vitro partial thickness injured bovine articular cartilage model 
 Full depth bovine osteochondral explants 6.4.1.1
 Cartilage preparation and application of scalpel injury 6.4.1.1.1
 
Metacarpophalangeal joints of 3yr old cows obtained from local abattoir were 
washed, skinned, sprayed with 70% (v/v) alcohol (Fig. 6.1a) and dissected in a class 
1-flow hood under strict aseptic conditions within 12hrs of slaughter (Fig. 6.1b). 
Osteochondral strips comprising full depth cartilage with subchondral bone attached 
were harvested from the articular surface between the condylar ridges of each joint 
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(Fig. 6.1c) and trimmed approximately into rectangular blocks with 5x6x1mm size 
(Fig. 6.1e). The articular surface of each cartilage explant was then injured with fresh 
scalpel No. 11 in a ‘push through mode’ along the long axis of the explant as 
previously described (Amin et al., 2008b). The injury was always produced in the 
same direction, avoiding any additional movements of scalpel, cutting carefully 
through the thickness of cartilage without touching the bone and using fresh scalpel 
blade for each explant (Fig. 6.1c). In some experiments, partial-thickness injury was 
not produced rather a full-thickness injury was applied involving the subchondral 
bone and the osteochondral explants were cut into two halves and left in culture to 
study the response of injured chondrocytes to various culture media in various layers 
of cartilage in the coronal view (Fig. 6.1d). 
 
Figure 6.1: Preparation of injured bovine osteochondral explants. 
(a) Bovine feet obtained from local abattoir, washed and prepared for dissection (b) 
metacarpophalangeal joint dissected out and cartilage explants harvested from 
articular surface between condylar ridges (c) an osteochondral strip comprising of 
full thickness of cartilage and substantial amount of underlying subchondral bone, 
injured along the long axis (d) osteochondral explant cut into two halves for coronal 
images of injured cartilage (e) trimmed injured explants for axial images of bovine 
cartilage. Photographs (a, b, c) kindly provided by Dr. Innes D M Smith and (e) by 




 Preparation of cartilage explants for microscopy 6.4.1.2
 
At appropriate time points, injured explants from the culture were incubated with 
CMFDA and PI with final concentrations of 12.5 and 5µM respectively, during the 
last hour of incubation at ambient temperature to label living and dead cells 
respectively. The explants were then washed in PBS, fixed in 4% formaldehyde for 
30mins and mounted in small cell culture dishes (Cellstar
®
; 35x10mm) with Super 
Glue gel (Loctite). For the axial images, a pin-head size drop of glue was applied to 
the base of the dish and one of the explant edges was gently placed on it and allowed 
to attach. The cells distant from the point of attachment were imaged within ~30 
minutes by confocal microscopy to avoid any interference of the glue while imaging 
(Fig. 6.2A). For the coronal images, two tiny pieces of blue tack
®
 (Bostik; UK) 
adhesive were applied in the culture dish and osteochondral explant was oriented in 
the lateral view without touching the coronal cut side of the explant (Fig. 6.2B). The 




Figure 6.2: Axial and coronal CLSM for injured bovine articular cartilage 
explants imaged with low power (x10) objective. 
The x, y and z axes labelled on the diagram of the explant. (A) Axial optical sections 
of the articular cartilage with injury imaged top-down and the series of optical 
sections reconstructed in the axial plane, (B) Coronal optical sections of injured 
cartilage imaged the full thickness of the cartilage and the series of optical sections 
reconstructed in the coronal plane. Scale bar = 100µm for both axial and coronal 
reconstructed images. 
 
 CLSM in the axial and coronal planes of injured cartilage explants 6.4.1.3
 
A Zeiss Axioskop LSM 510 upright CLSM was used with an Ar/2 laser with 
excitation wavelength (EXλ) of 488nm and HeNe laser with EXλ 543 to excite the 
fluorophores CMFDA and PI respectively. The emission light was then measured 
through a band pass filter of 505-530nm and a long pass filter of 650nm respectively. 
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The fluorescently-labelled chondrocytes in situ were imaged in the axial plane at the 
site of injury and ~400µm either side to observe cells distant from the injury. The 
viability of chondrocytes was assessed by images obtained using a low power (x10 
dry; NA 0.3) objective with a standard protocol (Amin et al., 2008b) and 
chondrocyte morphology was studied by using x40 (NA 0.8) dipping water (DW) 
lens. The z stack images comprising single confocal sections through the z-axis of 
the tissue, typically to a depth of 50µm for high and 100µm for low power objective 
magnification measurements were collected at an interval of 1µm and 10µm 
respectively. The fluorescently-labelled chondrocytes in situ were imaged in the 
coronal plane at the injured site to observe cells in all the layers of cartilage both 
with low power and high power lenses. The z stack images comprising single 
confocal sections through the z-axis of the tissue, typically to a depth of 60µm for 
high and ~100-150µm for low power objective magnification measurements were 
collected at an interval of 1.1µm and 5.2µm respectively. The scanning speed was 9 
frames/sec, with a pinhole setting of 1 Airy unit and a frame size of 1024x1024 
pixels. The optical sections obtained by CLSM were converted into three-
dimensional reconstructions/projections using Volocity
TM 
version 5.4.1  image 
analysis
 
software (Amin et al., 2008a).  
 
 Quantification of CMFDA and PI-labelled chondrocytes 6.4.1.4
 
The green and red staining pattern of CMFDA and PI-labelled (live and dead) 
chondrocytes was used for counting following a standard protocol published 
previously (Amin et al., 2008b). Briefly, the low power axial extended focus 
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confocal images were analysed on Volocity
TM
 for quantifying the percentage of PI-
labelled chondrocytes or percentage cell death (PCD). A 3D ROI was created and 
applied on the injured site with the dimensions of x, y, z 400, 913 and 100µm 
respectively (Fig. 6.3a). Cell death distant from the injury was determined by 
applying ROIs with dimensions of x, y and z 200, 913 and 100µm respectively on 
both sides of the injury and the average calculated (Fig. 6.3b). The counting protocol 
was run on the images which identified objects (individual cells) as green (live) and 
red (dead) on the basis of percentage threshold intensity in two channels. The mean 
number of live and dead cells in each ROI was calculated and % PI-labelled 
cells/PCD determined with the formula 100 × (number of dead cells/number of dead 
and live cells) %. The high power (x40 DW) axial extended focus confocal images 
were analysed to measure the width of the injury by Volocity
TM 
software and 
determined by drawing two straight lines on either sides of injury enclosing the area 
containing no cells and measuring the distance between the lines (Fig. 6.3c). 
 Quantification of PCD at, and distant from the injury 6.4.1.4.1
 
PI-labelled chondrocytes at and distant from the injury were quantified by image 
analysis (section 6.4.1.4) and ROIs selected and applied as shown in Fig. 6.3. 
Quantification of PCD distant from the injury and its comparison with PCD at the 
injury was important as it gave an indication of whether there was any cell death due 




Figure 6.3: Method for quantification of PI-labelled chondrocytes at and distant 
from the injury and measurement of the width of injury. 
Dashed white lines indicate the ROIs applied and solid white lines indicate the 
measurement of width of the injury. (a) Identification and counting of CMFDA and 
PI-labelled chondrocytes in an ROI at the injury. A projected low magnification 
image obtained by CLSM with an ROI applied to encompass the site of injury and 
PCD calculated (see Materials and Methods) (b) Chondrocyte death distant from the 
injury was determined by applying an ROI 200µm away from the injury both on left 
and right sides of image, and the average calculated. (c) A projected high 
magnification image showing the method for measurement of the width of injury by 
Volocity
TM
. Scale bar for all panels = 100µm. 
 Volume and morphological analysis of in situ chondrocytes 6.4.1.5
 
The methodology applied to determine chondrocyte volume/morphology was similar 
to the methods utilised for cultured chondrocytes in agarose gels (section 4.4.1.7.1). 
The quantitative data regarding volume and 3D morphological analysis of in situ 
chondrocytes were obtained from the CLSM (x40 DW objective) images by using a 
measurement protocol on Volocity
TM
. The calibration technique and correction factor 
applied were also similar to those applied for cultured chondrocytes in agarose gels 
(section 4.4.1.7.2). 
The definition of a cluster formed and methodology employed for quantitative 
analysis of clusters was similar to the one applied for the cultured chondrocytes in 




of individual chondrocytes was measured along the longest (y-axis) of the cell in 3D 
by using the same software. The chondrocytes which were elliptical/spheroidal in 
shape with no cytoplasmic processes were considered relatively ‘normal’ in 
morphology. However, cells with elongated and non-spheroidal shapes, with 
cytoplasmic processes emanating from cell bodies were considered ‘abnormal’ in 
morphology (Bush and Hall, 2003). These abnormal chondrocytes had a variety of 
characteristics based on (a) shape of cells (b) presence or absence of cytoplasmic 
processes (c) presence of single or multiple processes and examples are illustrated in 
Results. The percentage of abnormal chondrocytes was calculated with the formula 
100 × (number of abnormal cells/total number of all normal and abnormal cells) %. 
6.5 RESULTS 
6.5.1 Standardisation of the injury 
 
The first step was to standardise the application of the injury to ensure that the 
amount of cell death along the length of injury was relatively constant and it required 
considerable practice. This was attained by keeping the force on the scalpel constant 
and the percentage cell death (PCD) within a set ROI was determined and compared 
at various positions along the length of injury. There was no significant difference in 
the PCD throughout the length of the injury (Fig. 6.4) indicating that the PCD was 
constant.  
The injured explants were incubated in (1) standard-DMEM (2) SF-DMEM or (3) 
FCS-DMEM for up to 14 days and media changed on alternate days. The injured 
explants from the various culture conditions at different time points (day 0, 3, 7 and 




Figure 6.4: Standardisation of the scalpel injury applied along the long axis of 
the bovine cartilage explants. 
Dashed white lines indicate the ROIs applied. Top, CLSM projected images of 
injured cartilage illustrating the three different ROIs along the length of injury 
ranging from (a) 0-300µm (ROI 1), (b) 300-600µm (ROI 2) and (c) 600-900µm (ROI 
3). Individual chondrocytes within the ROI were identified on the basis of voxel 
intensity, CMFDA-labelled (living) and PI-labelled (dead) cells identified using 
purple and yellow respectively (colour codes given to identify cells separately) and 
the PCD calculated. Also shown is a comparison between % PI-labelled cells 
calculated after applying ROIs at the three different sites along the length of injury. 
Scale bar for all panels = 100µm. Data were for [N(n)] = [6(9)].  
6.5.2 Morphological characteristics of chondrocytes in injured cartilage 
cultured under various conditions (axial view) 
Osteochondral explants were injured and kept in culture with either (a) standard-
DMEM (b) SF-DMEM or (c) FCS-DMEM up to 14 days (section 2.1.1). The injured 
explants incubated in various culture conditions were fluorescently labelled at 
different time points (Days 0, 3, 7 and 14), prepared for confocal microscopy and 
imaged AXIALLY with low and high power magnification objectives. 
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 Changes to the width of the injury following in vitro culture under various 6.5.2.1
conditions 
It was a reproducible standard injury (Fig. 6.4) and width of the injury was measured 
as shown in Fig 6.3c. At day 0, the width of the injury was same for all culture 
conditions. The nature of the culture medium strikingly affected width of the injury 
during the course of culture. In standard-DMEM the width of the injury remained 
almost unaffected during the first week of culture. However, injury width increased 
significantly by day 14 compared to the earlier time points of culture in standard-
DMEM (P<0.05; ANOVA over the 4 days; Fig. 6.5). The explants cultured in the 
presence of SF-DMEM or FCS-DMEM exhibited no change in width at day 3 but the 
width increased significantly in FCS-DMEM at day 7 in comparison with those in 
standard-DMEM (P<0.01; ANOVA). However, by day 14 the width of the injury 
decreased significantly in both of these conditions compared with day 7 (P<0.05; 
P<0.001 respectively) and also in comparison with the explants in the presence of 
standard-DMEM (Fig. 6.5; P<0.001; P<0.01 respectively). These data suggested that 
in explants cultured with standard-DMEM during the culture period the width of the 
injury remained unchanged by day 7 but increased significantly by day 14. However, 
in contrast in the presence of SF-DMEM and FCS-DMEM the width of the injury 
increased initially by day 7 but decreased markedly by day 14 of culture. This 
suggested the proliferation of chondrocytes at the injury possibly in response to the 




Figure 6.5: Changes in the width of the injury following culture under various 
conditions. 
The measurements of injury width were determined as described in Materials and 
Methods. Data are from [N(n)]=[9(43)]. # indicated a significant difference 
according to one-way ANOVA followed by Tukey’s multiple comparison post-hoc 
test. The single, double and triple symbols showed the level of significance for 
P<0.05, 0.01 and 0.001 respectively. 
 
  Loss of PI-labelled cells at the site and distant from the injury 6.5.2.2
 
The percentage of PI-labelled chondrocytes within the ROI (section 6.4.1.4) 
depended strongly on the various culture conditions used (Fig. 6.6a-j). The low 
power (x10) CLSM reconstructions as shown in Fig. 6.6, demonstrated the decrease 
in PI-labelled chondrocytes in the presence of SF-DMEM and FCS-DMEM even at 
day 3 of culture but this decrease in PI-labelled chondrocytes was not seen in the 
presence of standard-DMEM.  
There was no significant difference between the % PI-labelled cells at the injury in 
explants cultured with standard-DMEM even after 14 days of culture (Fig. 6.7a; 
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P>0.05; one-way ANOVA). In marked contrast, the % PI-labelled cells at the injury 
in explants cultured in the presence of SF-DMEM or FCS-DMEM decreased 
significantly (Fig. 6.7a; P<0.01; P<0.001 respectively; ANOVA) at day 3. However, 
the loss of PI-labelled cells in FCS-DMEM compared with SF-DMEM showed no 
difference (Fig. 6.7a). Similarly, at day 7 and 14 of culture the % PI-labelled 
chondrocytes decreased significantly in SF-DMEM and FCS-DMEM compared to 
injured explants cultured in standard-DMEM (Fig. 6.7a; P<0.01; P<0.001 
respectively at day 7; P<0.001 for both conditions at day 14; ANOVA). As expected 
the % PI-labelled chondrocytes at the injury were significantly higher under all 
culture conditions as compared to those distant from the injury at all the time points 
(Fig. 6.7b),  only by day 7 the difference was not significant in the explants cultured 
with SF-DMEM (P<0.0001 at day 0, P<0.0001; P=0.0054; P<0.002 at day 3; 
P=0.0005; P>0.05; P=0.04 at day 7 and P<0.0001; P=0.0012; P=0.005 at day 14; for 
standard-DMEM, SF-DMEM and FCS-DMEM respectively). These results 
suggested that in the presence of SF-DMEM and FCS-DMEM, the % PI-labelled 
chondrocytes decreased dramatically by approximately 80-90% in comparison with 




Figure 6.6: Axial CLSM reconstructions of injured cartilage explants cultured 
in various conditions showing the loss of PI-labelled chondrocytes in SF-DMEM 
and FCS-DMEM as compared to standard-DMEM. 
CLSM reconstructions of low magnification (x10) images, typically to a depth of 
100µm collected at an interval of 10µm of CMFDA and PI-labelled chondrocytes 
(live/dead, respectively) in injured explants at (a) day 0, (b,c,d) day 3, (e,f,g) day 7 
and (h,I,j) day 14 cultured in standard-DMEM, SF-DMEM and FCS-DMEM 




Figure 6.7: The percentage of PI-labelled cells at and distant from the injury in 
cartilage cultured under various conditions. 
Graphs show a comparison between the % PI-labelled cells (a) at the injury and (b) 
distant from the injury under the three culture conditions. Data were from 
[N(n)=18(52)]. # indicated a significant difference between different culture 
conditions at one time point according to one-way ANOVA followed by Tukey’s 
multiple comparison post-hoc test. ^ indicated a significant difference between the 
values at and distant from the injury according to unpaired student’s t-test. The 
single, double and triple symbols showed the level of significance for P<0.05, 0.01 





 Morphological characteristics of chondrocytes in response to various 6.5.2.3
culture media 
During the course of culture, chondrocyte morphology changed dramatically in the 
presence of the different culture media following what appeared to be a complex 
sequence of events. In order to understand aspects of these changes, the results were 
presented at distinct time points as related to changes in (A) chondrocyte volume, (B) 
chondrocyte clustering and (C) abnormal chondrocyte morphology and are now 
described in the following 3 sections.   
 Changes to the volume of chondrocytes at and distant from the injury 6.5.2.3.1
at day 3 
At day 3, the volume of chondrocytes changed considerably under the influence of 
different culture media. The high power (x40DW) images showed the increase in 
volume and abnormal morphology of chondrocytes at the injury in the presence of 
SF-DMEM and FCS-DMEM (Fig. 6.8a-j).  
The volume of chondrocytes at the injury at day 0 was 711±25µm
3
, and this did not 
change significantly by day 3 when explants were cultured in standard-DMEM (Fig. 
6.9a). The volume of chondrocytes within explants cultured with SF-DMEM and 
FCS-DMEM increased approximately by 55% at day 3 as compared to standard-
DMEM (P<0.0001 for both SF-DMEM and FCS-DMEM) and approximately 70% in 
comparison with the volume at day 0 (P<0.0001 for both SF-DMEM and FCS-
DMEM) at the injury (Fig. 6.9a). Moreover, chondrocyte volume at the injury at day 
3 increased approximately 32% in the presence of SF-DMEM and 13% in the 
presence of FCS-DMEM as compared to that distant from the injury (Fig. 6.9b; 
P<0.0001; P=0.0002 for SF-DMEM and FCS-DMEM respectively). However, in 
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standard-DMEM no difference in volume was observed at and distant from the injury 
(Fig. 6.9b).  
 
Figure 6.8: Axial CLSM reconstructions of injured cartilage cultured in various 
culture media showing morphological changes to chondrocytes at injury in the 
presence of SF-DMEM and FCS-DMEM as compared to standard-DMEM. 
CLSM reconstructions of images obtained by x40(DW) objective typically to a depth 
of 50µm at an interval of 1µm through the z-axis of the tissue. These images were of 
CMFDA and PI-labelled chondrocytes (live/dead respectively) in injured explants at 
(a) day 0, (b,c,d) day 3, (e,f,g) day 7 and (h,i,j) day 14 cultured in standard-DMEM, 




Figure 6.9: Changes to chondrocyte volume at and distant from the injury at 
day 3 in response to various culture conditions. 
Graphs summarise the pooled data for the volume of chondrocytes at days 0 and 3 
demonstrating significant changes in chondrocyte volume (a) at and (b) distant from 
the injury. Data were from [N(nʹ)=18(55,55) at day 0, 18(289,134) for standard-
DMEM, (112,108) for SF-DMEM and (253,111) for FCS-DMEM, at the injury and 
distant from the injury respectively]. # indicated a significant difference between 
different culture conditions and at two time points according to one-way ANOVA 
followed by Tukey’s multiple comparison post-hoc test. ^ indicated a significant 
difference between the values at and distant from the injury according to unpaired 
student’s t-test. The single, double and triple symbols showed the level of 




These results indicated that chondrocyte volume at the injury increased in the 
presence of SF-DMEM and FCS-DMEM as compared to standard-DMEM. 
Additionally, at day 3 the volume of chondrocytes at the injury was higher as 
compared to those distant from the injury in both the culture conditions. 
 Chondrocyte cluster formation at day 7 6.5.2.3.2
An obvious morphological feature of chondrocytes at the injury which was observed 
routinely was the formation of clusters in response to some of the culture media (Fig. 
6.8f,g). In order to quantify this so that various culture conditions could be 
compared, different parameters of clusters were analysed at day 0 and 7 at and 
distant from the injury (Figs. 6.10A & B). Clusters were defined and quantitative 
data regarding their number, number of cells/cluster, percentage of cells involved, 
volume of clusters and the volume of individual cells in a cluster (section 4.4.1.7.1) 
were obtained. At day 0 in the normal fresh osteochondral explants chondrocytes 
were typically present in pairs and only 3±1% chondrocytes within the specified ROI 
formed approx. 3-4 clusters with no more than 3 cells per cluster. 
The pooled data regarding average number of clusters formed at the injury exhibited 
an increasing trend in the presence of SF-DMEM and FCS-DMEM as compared to 
the explants cultured in standard-DMEM (Fig. 6.10Aa). The number of clusters 
formed in the presence of FCS-DMEM was significantly higher as compared to day 
0 (P<0.05) and standard-DMEM at day 7 (P<0.01) but the difference between SF-
DMEM and standard-DMEM was not significant at both time points (Fig. 6.10Aa). 
Moreover, at day 7 the number of clusters formed in the presence of FCS-DMEM 
were significantly higher than SF-DMEM (P<0.05; Fig. 6.10Aa). The number of 
clusters formed at the injury were significantly higher as compared to distant from 
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the injury in the explants cultured in the presence of FCS-DMEM (P=0.03) but the 
difference at and distant from the injury was not significantly different in the 
presence of SF-DMEM (Fig. 6.10Ba). These data indicated that the effect of FCS-
DMEM on chondrocyte clustering appeared to more potent than SF-DMEM. 
The number of cells per cluster at the injury was significantly higher in the explants 
cultured in the presence of FCS-DMEM by day 7 as compared to day 0 (Fig. 6.10Ab; 
P<0.0001). At day 7, significantly greater number of cells per cluster were found at 
the injury in the presence of FCS-DMEM as compared to standard-DMEM (Fig. 
6.10Ab; P<0.0001). Number of cells per cluster was significantly greater in FCS-
DMEM as compared to SF-DMEM (Fig. 6.10Ab; P<0.05) Additionally, the average 
number of cells in a cluster was significantly greater at the injury as compared to 
distant from the injury in the presence of FCS-DMEM (Fig. 6.10Bb; P=0.02). 
At the site of injury, the percentage of chondrocytes forming clusters increased by 
day 7 in the presence of SF-DMEM and FCS-DMEM as compared to standard-
DMEM (Fig. 6.10Ac). In the explants cultured with FCS-DMEM, a significantly 
higher percentage of chondrocytes formed clusters (27±4%) as compared to those in 
standard-DMEM (7±3%; P<0.05) and percentage of chondrocytes forming clusters 
at day 0 (3±1%; P<0.05). However, in the presence of SF-DMEM, 11±4% 
chondrocytes formed clusters but the difference from standard-DMEM was not 
statistically significant. Moreover, a significantly higher percentage of chondrocytes 
formed clusters at the site of injury as compared to distant from the injury in the 
explants cultured in the presence of FCS-DMEM (Fig. 6.10Bc; P=0.01). 
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At day 7 of culture, the volumes of clusters close to and distant from the injury 
showed no significant change in injured explants in the presence of standard-DMEM 
(Figs. 6.10Ad and 6.10Bd). However, chondrocytes at the injury in the presence of 
SF-DMEM and FCS-DMEM formed large clusters having on the average 4-5 cells 
per cluster (P<0.01; P<0.001 respectively) as compared to standard-DMEM 
comprising of average 3 cells per cluster and also in comparison with the volume of 
clusters at day 0 containing 3 cells per cluster (Fig. 6.10Ad; P<0.01 for both 
conditions). Additionally, although a similar trend of volume increase was observed 
distant from the injury yet significantly large sized clusters were formed at the injury 
as compared to those distant from the injury both in SF-DMEM and FCS-DMEM 
(Fig. 6.10Bd; P=0.0005; P=0.01 respectively) and no significant change observed in 
standard-DMEM.  
The volume of individual chondrocytes in a cluster was calculated (section 4.4.1.7.1) 
and compared in different culture conditions at and distant from the injury. At day 7 
the volume of individual chondrocytes in a cluster increased significantly in the 
presence of SF-DMEM as compared to standard-DMEM (Fig. 6.10Ae; P<0.01). The 
volume of individual chondrocytes in a cluster increased significantly in the presence 
of SF-DMEM and FCS-DMEM as compared to volume at day 0 (P<0.001 for both 
SF-DMEM and FCS-DMEM). Moreover, in the explants cultured in the presence of 
SF-DMEM and FCS-DMEM, the volume of individual chondrocytes in a cluster was 




Total number of chondrocytes in specified ROI did not show any significant change 
at day 7 in the three culture conditions (158±14 in standard-DMEM, 133±21 in SF-
DMEM and 137±12 in FCS-DMEM) and also in comparison with day 0 (168±28).  
 
Figure 6.10A: Analysis of chondrocyte clusters formed at day 7 in response to 
various culture conditions at the injury. 
Graphs show pooled data for (a) average number of clusters formed (b) average 
number of cells in a cluster (c) % of cells involved in forming clusters (d) average 
volume of clusters (µm
3
) of chondrocytes formed (e) average volume of individual 
cell in a cluster (µm
3
) at the injury. Data were from [N(n)=18(19)]. # indicated a 
significant difference between different culture conditions and at two time points 
according to one-way ANOVA followed by Tukey’s multiple comparison post-hoc 
test. The single, double and triple symbols showed the level of significance for 





Figure 6.10B: Analysis of chondrocyte clusters formed at day 7 in response to 
various culture conditions distant from the injury. 
Graphs show pooled data for (a) average number of clusters formed (b) average 
number of cells in a cluster (c) % of cells involved in forming clusters (d) average 
volume of clusters (µm
3
) of chondrocytes formed (e) average volume of individual 
cell in a cluster (µm
3
) distant from the injury. Data were from [N(n)=18(19)]. # 
indicated a significant difference between different culture conditions and at two 
time points according to one-way ANOVA followed by Tukey’s multiple 
comparison post-hoc test. ^ indicated a significant difference between the values at 
and distant from the injury according to unpaired student’s t-test. The single, double 




To summarise this section, at day 0, only few chondrocytes were present in clusters. 
At day 7, at the injury, chondrocytes were present in large clusters in the presence of 
SF-DMEM and FCS-DMEM as compared to standard-DMEM. Chondrocyte 
clustering was observed to be stimulated to a greater extent in the presence of FCS-
DMEM compared to SF-DMEM. This suggested that although the trends between SF 
and FCS were similar, subtle differences existed between their effects possibly 
because of differences in their chemical composition. Therefore, FCS seemed to be 
more potent in triggering chondrocyte clustering as compared to SF. Distant from the 
injury, in the presence of SF-DMEM and FCS-DMEM only few chondrocytes 
formed small sized clusters and the difference at the site and distant from the injury 
was significant but no difference was observed in the presence of standard-DMEM.  
 Development of abnormal chondrocyte morphology/volume by day 14 6.5.2.3.3
 
Chondrocytes in the superficial layers at the injury displayed marked shape changes 
by day 14 in the presence of SF-DMEM and FCS-DMEM (Fig. 6.11b,c) but not in 
standard-DMEM. Chondrocyte morphology was relatively ‘normal’ 
(elliptical/spheroidal in shape with no cytoplasmic processes) at days 0, 3 and 7 
under all culture conditions. The chondrocytes cultured in standard-DMEM exhibited 
normal morphology after 14 days both in the superficial and deeper regions of 
cartilage (Fig. 6.11a,d). However, at day 14 of culture in the presence of SF-DMEM 
and FCS-DMEM chondrocytes showed a dramatic change to ‘abnormal’ forms 
characterised by cell enlargement, elongation of the cell body and production of 
cytoplasmic processes (Fig. 6.12b-f) at the injury.  
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The changes to chondrocyte morphology occurred in the presence of SF-DMEM and 
FCS-DMEM and not in standard-DMEM in the superficial layers of cartilage (Fig. 
6.11b,c). These abnormal chondrocytes were restricted to the superficial 30µm of the 
cartilage and the chondrocytes residing deeper than 30µm of cartilage (Fig. 6.11e,f) 
demonstrated relatively normal volume and morphology.  
Morphological characteristics of chondrocytes were quantified (section 6.4.1.5.) and 
the data compared at day 0 and day 14 in various culture conditions. After 14 days of 
culture, 15±3% [N(n)]=[18(23)] cells in SF-DMEM and 31±5% [N(n)]=[18(23)] 
cells in FCS-DMEM showed significant morphological changes as compared to 
chondrocytes at the injury in standard-DMEM (Fig. 6.12a; P=0.0013; P<0.0001 
respectively) and chondrocytes at day 0 (P<0.01; P<0.001 respectively) which were 
all ‘normal’ in morphology. However, the abnormal cells were greater in number in 
the presence of FCS-DMEM as compared to SF-DMEM (P<0.01). Distant from the 
injury in relatively normal cartilage chondrocytes with abnormal morphology were 
occasionally observed (Fig. 6.12b). However, the percentage of abnormal cells was 
significantly greater at the injury as compared to distant from the injury in the injured 
explants cultured with SF-DMEM and FCS-DMEM (Fig. 6.12b; P<0.05 for SF-
DMEM and FCS-DMEM). Additionally, in the presence of standard-DMEM, 
chondrocyte morphology remained unaffected at or distant from the injury (Fig. 
6.12b). 
Chondrocyte volume was measured at and distant from the injury in addition to the 
volume measurements at day 3, were compared between the three different culture 
conditions. There was an overall three-fold increase in the volume of chondrocytes at 
the injury in the presence of SF-DMEM and FCS-DMEM as compared to standard-
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DMEM. The average volume of individual abnormal chondrocytes at the injury by 
day 14 was 2965±438µm
3 
[N(n)=18(23)] following culture in the presence of SF-
DMEM. Chondrocyte volume measured 2197±185µm
3
 [N(n)=18(23)] in FCS-
DMEM and 790±17µm
3
 [N(n)=18(23)] following culture in standard-DMEM. 
Volume was significantly higher in SF-DMEM and FCS-DMEM as compared to 
standard-DMEM (Fig. 6.12c; P<0.0001 for both SF-DMEM and FCS-DMEM). 
Additionally, the volume of chondrocytes at the injury after 14 days of culture in SF-
DMEM and FCS-DMEM was significantly greater than the volume of chondrocytes 




(P<0.0001 for both SF-DMEM and FCS-
DMEM). However, distant from the injury in the presence of SF-DMEM and FCS-
DMEM, the volume of chondrocytes was significantly lower than those at the injury 
(Fig. 6.12d; P<0.0001 for both SF-DMEM and FCS-DMEM). In the presence of 
standard-DMEM, the volume of chondrocytes showed no significant changes at the 
site or distant from the injury. 
The average length of the cell body of individual abnormal cells at the injury 
increased by approx. x4 in the presence of SF-DMEM and FCS-DMEM as compared 
to standard-DMEM (Fig. 6.12e; P<0.0001 for both SF-DMEM and FCS-DMEM) 
and also in comparison with the length of cell body at day 0 (P<0.0001 for both SF-
DMEM and FCS-DMEM). The length of cell bodies at the injury was found to be 
significantly greater as compared to those distant from the injury in the explants 
cultured in the presence of SF-DMEM and FCS-DMEM (Fig. 6.12f; P<0.0001 for 
both SF-DMEM and FCS-DMEM). In the presence of standard-DMEM there was no 
significant change observed in the length of cell bodies at or distant from the injury. 
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These results demonstrated the marked heterogeneity of chondrocyte morphology by 
day 14 of culture in SF-DMEM and FCS-DMEM, which was not present following 
culture in standard-DMEM. However distant from the injury, changes in chondrocyte 
morphology were also occasionally observed but these changes were significantly 
less as compared to those at the injury (Fig. 6.12b). Additionally, the effect of FCS 
was significantly more potent in producing changes to chondrocyte morphology and 
volume as compared to SF (Fig. 6.12a; P<0.05).    
 
 
Figure 6.11: Heterogeneity of chondrocyte morphology at day 14 at the injury in 
response to different culture media. 
High magnification axial CLSM reconstructions of fluorescently-labelled 
chondrocytes at day 14, (a, b, c) superficial 30µm and (d, e, f) a further deep 20µm 
of the cartilage, cultured in standard-DMEM, SF-DMEM and FCS-DMEM 





Figure 6.12: Examples and characteristics of the heterogeneous nature of 
chondrocyte morphology. 
Top panel shows examples of ‘abnormal’ chondrocytes in response to injury in the 
presence of SF-DMEM and FCS-DMEM at day 14 of culture. The varieties of 
chondrocytes observed were (a) relatively ‘normal’ with spheroidal shape (b) 
‘abnormal chondrocyte’ with flattened, elongated cell body. ‘Abnormal’ 
chondrocytes as illustrated in (c,d,e,f), had elongated body and single/multiple 
cytoplasmic processes emanating from the cell body. High magnification CLSM 
images and scale bar for all panels = 10µm. Graphs show pooled data for (a, b) % 
abnormal cells at and distant from the injury, (c, d) average volume of cells (µm
3
) at 
and distant from the injury and (e, f) average length of cells (µm) at and distant from 
the injury. Data were for [N(n)]=[18(23)]. # indicated a significant difference 
between different culture conditions and at two time points according to one-way 
ANOVA followed by Tukey’s multiple comparison post-hoc test. ^ indicated a 
significant difference between the values at and distant from the injury according to 
unpaired student’s t-test. The single, double and triple symbols showed the level of 
significance for P<0.05, 0.01 and 0.001 respectively. 
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6.5.3 Morphology of chondrocytes in injured cartilage cultured under various 
conditions (coronal view) 
 
Injured osteochondral explants for coronal imaging were prepared and imaged as 
described earlier (sections 6.4.1.1.1. & 6.4.1.2). The explants were imaged coronally 
to study the morphological characteristics of chondrocytes in the various zones. Full-
depth osteochondral explants comprising of full thickness of the cartilage and 
subchondral bone were trimmed approximately into 6x5x1mm size and kept in 
various culture conditions for 14 days. The various culture conditions used in these 
experiments were (a) standard-DMEM, (b) SF-DMEM (10%) or (c) FCS-DMEM 
(10%). These explants were not injured axially and the cut edges of the explants were 
the injured coronal areas focussed at in these experiments. The chondrocytes were 
fluorescently-labelled and imaged for the CORONAL view at different time points 
(Days 0, 3, 7 and 14) to study the effect of culture media on chondrocyte morphology 
in superficial, mid and deep zones of cartilage (SZ, MZ, DZ). The CLSM images 
were obtained at low (x10dry) and high power (x40DW) magnification. 
Chondrocyte morphology remained unaffected in all the layers of cartilage in the 
explants cultured in the presence of standard-DMEM (Fig. 6.13b,e&h). The cartilage 
explants cultured in the presence of SF-DMDM and FCS-DMEM showed changes to 
chondrocyte morphology during the course of culture. By day 3 of culture 
chondrocytes in the deeper layers of cartilage changed morphology in the presence of 
SF-DMEM (Fig. 6.13c) and FCS-DMEM (Fig. 6.13d). By day 7, chondrocytes in the 
middle layers also showed morphological changes in the explants cultured in the 
presence of SF-DMEM and FCS-DMEM (Fig. 6.13f,g). By day 14, of culture the 
274 
 
abnormal chondrocytes were present throughout the thickness of the cartilage 
involving the superficial layers also in the explants cultured in the presence of SF-
DMEM and FCS-DMEM (Fig. 6.13i,j).  
The morphology of chondrocytes remained relatively normal in the superficial and 
middle layers of cartilage cultured in standard-DMEM even after 14 days of culture 
(Fig. 6.14a,b,e&h). The chondrocytes in the middle zone of cartilage showed marked 
heterogeneity in terms of morphology in explants cultured in the presence of SF-
DMEM and FCS-DMEM by day 7 (Fig. 6.14f,g). By day 14 of culture these 
abnormal chondrocytes could be seen even in the superficial layers of cartilage 
explants cultured with SF-DMEM and FCS-DMEM (Fig. 6.14i,j). The abnormal 
chondrocytes were enlarged, flattened and had cytoplasmic processes emanating 
from their cell bodies.  
The coronal images of cartilage explants suggested that the composition of culture 
media had affected the morphology of chondrocytes. Chondrocytes changed 
morphology in the presence of SF-DMEM and FCS-DMEM as compared to 
standard-DMEM and the changes started in the deeper layers of cartilage extending 
upwards progressively. This suggested that chondrocytes in deep layers had greater 
access to factors present in SF-DMEM and FCS-DMEM and therefore changed 
morphology earlier as compared to the cells in upper layers of cartilage.  
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Figure 6.13: Coronal CLSM reconstructions of injured cartilage explant 
showing progressive changes to chondrocyte morphology. 
Coronal CLSM reconstructions of low power (x10) magnification images, typically 
taken to a depth of ~100-150µm in the z axis of the cartilage (see Materials and 
Methods) collected at an interval of 5.2µm z stacks. Cartilage explants labelled with 
CMFDA and PI (live/dead cells respectively) imaged at (a) day 0, (b,c,d) day 3, 
(e,f,g) day 7 and (h,i,j) day 14 cultured in standard-DMEM, SF-DMEM and FCS-




Figure 6.14: Coronal CLSM reconstructions of mid to deep zones of injured 
cartilage explants cultured in various culture conditions. 
Coronal CLSM reconstructions of high power (x40DW) magnification images, 
typically taken to a depth of ~60µm in the z axis of the cartilage collected at an 
interval of 1.1µm z stacks. Cartilage explants labelled with CMFDA and PI 
(live/dead cells respectively) imaged at (a) day 0, (b,c,d) day 3, (e,f,g) day 7 and 
(h,i,j) day 14 cultured in standard-DMEM, SF-DMEM and FCS-DMEM 
respectively. Scale bar for all panels = 25µm.  
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6.5.4 Morphological characteristics of chondrocytes in injured cartilage 
without subchondral bone cultured under various conditions 
 
It was possible that some of the cells observed originated from the bone component 
of the osteochondral explants. Accordingly, injured cartilage explants without 
subchondral bone were cultured under various conditions to rule out any possibility 
of contamination of injury with bone cells and to exclude the effect of any factors 
released from the exposed bone parts. Explants comprising of the full thickness of 
cartilage without subchondral bone were injured and kept in various culture 
conditions for 14 days. The full depth cartilage explants without subchondral bone 
were obtained with careful dissection (example shown in Fig. 6.15) and injured with 
the standardised injury protocol (section 6.4.1.1.1). The various culture media used 
for these experiments were (a) standard-DMEM (b) SF-DMEM or (c) FCS-DMEM. 
Explants were labelled for the live and dead chondrocytes with CMFDA and PI 
respectively. These fluorescently-labelled chondrocytes were imaged at days 0, 3, 7 
and 14 by CLSM and both low and high power magnification images were obtained. 
The images were analysed for various features regarding PCD, volume of 





Figure 6.15: Coronal CLSM reconstructed image of full depth cartilage without 
subchondral bone. 
An example of CMFDA and PI labelled (for live and dead cells respectively) coronal 
image taken at low power magnification (x10) of full depth cartilage without bone at 
day 0 of culture showing SZ, MZ and DZ. Scale bar = 100µm. 
 
 Changes to the width of injury in explants without bone following culture 6.5.4.1
in various culture media 
The width of the injury was measured (Fig. 6.3) to assess the reaction of the injured 
area to varying culture media. The width of injury remained unaffected in cartilage 
explants without subchondral bone cultured in standard-DMEM during first 7 days of 
culture (Fig. 6.16; P>0.05 according to ANOVA). By day 14 the width of injury 
increased significantly in explants cultured with standard-DMEM as compared to all 
the three earlier time points (Fig. 6.16; P<0.001 for days 0, 3 and 7 of culture). The 
width of injury increased significantly in the explants cultured in the presence of SF-
DMEM and FCS-DMEM as compared to standard-DMEM (Fig. 6.16; P<0.0001 for 
both conditions) at day 3 and (Fig. 6.16; P<0.0001 for both conditions) at day 7 of 
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culture. However, by day 14 of culture the width of injury decreased significantly in 
the presence of SF-DMEM and FCS-DMEM as compared to standard-DMEM (Fig. 
6.16; P<0.0001 for both conditions). During the initial 7 days of culture, the width of 
injury increased in SF-DMEM and FCS-DMEM but decreased dramatically during 
the last 7 days of culture. These results proposed that during the course of culture in 
explants cultured in SF-DMEM and FCS-DMEM the width of injury was reduced as 
compared to standard-DMEM. 
 
Figure 6.16: Variations in the width of injury (explants without bone) following 
culture under various conditions. 
Graph shows pooled data regarding width of the injury at days 0, 3, 7 and 14 of 
culture in three different culture conditions. Data were from [N(n)]=[6(25)]. # 
indicated a significant difference between different culture conditions and at various 
time points according to one-way ANOVA followed by Tukey’s multiple 
comparison post-hoc test. The single, double and triple symbols showed the level of 





 Loss of PI-labelled cells at and distant from the injury 6.5.4.2
 
In a previous section (section 6.5.2.2) the loss of PI-labelled chondrocytes at the 
injury in axially imaged osteochondral explants was determined in various culture 
conditions. Likewise, % of PI-labelled chondrocytes was determined within specified 
ROIs at and distant from the injury (section 6.4.1.4) in the injured cartilage explants 
without subchondral bone to determine the effect of varying culture media. The 
composition of the culture medium markedly affected the % of PI-labelled 
chondrocytes (Fig. 6.17a-j). In the explants cultured with SF-DMEM and FCS-
DMEM the PI-labelled cells reduced dramatically even at day 3 of culture (Fig. 
6.17c&d) as compared to standard-DMEM (Fig. 6.17b).  
In the injured explants without bone the percentage of PI-labelled chondrocytes at 
the injury remained unaffected throughout the culture period in the explants cultured 
with standard-DMEM (Fig. 6.18a; P>0.05; one-way ANOVA). There was a 
significant decrease in the % of PI-labelled chondrocytes in the explants cultured 
with SF-DMEM and FCS-DMEM as compared to standard-DMEM (Fig. 6.18a; 
P<0.001; P<0.0001) at day 3, (Fig. 6.18a; P<0.001; P<0.0001) at day 7 and (Fig. 
6.18a; P<0.0001 for both conditions) at day 14 of culture. The loss of PI-labelled 
chondrocytes was significantly higher in the explants cultured with FCS-DMEM as 
compared to SF-DMEM at day 3 and 7 of culture (Fig. 6.18a; P<0.001 and P<0.05 
respectively).  
The percentage of PI-labelled chondrocytes was significantly higher at the injury as 
compared to distant from the injury throughout the culture period in the explants 
cultured with standard-DMEM (Fig. 6.18b; P=0.002; P=0.0009; P=0.0001 and 
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P=0.0001) at days 0, 3, 7 and 14 respectively. In the explants cultured with SF-
DMEM the % of PI-labelled chondrocytes was higher at the injury as compared to 
distant from the injury at days 3 and 7 of culture (Fig. 6.18b; P=0.007 and P=0.001 
respectively. However, by day 14 no difference existed in the % of PI-labelled cells 
at and distant from the injury in the explants cultured with SF-DMEM. Moreover, it 
was found that there existed no significant difference at days 3, 7 and 14 in the % of 
PI-labelled chondrocytes at and distant from the injury in the explants cultured with 
FCS-DMEM (Fig. 6.18b; P>0.05 for all conditions).  
These results suggested that the % of PI-labelled chondrocytes decreased markedly 
in the explants without subchondral bone cultured in the presence of SF-DMEM and 
FCS-DMEM as compared to standard-DMEM throughout the culture. In general, the 
effect of FCS-DMEM appeared to be more potent as compared to SF-DMEM. In 
summary the pattern of loss of PI-labelled chondrocytes in the injured explants 





Figure 6.17: Axial CLSM reconstructions of injured cartilage explants without 
subchondral bone in various culture conditions. 
CLSM reconstructions of low magnification (x10) images, typically to a depth of 
100µm collected at an interval of 10µm of CMFDA and PI-labelled chondrocytes 
(live/dead, respectively) in injured explants at (a) day 0, (b,c,d) day 3, (e,f,g) day 7 
and (h,I,j) day 14 cultured in standard-DMEM, SF-DMEM and FCS-DMEM 




Figure 6.18: The percentage of PI-labelled cells at and distant from the injury in 
cartilage without bone cultured under various conditions. 
Graphs show a comparison between the % PI-labelled cells (a) at the injury and (b) 
distant from the injury under the three culture conditions. Data were from 
[N(n)=6(25)]. # indicated a significant difference between different culture 
conditions at various time points according to one-way ANOVA followed by 
Tukey’s multiple comparison post-hoc test. ^ indicated a significant difference 
between the values at and distant from the injury according to unpaired student’s t-
test. The single, double and triple symbols showed the level of significance for 




 Changes to chondrocyte volume by day 3 of culture 6.5.4.3
 
Considerable changes to chondrocyte volume and morphology were seen at the 
injury in the cartilage explants (without bone) cultured in SF-DMEM and FCS-
DMEM as compared to standard-DMEM as shown in high power (x40) 
magnification CLSM images (Fig. 6.19a-j).  
The volume of chondrocytes at day 0 at the injury was 888±33µm
3
, and did not 
change by day 3 for the explants cultured in standard-DMEM (Fig. 6.20; P>0.05; 
one-way ANOVA). Chondrocyte volume at the injury increased significantly in the 
explants cultured with SF-DMEM and FCS-DMEM as compared to standard-DMEM 
by day 3 of culture (Fig. 6.20; P<0.0001 and P<0.01 respectively). Additionally, the 
volume of chondrocytes increased in the presence of SF-DMEM and FCS-DMEM by 
day 3 in comparison with the volume of chondrocytes at day 0 (Fig. 6.20; P<0.001 
for both the conditions according to ANOVA).  
These results suggested that by day 3 of culture chondrocyte volume increased at the 
injury in the presence of SF-DMEM and FCS-DMEM as compared to standard-





Figure 6.19: Axial CLSM reconstructions of injured cartilage without bone 
cultured in various conditions showing morphological changes to chondrocytes 
at the injury. 
Images obtained by x40(DW) objective typically to a depth of 50µm at an interval of 
1µm through the z-axis of the tissue. Chondrocytes were incubated with CMFDA 
and PI (live/dead respectively) in injured explants without bone at (a) day 0, (b,c,d) 
day 3, (e,f,g) day 7 and (h,i,j) day 14 cultured in standard-DMEM, SF-DMEM and 




Figure 6.20: Changes to chondrocyte volume at the injury (explants without 
bone) in response to various culture conditions. 
Graph shows pooled data on volume of chondrocytes at the injury indicating changes 
in response to various culture media by day 3 of culture. Data were from 
[N(nʹ)=6(38)]. # indicated a significant difference between different culture 
conditions and at two time points according to one-way ANOVA followed by 
Tukey’s multiple comparison post-hoc test. The single, double and triple symbols 
showed the level of significance for P<0.05, 0.01 and 0.001 respectively. 
 
  Chondrocyte clustering by day 7 of culture 6.5.4.4
 
Cluster formation, being a characteristic feature of chondrocytes was observed 
routinely. The clusters were defined and various characteristics of clusters were 
analysed (section 4.4.1.7.1) in different culture conditions and displayed (Fig. 6.21a-
e). Chondrocytes formed a significantly higher number of clusters at the injury in the 
explants cultured in the presence of FCS-DMEM as compared to standard-DMEM 
by day 7 of culture (Fig. 6.21a; P<0.05). The number of clusters formed in the 
presence of FCS-DMEM increased by day 7 as compared to the number of clusters at 
day 0 (Fig. 6.21a; P<0.05; ANOVA). However, the number of clusters formed in SF-
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DMEM by day 7 did not differ significantly from those in standard-DMEM and from 
day 0 (Fig. 6.21a; P>0.05; ANOVA). 
At day 7, the number of cells per cluster increased in the presence of FCS-DMEM as 
compared to standard-DMEM but the difference was not statistically significant (Fig. 
6.21b; P>0.05) however, increased significantly in comparison to the number of cells 
per cluster at day 0 of culture (Fig. 6.21b; P<0.05; ANOVA). However, at day 7 the 
number of cells per cluster remained unaffected in the presence of SF-DMEM as 
compared to standard-DMEM and also in comparison to day 0 (Fig. 6.21b). 
The volume of clusters formed at day 7 in the injured explants cultured in SF-
DMEM and FCS-DMEM was significantly greater than the volume of clusters 
formed in standard-DMEM (Fig. 6.21c; P<0.01 and P<0.05 respectively). The 
volume of clusters formed at day 7 in the presence of SF-DMEM and FCS-DMEM 
was also significantly higher than the volume of clusters present at day 0 (Fig. 6.21c; 
P<0.01 and P<0.05 respectively; ANOVA). The volume of individual cell in a 
cluster was significantly higher in the explants cultured with SF-DMEM as compared 
to standard-DMEM by day 7 (Fig. 6.21d; P=0.04).  
At the injury, at day 7 of culture, the percentage of chondrocytes forming clusters 
increased in the presence of SF-DMEM and FCS-DMEM as compared to standard-
DMEM (Fig. 6.21e). At day 7, in the presence of SF-DMEM and FCS-DMEM, a 
significantly higher percentage of chondrocytes (17±2% and 18±2% respectively) 
formed clusters as compared to standard-DMEM (8±0.2%; P<0.05 for both 
conditions). Additionally, a significantly higher percentage of chondrocytes formed 
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clusters in the presence of SF-DMEM and FCS-DMEM by day 7 of culture as 
compared to day 0 (P<0.05 for both conditions; ANOVA). 
 
Figure 6.21: Various characteristics of clusters formed at injury in the explants 
(without bone) cultured in various culture conditions. 
Graphs show pooled data for (a) number of clusters, (b) number of cells per cluster, 
(c) volume of clusters (µm
3
), (d) volume of individual cell in cluster (µm
3
) and (e) % 
of chondrocytes forming clusters. Data were for [N(n)=6(10)]. # indicated a 
significant difference between different culture conditions and at two time points 
according to one-way ANOVA followed by Tukey’s multiple comparison post-hoc 
test. The single, double and triple symbols showed the level of significance for 
P<0.05, 0.01 and 0.001 respectively. 
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To summarise this section, at day 0 very few chondrocytes were present in clusters. 
By day 7 of culture, chondrocytes were present in large clusters at the injury in the 
explants cultured with SF-DMEM and FCS-DMEM as compared to standard-
DMEM. The effects of SF and FCS appeared to be almost similar but clustering was 
triggered more in the presence of FCS as compared to SF. 
 
  Abnormal chondrocyte morphology by day 14 of culture 6.5.4.5
 
The nature of some of the culture media led to marked heterogeneity in chondrocyte 
morphology at the injury. In the presence of standard-DMEM chondrocyte 
morphology at the injury remained unaffected throughout the culture period (Fig. 
6.19a,b,e,h). However, chondrocytes at the injury in the presence of SF-DMEM and 
FCS-DMEM showed dramatic changes in terms of morphology (Fig. 6.19c,f,i & 
6d,g,j respectively). The morphology of chondrocytes changed from normal 
spheroidal shape to abnormal shapes characterised by cell enlargement, 
flattening/elongation of cell bodies and production of cytoplasmic processes 
emanating from the cell bodies (examples shown in Fig. 6.22). These morphological 
changes were seen in the explants cultured in the presence of SF-DMEM and FCS-
DMEM and not in standard-DMEM and were restricted to the superficial 30µm of 
the cartilage (Fig. 6.23b,c). The chondrocytes in the deeper layers beyond 30µm 






Figure 6.22: Altered morphology of chondrocytes in various culture conditions 
by day 14. 
Examples of abnormal chondrocytes at the injury in the explants cultured in the 
presence of SF-DMEM and FCS-DMEM at day 14. Varieties of shape changes were 
seen at high power magnification (a) relatively normal chondrocyte with spheroidal 
shape. Abnormal chondrocytes (b, c, d and e) showing enlarged, flattened cells with 
multiple cytoplasmic processes emanating from cell bodies. Scale bar = 10µm.  
 
Figure 6.23: Heterogeneity in chondrocyte morphology at the injury in the 
presence of various culture media at day 14. 
Axial CLSM reconstructions of high power magnification images of fluorescently 
labelled chondrocytes at the injury by day 14, (a, b, c) superficial 30µm and (d, e and 
f) a further 20µm deep of the cartilage cultured in standard-DMEM (a, d), SF-
DMEM (b, e) and FCS-DMEM (c, f). Scale bar = 25µm.  
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Quantitative data regarding various characteristics of chondrocyte morphology at the 
injury were obtained by the 3D image analysis software (section 6.4.1.5) and 
compared for day 0 and 14 of culture in various conditions. At the injury, 17±5% and 
25±3% chondrocytes were morphologically abnormal [N(n)=6(10); in SF-DMEM 
and FCS-DMEM respectively] as compared to standard-DMEM at day 14 (P<0.0001 
for both conditions) and also in comparison to day 0 (Fig. 6.24a; P<0.0001 for both 
conditions) where chondrocytes were relatively normal in shape.  
There was an overall three-fold increase in the volume of chondrocytes at the injury 
following culture in SF-DMEM and FCS-DMEM as compared to standard-DMEM. 
The average volume of individual abnormal chondrocytes at injury by day 14 of 
culture was significantly higher in SF-DMEM and FCS-DMEM as compared to 
standard-DMEM (Fig. 6.24b; P<0.0001 for both conditions) and also in comparison 
to day 0 (P<0.0001 for both conditions).  
There was an approximate x4 increase in the length of cell bodies of individual 
abnormal chondrocytes at the injury cultured in the presence of SF-DMEM and FCS-
DMEM as compared to standard-DMEM by day 14 of culture (Fig. 6.24c; P<0.0001 
for both conditions) and also in comparison to day 0 (P<0.0001 for both conditions). 
Moreover, the length of cell bodies at injury was significantly greater in FCS-DMEM 




Figure 6.24: Morphological characteristics of chondrocytes at the injury in 
various culture conditions at day 14. 
Graphs show pooled data regarding (a) percentage of abnormal cells with 
cytoplasmic processes at injury (b) average volume of cells at the injury (µm
3
) and 
(c) average length of cell bodies of chondrocytes (µm) at the injury in the presence of 
standard-DMEM, SF-DMEM and FCS-DMEM at day 0 and 14 of culture. Data were 
from [N(n)=6(10)]. # indicated a significant difference between different culture 
conditions and at two time points according to one-way ANOVA followed by 
Tukey’s multiple comparison post-hoc test. The single, double and triple symbols 
showed the level of significance for P<0.05, 0.01 and 0.001 respectively. 
 
To summarise the results of this section, there was marked heterogeneity in 
chondrocyte morphology at the injury in the cartilage explants (without subchondral 
bone) cultured with SF-DMEM and FCS-DMEM and not in the presence of 
standard-DMEM. Moreover, the effect of FCS appeared to be more potent as 
compared to SF. Therefore, these results suggested that the morphological changes 
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observed in chondrocytes at the injury were similar to those in the explants with 
subchondral bone. 
6.5.5 Morphological characteristics of chondrocytes in injured cartilage 
without superficial layers cultured under various conditions 
 
It is possible that the chondrocytes which changed shape at the injury in response to 
factors present in FCS/SF are limited to the superficial zone alone and the 
chondrocytes residing deep in the cartilage do not possess this property. In view of 
investigating this, cartilage explants containing the deeper layers of chondrocytes 
with a substantial amount of subchondral bone were injured with the standardised 
injury method. The superficial layers of cells with the thickness of 431±42µm (n=4; 
Fig. 6.25a) were removed with careful dissection and the deep layers of cartilage 
with the thickness of 314.9±23µm (n=6; Fig. 6.25b) along with the underlying 
subchondral bone were injured and kept in culture for 14 days. The culture media 
used in these experiments were either (a) standard-DMEM or (b) FCS-DMEM and in 
these experiments SF was not used.  
These injured explants without the superficial layers of cells were labelled with 
CMFDA and PI (live and dead cells respectively) at days 0, 7 and 14. The 
fluorescently labelled chondrocytes were imaged with CLSM with both low and high 
power magnification objectives. Quantitative data regarding PCD (% of PI-labelled 
chondrocytes), volume, cluster formation and abnormal morphology of cells in the 




Figure 6.25: Coronal CLSM reconstructions of superficial and deep layers of 
cartilage. 
Examples of coronal view of CMFDA and PI (live and dead cells respectively) 
labelled chondrocytes imaged at low power magnification (x10 dry) showing (a) 
superficial layers of cartilage (b) deep layers of cartilage with the underlying 
subchondral bone. Explants shown in panel b were used in these experiments. Scale 
bar = 100µm.  
 
 PI-labelled cells at and distant from the injury 6.5.5.1
 
In the previous sections the loss of PI-labelled chondrocytes at the injury in 
osteochondral explants and explants without subchondral bone in the presence of 
some of the culture media has been detailed (sections 6.7 & 6.18 respectively). 
Likewise, the percentage of PI-labelled chondrocytes changed considerably in the 
presence of FCS-DMEM as compared to standard-DMEM (Fig. 6.26b,d). 
Quantitative data regarding the % of PI-labelled chondrocytes was obtained at and 
distant from the injury in the cartilage explants without superficial layers cultured in 
standard-DMEM and FCS-DMEM. The PI-labelled chondrocytes decreased in the 
explants cultured in the presence of FCS-DMEM even by day 7 of culture as shown 
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in low power magnification images (Fig. 6.26d) but no such effect was seen in 
standard-DMEM (Fig. 6.26b). By day 14, in the explants cultured in serum-rich 
medium, chondrocyte morphology changed dramatically on the whole surface of the 
cartilage irrespective of at and distant from the injury (Fig. 6.26e). The % of PI-
labelled chondrocytes was similar at and distant from the injury due to the fact that in 
addition to the experimental scalpel injury applied to these explants, they were also 
injured while dissecting out the superficial layers of cartilage (Fig. 6.26a). 
 
Figure 6.26: Axial CLSM reconstructions of injured cartilage explants without 
the superficial layers showing abnormal chondrocyte morphology by day 14 in 
FCS-DMEM. 
Low magnification (x10) reconstructed images of CMFDA and PI labelled (live and 
dead cells respectively) chondrocytes of the injured cartilage explants without 
superficial layers at (a) days 0, (b, d) 7 and (c, e) 14 of culture in standard-DMEM 




The % of PI-labelled chondrocytes at the injury remained unaffected in the explants 
cultured with standard-DMEM throughout the culture period at days 0, 7 and 14 of 
culture (Fig. 6.27a; P>0.05; ANOVA for the three time points). In the injured 
explants without superficial layers cultured in FCS-DMEM the % of PI-labelled 
chondrocytes decreased significantly as compared to standard-DMEM at days 7 and 
14 of culture (Fig. 6.27a; P<0.0001 for both time points).  
The % of PI-labelled chondrocytes distant from the injury remained unaffected in 
the explants cultured with standard-DMEM during the course of culture at days 0, 7 
and 14 (Fig. 6.27b; P>0.05; ANOVA for the three time points). As expected in the 
presence of FCS-DMEM, there was a significant reduction in the % of PI-labelled 
chondrocytes as compared to standard-DMEM at days 7 and 14 of culture (Fig. 
6.27b; P<0.0001 for both the days). Additionally, no difference was found between 
the % of PI-labelled chondrocytes at or distant from the injury in the explants 
cultured with either standard-DMEM or FCS-DMEM throughout the culture (Fig. 
6.27a,b; P>0.05).  
These results suggested that under the effect of FCS there was ~96% decrease in the 
% of PI-labelled chondrocytes at the injury as compared to standard-DMEM similar 




Figure 6.27: Decreased percentage of PI-labelled chondrocytes at and distant 
from the injury in the explants without SZ cultured in the presence of FCS-
DMEM. 
The graphs show pooled data regarding the percentage of PI-labelled chondrocytes 
(a) at the injury and (b) distant from the injury in the explants (without superficial 
layers) cultured in various conditions throughout the culture period. Data were from 
[N(n)=6(25)]. * indicated a significant difference between two culture conditions at 
one time point according to t-test. The single, double and triple symbols showed the 
level of significance for P<0.05, 0.01 and 0.001 respectively. 
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 Morphology of deep zone chondrocytes in response to various culture 6.5.5.2
conditions 
 
This study aimed at investigating whether the DZ chondrocytes in the presence of 
serum-rich medium change morphology or this is exclusively the property of 
chondrocytes in the SZ. The data showed that the morphology of chondrocytes 
changed markedly during the course of culture in the presence of FCS-DMEM. 
These morphological changes were analysed in terms of volume, cluster formation 
and abnormal morphology of chondrocytes and the results were presented at different 
time points (Days 0, 7 and 14).   
 
 Volume/cluster formation of deep layer chondrocytes at and distant 6.5.5.2.1
from the injury by day 7 
 
In these experiments, the superficial layers of cartilage were removed, therefore the 
majority of cells studied here were from middle and deep layers of cartilage. The 
morphology of chondrocytes in the deep zone of cartilage changed markedly in the 
explants cultured in the presence of FCS-DMEM as compared to standard-DMEM 
(Fig. 6.28).  
At day 7, volume of chondrocytes appeared to be slightly elevated at the injury in the 
explants cultured in FCS-DMEM (1491.9±155.8µm
3
) than the volume of those 
cultured in the presence of standard-DMEM (1351.4±105µm
3
) and also in 
comparison to day 0 (1117.8±82.9µm
3
) but the difference was not statistically 
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significant (Fig. 6.29a; P>0.05). The volume of chondrocytes in the DZ of healthy 
cartilage at day 0 was higher than the volume of chondrocytes in the SZ of cartilage 
as measured in the earlier experiments mentioned in this chapter (711±25µm
3
). 
Additionally, the volume of chondrocytes in both the culture conditions was similar 
at and distant from the injury (Fig. 6.29b; P>0.05).  
 
 
Figure 6.28: Axial CLSM reconstructions of injured cartilage without SZ cells 
showing changes to chondrocyte morphology by day 14 of culture in FCS-
DMEM as compared to standard-DMEM. 
High power magnification (x40DW) reconstructed images taken at a depth of 50µm 
with an interval of 1µm through the z-axis of the tissue. Chondrocytes were 
incubated with CMFDA and PI (to identify live and dead cells respectively) in the 
injured explants without superficial layers and imaged at days (a) 0, (b, d) 7 and (c, 
e) 14 of culture in standard-DMEM and FCS-DMEM respectively. Scale bar for all 




Figure 6.29: Volume of chondrocytes at and distant from the injury in the 
injured explants (without superficial layers) by day 7. 
Graphs summarise pooled data regarding the volume of chondrocytes in standard-
DMEM and FCS-DMEM showing no volume changes (a) at the injury and (b) 
distant from the injury. Data were from [N(nʹ)=6(11,8) at day 0, (19,52) in standard-
DMEM, (20,20) in FCS-DMEM at day 7, at and distant from the injury respectively. 
The differences between the volume of chondrocytes at and distance from the injury 




In the injured explants without superficial layers chondrocyte clustering was 
observed and was affected by the nature of the culture medium. At day 7, the number 
of clusters formed at and distant from the injury in the explants cultured with FCS-
DMEM were significantly higher than those found in standard-DMEM (Figs. 6.30Aa 
and 6.30Ba; P<0.05 for both at and distant from the injury; ANOVA) and also in 
comparison to those at day 0 (Fig. 6.30Aa and 6.30Ba; P<0.05 for both conditions; 
ANOVA). However, the number of clusters formed at the injury and distant from the 
injury in both the culture conditions was not different. The number of cells/cluster 
was found to be similar in both the culture conditions at and distant from the injury 
(Figs. 6.30Ab and 6.30Bb; P>0.05 for all the conditions). 
A higher percentage of chondrocytes formed clusters by day 7 of culture in the 
explants cultured in the presence of FCS-DMEM as compared to standard-DMEM at 
and distant from the injury (Figs. 6.30Ac and 6.30Bc). In the injured explants 
(without superficial layers) cultured in the presence of FCS-DMEM at the injury a 
significantly higher percentage (20±3%) of chondrocytes formed clusters comapred 
to those in standard-DMEM (7±1%; P<0.05) and percentage of chondrocytes 
forming clusters at day 0 (5±1%; P<0.05). Similarly, distant from the injury, a higher 
percentage of chondrocytes formed clusters in the presence of FCS-DMEM (23±1%) 
as compared to those in standard-DMEM (5±1%; P<0.01) and also in comparison to 
day 0 (5±1%; P<0.01). However, no difference was found between the percentages 
of chondrocytes forming clusters at and distant from the injury in both the culture 
conditions (Figs. 6.30Ac and 6.30Bc; P>0.05). 
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At day 7 of culture, the volumes of clusters formed at and distant from the injury in 
the presence of FCS-DMEM were significantly greater as compared to those in 
standard-DMEM (Figs. 6.30Ad and 6.30Bd; P<0.05 for both conditions) and also in 
comparison to day 0 (P<0.05 for both conditions). However, no difference was found 
between the volumes of clusters formed at and distant from the injury in both the 
culture conditions (P>0.05).  
The volume of individual cells in a cluster was calculated (section 4.4.1.7.1) and 
compared in both the culture conditions at days 0 and 7. The volume of individual 
cells in a cluster at and distant from the injury increased significantly by day 7 for the 
explants cultured in FCS-DMEM as compared to standard-DMEM (Figs. 6.30Ae and 
6.30Be; P<0.001 and P<0.01 respectively) and also in comparison to day 0 (P<0.001 
and P<0.05 respectively). However, no difference was found between the volumes of 
individual cells in a cluster at and distant from the injury in both the culture 
conditions (P>0.05).  
To summarise the results of this section, the volume of chondrocytes at and distant 
from the injury in both the culture conditions remained unaffected by day 7 of 
culture. At day 0 only few chondrocytes formed small sized clusters. At day 7, 
numerous chondrocytes formed large clusters at and distant from the injury in the 
injured explants (without superficial layers of cells) cultured in the presence of FCS-
DMEM as comapred to standard-DMEM. Moreover, there was no difference 




Figure 6.30A: Characteristics of clusters formed in injured explants without 
superficial layers at the injury cultured in various culture conditions. 
Graphs show pooled data for (a) average number of clusters formed (b) average 
number of cells in a cluster (c) % of cells involved in forming clusters (d) average 
volume of clusters (µm
3
) of chondrocytes formed and (e) average volume of 
individual cell in a cluster (µm
3
) at the injury. Data were from [N(n)=6(12)]. # 
indicated a significant difference between different culture conditions and at two 
time points according to one-way ANOVA followed by Tukey’s multiple 
comparison post-hoc test. The single, double and triple symbols showed the level of 




Figure 6.30B: Characteristics of clusters formed in injured explants without 
superficial layers distant from the injury cultured in various culture conditions. 
Graphs show pooled data for (a) average number of clusters formed (b) average 
number of cells in a cluster (c) % of cells involved in forming clusters (d) average 
volume of clusters (µm
3
) of chondrocytes formed and (e) average volume of 
individual cell in a cluster (µm
3
) distant from the injury. Data were from 
[N(n)=6(12)]. # indicated a significant difference between different culture 
conditions and at two time points according to one-way ANOVA followed by 
Tukey’s multiple comparison post-hoc test. The single, double and triple symbols 
showed the level of significance for P<0.05, 0.01 and 0.001 respectively. 
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 Development of abnormal morphology of deep layer chondrocytes at 6.5.5.2.2
and distant from the injury by day 14 
 
The morphology of chondrocytes remained unaffected in the injured explants 
(without superficial layers) cultured in the presence of standard-DMEM and cells 
were relatively normal in morphology characterised by spheroidal shape (Fig. 
6.31a,c). However, presence of FCS in the culture medium markedly affected 
chondrocyte morphology by day 14. The morphological changes observed were 
associated with cell enlargement, flattening, lengthening and production of 
cytoplasmic processes from the cell bodies. Therefore abnormal chondrocytes were 
not restricted to the upper layers of the injured explants but the abnormal cells were 
also present in the deeper layers of cartilage (Fig. 6.31b,d). 
 
Quantitative data regarding various morphological properties of chondrocytes at and 
distant from the injury was obtained by the use of 3D image analysis software and 







Figure 6.31: Heterogeneity of chondrocyte morphology by day 14 in the injured 
explants (without superficial layers) cultured in various culture conditions. 
Axial CLSM reconstructions of high power magnification images of CMFDA and PI 
labelled chondrocytes (live and dead cells respectively) at the injury by day 14 (a,b) 
superficial 30µm (c,d) a further deep 20µm in the cartilage cultured in standard-
DMEM and FCS-DMEM respectively. Scale bar for all panels=25µm. 
 
At day 14, the percentage of abnormal chondrocytes with processes at and distant 
from the injury was significantly higher in the explants cultured in the presence of 
FCS-DMEM as compared to standard-DMEM (Fig. 6.32a,b; P<0.0001 for both 
conditions) and also in comparison to day 0 (Fig. 6.32a,b; P<0.0001 for both 
conditions) where cells were relatively normal. However, there existed no difference 
307 
 
(P>0.05) between the percentages of abnormal chondrocytes cultured in the presence 
of FCS-DMEM at and distant from the injury by day 14.  
The volume of these abnormal chondrocytes increased overall approximately x2 at 
and distant from the injury in the presence of FCS-DMEM as compared to the 
volume of chondrocytes in standard-DMEM (Fig. 6.32c,d; P<0.0001 for both 
conditions) and also in comparison to day 0 (P<0.001 for both conditions). 
Additionally, there was no difference between the volume of chondrocytes at and 
distant from the injury in the presence of FCS-DMEM by day 14 (Fig. 6.32c,d; 
P>0.05).  
The length of cell bodies increased approximately x5 at and distant from the injury 
by day 14 in the explants cultured with FCS-DMEM as compared to standard-
DMEM (Fig. 6.32e,f; P<0.0001 for both conditions) and also in comparison to day 0 
(P<0.001 for both conditions). Moreover, there was no difference between the 
average length of cell bodies of these abnormal chondrocytes at and distant from the 




Figure 6.32: Heterogeneous morphology of chondrocytes at and distant from the 
injury cultured in various culture media. 
Graphs show pooled data regarding the (a,b) percentage of abnormal chondrocytes, 
(c,d) average volume of chondrocytes (µm
3
) and (e,f) average length of cell bodies of 
chondrocytes (µm), at and distant from the injury respectively in the presence of 
standard-DMEM and FCS-DMEM at day 0 and 14 of culture. Data were from 
[N(n)=6(17)]. # indicated a significant difference between different culture 
conditions and at two time points according to one-way ANOVA followed by 
Tukey’s multiple comparison post-hoc test. The single, double and triple symbols 
showed the level of significance for P<0.05, 0.01 and 0.001 respectively. 
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To summarise the results of this section, chondrocytes displayed marked 
heterogeneity in terms of morphological characteristics in the cartilage explants 
(without superficial layers) cultured in the presence of FCS-DMEM as compared to 
standard-DMEM where the morphology remained unaffected. Additionally, in the 
presence of FCS the characteristics and extent of these morphological changes was 
similar at and distant from the injury.  
In this study, in the injured osteochondral explants chondrocytes at the injury in 
response to factors present in FCS/SF displayed morphological changes restricted to 
the superficial layers of cartilage. However, in the injured explants without 
superficial layers chondrocytes at and distant from the injury displayed 
morphological changes in the presence of serum-rich medium. These results 
suggested that the triggering factor for these shape changes could possibly be the 
morphogenic factors present in the serum and more the accessibility of these factors 
more marked the shape changes will be.   
6.6 DISCUSSION 
 
This study aimed to develop and utilise an in vitro model of injured bovine articular 
cartilage to study the response of chondrocytes to sharp injury in the presence of 
varying culture media. The results strongly supported the primary hypothesis of the 
study that chondrocytes in the superficial layers at the injury displayed marked shape 
changes in response to the factors present in SF and FCS as compared to standard-
DMEM. In the present work the results also supported the secondary hypothesis that 
the chondrocytes throughout the cartilage were vulnerable to shape changes under 
the effect of factors present in SF and FCS. Additionally, the results also supported 
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the tertiary hypothesis that chondrocytes at the injury produced morphological 
changes in the presence of SF and FCS even in the absence of subchondral bone.  
The concerns with the use of this model were (a) production of a standardized injury 
required practice and several attempts (b) it did not resemble the in vivo mechanical 
and biochemical environment and (c) the explants when removed from the bone 
underwent a generalised swelling of the cartilage. The advantages of utilising this 
model have been explained in detail (section 6.2) which clearly suggested it to be a 
reproducible and a highly controlled model to study chondrocyte response to injury.  
In this study the changes to in situ chondrocyte viability and morphology near scalpel 
induced mechanical injury in full depth osteochondral explants in response to varied 
culture media over a period of 14 days by utilising CLSM both in the axial and 
coronal planes have been investigated. In addition to this, we also studied similar 
parameters in cartilage explants without subchondral bone and without superficial 
zone. The results showed that width of the injury decreased significantly in the 
explants cultured in the presence of SF/FCS-DMEM and increased significantly with 
standard-DMEM. In the presence of SF and FCS there was a significant loss of PI-
labelled chondrocytes near injury as compared to standard-DMEM. At the site of 
injury, volume of chondrocytes significantly increased, formed large sized clusters 
by day 7 and exhibited marked heterogeneity in morphology by day 14 in the 
explants cultured with SF/FCS as compared to standard-DMEM. Moreover, these 
changes in chondrocyte viability and morphology were found to be significantly 
obvious at the site of injury and only in the superficial zone, as compared to the 
control uninjured cartilage distant from the injury, in the injured explants with and 
without subchondral bone. In contrast to this, in the injured explants without 
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superficial zone these changes to viability and morphology of chondrocytes showed 
no difference between at and distant from the injury and were not restricted to the 
superficial layers. These results will now be discussed in detail. 
There were marked changes at the injury in the presence of different types of culture 
media. Initially at the beginning of the experiments width of the injury created was 
same in all the explants (Fig. 6.5). The width of injury increased significantly in the 
presence of standard-DMEM as compared to SF and FCS (Figs. 6.5 & 6.16) and 
could be attributed to collagen damage due to injury leading to invariable increase in 
water content  and tissue swelling (Maroudas, 1976) and loss of GAGs (Torzilli and 
Grigiene, 1998). There exists a paradox that although the tissue is swelling but there 
is loss of GAGs. In contrast, the width of injury decreased in explants cultured in the 
presence of SF-DMEM and FCS-DMEM. The underlying mechanism for this 
decrease in width of injury is not known however, a simple explanation could 
possibly be the cytoplasmic extensions protruded by chondrocytes at the injured site 
under the effect of serum led to the reduction in the width of injury. Additionally, it 
is possible that chondrocytes get metabolically stimulated by the factors present in 
SF and FCS and the new matrix formed at the injury led to the decrease in width of 
injury in these culture conditions. 
Chondrocyte death following tissue trauma leading to reduction in the cellularity and 
malfunctioning of chondrocytes has been suggested to predispose the cartilage to the 
development of PTOA (Simon et al., 1976, Blanco et al., 1998). Cell death is a 
common feature of mechanical trauma (Tew et al., 2000, Bush et al., 2005) here we 
have used low power (x10 dry) images of CLSM with CMFDA/PI labelling for the 
quantification of living/dead chondrocytes respectively (Amin et al., 2008a) and 
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PCD (Fig. 6.6a-j, 6.17a-j & 6.26a-e). The use of fluorescent probes as indicators of 
viability of chondrocytes serves as a valuable tool in the cartilage research. In this 
work PI-labelled chondrocytes were lost significantly in the explants cultured in the 
presence of SF/FCS as compared to DMEM (Fig. 6.7a, 6.18a & 6.27a). Moreover, 
the % PI-labelled chondrocytes were significantly higher at the site of injury as 
compared to those distant from the injury in the presence of SF-DMEM and FCS-
DMEM in the explants with and without bone (Fig. 6.7b, 6.18b). However, in the 
injured explants without the superficial zone there existed no difference between the 
% of PI-labelled chondrocytes at and distant from the injury (Fig. 6.27b) possibly 
because the explants were additionally injured while dissecting out the superficial 
layers of cartilage. Although use of PI labelling for assessing amount of cell death is 
a widely used method (Bush and Hall, 2001a, Chen et al., 2003) it has recently been 
reported that it might be misleading especially with the use of FCS in the tissue 
cultures (Zhou et al., 2011). Data were presented suggesting that most likely DNase I 
(Gaipl et al., 2006) and heat stable nucleases (von Kockritz-Blickwede et al., 2009) 
present in serum degraded the DNA of dead cells and thus PI, the DNA binding dye 
could not detect dead cells accurately. However, they compared the effects of serum 
and serum-free media but not considered the effect of SF on the PI-labelling of dead 
chondrocytes despite of the fact that SF is also used in tissue cultures (Lee et al., 
1997) and it more closely approximates the in vivo environment. The results of 
present experiments augmented these observations suggesting that SF seems to have 
the same effect but less potent than FCS which possibly prevented labelling of dead 
chondrocytes. Moreover, the loss of PI-labelled chondrocytes was reduced in the 
presence of SF as compared to FCS, indicating the possibility that DNA degrading 
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enzyme(s) were present at higher concentrations in FCS as compared to SF, although 
they were both diluted to the same extent (10%) in the culture media. The differences 
in the cartilage ECM metabolism by the use of FCS and SF supplemented culture 
media had already been established (Martin et al., 2002) indicating that FCS was 
more potent than SF.  
At day 0, in fresh cartilage the volume of DZ chondrocytes was higher than the 
volume of chondrocytes in the SZ (section 6.5.5.2.1), these observations are in 
agreement with already reported volume of chondrocytes in different zones of bovine 
cartilage (Bush and Hall, 2001a). Chondrocyte volume in injured explants with and 
without subchondral bone near injury increased significantly in the presence of SF 
and FCS as compared to standard-DMEM and those distant from the injury. Initial 





respectively which were found to be within the range of the volume of 
superficial zone chondrocytes  (252 to 836 µm
3
) in intact bovine articular cartilage 
(Bush and Hall, 2001a). There was a significant increase in the volume of 
chondrocytes near injury in the presence of SF and FCS (55% for both) as compared 
to the volume of cells in standard-DMEM (Figs. 6.9 & 6.20). These findings may be 
similar to the increased chondrocyte volume changes observed in degenerative 
osteoarthritic cartilage where enhanced access of growth factors due to weakened 
matrix are thought to stimulate hypertrophic changes in chondrocytes (Dreier, 2010, 
van der Krann and van den Berg, 2012, Turunen et al., 2013). However, in the 
injured cartilage explants without superficial zone the volume of chondrocytes at the 
beginning of culture was 1117.8±82.9µm
3 
which was within the volume range of mid 
and deep zone (266 to 1149 µm
3 
and 372 to 1377 µm
3 
respectively) intact bovine 
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cartilage (Bush and Hall, 2001a). Additionally, the volume of these chondrocytes 
increased but not significantly following culture in FCS-DMEM which is also in 
agreement with the previously reported findings (Bush and Hall, 2001a). Therefore 
possibly serum factors caused volume increase in chondrocytes at the injury.   
Chondrocyte cluster formation was another key morphological feature observed in 
the experimental model and is also a hallmark of OA (Pfander et al., 2001). In fresh 
healthy cartilage, chondrocytes typically occur in pairs (Sasazaki et al., 2008). 
Therefore, in this study 3 or more cells together were considered as a cluster and it 
was also noticed that in healthy control cartilage rarely chondrocytes were present as 
a cluster (with no more than 3 cells). In a previous study the clusters have been 
defined to contain 2-6 cells in bovine OA cartilage model (McGlashan et al., 2008). 
In the presence of standard-DMEM, chondrocytes formed few clusters at the injured 
site. However, under the effect of SF-DMEM and FCS-DMEM increased number 
and size of chondrocyte clusters were formed at the injury (Figs. 6.10A, 6.21 & 
6.30A), suggesting the presence of growth factors in SF and FCS (Martin et al., 
2002, Khan et al., 2010). Moreover, the morphological changes observed were 
almost similar in the presence of SF/FCS but faster in FCS due to the fact that FCS 
would appear to be a more potent chondrocyte stimulator than SF (Figs. 6.10, 6.12, 
6.21, 6.24 & 6.30) as reported already (Martin et al., 2002). Chondrocytes distant 
from the injury also exhibited some cluster formation under the effect of SF and 
FCS. The factors present in SF and FCS influenced chondrocytes distant from the 
injury but the effect was less marked possibly because the matrix distant from the 
injury was intact thereby hindering diffusion of these factors. The average total 
number of chondrocytes in the specified ROI did not change significantly during the 
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course of culture in various culture conditions (section 6.5.2.3.2.). This suggested the 
possibility that the chondrocytes can move toward one another within the matrix and 
form clusters. This phenomenon was suggested in a previous study (Kouri et al., 
1996b) carried out on human OA and non-OA cartilage. Findings in this previous 
study discovered the presence of clusters in fibrillated areas but the total number of 
cells in the fibrillated and non-fibrillated areas of cartilage was not different. 
Therefore, the phenomenon that chondrocytes actually migrate and form clusters can 
be considered. 
The ‘abnormal’ chondrocyte morphology observed in the explants cultured in the 
presence of SF and FCS but not present in standard-DMEM (Figs. 6.12, 6.13, 6.24 & 
6.32) might indicate a potential role of growth factors in cartilage injuries. The role 
of specific growth factors and combinations of growth factors in cartilage 
regeneration has been extensively reviewed (Fortier et al., 2011). There were 
significant morphological changes which included cellular enlargement, elongation 
of the cell body and formation of cytoplasmic processes (Figs. 6.12a-f, 6.14a-j, 
6.22a-e & 6.28a-e). These abnormal chondrocytes were present in the superficial 
layers of cartilage near injury (Figs. 6.11 & 6.23). However, the cells in the deeper 
layers were spheroidal and relatively ‘normal’ in the injured explants with and 
without subchondral bone. These findings might be taken to indicate enhanced 
penetration and activity of factors from SF and FCS on these cells. However, in the 
injured explants (coronal view) and the ones without superficial zone, these 
abnormal chondrocytes were not restricted to a specific zone (Figs. 6.13 & 6.31 
respectively) which suggested that greater the access of these growth factors the 
more the shape changes. These results thus suggested that chondrocytes irrespective 
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of the zone are capable of showing morphological changes and this is not the 
property of chondrocytes in the superficial layers alone rather it is due to the extent 
of penetration of the ‘factors’ into the matrix.  
There are some interesting parallels of this heterogeneous population of cells with 
the chondrogenic progenitor cells in the superficial layers of cartilage (Dowthwaite et 
al., 2004). It has been reported in a study that in an adult human articular cartilage 
chondrogenic progenitor cells constitute 7.5% of the total cell population (Alsalameh 
et al., 2004). Additionally these progenitor cells are localised mostly to the 
superficial layers of cartilage (Alsalameh et al., 2004, Dowthwaite et al., 2004). It is 
unlikely that the morphologically heterogeneous population of chondrocytes in this 
work are progenitor cells because of two reasons. Firstly, the percentage of 
progenitor cells in adult articular cartilage is far less than the percentage of 
morphologically heterogeneous chondrocytes seen in the study presented here. 
Secondly, progenitor cells are mostly present in the superficial layers of cartilage 
whereas, in this work the morphologically heterogeneous chondrocytes could be 
observed irrespective of the cartilage zone. In a recent study it has also been 
proposed that chondrogenic progenitor cells migrate to the site of injury in response 
to the chemotactic factors to repopulate the injured site (Seol et al., 2012). In this 
study the triggering element for shape changes is less likely to be the chemotactic 
factors because of three possible reasons: (a) in this study the chemotactic factors 
produced from injured explants (from dead cells) were thought to be minimal as most 
of the PI-labelled chondrocytes were lost under the effect of SF and FCS (b) the 
amount of cell death in this injured cartilage model was minimal due to sharp injury 
whereas in the previous work blunt trauma was applied producing greater cell death 
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(Redman et al., 2004) and therefore, possibly the quantity of chemotactic factors 
produced in the present study was less compared to the previous work (c) if 
chemotactic factors alone would have the ability to stimulate these cells then in our 
control explants cultured in standard-DMEM chondrocytes with abnormal 
morphologies would have been seen (Fig. 6.8). Therefore, it might be possible that 
either the growth factors alone excited these cells or the growth factors triggered the 
chemotactic factors to stimulate chondrocytes. As already mentioned the possibility 
of having chemotactic factors as stimulators for chondrocytes is minimal in the 
experiments detailed in this study therefore, morphogenic factors present in FCS/SF 
are the possible regulators of chondrocyte morphology. 
In the present study, chondrocytes produced cytoplasmic processes at the injury in 
the presence of FCS/SF in the culture media and these processes were aligned along 
the edge of the injury (Fig. 6.8). These results are in agreement with a recent study 
where it was reported that in the presence of FCS the chondrocytes produced 
cytoplasmic processes and these tend to move and align along the edge of the defect 
produced in cartilage (Lyman et al., 2012). However, the present work builds upon 
the already reported observations regarding the response of chondrocytes to 
mechanical injury in the previous study in several ways. Firstly, the modes of injury 
in the present and previous study were different. In the previous study drill-bit was 
used and in the present study scalpel cut was produced to mechanically injure 
cartilage. The advantages of utilising sharp injury model as compared to other forms 
of trauma have already been discussed (section 6.2). Secondly, in the previous study 
the production of cytoplasmic processes in the presence of FCS has been reported but 
in the present study their existence in the presence of SF and absence in standard-
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DMEM were novel findings. Thirdly, in the previous study the injured explants with 
subchondral bone were studied as injury model. However, in the present study 
chondrocytes in the injured cartilage explants without subchondral bone were also 
studied and displayed marked shape changes thus ruling out any possibility of 
interference of injured site with osteocytes or bone factors. Whether these cells are 
progenitor cells and they are migratory in nature has not been addressed in the 
present study. However, in author’s opinion in response to injury chondrocytes 
residing in any zone of cartilage have the ability to change shape in the presence of 
serum morphogenic factors.  
The existence of chondrocyte cytoplasmic processes in non-degenerate and 
degenerate human tibial plateau cartilage and the possible theories for their 
appearance have been described already (Bush and Hall, 2003). There are some 
parallels between these already reported abnormal chondrocytes in the previous 
study and the abnormal chondrocytes at injury observed in the present study. 
However, direct comparison is hard because in the study presented here bovine 
cartilage was used as the experimental material whereas this previously reported 
study was conducted on human cartilage. The common morphological feature 
observed between bovine chondrocytes in this work and human chondrocytes in 
previous study was the presence of single or multiple cytoplasmic processes 
emanating from cell bodies. However, the main difference existed was the shape of 
the cell body. In the bovine cartilage in this work majority of these abnormal 
chondrocytes had flattened and elongated cell bodies. In contrast in the previous 
study on human cartilage the cell bodies of these abnormal chondrocytes with 
processes were neither elongated nor flattened rather they had irregular shapes.  
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There was a possibility that some factors released from exposed bone parts and also 
bone cells released in culture medium could migrate at the site of injury. This seems 
unlikely because these possibilities have been ruled out fully as detailed in the results 
section on the injured cartilage explants without subchondral bone. In the absence of 
subchondral bone the response of chondrocytes to injury was similar to those with 
subchondral bone. 
It had already been established that chemical composition of the culture medium 
greatly affected the properties of cartilage and chondrocytes in culture (Bian et al., 
2008). FCS (McQuillan et al., 1986, van Susante et al., 2000) and SF (Nuver-Zwart 
et al., 1988, Lee et al., 1997) had been widely used in cartilage research to study 
mechanical and biochemical properties of chondrocytes with the aim to provide 
chondrocytes all the nutrients needed for survival whereas, in several other studies 
serum-free media had been utilized (Glaser and Conrad, 1984). The use of serum/SF-
rich and serum/SF-free media was based upon requirements for tissue culture of 
these studies and the basic focus had been to demonstrate the metabolism of 
chondrocytes in terms of production of ECM assuming that morphology of 
chondrocytes remained normal. However, the results of our study strongly suggested 
that the morphological characteristics of chondrocytes were strikingly altered in the 
serum and SF supplemented culture media. It is therefore possible that these changes 
in morphology reported here would reflect altered phenotype of these chondrocytes, 
resulting in altered ECM production (Sandell and Aigner, 2001, Tesche and Miosge, 
2005). It has been reported previously that presence of FCS in the culture medium 
also potentially directly affects the matrix by reduction in GAG content and loss of 
mechanical properties of the cartilage (Bian et al., 2008). Based upon our results we 
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suggested that great care should be taken with the use of FCS and SF in long-term 
cartilage and chondrocyte culture experiments. There may also be a marked 
difference between the actions of FCS and SF present in the culture medium as 
shown in the data suggesting FCS to be more potent in its actions as compared to SF 
(Figs. 6.10 & 6.12) therefore; chondrocyte phenotype when cultured in the presence 
of FCS/SF should be monitored. 
The morphological alterations observed in chondrocytes near the injured site in the 
presence of SF and FCS resembled some of the key changes in terms of hypertrophy-
like changes (Dreier, 2010), cluster formation (Kouri et al., 1998) and abnormal 
morphology with cytoplasmic processes (Bush and Hall, 2003) seen in early OA. It is 
tempting to speculate that there are similarities between the changes occurring in OA 
and those observed in the injury model with SF/FCS. By identifying the factors 
present in SF and FCS that stimulated chondrocytes leading to morphological 
changes in injured/weakened cartilage, treatment strategies may be developed or 
modified in order to prevent these changes with the aim to avoid cartilage 
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7.1 CHAPTER SUMMARY 
 
This chapter aimed to assess the extracellular matrix (ECM) produced by 
chondrocytes at the injury in the presence of various culture media. The histological 
and immunohistochemical (IHC) examination of chondrocyte morphology and ECM 
produced by them in response to injury was performed with various dyes. The 
quantification of staining intensity was performed with image J analysis software. 
The haematoxylin and eosin (H&E) staining showed presence of chondrocyte 
clusters within superficial layers in the explants cultured in the presence of SF-
DMEM and FCS-DMEM as compared to standard-DMEM. By day 14, percentage of 
Alcian blue stained area around chondrocytes was significantly less in the explants 
cultured with SF-DMEM and FCS-DMEM as compared to standard-DMEM 
(P<0.001). Masson’s trichrome staining technique stained collagen blue and revealed 
no difference in the percentage stained area after 14 days of culture in either of the 
culture conditions. IHC staining of the coronal sections of these injured explants 
showed no difference in staining pattern of collagen types I & II in the explants 
cultured in various culture conditions. Therefore, chondrocytes at the injury in the 
presence of FCS produced an altered matrix as compared to standard-DMEM. 
7.2 INTRODUCTION 
 
Several studies performed in the past have shown that in degenerate/damaged 
cartilage, chondrocytes frequently show decreased viability, increased volume, 
cluster formation and phenotypic changes (Anderson et al., 2011, Kramer et al., 
2011). These changes may lead to abnormal matrix production, poor repair and thus 
enhanced predisposition to secondary/post traumatic osteoarthritis (PTOA). In this 
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work as detailed in chapter 6, a mechanical injury cartilage model has been 
developed in a defined way to determine the morphological response of chondrocytes 
in the presence and absence of synovial fluid (SF) and foetal calf serum (FCS).  
Chondrocytes regulate the ECM architecture of articular cartilage and is dependent 
upon the presence of large quantities of PGs entangled within a frame-work of 
predominantly type II collagen fibres (McDevitt, 1973). In healthy cartilage there 
normally exists a balance between the anabolic and catabolic activities of 
chondrocytes thereby steady state equilibrium exists in their metabolic activities 
responsible for maintenance of normal homeostasis of the cartilage matrix (Pearle et 
al., 2005). 
Mechanical partial thickness injuries lead to chondrocyte death (Tew et al., 2000) 
and damage to the cartilage matrix (Milentijevic et al., 2005). As a result of 
mechanical trauma the cartilage healing process is ineffective and this may lead to 
the development of PTOA (Buckwalter and Brown, 2004). Apart from chondrocyte 
death another main feature of PTOA is cartilage degeneration due to an imbalance in 
the metabolic activities of chondrocytes (Guilak et al., 2004). This imbalance occurs 
when the catabolic activities override anabolic activities (Goldring and Goldring, 
2004). The inflammatory cytokines such as IL-1, IL-6 and TNFα are most likely 
contributors to the enhanced catabolic activities in the pathophysiology of cartilage 
degeneration and their levels increase after joint injury (Melchiorri et al., 1998, Lee 
et al., 2009).  
During degeneration of cartilage, chondrocytes change their phenotype (Tesche and 
Miosge, 2005). However, strong interactions between chondrocyte phenotype and 
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functions impact cartilage in such a way that it is difficult to know where and when 
pathological changes begin. The cell phenotype comprises of its morphology, 
biochemistry and behaviour. One aspect of chondrocyte differentiated phenotype is 
spheroidal/ellipsoidal shape and has been associated with the expression of large 
aggregating PGs (aggrecan) and collagen type II in healthy cartilage. However, 
chondrocyte phenotype is unstable (Darling and Athanasiou, 2005) and during 
cartilage degeneration, chondrocytes change their phenotype and are de-
differentiated (Sandell and Aigner, 2001). The de-differentiated phenotype has been 
associated with the expression of type I collagen (Glowacki et al., 1983) and altered 
pattern of production of PGs with predominant production of small molecular weight 
PGs (Tesche and Miosge, 2005).  
In a recent study it has been reported that in response to trauma to the cartilage 
several changes occur in chondrocyte morphology such as cell flattening and 
extension of filopodia towards the injured site (Lyman et al., 2012). In another recent 
study the response of chondrocytes to injury has been studied which stated the 
emergence and repopulation of injured site by chondrogenic progenitor cells via the 
chemokines synthesised by dead chondrocytes (Seol et al., 2012). In the present 
thesis in the preliminary work by using fluorescent-mode CLSM marked 
chondrocyte shape changes were observed at the injury in the presence of SF/FCS in 
the culture media (Chapter 6). There exists a close relationship between chondrocyte 
metabolic activities and cell morphology (Glowacki et al., 1983). The key question 
addressed in this study is whether morphologically abnormal chondrocytes at the 
injury in the presence of SF/FCS produced altered matrix in comparison to relatively 
normal chondrocytes in standard-DMEM. This work was therefore performed to 
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study the effect of chondrocyte shape on the matrix produced. Although with the 
histological techniques it is not possible to study changes to chondrocyte morphology 
but the aim of applying these techniques on the injured cartilage samples was (a) to 
develop standard histological methods for investigating ECM produced by 




The abnormal chondrocytes at the injury in the presence of FCS-DMEM and SF-
DMEM produced altered ECM in comparison to normal chondrocytes in standard-
DMEM. 
7.4 MATERIALS AND METHODS 
7.4.1 Tissue processing for histology and IHC of injured bovine cartilage 
explants 
 Fixation and decalcification 7.4.1.1
 
The injured bovine osteochondral explants at separate time points (day 0 and 14) 
cultured in various culture media were fixed in 4% PFA (v/v in water) overnight at 
4°C and then washed in PBS. The explants were viewed under a dissection 
microscope and with scalpel No. 24 cut through the injured site along with the 
underlying bone in order to obtain the coronal sections of the cartilage at the site of 
injury. The samples were decalcified in 10% EDTA; 20 g of EDTA was dissolved in 
80 g of distilled water (D/W) and pH adjusted by using NaOH to pH 8.0; diluted to 
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prepare 10% EDTA and stored at room temperature) over a rolling plate for two 
weeks, at room temperature with changing the solution every three days.  
 Paraffin embedding 7.4.1.2
 
After fixation and decalcification, the sections were washed in PBS, fitted in the 
embedding cassettes and processed in the Sakura Tissue-Tek VIP tissue processor 
(Sakura Finetek Ltd, UK) following a standard protocol as given below: 
1. 70% alcohol, 1 hour. 
2. 90% alcohol, 1 hour. 
3. 95% alcohol, 1 hour. 
4. Industrial methylated spirit (IMS) 99, 1 hour. 
5. IMS 99, 1 hour. 
6. IMS 99, 1 and half hour. 
7. 100% alcohol, 2 hours. 
8. Xylene, 1 hour. 
9. Xylene, 2 hours. 
10.  Xylene, 2 hours. 
11. Paraffin wax, 4 hours. 
Finally, the samples were placed on a cold plate after embedding in paraffin blocks 
to set for at least 2 hours. The explants were embedded with the coronal side facing 
down so that after cutting the sections would contain the whole thickness of cartilage 
along with the underlying bone. The paraffin embedded cartilage samples were 
stored in boxes, labelled and stored at room temperature until used. 
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 Sample sectioning 7.4.1.3
 
The paraffin embedded coronal sections of injured cartilage were placed on ice 
before cutting. The samples were then sectioned (5µm thick) serially on wax 
microtome Leica RM2245 (Leica Microsystems Ltd., UK). The sections were then 
floated in a water bath at 40°C to straighten them out and picked up carefully onto 
Superfrost microscope slides. The slides were kept overnight in the oven set at 37°C 
to dry. After overnight drying, the slides were kept in boxes at room temperature 
until used. 
7.4.2 Histological and histochemical stainings 
 H&E staining of wax embedded sections 7.4.2.1
 
H&E are extensively used dyes in histology to label the nuclei and cytoplasm of cells 
as purple and pink respectively to study the gross morphology and topographical 
arrangement of cells (Avwioro, 2011). However, with this technique it is impossible 
to study the fine details of chondrocyte morphology (cytoplasmic processes). The 
microscopic structure of the injured cartilage kept in various culture conditions was 
viewed by H&E staining performed according to the standard protocol (Avwioro, 
2011). The sections were stained with H&E as previously described for frozen 
sections (section 5.4.3.1) with only differences in first and last steps. As a first step 
they were dewaxed in xylene for 25 min and then rehydrated gradually through 
descending grades of alcohols (absolute, 90% and 70% alcohols for 5 min each). As 
a last step they were dehydrated through ascending grades of alcohol (70%, 90%, 
95%, absolute alcohol 1 & 2) for 5 min each and cleared in mounting xylene. The 
slides were then mounted and stored as previously described (section 5.4.3.1). 
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 Alcian blue staining of wax embedded sections 7.4.2.2
 
Alcian blue staining was performed on the coronal sections of the injured bovine 
cartilage cultured under various culture conditions to stain the negatively charged 
GAGs present in the cartilage tissue. The sections were deparaffinised and 
rehydrated as previously described (section 7.4.2.1). The sections were incubated in 
3% (v/v) acetic acid (3 ml of glacial acetic acid were added to 97 ml of D/W) for 3 
min and then stained in Alcian blue solution 8GX; pH 2.5 (1 g of Alcian blue 8GX 
was dissolved in 100 ml of 3% acetic acid; mixed well and pH adjusted to 2.5 using 
acetic acid; filtered and stored at room temperature) for 45 min. The slides were 
washed in running tap water for 2 min, counterstained in Nuclear fast red solution 
(prepared as described in section 5.4.3.2) for 3 min and washed again in running tap 
water for 1 min. Finally, the slides were rinsed in D/W for 2 min, dehydrated in 
series of ascending alcohols and cleared in xylene. The slides were then mounted and 
stored as previously described (section 5.4.3.1). 
 
 Masson’s trichrome staining of wax embedded sections 7.4.2.3
 
This technique stains nuclei black, cytoplasm/muscle red and collagen blue (Kiernan, 
2008). The collagen present in the cartilaginous tissue was stained blue with 
Masson’s trichrome staining (Figs. 7.7 and 7.8). As a first step the sections were 
deparaffinised and rehydrated as already described (section 7.4.2.1). The sections 
were then stained with the same protocol (section 5.4.3.3) regarding the staining of 
collagen around cultured chondrocytes in agarose gels with the exception of the first 
and last steps. Lastly, the slides were dehydrated in series of ascending alcohols, 
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cleared in xylene, cover slipped with DPX mounting medium, dried and stored as 
previously described.  
 IHC for collagen type I and II 7.4.2.4
 
The wax embedded cartilage sections were deparaffinised by incubating slides in 
xylene for 25 min. The sections were then rehydrated gradually through descending 
grades of alcohols (absolute, 90% and 70% alcohols for 5 min each). The sections 
were circled with DAKO pen (DakoCytomation, UK), post fixed in 4% PFA at room 
temperature for 5 min and washed thoroughly in PBS for 5 min on the rocking table. 
For antigen retrieval, sections were equilibrated for 10 min in 0.02% HCl pre-
warmed at 37°C and then digested in 6 mg/ml of pepsin (Sigma-Aldrich, UK) in 
0.02% HCl for 45 min at 37°C (Ward et al., 2006). After antigen retrieval, the slides 
were dipped first in PBS and then in water and air dried at room temperature. The 
sections were post fixed in 4% PFA for 10 min at room temperature and washed in 
PBS for 5 min on rocking table. In order to avoid non-specific staining with DAB 
substrate (Streefkerk, 1972), endogenous peroxidase activity was quenched by 
incubating the slides twice with 3% H2O2 (6ml H2O2 in 54ml of D/W) for 10 min 
each at room temperature. The slides were then washed in PBS on the rocking table 
(5 min each washing). The sections were blocked first in Avidin and then in Biotin 
blocking solution (DakoCytomation, UK) for 10 min each by incubating slides in 
humid chamber. The slides were washed in PBS for 5 min on rocking table. The 
sections were blocked in serum free protein blocking solution (DakoCytomation, 
UK) for 45 min at room temperature in the humid chamber. The sections were 
blotted to draw out all the extra fluid and incubated overnight with the primary 
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antibody (anti collagen type I or type II) diluted in the antibody diluent 
(DakoCytomation, UK) at 4°C in a humid chamber. The dilutions used were 1:200 
for anti-collagen I mouse monoclonal antibody, species reactivity with rat, rabbit, 
cow, human, pig and deer (ab90395, Abcam, UK) and 1:50 for anti-collagen II 
mouse antibody, species reactivity with human, bovine, chick, rat, mouse, xenopus 
and ovine (CIICI, Developmental Studies Hybridoma Bank, Iowa). The sections 
were washed x3 in PBS (5 min each on the rocking table) and incubated for 30 min 
with EnVision®+Dual Link system-HRP (containing goat anti-mouse and anti-rabbit 
immunoglobulins conjugated to peroxidase-labelled polymer; DakoCytomation, UK) 
at room temperature and washed x3 in PBS (5 min each on the rocking table). The 
sections were then incubated with liquid DAB substrate chromogen system 
(DakoCytomation, UK) and staining checked under the microscope. Lastly, the slides 
were washed in PBS and mounted directly with Mowiol (Polysciences, Germany).  
Pilot experiments were carried out (data not shown) to determine the optimum 
working dilutions (1:200 for type I & 1:50 for type II) for the primary antibodies 
used to detect collagen type I and II. In the negative control slides the sections were 
treated with PBS instead of primary antibodies.  
Images of histological and IHC stained sections of bovine injured cartilage were 
captured using Leica DMRE 35578 upright microscope with mounted digital 
QImaging Retiga 2000R-monochrome cooled CCD camera.  
 Analysis of images by using ImageJ analysis software 7.4.2.5
 
The low power (x10) magnification images were analysed using ImageJ software and 
quantitative data were acquired and compared regarding stained area in the injured 
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explants cultured with various culture media. Data from Alcian blue, Masson’s 
trichrome, collagen type I and II were acquired to determine matrix remodelling 
associated with response of cartilage to injury. In the preliminary experiments with 
CLSM, heterogeneity of chondrocyte morphology was observed at the injury in the 
superficial layers of explants cultured in presence of some of the culture media. 
Therefore, a ROI with the dimensions of x, y, z 542, 106 and 5µm respectively was 
selected (Fig. 7.1a) aiming at the analysis of matrix present around chondrocytes in 
the superficial layers of cartilage.  Firstly, after applying the ROI the image was 
cropped and the area of the whole ROI was measured by the software (Fig. 7.1b). 
Secondly, colour threshold was adjusted manually and stained area around cells was 
measured by the software (Fig. 7.1c). Lastly, a percentage of stained area was 
determined with the formula 100 x (stained area around cells/total area of ROI 
applied) %. In order to standardise our technique of adjusting colour threshold firstly 
control images from day 0 of healthy uninjured cartilage were utilised to measure the 
intensity of threshold and then it was applied to all the images from experimental 




Figure 7.1: Determination of stained area of images by Image J analysis 
software. 
Example of determination of Alcian blue stained area for the superficial layers of 
cells (a) application of specified ROI (b) cropped image within ROI and (c) 
comprises of image outlining the blue area determined after adjusting for colour 
threshold. Scale bar = 100µm. 
7.5 RESULTS 
 
7.5.1 Histological and IHC evaluation of ECM in the injured cartilage 
explants cultured under various conditions 
 
In the preliminary set of experiments by using fluorescent-mode CLSM (chapter 6) 
the results showed marked heterogeneity to chondrocyte morphology in response to 
injury in the presence of FCS and SF as compared to standard-DMEM in the culture 
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media. In order to investigate whether chondrocytes at the site of injury with 
cytoplasmic processes produced altered ECM in comparison to normal chondrocytes, 
the histology and immunohistochemistry was performed and the results presented in 
the following sections. The techniques used for the histological preparation of the 
samples may introduce artefacts and have been discussed later (section 7.6).  
The injured explants in various culture conditions were processed for histology and 
IHC (section 7.4.2) at day 0 and 14 of culture. The sections were stained with H&E, 
Alcian blue or Masson’s trichrome for histological evaluation and the presence of 
type I and type II collagen was analysed by IHC. The stained coronal sections were 
imaged with both low (x10) and high (x20 oil immersion) power magnification 
objectives. Results regarding the histological and IHC evaluation of matrix 
components around chondrocytes in response to injury following culture under 
various conditions were given in the following sections. 
 H&E staining 7.5.1.1
 
Low power images of coronal view of the injured cartilage site (section 7.4.1.1) 
stained with H&E cultured under various conditions at day 0 and 14 of culture (Fig. 
7.2). At day 14, the staining intensity appeared to be less in the explants cultured in 
the presence of SF-DMEM as compared to FCS-DMEM and standard-DMEM (Figs. 
7.2c & 7.3c). At high power magnification by day 14, chondrocyte clusters were 
observed at the injury in the superficial layers of cartilage in explants cultured in the 
presence of SF-DMEM and FCS-DMEM as compared to standard-DMEM and also 
in comparison to day 0 (Fig. 7.3). It was not possible to visualise the fine 
morphological details (cytoplasmic processes) with H&E staining technique even at 
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high power magnification (Fig. 7.3). Therefore, with H&E staining chondrocyte 
abnormalities in cell shape could not be studied but the clusters were visible. 
 
Figure 7.2: Typical photomicrographs of H&E stained coronal sections at the 
injury at low power magnification. 
The histological sections of injured cartilage stained with H&E and imaged (x10) at 
(a) day 0 and (b, c, d) day 14 following culture in standard-DMEM, SF-DMEM and 
FCS-DMEM respectively. The results obtained from at least three independent 
experiments. Photomicrograph (a) represents the H&E staining in uninjured 




Figure 7.3: Typical photomicrographs of H&E stained coronal sections from 
site of injury at high power magnification. 
The histological sections of injured cartilage stained with H&E and imaged (x20oil 
immersion) at (a) day 0 and (b, c, d) day 14 following culture in standard-DMEM, 
SF-DMEM and FCS-DMEM respectively. The examples of chondrocyte clusters 
shown in twice as zoomed inset images. The results obtained from at least three 
independent experiments. Photomicrograph (a) represents the H&E staining in 
uninjured cartilage. Scale bar = 25µm.  
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 Alcian Blue staining 7.5.1.2
 
The coronal sections at the injured site were stained with Alcian blue to detect the 
presence of GAGs (within specified ROI) by chondrocytes in response to injury 
following culture under various media. At day 14 of culture, Alcian blue staining 
appeared to be less in the explants cultured in the presence of SF-DMEM and FCS-
DMEM as compared to standard-DMEM and also in comparison to day 0 (Figs. 7.4 
& 7.5).  
The percentage of Alcian blue stained area within the ROI (Fig. 7.1a) varied under 
the different culture conditions. There was no significant difference between the 
percentage of Alcian blue stained area at the injury in the explants cultured with 
standard-DMEM even after 14 days of culture (Fig. 7.6; P>0.05; one-way ANOVA). 
In contrast, by day 14 the percentage of Alcian blue stained area was significantly 
less in explants cultured in the presence of SF-DMEM (15±1.4%) and FCS-DMEM 
(21±3%) as compared to standard-DMEM (56±1%; P<0.001; ANOVA for both the 
conditions) and also in comparison to day 0 (59±2.5%; Fig. 7.6; P<0.001; ANOVA 
for both the conditions). Additionally, by day 14 no significant difference existed 
between the % of Alcian blue stained area in the explants cultured in the presence of 
SF-DMEM and FCS-DMEM (Fig. 7.6; P>0.05; one-way ANOVA). 
To summarise the results of this section, in the presence of SF-DMEM and FCS-
DMEM chondrocytes at the injury showed the presence of less GAGs as compared to 
standard-DMEM. These coronal sections have been obtained from the site of injury 
by cutting through the full-depth of the cartilage. The images were analysed by 
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applying a specified ROI already explained (section 7.4.2.5) to ensure that the ECM 
evaluation was performed around the chondrocytes at the injury.  
 
Figure 7.4: Typical photomicrographs of Alcian blue stained coronal sections 
from the site of injury at low power magnification. 
The histological sections of injured cartilage stained with Alcian blue and imaged 
(x10) at (a) day 0 and (b, c, d) day 14 following culture in standard-DMEM, SF-
DMEM and FCS-DMEM respectively. The results obtained from at least three 
independent experiments. Photomicrograph (a) represents the Alcian blue staining in 




Figure 7.5: Typical photomicrographs of Alcian blue stained coronal sections 
from the site of injury at high power magnification. 
The histological sections of injured cartilage stained with Alcian blue and imaged 
(x20 oil immersion) at (a) day 0 and (b, c, d) day 14 following culture in standard-
DMEM, SF-DMEM and FCS-DMEM respectively. The results obtained from at 
least three independent experiments. Photomicrograph (a) represents the Alcian blue 





Figure 7.6: The percentage of Alcian blue stained area at the injury in cartilage 
explants cultured under various conditions. 
Graphs show pooled data regarding percentage of Alcian blue stained area at day 0 
and 14 of culture under three culture conditions. Data were from [N(n) = 9(16)]; 
ANOVA. # indicated a significant difference between different culture conditions 
and at two time points according to one-way ANOVA followed by Tukey’s multiple 
comparison post-hoc test. The single, double and triple symbols showed the level of 
significance for P<0.05, 0.01 and 0.001 respectively. 
 
 Masson’s trichrome staining 7.5.1.3
 
The coronal histological sections of injured cartilage at two time points (day 0 and 
14) during the course of culture were stained with Masson’s trichrome staining to 
determine the presence of collagen in response to injury cultured under various 
conditions. The low and high power magnification images of cartilage sections 
revealed relatively similar Masson’s trichrome stained area in all the culture 
conditions (Figs. 7.7 & 7.8). At day 14 the percentage of Masson’s trichrome stained 
area (within ROI) was unaffected by the nature of culture media and no significant 
difference existed between the explants cultured under various conditions and also in 
comparison to day 0 (Fig. 7.9; P>0.05; one-way ANOVA). 
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To summarise the results of this section, presence of collagen around chondrocytes in 
response to injury following cultured under various conditions remained unaffected 
after 14 days of culture. 
 
Figure 7.7: Typical photomicrographs of Masson’s trichrome stained coronal 
sections of injured cartilage at low power magnification. 
The histological sections of injured cartilage stained with Masson’s trichrome and 
imaged (x10) at (a) day 0 and (b, c, d) day 14 following culture in standard-DMEM, 
SF-DMEM and FCS-DMEM respectively. The results obtained from at least three 
independent experiments. Photomicrograph (a) represents the Masson’s trichrome 




Figure 7.8: Typical photomicrographs of Masson’s trichrome stained coronal 
sections of injured cartilage at high power magnification. 
The histological sections of injured cartilage stained with Masson’s trichrome and 
imaged (x20 oil immersion) at (a) day 0 and (b, c, d) day 14 following culture in 
standard-DMEM, SF-DMEM and FCS-DMEM respectively. The results obtained 
from at least three independent experiments. Photomicrograph (a) represents the 




Figure 7.9: Percentage of Masson’s trichrome stained area at the injury in 
cartilage explants cultured under various conditions. 
Graphs show pooled data regarding percentage of Masson’s trichrome stained area at 
day 0 and 14 of culture under three culture conditions. Data were from [N(n) = 
9(16)]. There was no significant difference between the percentages of Masson’s 
trichrome stained area at day 0 and 14 in various culture conditions. 
 
 Type II collagen 7.5.1.4
 
IHC is a powerful technique for the identification of proteins in a tissue and its 
specificity depends on how efficiently the antibody (known) binds to the antigen 
(unknown). The specificity can be determined by the use of positive control labelling 
the cells already known to have the protein and negative controls by substituting the 
primary antibody with serum (Burry, 2000). In this study the positive and negative 
controls for type II collagen were sections of articular cartilage with the subchondral 
bone (Fig. 7.10B) as type II collagen is present in abundance in the cartilage matrix 
(Eyre, 2002) and absent in the bone. IHC staining of the coronal sections of injured 
cartilage was done to determine the presence of type II collagen around chondrocytes 
at the injury following culture under various conditions (Figs. 7.10 & 7.11).  
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At day 0, 49±3% of the area (within ROI) exhibited collagen type II staining. There 
was no difference between the percentage of type II collagen staining in the explants 
cultured in the presence of various culture media at day 14 and also in comparison to 
day 0 (Fig. 7.12; P>0.05; one-way ANOVA).  
These results suggested that the presence of type II collagen around chondrocytes in 
response to injury remained unaffected following culture in various media.  
 
 
Figure 7.10: Representative images of IHC staining for type II collagen of 
injured cartilage explants. 
(A) Low power magnification (x10) photomicrographs of type II collagen staining of 
cartilage at (a) day 0 and (b, c, d) day 14 cultured in standard-DMEM, SF-DMEM 
and FCS-DMEM respectively. (B) The representative images of (a) negative and (b) 
positive controls for type II collagen IHC in bovine articular cartilage showing the 
presence of type II collagen in all the zones of cartilage. The results obtained from at 
least three independent experiments. Photomicrograph A (a) represents collagen type 






Figure 7.11: Representative photomicrographs of IHC of type II collagen in 
injured cartilage. 
High power (x20 oil immersion) photomicrographs of type II collagen stained 
cartilage at (a) day 0 and (b, c, d) day 14 of culture in standard-DMEM, SF-DMEM 
and FCS-DMEM respectively. The results obtained from at least three independent 
experiments. Photomicrograph (a) represents collagen type II staining in uninjured 




Figure 7.12: Percentage of type II collagen stained area in the injured cartilage. 
Graphs show pooled data regarding percentage of type II collagen stained area at day 
0 and 14 of culture under three culture conditions. Data were from [N(n) = 9(16)]. 
There was statistically no significant difference between percentages of type II 
stained areas at day 0 and 14 of culture in various culture conditions. 
 
 Type I collagen 7.5.1.5
 
IHC for type I collagen was performed to determine the presence of type I collagen 
around chondrocytes in response to injury following culture under various culture 
conditions. The low and high power IHC photomicrographs of injured cartilage 
stained for type I collagen showed no difference in the presence of type I collagen by 
chondrocytes at the injury cultured in the presence of various culture media (Fig. 
7.13 & 7.14).  
At day 0, in the control explants 0.8±0.1% (within ROI) of type I collagen stained 
area was observed. Type I collagen remained unaffected in the explants cultured in 
the presence of various culture media after 14 days of culture. There was no increase 
in the percentage of type I collagen stained area in the explants cultured in the 
presence of SF-DMEM/FCS-DMEM (Fig. 7.15). To summarise the results of this 
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section, in the injured explants cultured in various culture media chondrocytes at the 
injury showed no alterations in expression of collagen type I.  
 
Figure 7.13: Representative images of immunohistochemical staining for type I 
collagen of injured cartilage explants. 
(A) Low power magnification (x10) photomicrographs of type I collagen staining of 
cartilage at (a) day 0 and (b, c, d) day 14 cultured in standard-DMEM, SF-DMEM 
and FCS-DMEM respectively. (B) The representative images of (a, b) negative and 
(c, d) positive controls for type I collagen IHC in bovine articular cartilage showing 
the absence of type I collagen in all the zones of cartilage and present in the 
subchondral bone. The results obtained from at least three independent experiments. 
Photomicrograph A (a) represents collagen type I staining in uninjured cartilage. 






Figure 7.14: Representative photomicrographs of IHC of type I collagen in 
injured cartilage. 
High power (x20 oil immersion) photomicrographs of type I collagen stained 
cartilage at (a) day 0 and (b, c, d) day 14 of culture in standard-DMEM, SF-DMEM 
and FCS-DMEM respectively. The results obtained from at least three independent 
experiments. Photomicrograph (a) represents collagen type I staining in uninjured 




Figure 7.15: Percentage of type I collagen stained area in the injured cartilage. 
Pooled data regarding percentage of type I collagen stained area at day 0 and 14 of 
culture under three culture conditions. Data were from [N(n) = 9(16)]. There was no 
significant difference between percentages of type I collagen stained areas at day 0 
and 14 cultured in the presence of varying culture media. 
 
In summary, in response to injury, GAGs and collagen type II remained unaffected in 
the explants cultured in the presence of standard-DMEM even after 14 days in 
comparison to day 0, also type I collagen was not present. Chondrocytes at the injury 
showed significant reduction in GAGs in the explants cultured in the presence of SF-
DMEM and FCS-DMEM. However, there was no change in the expression of 
collagen types I & II by chondrocytes in response to injury in the explants cultured in 
the presence of SF-DMEM and FCS-DMEM. 
7.6 DISCUSSION 
 
There were two basic aims of the study firstly, to develop methods to study ECM 
produced by chondrocytes at the injury in the presence of various culture media and 
secondly to evaluate whether matrix produced by abnormal chondrocytes at the 
injury in the presence of SF/FCS was altered as compared to the matrix produced by 
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relatively normal chondrocytes at the injury in the presence of standard-DMEM. The 
results obtained supported the hypothesis to an extent that in the explants cultured in 
the presence of SF-DMEM and FCS-DMEM the Alcian blue staining was 
significantly less, Masson’s trichrome staining and IHC of collagen types I & II 
remained unaffected as compared to standard-DMEM. 
There were certain technical issues related to the development of histological and 
IHC techniques used here to study the matrix produced and will be discussed in 
detail. In the preliminary experiments with CLSM (chapter 6) chondrocytes in 
response to injury in the presence of SF and FCS displayed marked heterogeneity to 
chondrocyte morphology with the presence of cytoplasmic processes after 14 days of 
culture. In the H&E stained sections the technique involved in the histological 
procedure obscured the fine morphological details of these abnormal chondrocytes 
and the cytoplasmic processes were not visible, but clusters were still observed even 
with routine histology. In the Alcian blue stained histological sections the staining 
intensity was strikingly reduced in explants cultured in the presence of SF/FCS as 
compared to standard-DMEM. When injured cartilage explant sections were stained 
with Masson’s trichrome staining which is a crude method of estimation of presence 
of collagens (Chung et al., 2014) revealed no significant difference between different 
culture conditions. Similarly, IHC of collagen types I & II showed no difference 
around chondrocytes at the injury in explants cultured in different conditions. The 
results obtained and the technical issues regarding the methods involved will now be 
discussed in detail. 
The technical problems encountered while obtaining sections and with staining 
procedures were attempted to be minimised. First difficulty was to obtain sections of 
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cartilage explants at the site of injury. Several attempts were made but it was 
impossible to obtain axial sections on cutting from paraffin-embedded tissue because 
the surface of the cartilage was irregular. Next, it was attempted to cut the tissue in 
the coronal view. Although sectioning was possible but while cutting with 
microtome the tissue often split apart at the site of injury. The last attempt was 
successful where under the dissection microscope the cartilage explants were split 
into two at the site of already produced injury and marked for the injured site. With 
the microtome from the marked injured site coronal sections of the injured site of 
tissue were obtained. Second problem was with the H&E staining fine details of 
morphology (cytoplasmic processes) were not visible but the clusters could be 
observed. This technical issue has already been discussed (section 5.6).  
In this study with H&E staining chondrocyte clusters were present at the injury in the 
explants cultured in the presence of SF/FCS (Fig. 7.3). These results are in 
agreement with previously reported work on rat articular cartilage where a greater 
number of chondrocyte clusters was observed after traumatic loading and culturing 
cartilage in the presence of FCS (Henson and Vincent, 2008). The cluster formation 
in articular cartilage after trauma can possibly be explained to be stimulated by the 
growth/proliferative factors especially in the superficial layers of cartilage 
(Schumacher et al., 2002, Lotz et al., 2010). Several growth factors are known to 
stimulate cluster formation in chondrocytes and fibroblast growth factor-2 (FGF-2) is 
thought to be the principal/potent factor to stimulate clustering (Khan et al., 2010). 
Therefore, it is likely that chondrocytes at the injury in the presence of SF/FCS 
formed clusters due to enhanced access to factors.  
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In this study, Alcian blue staining decreased considerably in the injured explants 
cultured in the presence of SF-DMEM and FCS-DMEM as compared to standard-
DMEM (Fig. 7.6). Alcian blue staining reflects an estimate of PGs present in the 
tissue and there can be four possible explanations for this staining pattern. First 
possibility could be reduction in PGs due to breakdown by the action of factors in 
SF/FCS. This is unlikely because FCS used in explant cultures is known to stimulate 
PG synthesis by chondrocytes through insulin-like growth factor-1 present in it 
(McQuillan et al., 1986). Second possibility could be that the PGs were lost in the 
culture medium by diffusion through the injured site. This is unlikely to occur 
because if this would also have happened then in the control samples of this study 
cultured in the presence of standard-DMEM there would have been less staining with 
Alcian blue (Fig. 7.6). However, there was no statistically significant difference 
between the percentages of Alcian blue staining at day 0 and day14 in standard-
DMEM suggesting no loss of PGs by diffusion during the culture period. The loss of 
PGs in culture can be determined by quantitative analysis of culture media for 
presence of PGs. Third possibility could be the loss of PGs under the effect of 
enhanced catabolic activity of morphologically abnormal chondrocytes at injury in 
the presence of SF/FCS. In the initial experiments on injured cartilage, chondrocytes 
at the injury changed shape (flattened, elongated and with cytoplasmic processes) in 
the presence of SF-DMEM and FCS-DMEM (Results chapter 6) as compared to 
standard-DMEM. In the Alcian blue stained sections less staining was observed in 
the explants cultured with SF-DMEM and FCS-DMEM. Therefore, this suggested 
that morphologically heterogeneous chondrocytes at the injury under the effect of 
SF/FCS showed loss of PGs. These results can be explained by previous work which 
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suggested loss of PGs following trauma to bovine and human cartilage augmented by 
the catabolic cytokines (Sui et al., 2009). This previous study and the results of 
present study cannot be directly compared because the time course of experiments in 
the previous study was different from the present work. However, the findings from 
the previous work can be used to explain the results in the present work. Fourth 
possibility could be the production of low molecular weight PGs such as decorin and 
biglycan by abnormal chondrocytes at the injury cultured in the presence of SF/FCS-
DMEM which stain less intensely with Alcian blue (Bock et al., 2001, Tesche and 
Miosge, 2004). In author’s opinion the third and fourth possibilities are the most 
likely causes of differences in Alcian blue stained area in injured cartilage samples 
cultured in various conditions. 
The results of the Masson’s trichrome staining in this work showed no difference in 
the overall collagen stained area in various culture conditions (Fig. 7.9). This staining 
technique is just a rough estimate of the overall collagen content in the cartilage 
(Chung et al., 2014) therefore; results are indecisive. Type I and II collagen were 
detected by performing IHC and the standardisation of the technique was performed 
by using positive and negative control samples (Figs. 7.10 & 7.13). IHC of the 
injured cartilage sections cultured under various conditions revealed no difference in 
collagen type II (Fig. 7.12) and type I staining (Fig. 7.15) around chondrocytes in the 
injured explants cultured in the presence of various culture conditions. This can be 
possibly explained by considering the low turnover rate of collagen type II in the 
cartilage tissue (Lippiello et al., 1977). Collagens in the normal adult human cartilage 
have a half-life of 117 yrs. (Verzijl et al., 2000). The results in this study also showed 
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slight staining of type I collagen at day 0 (Fig. 7.15). The possible explanation for 
this can be non-specific staining of type I collagen antibodies.  
A limitation of this study was that direct relationship between chondrocyte 
morphology and matrix components could not be established. Here overall matrix of 
the cartilage was being analysed and not being matched precisely to the individual 
chondrocytes with altered morphology. The techniques utilised in this study rendered 
it impossible to visualise the fine details of chondrocyte morphology (cytoplasmic 
processes) in these histological sections. An interesting future experiment will be to 
fluorescently label chondrocytes and matrix components to visualise morphology and 
matrix on the same tissue sections. 
In summary, the results have supported the hypothesis that morphologically 
abnormal chondrocytes at injury in the presence of SF/FCS-DMEM produced altered 











8 CHAPTER 8: RESULTS                                                                   
EFFECTS OF VARIOUS CULTURE CONDITIONS ON THE 
SHORT- AND LONG-TERM MORPHOLOGY OF 
























8.1 CHAPTER SUMMARY  
 
In this study it was hypothesised that chondrocytes at the injury in hyperosmolar 
serum-rich medium do not produce morphological changes as compared to standard 
serum-rich culture medium. The aim of this chapter was to assess in situ chondrocyte 
viability and morphological characteristics at the scalpel injury in response to 
varying culture media. Osteochondral explants were exposed initially to the altered 
osmolarities (320 and 615 mOsm) then injured with standardised scalpel injury and 
then again exposed to the two osmolarities. The injured explants were divided into 
two experimental groups to determine short- and long-term response of chondrocytes 
to varying culture media after 14 days of culture in Group 1: either (a) standard-
DMEM or (b) standard-FCS Group 2: (a) standard-DMEM (b) standard-FCS (c) 
hyperosmolar-DMEM and (d) hyperosmolar-FCS. Chondrocytes were examined by 
fluorescent-mode confocal microscopy and analysed by Volocity
TM 
software. At day 
0, the width of injury, percentage of PI-labelled chondrocytes and the volume of 
chondrocytes at the injury was significantly less in the explants exposed to 615 
mOsm as compared to 320 mOsm (P<0.0001); all the cells were with normal 
morphology. In group 1, the percentage of PI-labelled chondrocytes decreased ~96% 
in the presence of standard-FCS throughout the culture period irrespective of 
osmolarities. At day 7, the volume of chondrocytes increased in explants exposed to 
615 mOsm and kept in culture with either standard-DMEM or standard-FCS and in 
explants exposed to 320 mOsm and cultured with standard-FCS. Chondrocyte 
clustering was stimulated in the presence of FCS irrespective of the osmolarities. At 
day 14, chondrocytes at the injury in standard-DMEM were mostly spheroidal. 
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However, at the injury 17±3% and 13±1% chondrocytes exposed to 320 and 615 
mOsm (P=0.0003 and P<0.0001; respectively) and cultured in standard-FCS 
displayed marked shape changes. In group 2, width of the injury remained 
unaffected in hyperosmolar-DMEM, increased in standard-DMEM and decreased 
markedly in the presence of FCS (both osmolarities). Throughout the culture period 
percentage of PI-labelled chondrocytes decreased in the presence of FCS irrespective 
of the osmolarities. At day 7, the volume of chondrocytes and cluster formation 
increased significantly in the presence of FCS in both the osmolarities, the effect was 
more pronounced in standard-FCS as compared to hyperosmolar-FCS. At day 14, at 
the injury the morphology of chondrocytes changed strikingly in the presence of 
standard-FCS alone. In contrast, morphology of chondrocytes remained unaffected in 
standard-DMEM, hyperosmolar-DMEM and hyperosmolar-FCS. In summary, 
medium osmolarity significantly affected viability and morphology of chondrocytes 
at the injury. Therefore, medium osmolarity would appear to be a more powerful 
regulator of chondrocyte morphology than the growth factors in serum. 
8.2 INTRODUCTION 
 
Mechanical injuries to articular cartilage heal poorly, producing a functionally and 
structurally inferior tissue because of poor regenerative capacity of the cartilage 
(Buckwalter, 1998). It is suggested that these injuries lead to chondrocyte death and 
damage to matrix (Tew et al., 2000) and may play a role in causing cartilage 
degeneration and ultimately development of PTOA (Hunziker, 2001). As a 
consequence of mechanical injury, the collagen network is disrupted and PGs are lost 
(D’Lima et al., 2001b, Quinn et al., 2001, Redman et al., 2004). PGs are negatively 
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charged and are responsible for maintaining the hydration status of cartilage by 
creating osmotic pressure within cartilage via Gibbs-Donnan equilibrium conditions 
(Urban, 1994, Hopewell and Urban, 2003). This high extracellular osmolarity of the 
cartilage (350-450 mOsm) as compared to synovial fluid or plasma increases the 
tendency of fluid movement into the cartilage which is restricted by the intact 
collagen network (Maroudas, 1976, Lai et al., 1991, Urban, 1994). This explains the 
high tendency of the cartilage swelling and when in injury the matrix is damaged 
there is loss of PGs and the water content of the cartilage is increased (Maroudas, 
1976, Maroudas and Venn, 1977, McArthur and Gardner, 1992, Wheaton et al., 
2004). 
Chondrocytes are very sensitive to changes in extracellular osmolarity of the 
cartilage and behave as osmometers over a certain range of osmotic pressure (Bush 
and Hall, 2001a). In response to hypotonic challenge, chondrocytes swell up by 





taurine (to decrease intracellular osmolarity) facilitating osmotic efflux of water and 
this mechanism is termed regulatory volume decrease (RVD) (Lang et al., 1998, 
Bush and Hall, 2001b, Hoffmann et al., 2009). In contrast, following exposure to 
hypertonic challenge chondrocytes shrink and then they recover their volume 











 exchange and Na
+
 channels (Hall et al., 1996a, 
Kerrigan et al., 2006, Hoffmann et al., 2009). These membrane electrolyte 







into the cell to balance the intracellular ionic concentration and extracellular ionic 
concentration thereby, limiting volume change (Hall et al., 1996b, Cheung and Ko, 
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2013). The volume regulatory mechanisms in chondrocytes have been studied 
extensively (Bush and Hall, 2001a, Bush and Hall, 2005, Lewis et al., 2011). In 
response to the hypotonic challenge, the over distended cells become highly sensitive 
and are more prone to injury (Bush et al., 2005) and this explains that chondrocyte 
viability following mechanical injury is inversely related to the extracellular 
osmolarity (Amin et al., 2008b). Chondroprotective effect of hyperosmolarity on 
injured articular cartilage has been reported previously where cell death was 
markedly reduced in hyperosmolar environment (480 mOsm) as compared to 0 
mOsm (Amin et al., 2008b). Additionally it has been reported recently that 
hyperosmolarity enhances cartilage repair (Eltawil et al., 2014, Huang et al., 2015). 
The studies regarding chondroprotective effects of hyperosmolarity on injured 
cartilage suggested that the onset of PTOA could possibly be delayed by using 
strategies to reduce chondrocyte morbidity due to trauma. In addition to chondrocyte 
volume alterations in extracellular osmolarity may influence protein synthesis (Urban 
et al., 1993, Hopewell and Urban, 2003) and cytoskeletal organisation (Chao et al., 
2006).  
Hyperosmotic conditions (550 mOsm) in human articular chondrocytes are known to 
up- and down- regulate 88 and 51 genes respectively at the post transcription levels, 
thereby controlling chondrocyte functions (Tew et al., 2011). SOX9 is an essential 
transcription factor required for the ECM synthesis and regulates expression of 
collagen type II (Bell et al., 1997) and aggrecan (Bi et al., 1999), two very important 
ECM macromolecules. Additionally, SOX9 regulates chondrocyte phenotype as 
shown in a previous study where osteoarthritic human chondrocytes regained 
chondrocytic properties when transduced with SOX9 gene (Tew et al., 2005). In turn, 
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SOX9 is regulated by hyperosmotic conditions (Tew et al., 2009) and its expression 
is enhanced by hyperosmolar loading of chondrocytes (Peffers et al., 2010). Various 
studies have reported hyperosmotic extracellular environment to be 
chondroprotective in nature and more suitable for phenotypic stability of human 
articular chondrocytes (Tew and Hardingham, 2006, Tew et al., 2009). These studies 
suggested that hyperosmolar environment may play role in controlling chondrocyte 
phenotype via SOX9 regulation at the post transcriptional level. The phenotype 
comprises cell morphology and metabolism and there exists a close relationship 
between chondrocyte morphology and metabolism. Several studies conducted on 
degenerate cartilage in the past reported changes to chondrocyte phenotype and their 
biosynthetic activity (Kouri et al., 1996a, Darling and Athanasiou, 2005, Tesche and 
Miosge, 2005, Yagi et al., 2005, Murray et al., 2010). Therefore, it is suggested that 
hyperosmotic environment regulates chondrocyte phenotype and may play role in 
controlling matrix metabolism. 
The chondroprotective role of hyperosmolarity in injured cartilage in terms of 
viability has already been established therefore studying morphological response of 
chondrocytes in injured cartilage to the hyperosmolar conditions will enhance 
knowledge regarding the chondroprotective role of hyperosmolarity to trauma. The 
osmolarities used in these experiments are based upon previous experiments where 
380 mOsm was used as a control being very similar to that experienced by 
chondrocytes in situ and 550 mOsm as a hyperosmolar condition (Palmer et al., 
2001, Hopewell and Urban, 2003, Tew et al., 2009). The objective was to use our 
full-depth osteochondral explant with scalpel induced injury model to study the 





Chondrocytes at the injury do not produce morphological changes in response to 
hyperosmolar serum-rich medium compared with exposure to standard serum-rich 
culture medium.  
 
8.4 MATERIALS AND METHODS 
8.4.1 Culture media with varying osmolarity 
 
The culture media with varying osmolarities utilised in these experiments were 
prepared as detailed earlier (section 2.1.1.1). The two groups of injured cartilage 
explants were kept in culture under four experimental conditions (a) standard-
DMEM; 343±2.6 mOsm; mean±S.E.M.; N=3 (DMEM-343) (b) standard-FCS; 
339±2.6 mOsm; mean±S.E.M.; N=3 (FCS-339) (c) hyperosmolar-DMEM; 609±1.4 
mOsm (DMEM-609) and (d) hyperosmolar-FCS; 606±0.8 mOsm (FCS-606). 
Therefore, for simplicity the two types of culture media used in short-term exposure 
experiments have been abbreviated as (a) standard-DMEM and (b) standard-FCS. 
The four types of culture media used for the long-term exposure experiments have 
been abbreviated formally as (a) standard-DMEM (b) standard-FCS (c) 
hyperosmolar-DMEM and (d) hyperosmolar-FCS. 
8.4.2 In vitro partial thickness injured bovine articular cartilage model 
 
The partial thickness injury model described in chapter 6 was utilised here to study 
the effect of various culture conditions on short- and long-term morphology of 
chondrocytes. Full-depth osteochondral bovine cartilage explants were obtained from 
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bovine metacarpophalangeal joints following the methodology explained earlier 
(section 6.4). For experiments on short-term exposure to hyperosmolarity 
osteochondral explants were divided into two groups and exposed to either (a) 
320±1.5 mOsm (mean±S.E.M.; N=3) or (b) 615±1.6 mOsm (mean±S.E.M.; N=3) for 
5 min. The explants were then injured with the standardised protocol (section 
6.4.1.1.1) and exposed post-injury to the two osmolarities for another 5 min. The 
injured explants were then kept in freshly prepared culture media with either (a) 
standard-DMEM or (b) standard-FCS up to 14 days. 
The experiments on long-term exposure to hyper-osmolarity composed exposure of 
injured explants for 14 days in culture with media of varying osmolarities. 
Osteochondral explants were divided into two groups and exposed to either (a) 
320±1.5 mOsm (mean±S.E.M.; N=3) or (b) 615±1.6 mOsm (mean±S.E.M.; N=3) for 
5 min. The explants were then injured with the standardised injury protocol and 
again exposed to the two osmolarities for 5 min post-injury. These injured cartilage 
explants were then kept in culture under four experimental conditions (a) standard-
DMEM (b) standard-FCS (c) hyperosmolar-DMEM and (d) hyperosmolar-FCS. 
8.4.3 Preparation of cartilage explants for microscopy 
 
During culture period, for short- and long-term exposure to hyperosmolarity 
experiments chondrocytes in the explants were fluorescently-labelled at three time 
points i.e. days 0, 7 and 14 (section 6.4.1.2), prepared for CLSM and imaged axially 




8.4.4 Quantification of chondrocyte viability and morphology 
 
The CLSM low and high power magnification images were analysed by Volocity
TM 
software. Quantitative data regarding the width of injury, percentage cell death 
(PCD), volume of chondrocytes, cluster formation and morphology of chondrocytes 
was determined by the similar methodology as applied for the experiments in chapter 




8.5.1 Morphological characteristics of chondrocytes in injured cartilage after 
short-term exposure to varying osmolarities cultured under various 
conditions 
 
Hyperosmolarity markedly alters the response of chondrocytes to injury. Injured 
osteochondral explants were exposed to two different osmolarities pre- and post-
injury and then cultured in either (a) standard-DMEM or (b) standard-FCS to study 
the short-term response of chondrocyte morphology. The low power (x10) 
magnification images of CMFDA and PI-labelled chondrocytes showed markedly 
reduced cell death at the injury after exposure to hyperosmolar solution at day 0 (Fig. 
8.1a & b). The width of injury seemed to be less in explants exposed to 615mOsm 
solution as compared to 320mOsm at day 0. At day 14, chondrocytes cultured in 






Figure 8.1: Axial CLSM reconstructions of injured cartilage explants exposed to 
different osmolarities for short-term following culture in various conditions. 
CLSM reconstructions of low power (x10) magnification images of injured cartilage, 
CMFDA and PI labelled chondrocytes (live/dead cells respectively). The left panel 
shows images of injured cartilage after short-term exposure to 320 mOsm and right 
panel contains images after exposure to 615 mOsm at (a,b) day 0, (c,d,e,f) day 7 and 
(g,h,i,j) day 14 cultured in standard-DMEM and standard-FCS respectively. Scale 







 Changes to the width of injury after short-term exposure to varying 8.5.1.1
osmolarities following in vitro culture under various conditions 
 
The width of injury was measured (section 6.4.1.4) to assess the response of cartilage 
to the trauma after short-term exposure to varying osmolarities and culture in various 
conditions (Fig. 8.1). In the presence of FCS by day 14, the width of injury was 
decreased and the gap was filled with morphologically abnormal chondrocytes and 
matrix (Fig. 8.1).  
In the explants exposed to 320 mOsm pre- and post-injury, the width of injury 
remained unaffected in the presence of standard-DMEM during the first week of 
culture. However, it increased significantly by day 14 of culture in standard-DMEM 
compared to earlier time points (P<0.05; ANOVA over the three days; Fig. 8.2a). In 
the injured explants exposed to 320 mOsm and cultured in standard-FCS the width of 
injury appeared to increase during the first week of culture in comparison to 
standard-DMEM but the difference was not statistically significant (P>0.05). 
However, by day 14 the width of injury decreased significantly compared to earlier 
time points of culture (P<0.001; ANOVA over the three days; Fig. 8.2a) and also in 
comparison with the explants cultured in standard-DMEM (P<0.0001; Fig. 8.2a). 
After short-term exposure to 615 mOsm, the width of injury remained unaffected in 
explants cultured with standard-DMEM during the first week of culture. However, 
the width of injury decreased significantly by day 14 of culture in standard-DMEM 
as compared to day 7 (P<0.01; ANOVA; Fig. 8.2b). In the injured explants exposed 
to 615 mOsm and then cultured in the presence of standard-FCS, the width of injury 
remained unaffected during first week of culture. However, the width of injury 
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decreased significantly by day 14 in these explants in comparison to earlier time 
points of culture (P<0.001; ANOVA over the three days; Fig. 8.2b) and also in 
comparison to standard-DMEM (P<0.0001; Fig 8.2b). 
The width of injury was significantly less in the explants exposed to 615 mOsm as 
compared to 320 mOsm at all the time points and in both the culture conditions (Fig. 
8.2b), only by day 14 no difference existed between the explants cultured in the 
presence of standard-FCS (P<0.0001 at day 0; P=0.0003; P=0.001 at day 7 and 
P<0.0001; P>0.05 at day 14; for standard-DMEM and standard-FCS respectively). 
These data suggested that at day 0, the width of injury was significantly less in the 
explants exposed to 615 mOsm as compared to 320 mOsm. Moreover, in the 
explants exposed to 320 mOsm and cultured with standard-DMEM the width of 
injury increased significantly by day 14. In contrast, in the explants exposed to 615 
mOsm and kept in culture with standard-DMEM the width of injury decreased 
significantly by day 14. However, in the presence of standard-FCS, the width of 
injury decreased markedly by day 14 of culture in the explants exposed to both 320 
mOsm and 615 mOsm osmolarities and the injury gap was almost completely filled 
with chondrocytes of varying morphology (Fig. 8.4h,j).  
To summarise this section, by day 14 of culture the morphology of chondrocytes at 
the injury in the serum-rich culture media was markedly altered irrespective of short-
term exposure to the two osmolarities and these enlarged, elongated chondrocytes 




Figure 8.2: Variations in the width of injury after exposure to varying 
osmolarities following culture under various conditions. 
Graphs summarise data regarding the width of injury after short-term exposure to (a) 
320 mOsm and (b) 615 mOsm following culture in standard-DMEM and standard-
FCS. Data given as [N(n)=8(30)]. * indicated a significant difference between two 
culture conditions at one time point according to t-test. # indicated a significant 
difference between different culture conditions at two time points according to one-
way ANOVA followed by Tukey’s multiple comparison post-hoc test. £ indicated 
significant difference between the two osmolarities. The single, double and triple 




 Loss of PI-labelled cells at and distant from the injury after short-term 8.5.1.2
exposure to varied osmolarities following culture in various conditions 
 
The objective was to determine the effect of varied osmolarities on the percentage of 
PI-labelled cells at and distant from the injury. Specified ROIs were created and 
applied (section 6.4.1.4) at and distant from the injury on the low power 
magnification CLSM images of the injured cartilage exposed to 320 mOsm and 615 
mOsm at three time points during culture (Days 0, 7 and 14). The percentage of PI-
labelled chondrocytes was determined at and distant from the injury to determine the 
effect of short-term exposure to varying culture media. The short-term exposure to 
various osmolarities and the composition of the culture medium markedly affected 
the percentage of PI-labelled chondrocytes (Fig. 8.1a-j). 
The percentage of PI-labelled chondrocytes at injury in the explants exposed to 320 
mOsm and 615 mOsm remained unaffected throughout the culture period in the 
presence of standard-DMEM (P>0.05; ANOVA over the three days for both 
conditions; Fig. 8.3a,c). The percentage of PI-labelled chondrocytes decreased 
significantly in the explants exposed to 320 mOsm and 615 mOsm and then cultured 
in the presence of standard-FCS as compared to standard-DMEM at day 7 and 14 of 
culture (P<0.0001; for both time points and both conditions; Fig. 8.3a,c) and also in 
comparison to day 0 (P<0.001; for both time points and both conditions; Fig. 8.3a,c).  
The percentage of PI-labelled chondrocytes was significantly higher at the injury as 
compared to distant from the injury throughout the culture period in the explants 
cultured in the presence of standard-DMEM after short-term exposure to 320 mOsm 
(P<0.0001; for all the three time points; Fig. 8.3b) and 615 mOsm (P<0.0001; 
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P=0.0006 and P=0.005; for day 0, 7 and 14 respectively; Fig. 8.3d). However, at day 
7 and 14 of culture no significant difference existed in the percentage of PI-labelled 
chondrocytes at and distant from the injury in the explants exposed to both 320 
mOsm and 615 mOsm and then cultured in the presence of standard-FCS (Fig. 8.3b, 
d). 
The percentage of PI-labelled chondrocytes was significantly less in the explants 
exposed to 615 mOsm as compared to 320 mOsm at all the time points in the 
explants cultured in the presence of standard-DMEM (P<0.0001; for all the three 
time points; Fig. 8.3c). However, at day 7 and 14 no difference existed in the 
percentage of PI-labelled chondrocytes in the explants exposed to 320 mOsm and 
615 mOsm and kept in culture with standard-FCS (Fig. 8.3c). 
These results suggested that the percentage of PI-labelled chondrocytes was 
significantly less in the explants exposed to 615 mOsm as compared to 320 mOsm 
throughout the culture period in the explants cultured in the presence of standard-
DMEM. Moreover, the percentage of PI-labelled chondrocytes decreased 
significantly in the explants cultured in the presence of standard-FCS as compared to 
standard-DMEM throughout the culture period irrespective of the short-term 






Figure 8.3: The percentage of PI-labelled chondrocytes at and distant from the 
injury after short-term exposure to different osmolarities following culture in 
various conditions. 
Graphs in the top panel show pooled data to compare the percentage of PI-labelled 
chondrocytes after short-term exposure to 320 mOsm (a) at the injury and (b) distant 
from the injury, bottom panel graphs show a comparison between the percentage of 
PI-labelled chondrocytes after short-term exposure to 615 mOsm (c) at the injury and 
(d) distant from the injury under the two culture conditions. Data were from 
[N(n)=8(30)]. * indicated a significant difference between two culture conditions at 
one time point according to t-test. # indicated a significant difference between 
different culture conditions at various time points according to one-way ANOVA 
followed by Tukey’s multiple comparison post-hoc test. £ indicated significant 
difference between the two osmolarities. ^ indicated a significant difference between 
at the injury and distant from the injury. The single, double and triple symbols 





 Volume/morphology of chondrocytes at the injury in response to short-8.5.1.3
term exposure to different osmolarities following culture in various 
conditions 
 
During the course of culture, chondrocyte volume/morphology at injury changed 
strikingly in response to the presence of FCS in the culture medium irrespective of 
exposure to varied osmolarities. These morphological changes were analysed by 
determining quantitative data regarding volume, cluster formation and heterogeneity 
to chondrocyte morphology. The results were acquired at different time points (Days 
0, 7 and 14) and given in the following two sections.  
 Volume of chondrocytes at the injury by day 7 8.5.1.3.1
 
At day 0, chondrocytes were normal (elliptical/spheroidal) in morphology at the 
injury in the explants exposed to varied osmolarities (Fig. 8.4). During the course of 
culture, marked changes to the morphology of chondrocytes were seen at the injury 
in the explants exposed to 320 mOsm and 615 mOsm and kept in culture in the 
presence of standard-FCS as compared to standard-DMEM. The high power CLSM 
images displayed the development of abnormal chondrocyte morphology at the 
injury in the presence of standard-FCS (Fig. 8.4h,j). 
At day 0, the volume of chondrocytes at the injury was found to be significantly 
higher in the explants exposed to 320 mOsm (1064.8±18µm
3
) as compared to 615 
mOsm (861.8±14.5µm
3
; P<0.0001; Fig. 8.5a,b). At day 7, the volume of 
chondrocytes at the injury increased significantly in the explants exposed to 320 
mOsm and cultured in the presence of standard-FCS (1160±41µm
3





; P=0.02) and also in comparison to day 0 
(1064.8±18µm
3
; P<0.05; Fig. 8.5a). It is worth noticing that increase in chondrocyte 
volume in the presence of standard-FCS was small but significantly different 
statistically. 
At day 7, the volume of chondrocytes at the injury increased significantly in the 
explants exposed to 615 mOsm and kept in culture in the presence of standard-
DMEM (1068.2±65.8µm
3
) as compared to day 0 (861.8±14.5µm
3
; P<0.001; Fig. 
8.5b). Moreover, at day 7 the volume of chondrocytes increased significantly (the 
difference was less) in the explants exposed to 615 mOsm and kept in culture in the 
presence of standard-FCS (1219±40.8µm
3
) as compared to standard-DMEM 
(1068.2±65.8µm
3
; P=0.04) and also in comparison to day 0 (861.8±14.5µm
3
; 
P<0.001; Fig. 8.5b). Therefore, the presence of FCS in the culture medium 
stimulated a slight increase (statistically significant) in cell volume compared to 
standard-DMEM irrespective of exposure to two different osmolarities. However, at 
day 7 there existed no difference between the volumes of chondrocytes cultured in 
either standard-DMEM or standard-FCS after exposure to both the osmolarities (Fig. 
8.5). 
These results indicated that at day 0 the chondrocytes in 615 mOsm were shrunken 
(Fig. 8.5b). At day 7, the volume increased significantly in the explants exposed to 
615 mOsm and kept in culture with standard-DMEM. Additionally, at day 7 the 
volume of chondrocytes at the injury increased significantly in the explants cultured 
in the presence of standard-FCS as compared to standard-DMEM regardless of the 




Figure 8.4: Axial CLSM reconstructions of injured cartilage explants exposed to 
different osmolarities for short-term showing changes to chondrocyte 
morphology following culture in various conditions. 
CLSM reconstructions of high power (x40DW) magnification images of injured 
cartilage of CMFDA and PI labelled chondrocytes (live/dead cells respectively). The 
left panel shows images of injured cartilage after short-term exposure to 320 mOsm 
and right panel contains images after short-term exposure to 615 mOsm at (a,b) day 
0, (c,d,e,f) day 7 and (g,h,i,j) day 14 cultured in standard-DMEM and standard-FCS 
respectively. Solid arrows indicate examples of chondrocytes with altered 




Figure 8.5: Changes to chondrocyte volume at the injury after short-term 
exposure to different osmolarities following culture in various conditions. 
Graphs show pooled data regarding the volume of chondrocytes at the injury 
demonstrating comparison between short-term exposure to (a) 320 mOsm and (b) 
615 mOsm following culture in the presence of standard-DMEM and standard-FCS. 
Data were from [N(nʹ)=8(98) at day 0, 8(37) and 8(44) at day 7 in standard-DMEM 
and standard-FCS respectively after exposure to 320 mOsm] and [N(nʹ)=8(116) at 
day 0, 8(36) and 8(57) at day 7 in standard-DMEM and standard-FCS respectively 
after exposure to 615 mOsm]. * indicated a significant difference between two 
culture conditions at one time point according to t-test. # indicated a significant 
difference between different culture conditions at two time points according to one-
way ANOVA followed by Tukey’s multiple comparison post-hoc test. £ indicated 
significant difference between the two osmolarities. The single, double and triple 
symbols showed the level of significance for P<0.05, 0.01 and 0.001 respectively. 
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 Chondrocyte cluster formation at the injury by day 7 8.5.1.3.2
8.5.1.3.2.1 Number of clusters formed 
 
At day 0, the average number of clusters formed at the injury in the explants exposed 
to 320 mOsm (3.4±0.2) were significantly higher than those formed in 615 mOsm 
(1.6±0.2; P=0.0004; Figs. 8.6Aa and 8.6Ba). The presence of clusters (although few) 
in healthy cartilage is unlikely and possibly suggested an artefact of the software 
(discussed in section 8.6). Moreover, the clusters present at day 0 involved on an 
average no more than 3 cells per cluster. During the course of culture, at day 7 in the 
explants exposed to 320 mOsm and kept in culture with standard-FCS, the number 
of clusters increased significantly as compared to standard-DMEM (P=0.0008) and 
also in comparison to day 0 (P<0.001; Fig. 8.6Aa). At day 7, in the explants exposed 
to 615 mOsm and kept in culture with standard-FCS, the number of clusters 
increased as compared to standard-DMEM but the difference was not statistically 
significant (P>0.05; Fig. 8.6Ba). However, in comparison to day 0, a significantly 
higher number of clusters were formed in explants exposed to 615 mOsm and 
cultured in standard-FCS (P<0.01; Fig. 8.6Ba). Additionally, at day 7, the number of 
clusters formed at the injury after exposure to 320 mOsm was significantly higher 
than 615 mOsm when cultured in the presence of standard-FCS (P=0.0005; Fig. 
8.6Ba). There were more clusters formed in the presence of standard-FCS following 
exposure to 320 mOsm as compared to 615 mOsm. This suggested that by raising the 





8.5.1.3.2.2 Number of cells/cluster 
 
At day 7, the number of cells/cluster increased significantly in the explants exposed 
to 320 mOsm and cultured with standard-FCS as compared to standard-DMEM 
(P=0.04) and also in comparison to day 0 (P<0.01; Fig. 8.6Ab). The number of 
cells/cluster remained unchanged in both culture conditions in the explants exposed 
to 615 mOsm (P>0.05; Fig. 8.6Bb). The number of cells/cluster after exposure to 
320 mOsm were significantly higher than 615 mOsm when explants were cultured in 
the presence of standard-FCS (P=0.03; Fig. 8.6Bb). 
8.5.1.3.2.3 Percentage of chondrocytes forming clusters 
 
The percentage of chondrocytes which formed clusters was calculated to determine 
chondrocyte proliferation for cluster formation. At day 0, a significantly higher 
percentage of chondrocytes formed clusters at the injury in the explants exposed to 
320 mOsm (7±0.7%) as compared to 615 mOsm (4±0.5%; P=0.006; Figs. 8.6Ac and 
8.6Bc). At day 7, in injured explants exposed to 320 mOsm and cultured in standard-
FCS, a significantly higher percentage of chondrocytes (39±4%) formed clusters as 
compared to standard-DMEM (11.3±0.2%; P=0.003) and percentage of chondrocytes 
forming clusters at day 0 (7±0.7%; P<0.001; Fig. 8.6Ac). At day 7, in the injured 
explants exposed to 615 mOsm and cultured in the presence of standard-DMEM the 
percentage of chondrocytes forming clusters increased significantly as compared to 
day 0 (P<0.05; Fig. 8.6Bc). Additionally, the percentage of chondrocytes forming 
clusters increased significantly by day 7, in the explants exposed to 615 mOsm and 
kept in culture with standard-FCS (13.5±2%) as compared to standard-DMEM 
(8±1%; P=0.04) and also in comparison to day 0 (4±0.4%; P<0.01; Fig. 8.6Bc). 
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Moreover, at day 7 a significantly higher percentage of chondrocytes formed clusters 
in explants exposed to 320 mOsm as compared to 615 mOsm and cultured in the 
presence of standard-DMEM and standard-FCS (P=0.04 and P=0.005; for both 
conditions respectively; Figs. 8.6Ac and 8.6Bc). This suggested that cluster 
formation was inhibited by raising the osmolarity. 
8.5.1.3.2.4 Volume of clusters 
 
At day 0, clusters with a slightly higher volume were formed at the injury in the 
explants exposed to 320 mOsm as compared to 615 mOsm (P=0.03; Figs. 8.6Ad and 
8.6Bd). However, the P value only 0.03 indicated the difference was less but 
statistically significant. These measurements take into account the number of 
cells/cluster considered later. At day 7, the volume of clusters at the injury in the 
explants exposed to 320 mOsm and cultured in standard-FCS increased significantly 
as compared to standard-DMEM (P=0.02) and also in comparison to the volume of 
clusters at day 0 (P<0.01; Fig. 8.6Ad). At day 7, the volume of clusters at the injury 
increased significantly in the explants exposed to 615 mOsm and kept in culture with 
standard-FCS (P<0.01; Fig. 8.6Bd). Additionally, the volume of clusters was 
significantly greater in the explants exposed to 320 mOsm as compared to 615 
mOsm and kept in culture with standard-FCS (P=0.04; Fig. 8.6Bd). These results 
suggested that volume of clusters increased in the presence of standard-FCS 
(irrespective of exposure to two osmolarities). Additionally, when the osmolarity was 





8.5.1.3.2.5 Volume of individual cells in a cluster 
 
This was determined to assess whether in the presence of FCS the cluster formation 
was either a result of cell proliferation or simply the cell volume increased or due the 
involvement of both the mechanisms. The volume of individual cells in a cluster was 
calculated and compared after exposure to 320 mOsm and 615 mOsm following 
culture in both conditions at day 0 and 7. At day 0, the volume of individual cells in a 
cluster at the injury was significantly greater in the explants exposed to 320 mOsm as 
compared to 615 mOsm (P=0.04; Figs. 8.6Ae and Be). After a week, the volume of 
individual cells in a cluster remained unaffected after exposure to 320 mOsm and 
kept in culture with standard-DMEM. However, the volume of individual cells in a 
cluster increased in the explants exposed to 320 mOsm and kept in culture with 
standard-FCS as compared to standard-DMEM but the difference was not 
statistically significant (P>0.05; Fig. 8.6Ae). At day 7, the volume of individual cells 
in a cluster increased significantly in the explants exposed to 615 mOsm and kept in 




Figure 8.6A: Characteristics of chondrocyte clusters formed at the injury after 
short-term exposure to 320 mOsm following culture under various conditions. 
Graphs represent pooled data for (a) average number of clusters formed (b) average 
number of cells in a cluster (c) percentage of cells involved in forming clusters (d) 
average volume of chondrocyte clusters (µm
3
) and (e) average volume of individual 
cell in a cluster (µm
3
) after exposure to 320 mOsm cultured in standard-DMEM and 
standard-FCS. Data were from [N(n)=8(24)]. * indicated a significant difference 
between two culture conditions at one time point according to t-test. # indicated a 
significant difference between different culture conditions at two time points 
according to one-way ANOVA followed by Tukey’s multiple comparison post-hoc 
test. The single, double and triple symbols showed the level of significance for 




Figure 8.6B: Characteristics of chondrocyte clusters formed at the injury after 
short-term exposure to 615 mOsm following culture under various conditions. 
Graphs represent pooled data for (a) average number of clusters formed (b) average 
number of cells in a cluster (c) percentage of cells involved in forming clusters (d) 
average volume of chondrocyte clusters (µm
3
) and (e) average volume of individual 
cell in a cluster (µm
3
) after exposure to 615 mOsm cultured in standard-DMEM and 
standard-FCS. Data were from [N(n)=8(24)]. * indicated a significant difference 
between two culture conditions at one time point according to t-test. # indicated a 
significant difference between different culture conditions at two time points 
according to one-way ANOVA followed by Tukey’s multiple comparison post-hoc 
test. £ indicated significant difference between the two osmolarities. The single, 




To summarise this section at day 0, in the explants exposed to 615 mOsm very few 
small sized clusters were formed as compared to 320 mOsm. During the course of 
culture, clustering was stimulated in the presence of FCS with fewer clusters after 
exposure to 615 mOsm as compared to 320 mOsm. After exposure to 320 mOsm the 
number of cells/cluster increased but the volume of individual cell in cluster 
remained unaffected. In contrast, after exposure to hyperosmolar solution the number 
of cells/cluster remained unaffected and the volume of individual cell in cluster 
increased significantly. The effects of FCS in terms of cluster formation appeared to 
be similar and more potent in the injured explants exposed to 320 mOsm as 
compared to 615 mOsm. 
 Development of abnormal chondrocyte morphology/volume by day 14 8.5.1.3.3
 
Chondrocytes exhibited marked shape changes at the injury by day 14 in the 
presence of FCS-DMEM but not in standard-DMEM. However, during the first week 
of culture chondrocyte morphology was relatively ‘normal’ under all culture 
conditions (Fig. 8.4c,d,e,f). Chondrocyte morphology at the injury remained 
unaffected and relatively ‘normal’ throughout the culture period in the injured 
explants exposed to 320 mOsm and 615 mOsm and cultured in standard-DMEM 
(Fig. 8.4g,i). However, marked changes to chondrocyte morphology/volume were 
seen in the explants exposed to both 320 mOsm and 615 mOsm and cultured in 
standard-FCS (Fig. 8.4h,j). The dramatic changes to chondrocyte morphology seen at 
the injury in the presence of FCS were characterised by cell flattening, elongation, 
enlargement and production of cytoplasmic processes. 
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Quantitative data regarding various parameters of morphology of chondrocytes were 
obtained (section 6.4.1.5) and compared at day 0 and 14 in various culture 
conditions. By day 14, at the injury 17±3% and 13±1% chondrocytes after short-term 
exposure to 320 mOsm and 615 mOsm respectively, showed significant 
morphological changes in standard-FCS as compared to chondrocytes in standard-
DMEM (P=0.0003 and P<0.0001; respectively) and also in comparison to cells at 
day 0 (P<0.001; for both the conditions; Fig. 8.7a,b) where all the cells were 
relatively ‘normal’ in morphology. Additionally, at day 14 the percentage of 
abnormal chondrocytes at the injury in the presence of standard-FCS was 
significantly higher in the explants exposed to 320 mOsm as compared to 615 mOsm 
(P=0.04; Fig. 8.7b).  
At day 14, chondrocyte volume was measured for all the four experimental 
conditions and compared with day 0. At day 0, the volume of chondrocytes at the 
injury was significantly higher in the explants exposed to 320 mOsm as compared to 
615 mOsm (P<0.0001). The average volume of individual abnormal chondrocytes at 
the injury in the presence of standard-FCS at day 14 was significantly higher as 
compared to standard-DMEM (P<0.0001) and also in comparison to day 0 (P<0.001; 
Fig. 8.7c). The morphology of chondrocytes remained unaffected (spheroidal) but the 
volume of cells at the injury increased significantly by day 14 in the explants 
exposed to 615 mOsm and kept in culture with standard-DMEM (P<0.001). At day 
14, the average volume of abnormal chondrocytes at the injury in the explants 
exposed to 615 mOsm and cultured in the presence of standard-FCS increased 
significantly as compared to standard-DMEM (P<0.0001) and also in comparison to 
day 0 (P<0.001; Fig. 8.7d). These results suggested that chondrocyte volume 
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increased after exposure to both the osmolarities and cultured in standard-FCS as 
compared to standard-DMEM. Moreover, by the end of culture period chondrocytes 
exposed to 615 mOsm and cultured in standard-DMEM displayed an increase in 
volume as compared to 320 mOsm and cultured in standard-DMEM. 
At day 0, the average length of cell body of chondrocytes at the injury was 
significantly greater in the explants exposed to 320 mOsm as compared to 615 
mOsm (P=0.02). By day 14 of culture, in the explants exposed to both the 
osmolarities (320 mOsm and 615 mOsm) the average length of cell bodies of 
individual abnormal cells at the injury in the presence of standard-FCS increased by 
approx. x5 as compared to standard-DMEM (P<0.0001; for both the conditions) and 
also in comparison to day 0 (P<0.001; for both the conditions; Fig. 8.7e,f). However, 
by day 14 the length of cell bodies of chondrocytes at the injury remained unaffected 
after exposure to both the osmolarities when the explants were cultured in standard-
DMEM.  
To summarise this section, marked heterogeneity of chondrocyte morphology was 
observed at the injury by day 14 in the presence of standard-FCS after exposure to 
both osmolarities and not in the presence of standard-DMEM. However, the effect of 
FCS appeared to be more pronounced on the morphology of chondrocytes which 
were exposed to 320 mOsm in comparison to 615 mOsm. Higher osmolarity helped 




Figure 8.7: Characteristics of the heterogeneous nature of chondrocyte 
morphology at the injury by day 14 of culture in various conditions after short-
term exposure to different osmolarities. 
Graphs show pooled data regarding (a, b) percentage of abnormal cells at the injury 
after exposure to 320 mOsm and 615 mOsm, (c, d) average volume of cells at the 
injury (µm
3
) after exposure to 320 mOsm and 615 mOsm and (e, f) average length of 
cell bodies (µm) of chondrocytes at the injury after exposure to 320 mOsm and 615 
mOsm following culture in standard-DMEM and standard-FCS respectively. Data 
were from [N(n)=8(24)]. * indicated a significant difference between two culture 
conditions at one time point according to t-test. # indicated a significant difference 
between different culture conditions at two time points according to one-way 
ANOVA followed by Tukey’s multiple comparison post-hoc test. £ indicated 
significant difference between the two osmolarities. The single, double and triple 
symbols showed the level of significance for P<0.05, 0.01 and 0.001 respectively. 
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8.5.2 Morphological characteristics of chondrocytes in injured cartilage after 
long-term exposure to culture media with varying osmolarities 
Osmolarity and composition of the culture medium markedly affected chondrocyte 
viability, proliferation and morphology at the injury. Injured explants were exposed 
to two different osmolarities pre- and post-injury and then cultured in four different 
culture conditions (a) standard-DMEM (b) standard-FCS (c) hyperosmolar-DMEM 
and (d) hyperosmolar-FCS to assess the response of chondrocytes at the injury. 
Quantitative data regarding the width of injury, % of PI-labelled chondrocytes, 
volume, cluster formation and morphology of chondrocytes was obtained and 
described in the following sections. 
 Changes to the width of injury after long-term exposure to varied 8.5.2.1
osmolarities under various culture conditions 
The width of the injury was measured to determine the response of injured cartilage 
to the long-term exposure to various osmolarities and also to the nature of the culture 
media used. During two weeks of culture, different osmolarities and the nature of the 
culture media strikingly affected the width of the injury.  
During the first week of culture, the width of the injury remained unaffected in the 
injured explants cultured in the presence of standard-DMEM. However, by day 14 
the width of injury increased significantly in the presence of standard-DMEM as 
compared to earlier time points (P<0.001; Fig. 8.8a). In the injured explants cultured 
with standard-FCS, the width of the injury remained unaffected by day 3 of culture, 
increased significantly by day 7 as compared to standard-DMEM (P<0.0001) and 
also in comparison to earlier time points (P<0.001). However, by day 14 the width of 
injury decreased significantly in the presence of standard-FCS as compared to 
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standard-DMEM (P<0.0001) and also in comparison to all the earlier time points 
(P<0.05; Fig. 8.8a). In the injured explants cultured in the presence of hyperosmolar-
DMEM, the width of the injury remained unaffected throughout the culture period 
(P>0.05; Fig. 8.8b). In the explants cultured in the presence of hyperosmolar-FCS, 
the width of the injury increased significantly by day 3 as compared to 
hyperosmolar-DMEM (P=0.0001) and also in comparison to day 0 (P<0.01). By day 
7, the width of the injury in these explants was greater than hyperosmolar-DMEM 
(P=0.0002). However, by day 14 the width of injury decreased significantly in these 
explants as compared to the earlier time points (Days 3 and 7) of culture (P<0.01; 
Fig. 8.8b). 
The width of the injury was also compared in the explants kept in culture following 
long-term exposure to standard and hyperosmolar DMEM and FCS. The width of the 
injury was significantly less in the explants cultured in the presence of hyperosmolar-
DMEM as compared to standard-DMEM throughout the culture period (P<0.001; 
Fig. 8.8b). Moreover, the width of injury was significantly less in the explants 
cultured with hyperosmolar-FCS as compared to standard-FCS (P=0.0002) at day 7 
and no difference existed between the two culture conditions at day 3 and 14 of 
culture.  
To summarise, during the course of culture, the width of injury increased 
significantly in the presence of standard-DMEM by day 14. However, in the 
presence of hyperosmolar-DMEM the width of injury remained unaffected 
throughout the culture period. In the presence of standard-FCS, the width of injury 
increased initially by day 7 but decreased markedly by day 14 of culture. However, 
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in hyperosmolar-FCS the width of injury increased initially by day 3 and decreased 
strikingly by day 14 of culture. 
 
Figure 8.8: Changes to the width of injury after long-term exposure to varied 
osmolarities. 
Graphs display pooled data giving a comparison between the long-term exposure to 
(a) 320 mOsm, cultured in either standard-DMEM or standard-FCS and (b) 615 
mOsm, cultured in either hyperosmolar-DMEM or hyperosmolar-FCS. Data were 
from [N(n)=8(42)]. * indicated a significant difference between two culture 
conditions at one time point according to t-test. # indicated a significant difference 
between different culture conditions at various time points according to one-way 
ANOVA followed by Tukey’s multiple comparison post-hoc test. £ indicated 
significant difference between the two osmolarities. The single, double and triple 
symbols showed the level of significance for P<0.05, 0.01 and 0.001 respectively. 
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 Loss of PI-labelled chondrocytes at the injury after long-term exposure to 8.5.2.2
varied osmolarities 
 
The percentage of PI-labelled chondrocytes was measured within the specified ROIs 
applied at the injury on the low magnification CLSM images of injured cartilage 
following culture in media of different osmolarities. The values of percentage of PI-
labelled cells were obtained at various time points (Days 0, 3, 7 and 14) during the 
course of culture and compared to assess the effect of long-term exposure of varied 
osmolarities and the nature of the culture medium used on the percentage of PI-
labelled chondrocytes at the injury. Different osmolarities and the nature of the 
culture media used strikingly affected the percentage of PI-labelled chondrocytes at 
the injury (Fig. 8.9. a-n). 
 
Throughout the culture, the percentage of PI-labelled chondrocytes at the injury 
remained unaffected in the explants cultured in the presence of standard- and 
hyperosmolar-DMEM (P>0.05; Fig. 8.10b). However, the percentage of PI-labelled 
chondrocytes decreased significantly at the injury in the presence of standard- and 
hyperosmolar-FCS as compared to standard- and hyperosmolar-DMEM respectively 
at days 3, 7 and 14 of culture (P≤0.001; Fig. 8.10a, b) and also in comparison to day 
0 (P<0.001).  
 
The percentage of PI-labelled chondrocytes was also compared between the explants 
cultured in standard and hyperosmolar media. The percentage of PI-labelled 
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chondrocytes was significantly less in the explants cultured in the presence of 
hyperosmolar-DMEM as compared to standard-DMEM throughout the culture 
period (P<0.0001, P<0.0001, P=0.0004, P<0.0001; for days 0, 3, 7 and 14 
respectively; Fig. 8.10b). However, in the presence of FCS no difference existed 
between the standard- and hyperosmolar-FCS at days 7 and 14 of culture. Only at 
day 3, the percentage of PI-labelled chondrocytes was significantly less in the 
presence of hyperosmolar-FCS as compared to standard-FCS (P=0.001; Fig. 
8.10a,b). 
 
These results suggested that the percentage of PI-labelled chondrocytes at the injury 
was significantly less in the explants cultured in the presence of hyperosmolar-
DMEM as compared to standard-DMEM throughout the culture period. Additionally, 
there was a significant reduction in the percentage of PI-labelled chondrocytes in the 
explants cultured in the presence of FCS as compared to DMEM irrespective of the 





Figure 8.9: Axial CLSM reconstructions of injured cartilage explants after long-
term exposure to varied osmolarities. 
CLSM reconstructions of low power (x10) magnification images of injured cartilage 
of CMFDA and PI labelled chondrocytes (live/dead cells respectively). The two left 
panels show images of injured cartilage after long-term exposure to standard media 
and two right panels contain images after long-term exposure to hyperosmolar media 
at (a,b) day 0, (c,d,e,f) day 3, (g,h,i,j) day 7 and (k,l,m,n) day 14 cultured in DMEM 




Figure 8.10: The percentage of PI-labelled chondrocytes at the injury after long-
term exposure to different osmolarities in various culture conditions. 
Graphs show pooled data to compare the percentage of PI-labelled chondrocytes at 
the injury after long-term exposure to (a) standard media and (b) hyperosmolar 
media cultured in DMEM and FCS. Data were from [N(n)=8(58)]. * indicated a 
significant difference between two culture conditions at one time point according to 
t-test. # indicated a significant difference between different culture conditions at 
various time points according to one-way ANOVA followed by Tukey’s multiple 
comparison post-hoc test. £ indicated significant difference between the two 
osmolarities. The single, double and triple symbols showed the level of significance 
for P<0.05, 0.01 and 0.001 respectively. 
 Changes to the volume/morphology of chondrocytes at the injury after 8.5.2.3
long-term exposure to two osmolarities in standard-DMEM and FCS-
DMEM 
Long-term exposure to two different osmolarities and the nature of the culture 
medium had a pronounced effect on the volume/morphology of chondrocytes at the 
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injury. Quantitative data regarding volume, cluster formation and heterogeneous 
nature of chondrocyte morphology following culture in different culture conditions 
was obtained at various time points and compared. The results acquired are given in 
the following sections. 
 Changes to volume/cluster formation of chondrocytes at the injury by 8.5.2.3.1
day 7 
The morphology of chondrocytes was markedly altered in the explants cultured in 
the presence of standard-FCS as compared to hyperosmolar-FCS and also in 
comparison to standard-DMEM and hyperosmolar-DMEM (Fig. 8.11) where 
chondrocyte morphology remained unaffected (spheroidal). 
8.5.2.3.1.1 Chondrocyte volume 
Following culture, by day 7 the volume of chondrocytes at the injury increased 
significantly in the explants exposed to 615 mOsm and cultured in the presence of 
hyperosmolar-DMEM (P<0.001). However, at day 7, the volume of chondrocytes 
exposed to 615 mOsm and cultured in the presence of hyperosmolar-FCS increased 
significantly as compared to hyperosmolar-DMEM (P=0.0019) and also in 
comparison to day 0 (P<0.001; Fig. 8.12b), but was found to be significantly less 
than those in standard-FCS (P=0.01). 
These results suggested that by day 7, the volume of chondrocytes in standard-
DMEM remained unaffected but increased significantly in the presence of 
hyperosmolar-DMEM. Moreover, the volume of chondrocytes increased 
significantly in the presence of FCS as compared to DMEM in both the osmolarities, 
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but the effect was more pronounced in the presence of standard-FCS as compared to 
hyperosmolar-FCS. 
 
Figure 8.11: Axial CLSM reconstructions of injured cartilage explants cultured 
for long-term in various osmolarities with DMEM and FCS. 
CLSM reconstructions of high power (x40DW) magnification images of CMFDA/PI 
labelled chondrocytes (Live and dead cells respectively). The two left panels contain 
images of explants exposed to 320 mOsm (a) at day 0, (c, d) at day 3, (g, h) at day 7 
and (k, l) at day 14 of culture in the presence of standard-DMEM and standard-FCS 
respectively. The two right panels contain images of explants exposed to 615 mOsm 
(b) at day 0, (e, f) at day 3, (i, j) at day 7 and (m, n) at day 14 of culture in the 
presence of hyperosmolar-DMEM and hyperosmolar-FCS respectively. Scale bar for 




Figure 8.12: Changes to chondrocyte volume at the injury after long-term 
exposure to various osmolarities. 
Graphs contain pooled data to compare the volume of chondrocytes at the injury 
following culture in (a) standard-DMEM/FCS and (b) hyperosmolar-DMEM/FCS. 
Data were from [N(nʹ)=8(98) at day 0, 8(83) and 8(81) at day 7 in standard-DMEM 
and standard-FCS respectively] and [N(nʹ)=8(116) at day 0, 8(93) and 8(42) at day 7 
in hyperosmolar-DMEM and hyperosmolar-FCS respectively]. * indicated a 
significant difference between two culture conditions at one time point according to 
t-test. # indicated a significant difference between different culture conditions at two 
time points according to one-way ANOVA followed by Tukey’s multiple 
comparison post-hoc test. £ indicated significant difference between the two 
osmolarities. The single, double and triple symbols showed the level of significance 




8.5.2.3.1.2 Chondrocyte clusters 
 
8.5.2.3.1.2.1 Number of clusters 
 
At day 7, in the presence of standard-FCS the number of clusters at the injury 
increased significantly as compared to standard-DMEM (P=0.02) and also in 
comparison to day 0 (P<0.01; Fig. 8.13Aa). At day 7, the number of clusters 
increased significantly in the presence of hyperosmolar-FCS as compared to day 0 
(P<0.05; Fig. 8.13Ba). Moreover, by day 7, the average number of clusters remained 
significantly lower in the presence of hyperosmolar-DMEM and hyperosmolar-FCS 
as compared to standard-DMEM and standard-FCS respectively (P=0.04; for both 
the conditions; Fig. 8.13Ba). These results suggested that hyperosmolarity inhibits 
cluster formation. 
8.5.2.3.1.2.2 Number of cells per cluster 
 
At day 7, the number of cells per cluster increased significantly in the presence of 
standard-FCS as compared to day 0 (P<0.05; Fig. 8.13Ab) and remained unaffected 
in all the other culture conditions (P>0.05; Figs. 8.13Ab and 8.13Bb). 
8.5.2.3.1.2.3 Percentage of chondrocytes forming clusters 
 
At day 7, in the injured explants exposed to 320 mOsm and cultured in the presence 
of standard-FCS a significantly higher percentage of chondrocytes formed clusters 
(24±3%) as compared to standard-DMEM (11±1%; P=0.01) and also in comparison 
to day 0 (7±1%; P<0.001; Fig. 8.13Ac). Similarly, in the injured explants exposed to 
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615 mOsm and cultured in hyperosmolar-FCS a significantly higher percentage of 
chondrocytes formed clusters (14±0.5%) as compared to hyperosmolar-DMEM 
(5±1%; P=0.006) and also in comparison to day 0 (4±0.5%; P<0.001; Fig. 8.13Bc). 
However, by day 7 in the explants exposed to 615 mOsm a significantly less 
percentage of chondrocytes formed clusters in hyperosmolar-DMEM and 
hyperosmolar-FCS as compared to standard-DMEM and standard-FCS respectively 
(P=0.03 & P=0.04 respectively).  
8.5.2.3.1.2.4 Volume of clusters 
 
At day 7, the volume of clusters remained unaffected in the explants cultured in 
standard-DMEM but increased significantly in the presence of hyperosmolar-DMEM 
as compared to day 0 (P<0.05). At day 7, in the explants exposed to 320 mOsm and 
615 mOsm and cultured in the presence of standard- and hyperosmolar-FCS 
respectively, the volume of clusters increased significantly as compared to standard- 
and hyperosmolar-DMEM respectively (P=0.03 and P=0.04 respectively) and also in 
comparison to day 0 (P<0.001; for both the conditions; Figs. 8.13Ad and 8.13Bd). 
8.5.2.3.1.2.5 Volume of individual cells in a cluster 
 
The volume of individual cells in a cluster was calculated and compared in all the 
four culture conditions at day 0 and 7. At day 7, in the explants exposed to 320 
mOsm and cultured with standard-FCS the average volume of individual cells in a 
cluster increased significantly in comparison to day 0 (P<0.001; Fig. 8.13Ae). At day 
7, in the injured explants exposed to 615 mOsm and kept in culture with 
hyperosmolar-DMEM and hyperosmolar-FCS, the volume of individual cells in a 
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cluster increased significantly in comparison to day 0 (P<0.05 and P<0.001 
respectively; Fig. 8.13Be).  
To summarise this section in the presence of standard- and hyperosmolar-FCS 
clustering was triggered resulting in the formation of numerous, large-sized clusters 
as compared to standard- and hyperosmolar-DMEM. However, the effects of 
standard-FCS were significantly more marked as compared to hyperosmolar-FCS. 
Therefore, hyperosmolarity inhibited cluster formation at the injury even in the 
presence of FCS, suggesting the antagonising action of raised osmolarity on the 





Figure 8.13A: Characteristics of clusters formed at the injury in the injured 
explants after long-term exposure to standard culture media. 
The graphs contain pooled data regarding (a) average number of clusters formed (b) 
average number of cells in a cluster (c) percentage of cells involved in forming 
clusters (d) average volume of chondrocyte clusters (µm
3
) and (e) average volume of 
individual cells in a cluster (µm
3
) after exposure to 320 mOsm, cultured in standard-
DMEM/FCS. Data were from [N(n)=8(26)]. * indicated a significant difference 
between two culture conditions at one time point according to t-test. # indicated a 
significant difference between different culture conditions at two time points 
according to one-way ANOVA followed by Tukey’s multiple comparison post-hoc 
test. The single, double and triple symbols showed the level of significance for 




Figure 8.13B: Characteristics of clusters formed at the injury in the injured 
explants after long-term exposure to hyperosmolar culture media. 
The graphs contain pooled data regarding (a) average number of clusters formed (b) 
average number of cells in a cluster (c) percentage of cells involved in forming 
clusters (d) average volume of chondrocyte clusters (µm
3
) and (e) average volume of 
individual cells in a cluster (µm
3
) after exposure to 615 mOsm, cultured in 
hyperosmolar-DMEM/FCS. Data were from [N(n)=8(26)]. * indicated a significant 
difference between two culture conditions at one time point according to t-test. # 
indicated a significant difference between different culture conditions at two time 
points according to one-way ANOVA followed by Tukey’s multiple comparison 
post-hoc test. £ indicated significant difference between the two osmolarities. The 
single, double and triple symbols showed the level of significance for P<0.05, 0.01 
and 0.001 respectively. 
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 Development of abnormal chondrocyte volume/morphology at the 8.5.2.3.2
injury after long-term exposure to varied osmolarities by day 14 
 
Marked heterogeneity to chondrocyte morphology was observed at the injury in the 
explants exposed to 320 mOsm and kept in culture in the presence of standard-FCS 
by day 14 (Fig. 8.11l). The morphology of chondrocytes remained unaffected and 
relatively ‘normal’ at days 0, 3 and 7 of culture. However, at day 14 only in the 
explants cultured with standard-FCS chondrocytes displayed marked shape changes 
in terms of elongation of cell bodies, cell enlargement, flattening and production of 
cytoplasmic processes from cell bodies. Chondrocyte morphology was unaffected 
following culture in standard-DMEM, hyperosmolar-DMEM and hyperosmolar-FCS 
(Fig. 8.11k,m&n respectively). Quantitative data regarding volume, length of cell 
bodies and percentage of abnormal chondrocytes with processes was obtained and 
compared in all the four culture conditions at days 0 and 14 of culture. 
8.5.2.3.2.1 Chondrocyte morphology 
 
At day 0, the morphology of chondrocytes was spheroidal and relatively normal in 
the injured explants exposed to 320 mOsm and 615 mOsm. At day 14, the percentage 
of abnormal chondrocytes at the injury was significantly higher in the explants 
cultured in standard-FCS as compared to standard-DMEM (P=0.006), in comparison 
to day 0 (P<0.01; Fig. 8.14a) and also in comparison to hyperosmolar-FCS 
(P=0.006; Fig. 8.14b) where all the cells were relatively ‘normal’. In addition, the 
explants exposed to 615 mOsm and cultured with hyperosmolar-DMEM also 





Figure 8.14: Characteristics of heterogeneous nature of chondrocyte 
morphology at the injury following long-term exposure to varied osmolarities in 
different culture conditions. 
Graphs in the left panels display pooled data for (a) % of abnormal cells (c) average 
volume of cells (µm
3
) and (e) average length of cell bodies (µm) at the injury in the 
presence of standard-DMEM/FCS. The right panels contain graph which show 
pooled data for (b) % of abnormal cells (d) average volume of cells (µm
3
) and (f) 
average length of cell bodies (µm) at the injury in the presence of hyperosmolar-
DMEM/FCS. Data were from [N(n)=8(24)]. * indicated a significant difference 
between two culture conditions at one time point according to t-test. # indicated a 
significant difference between different culture conditions at two time points 
according to one-way ANOVA followed by Tukey’s multiple comparison post-hoc 
test. £ indicated significant difference between the two osmolarities. The single, 




8.5.2.3.2.2 Chondrocyte volume 
 
At day 14, the average volume of individual abnormal chondrocytes following 
culture in standard-FCS was significantly greater than standard-DMEM (P<0.0001) 
and also in comparison to day 0 (P<0.001; Fig. 8.14c) where all the cells were 
relatively ‘normal’. However, in the explants exposed to 615 mOsm and cultured in 
the presence of hyperosmolar-DMEM and hyperosmolar-FCS the morphology of 
chondrocytes remained unaffected (spheroidal) but the volume increased 
significantly as compared to day 0 (P<0.001; for both the conditions; Fig. 8.14d). 
However, the volume of chondrocytes at day 14, in hyperosmolar-FCS was 
significantly greater than hyperosmolar-DMEM (P=0.01; Fig. 8.14d). Moreover, the 
average volume of relatively ‘normal’ chondrocytes at the injury in hyperosmolar-
FCS was significantly less than the volume of individual abnormal cells at injury in 
standard-FCS (P<0.0001; Fig. 8.14d). 
 
8.5.2.3.2.3 Length of cell bodies of chondrocytes 
 
At day 0 the average length of cell bodies of chondrocytes was significantly greater 
in the explants exposed to 320 mOsm (14.5±0.3µm) as compared to 615 mOsm 
(13.4±0.4µm; P=0.02; Fig. 8.14f). At day 14, in the injured explants exposed to 320 
mOsm and cultured in the presence of standard-FCS the average length of individual 
abnormal cells at the injury (56±2µm) increased approx. x4 as compared to standard-
DMEM (15±4µm) and also in comparison to day 0 (14.5±0.3µm; P<0.001 for both 
the conditions; Fig. 8.14e). At day 14, the length of cell bodies of chondrocytes 
increased significantly in the explants exposed to 615 mOsm and cultured in 
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hyperosmolar-DMEM (16±0.4µm) and hyperosmolar-FCS (17±0.4µm) as compared 
to day 0 (13.4±0.4µm; P<0.01 and P<0.001 respectively; Fig. 8.14f). Additionally 
the average length of cell bodies of abnormal chondrocytes at the injury in the 
presence of standard-FCS was approx. x3 greater than the average length of 
relatively ‘normal’ chondrocytes in hyperosmolar-FCS (P<0.0001; Fig. 8.14f). 
To summarise this section, chondrocyte volume/morphology changed strikingly at 
the injury in the explants cultured in the presence of standard-FCS. However, the 
morphology of chondrocytes remained unaffected (spheroidal) in the injured explants 





The hypothesis was that chondrocytes at the injury do not produce morphological 
changes in response to hyperosmolar serum-rich medium compared with exposure to 
standard serum-rich culture medium. The experiments described in this study were 
performed on two groups where in group I the effect of short-term exposure of 
hyperosmolarity on chondrocyte morphology was determined. The results suggested 
that after exposure to hyperosmolar solution, cell proliferation and cluster formation 
was inhibited. Although, at the site of injury marked changes to morphology were 
observed in the presence of FCS, but the effect was less pronounced after exposure to 
hyperosmolar solution. In group 2 the effect of long-term exposure of 
hyperosmolarity was studied. The results suggested that by increasing the osmolarity 
of serum-rich culture medium the clustering was inhibited and chondrocytes 
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maintained their normal (spheroidal) morphology at the injury. In other words 
hyperosmolarity reversed the effects of FCS. 
The scalpel injured bovine cartilage model utilised in this study was a reproducible 
and controlled model (section 6.5.1). However, when the cartilage explants were 
exposed to 320 mOsm and 615 mOsm and then injured following the standardised 
injury protocol, it was observed that the explants exposed to hyperosmolar solution 
‘felt’ tougher to produce injury. The quantitative data at day 0, regarding the width of 
injury also showed that the width of injury was markedly less in the explants exposed 
to hyperosmolar solution (Fig. 8.2). In a very recent in vivo study on injured rat 
cartilage no difference in width of injury was reported after exposure to 
hyperosmolar saline (600 mOsm) in comparison to normal saline (300 mOsm) 
(Eltawil et al., 2014). This dissimilarity in results regarding width of injury after 
exposure to hyperosmolar solution can be attributed to the differences in the tissue 
architecture/composition of rat and bovine cartilage samples. In order to explain the 
results from the present study one possible explanation could be that exposure of 
cartilage to hyperosmolar environment caused water withdrawal from the tissue 
rendering the matrix more resilient and difficult to produce the same injury as that 
experienced in lower osmolarity. The width of the injury remained unaffected after 
short-term exposure to 615 mOsm following culture in standard-DMEM (Fig. 8.2). 
Similarly the width of the injury remained unaffected in the explants after long-term 
exposure to hyperosmolar-DMEM (Fig. 8.8). The possible explanation could be that 
by providing hyperosmolar environment to cartilage, chondrocytes at the injury 
functioned normally because several processes within chondrocytes are known to be 
regulated by hyperosmotic environment (Tew et al., 2011). Thus possibly the normal 
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biosynthetic functions of chondrocytes led to less catabolism and the matrix was not 
destroyed further and width of the injury remained unaffected. In comparison to this 
in the injured explants cultured in the presence of hyperosmolar-FCS, during long-
term exposure to raised osmolarity there was an initial increase in the width of injury 
by day 3 and later on by day 14 it decreased markedly (Fig. 8.8). One possible 
explanation for these changes in the width of injury could be that in the earlier days 
of culture due to injury there was collagen loss and increased tissue hydration leading 
to swelling of tissue and increase in the width of injury (Maroudas, 1976). The 
decrease in the width of injury during later stages of culture in the hyperosmolar 
environment could possibly be explained by the previously reported findings where 
ECM synthesis was seen to be regulated by SOX9 (Bell et al., 1997, Bi et al., 1999) 
and expression of SOX9 was increased by hyperosmotic environment (Tew et al., 
2009). Therefore, by raising the osmolarity of the culture medium chondrocytes at 
the injury possibly expressed high levels of SOX9 thereby enhancing ECM synthesis 
leading to decrease in the width of injury. 
The percentage of PI-labelled chondrocytes at day 0 was significantly less in the 
explants exposed to 615 mOsm (hyperosmolar) solutions as compared to 320 mOsm 
and this in agreement with the previous work stating the chondroprotective effect of 
hyperosmolar solution on injured cartilage (Amin et al., 2008b, Eltawil et al., 2014). 
At day 0, by raising the osmolarity initially chondrocytes at the injury were shrunken 
(Figs. 8.5 & 8.12). During the course of culture by day 7, following short- and long-
term exposure to hyperosmolarity volume of chondrocytes increased and 
chondrocytes restored their original volume when cultured in standard-DMEM (Figs. 
8.5b & 8.12b). This phenomenon can be well explained by considering the RVI by 
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chondrocytes to restore their volume (Hall et al., 1996a, Kerrigan et al., 2006). The 
volume of chondrocytes increased markedly in the presence of FCS as compared to 
DMEM irrespective of short- and long-term exposure to both osmolarities (Figs. 8.5 
& 8.12). However, this stimulatory effect of FCS on chondrocyte volume was 
considerably less effective in the explants exposed to hyperosmolar environment for 
long-term thereby, suggesting that osmolarity is a more powerful regulator of 
chondrocyte volume or morphology. In other words the effects of FCS can be 
reversed by raising the medium osmolarity.  
In this injured bovine articular cartilage model, cluster formation was routinely 
observed in some of the culture conditions. Typically in healthy bovine superficial 
zone of cartilage, chondrocytes are arranged as pairs (Sasazaki et al., 2008). Apart 
from chondrocytes occurring in pairs few small sized clusters with no more than 
three cells per cluster were also observed in healthy cartilage. These small sized 
clusters were more frequent in the explants exposed to 320 mOsm as compared to 
615 mOsm (Figs. 8.6Aa,8.6Ba & 8.13Aa,8.13Ba). One possible explanation for these 
findings is that when cartilage was exposed to 320 and 615 mOsm the chondrocytes 
were swollen and shrunken respectively. The swollen cells in lower osmolarity 
possibly appeared to be closer together and were segmented as clusters by the 
Volocity
TM
 software. This could be considered as an artefact of the software and 
excluded from the data but in this thesis we have considered 3 cells together a cluster 
and included in data analysis. The definition of cluster utilised in the present study is 
based upon a previous definition of cluster (McGlashan et al., 2008). This 
explanation possibly justifies the presence of clusters on day 0 after exposure to 320 
mOsm. In the presence of FCS clustering was stimulated and numerous large sized 
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clusters having 3-8 cells per cluster were formed as compared to standard-DMEM 
which could be well explained as a consequence of the stimulatory effect of growth 
factors present in serum (Khan et al., 2010).  
A very interesting finding in this study was the inhibitory effect of hyperosmolarity 
on the chondrocyte cluster formation following short- and long-term exposure to two 
osmolarities (Figs. 8.6A,B & 8.13A,B). These findings are in agreement with the 
previously reported study where chondrocyte proliferation rate decreased at 550 
mOsm as compared to 280 mOsm (Xu et al., 2010). In summary, hyperosmolarity 
inhibited several effects of FCS as listed below: 
 Hyperosmolarity inhibited increase in the width of injury by day 7 of culture 
 Hyperosmolarity inhibited increase in the volume of chondrocytes at injury 
 Hyperosmolarity inhibited cluster formation at the injury 
 Hyperosmolarity prevented morphological changes to chondrocytes at injury 
These results suggested that by raising the osmolarity of the culture medium most of 
the effects of FCS can possibly be inhibited or reversed. 
The osmosensitive nature of chondrocytes regarding volume changes in healthy and 
degenerate cartilage (Bush and Hall, 2001a, Bush and Hall, 2005) and matrix 
production is already known (Urban et al., 1993, Negoro et al., 2008). However, the 
results of present study build up on the previous knowledge by reporting that effects 
of FCS on chondrocyte morphology can possibly be reversed by hyperosmolarity. 
The results presented in this chapter have highlighted two key findings regarding 
morphological changes of chondrocytes. The first finding was that when explants 
were exposed for short-term to hyperosmolar solution (615 mOsm) and cultured in 
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the presence of standard-FCS, by day 14 significantly less percentage of 
chondrocytes (13±1%) at the injury displayed morphological changes as compared to 
320 mOsm (17±3%; P=0.04; Fig. 8.7a,b). The second key finding was that when 
explants were exposed for long-term to hyperosmolar-FCS culture medium, even 
after two weeks of culture chondrocytes maintained their normal morphology and 
were spheroidal in shape (Fig. 8.14). This suggested two possibilities that either 
hyperosmolarity itself or through inhibition of morphogenic factors in serum 
regulated chondrocyte morphology. Therefore, by raising the osmolarity of the 
culture medium morphological changes to chondrocytes in the presence of serum 
could be prevented. One explanation could be that chondrocyte phenotype is known 
to be regulated by SOX9 transcription factor (Tew et al., 2005) and this factor in turn 
is controlled by hyperosmolarity (Tew et al., 2009). Therefore, it is possible that in 
the present study under the effect of hyperosmolar culture environment the 
expression of SOX9 may be enhanced thereby maintaining normal chondrocyte 
phenotype with normal (spheroidal/ellipsoidal) morphology.  
In a later study it has been reported that chondrocytes close to the injury produced 
cytoplasmic processes in the presence of serum-rich medium (Lyman et al., 2012). 
However, the study presented here has added to the previous work by Lyman and co-
workers in two ways. Firstly, by short-term exposure to hyperosmolar solution the 
proliferative and morphogenic effects of FCS can be reduced, Secondly, by raising 
the osmolarity of the culture medium for long-term the effects of FCS on the 
morphology of chondrocytes can be inhibited. Thus this study has provided new 
insights into the chondroprotective effect of hyperosmolar environment especially in 
terms of maintaining normal morphology.  
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In conclusion, FCS stimulates a morphological change in chondrocyte morphology at 
























The common underlying theme of the whole thesis was to study changes to 
chondrocyte morphology. This question was addressed by studying morphology of 
human and bovine chondrocytes in a range of different conditions (a) non-degenerate 
and mildly degenerate human cartilage (b) bovine chondrocytes cultured in strong 
and weak agarose gels (c) in situ chondrocytes in bovine injured cartilage explants 
cultured under various conditions and (d) in situ chondrocytes in bovine injured 
cartilage explants cultured in hyperosmolar conditions. Bovine chondrocytes were 
utilised in these experiments as bovine cartilage is non-degenerate and the 
chondrocytes have ‘normal’ morphology. However, if human cartilage have been 
used instead then there was possibility of having chondrocytes of mixed shapes i.e. 
both ‘normal’ and ‘abnormal’ cells. The basic aims of the studies conducted in this 
thesis were to determine changes to chondrocyte morphology in human cartilage, to 
utilise agarose gels and injured cartilage explants as in vitro models to introduce 
morphological changes to chondrocytes in various conditions and to compare 
morphological changes observed in these models to human cartilage. Therefore, in 
this work morphological changes to chondrocytes were introduced experimentally to 
determine whether these changes resemble those observed in human cartilage and 
ultimately to determine how morphological changes influence matrix metabolism. 
The main hypotheses of this work are summarised as following:  
1. In grade-0 human femoral head AC, chondrocytes show mild perturbation in 
morphology which exacerbates in grade-1 cartilage.  
2. Bovine chondrocytes cultured in weak 3D agarose gel moulds show volume 
and morphological changes which accelerate with the increasing 
concentrations of FCS. 
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3. Chondrocytes at the injury produce morphological changes in response to 
some factors present in FCS/SF, not restricted to the superficial layers of 
cartilage and produced even in the absence of subchondral bone. 
4. Chondrocytes at the injury do not produce morphological changes in response 
to hyperosmolar serum-rich medium. 
This chapter aimed at discussing the two experimental in vitro culture models (a) 
weak 3D agarose gel model and (b) partial thickness mechanically injured bovine 
cartilage model, utilised in this thesis to increase the current knowledge of changes to 
chondrocyte morphology in various experimental conditions. The techniques 
involved in designing and benefits of utilising 3D agarose gel and injured cartilage 
explant models have been discussed in Chapters 4 and 6 respectively. Here the key 
features of chondrocyte morphology in weak 3D agarose gel model and partial 
thickness injured cartilage model are discussed in comparison to human Grade-1 
cartilage. Additionally the effect of hyperosmolarity on the morphological changes in 
injured cartilage explants has been discussed.  
9.1 Comparisons between morphology of chondrocytes in weak 3D agarose 
gel and mechanically injured bovine articular cartilage models utilised 
and human grade-1 cartilage 
The morphology of chondrocytes in the two in vitro models utilised in the thesis and 
human grade-1 cartilage are compared and discussed. It is possible that the 
morphological changes observed in agarose gel and injured cartilage models have 
certain similarities/differences with those observed in human grade-1 cartilage 
therefore initially summarised in Table 9.1. and then discussed in detail. The main 
purpose of this comparison between chondrocyte morphology in different conditions 
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was to determine whether these shape changes are related or independent of each 
other.  
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↑↑ ↑↑↑ ↑ ↓↓ 
No. of clusters ↑ ↑↑↑ ↑↑ ↓↓ 
No. of 
cells/cluster 
↑↑↑ ↑↑ ↑ No difference 
Volume of 
clusters 











↑↑ ↑↑ ↑↑↑ None 
No. of 
processes/cell 
↑↑ ↑↑↑ No data No data 
Average length 
of processes 
↑↑↑ ↑↑↑ No data No data 
 
Table 9.1: Comparison of key morphological characteristics of chondrocytes in various 
clinical and experimental conditions in comparison to their respective control groups. 
The control groups for grade-1 cartilage, weak agarose gels, injured cartilage in serum-rich 
media and injured cartilage in hyperosmolar serum-rich media were grade-0 cartilage, strong 
agarose gels, injured cartilage in serum-free media and injured cartilage in standard serum-
rich media respectively. Scale bar for all images = 10µm. ↑ and ↓ arrows indicate relative 





In degenerate cartilage, chondrocytes exhibit increase in volume (Bush and Hall, 
2003) therefore, chondrocyte volume in weak agarose gel and in injured cartilage 
models was determined. The volume of chondrocytes increased significantly in the 
weak gels (Fig. 4.12) and at the injury in injured cartilage (Fig. 6.9) and this is in 
agreement with the volume changes observed in human degenerate cartilage (Bush 
and Hall, 2003). In weak gels and in injured cartilage models, a higher percentage of 
chondrocytes formed large clusters involving numerous cells per cluster in a pattern 
similar to those observed in human grade-1 cartilage (Table 9.1). Additionally, 
chondrocytes produced cytoplasmic processes following culture in weak gels and in 
response to injury in serum-rich medium similar to those observed in human grade-1 
cartilage (Table 9.1). Percentages of chondrocytes with cytoplasmic processes in the 
weak agarose gels, in injured cartilage in the presence of FCS and in grade-1 human 
cartilage were 67±1% [N(nʹ)]=[6(525)], 31±5% [N(n)]=[18(23)] and 35±5% 
[N(nʹ)=3(360)] respectively. The length of processes and number of processes per 
cell was comparable between cultured chondrocytes and those present in human 
grade-1 cartilage. The average length of cytoplasmic processes within cultured 
chondrocytes in weak gels and human grade-1 cartilage was 8.5±0.3 µm and 15.6±2 
µm respectively. Chondrocytes cultured in weak gels and in grade-1 human cartilage 
displayed number of processes per cell ranging from one (commonly) to twelve 
(rarely) and from one (commonly) to seven (rarely) respectively. 
In summary, there were various similarities and few differences between 
morphological changes observed within in vitro models to those present in grade-1 
cartilage. The volume changes and cluster formation observed in weak agarose and 
injured cartilage models were similar to those observed in grade-1 cartilage. 
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Cytoplasmic processes were exhibited by chondrocytes in all three conditions but 
there were subtle differences regarding the occurrence of these processes in terms of 
percentages of chondrocytes with processes, length and number of processes per cell. 
However, the main difference observed was in the shape of chondrocyte cell bodies. 
They were irregular in the weak agarose gels and in human grade-1 cartilage but 
flattened and elongated at the injury in injured cartilage (see examples in Table 9.1). 
This suggested that morphological changes observed in the two models were quite 
similar to those in the human grade-1 cartilage. 
It is well known that during progression of OA degenerative processes lead to several 
mechanical and physical changes in the cartilage matrix in terms of (a) loosening 
(Aigner and McKenna, 2002) (b) increased permeability (c) swelling (Wang et al., 
2013a) and (c) decreased rigidity (Maroudas, 1976). In an attempt to develop an in 
vitro model where chondrocytes could possibly be cultured in an environment 
resembling the weakened and less rigid matrix as observed in OA, weak gel moulds 
with very low concentration of agarose (0.2%) were used. A model of weakened 
matrix was also prepared by applying the sharp scalpel cut to bovine cartilage 
explants with a push-through mode which would possibly enhance the permeation of 
factors present in FCS. Therefore, two possible common features between weak 3D 
agarose gel and injured cartilage models in comparison to human grade-1 cartilage 
were (a) weakened matrix and (b) enhanced penetration of the factors and both the 
features may be inter-related. It has been reported previously that decreased 
concentration of agarose in gels leads to increased diffusivity (Johnson et al., 1996) 
and damage to the cartilage leads to enhanced penetration of nutritive/proliferative 
factors (Schumacher et al., 2002). Strength of the matrix and rate of penetration of 
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factors were not measured directly in this work and was beyond the scope of this 
work therefore can be considered a limitation of the study. However, based upon the 
observations of previous studies mentioned above weak agarose gels and injured 
cartilage were considered comparable to the weakened matrix in OA and therefore 
utilised as models in the present work. 
The results presented in Chapters 4 and 6, suggested that both weakened matrix and 
enhanced access to factors present in the culture media were responsible for the 
morphological changes in chondrocytes. In a separate set of experiments cultured 
chondrocytes in weak gels also exhibited accelerated shape changes with increasing 
FCS concentration. This suggested that gel strength and penetration of factors could 
be a related phenomenon such that increasing the gel strength may lead to decreased 
penetration of factors (see Results section 4.5.2).  
It is not possible to fully explain the basis of production of these cytoplasmic 
processes from the data presented in this work. However, possible mechanisms based 
upon the similarities between the two in vitro models and human grade-1 cartilage 
can be suggested as the key players leading to the production of cytoplasmic 
processes. A possible mechanism for the development of these cytoplasmic processes 
could be the defects in the immediate microenvironment of the chondrocytes due to 
loss of PGs. The narrow tissue region immediately surrounding the chondrocytes is 
called PCM. It is a highly organised matrix composed of collagen fibres with 
embedded PGs such that these macromolecules provide resilience to structure and 
help chondrocytes maintain their architecture. The PGs especially biglycans and 
decorins small leucine-rich PGs (SLRP) are concentrated in the PCM and interact 
with type VI collagen (Heinegard, 2009) present in the immediate vicinity of 
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chondrocytes (Guilak et al., 2006). Type VI collagen is present in the PCM of 
chondrocytes in the form of a network which is regulated by SLRPs in the cartilage 
(Wiberg et al., 2002). It has been reported that cartilage degeneration in OA is 
associated with loss of PGs (Pearle et al., 2005) and in this work also, chondrocytes 
in weak gels and injured explants cultured in the presence of serum showed 
decreased PGs (Figs. 5.5 and 7.6). Therefore, it is possible that the sites from where 
PGs are lost lead to disruption of collagen type VI and the cytoplasmic extensions 
protrude out through these potentially disrupted places in PCM. Based upon this 
theory it is possible that in strong agarose gels, chondrocytes in culture synthesised a 
stable and compact PCM around them thereby assisting them to maintain their 
morphology.  
The production of cytoplasmic processes may also possibly be due to increased 
metabolic activities of chondrocytes in relation to the enhanced penetration of 
morphogenic factors present in FCS. There are several hormones/proteins present in 
FCS which may serve as morphogenic factors stimulating growth/proliferation of 
chondrocytes such as growth hormone, thyroid hormones (T3 & T4), insulin etc. In a 
study it has been reported that the penetration of morphogenic factors to 
chondrocytes increases in cartilage degeneration with the formation of fissures 
(Meachim and Collins, 1962). This explains the possibility of greater access of FCS 
to chondrocytes cultured in weak gels. The growth factors play a pivotal role in 
cartilage healing and treatment of early OA as they are known to stimulate 
chondrocytes thereby enhancing their synthetic and metabolic activities (Fortier et 
al., 2011, Civinini et al., 2013). The metabolic activities constitute both anabolic and 
catabolic activities of chondrocytes. Some growth factors such as fibroblast growth 
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factor-2 (FGF-2) are also known to induce catabolic activities in human articular 
chondrocytes (Yan et al., 2011). FGF-2 is also thought to be a principal stimulating 
factor for cluster formation (Khan et al., 2010). In a previous study these abnormal 
chondrocytes with long processes were proposed to be associated with breakdown of 
PCM (Holloway et al., 2004). Additionally, it was reported in a study that the 
abnormal chondrocytes with processes were associated with high levels of 
intracellular IL1ß and disrupted type VI collagen in the PCM as compared to 
chondrocytes of normal (rounded) morphology (Murray et al., 2010). The increased 
production of degradative enzymes and catabolic cytokines in turn may degrade the 
matrix surrounding chondrocytes leading to production of cytoplasmic processes. 
This might lead to the establishment of a vicious circle with abnormal chondrocytes 
causing matrix damage and in turn weakened matrix leading to more abnormal 
chondrocytes due to enhanced penetration of morphogenic factors through weak 
matrix. The weak agarose gel model contains very low concentration of agarose 
thereby providing chondrocytes an environment which resembles the damaged 
matrix and greater penetration of morphogenic factors from the serum possibly 
leading to production of processes. 
In the injured cartilage explants, cells at the injury in response to SF/FCS showed 
marked changes to chondrocyte morphology comprised of cell enlargement, 
flattening and production of cytoplasmic processes (Figs. 6.8, 6.19 and 6.28). This 
heterogeneous population of cells has some interesting parallels with chondrogenic 
progenitor cells (CPCs) but whether these are chondrocytes or CPCs is not known. 
At the site of injury these heterogeneous cells produced cytoplasmic processes 
observed to be in the direction of injury while producing scalpel cut i.e. along the 
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damaged cartilage. These cytoplasmic processes appear to align at the injury (Fig. 
6.8). There are at least two possible sources for the appearance of this heterogeneous 
population of cells at the injury (a) migrating CPCs or (b) chondrocytes at the injury 
changed shape. It has been reported that chondrogenic progenitor cells in response to 
injury guided by ‘alarmins’ migrate to the site of injury (Seol et al., 2012). However, 
it is unlikely that in our experiments these were progenitor cells because possibility 
of presence of alarmins is less as the dead chondrocytes were lost in the serum-rich 
medium. The possible explanation for the loss of dead cells in serum would be the 
digestion of dead cell nuclei in the culture by DNase present in the serum (Zhou et 
al., 2011). This suggested that presence of alarmins was less likely to attract 
chondrogenic progenitor cells in the injured cartilage experiments in present study. 
Therefore, chondrocytes at the injury possibly produced cytoplasmic processes due 
to enhanced access to factors as a consequence of cartilage weakening produced by 
scalpel injury.  
In another recent study by Lyman and co-workers the production of cytoplasmic 
processes has been reported in response to cartilage injury (Lyman et al., 2012). This 
is an informative study and there are several similarities and differences between the 
work reported by Lyman et al and the study presented in this thesis. (a) In the 
previous study the production of cytoplasmic processes in the presence of serum-rich 
culture medium was reported similar to the findings in the present study. In the 
previous study no data were given for the response of chondrocytes in the absence of 
serum, however the present work gives a detailed comparison of response of 
chondrocytes to injury in the serum-rich and serum-free media. (b) In the previous 
study there were no data regarding volume and shape of these heterogeneous cells 
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with processes, however in the present study a detailed account of viability, volume 
and other morphological details of chondrocytes have been reported in response to 
injury. The results of the present study are in agreement with this previous study 
regarding the reaction of chondrocytes at injury to produce cytoplasmic processes in 
the presence of FCS. However, several additional findings in the present work build 
upon the previous knowledge regarding response of chondrocytes to injury.  
The injured cartilage explants were exposed to hyperosmolar serum rich medium for 
short- and long-term. The data displayed an inhibiting effect of raised osmolarity on 
the action of morphogenic factors present in serum. Chondrocyte proliferation/cluster 
formation at the injury was inhibited in the presence of hyperosmolar culture 
medium (Figs. 8.6A,B and 8.13A,B). Moreover, chondrocyte morphology remained 
unaffected (spheroidal) and no abnormal cells (with processes) were observed even 
after 14 days of in vitro culture in hyperosmolar serum-rich and serum-free culture 
media (Figs. 8.11 and 8.14). These findings suggested the protective action of 
hyperosmolarity on chondrocyte morphology. One possible underlying mechanism 
for these findings could be that hyperosmolarity causes the chondrocytes to shrink 
and possibly maintain their spheroidal shape. The explanation for this effect could be 
through the regulatory action of SOX9 transcription factor on chondrocyte 
morphology. SOX9 is a  key controller of chondrocyte phenotype and its expression 
is known to be increased by hyperosmolarity (Tew et al., 2005, Tew et al., 2009). 
Therefore, it is possible that when injured cartilage was cultured in the presence of 
raised osmolarity SOX9 was overexpressed and thus prevented morphological 
changes in chondrocytes. Secondly, another possibility is that the morphogenic 
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factors in FCS can only stimulate chondrocytes at a control osmolarity and 
hyperosmolarity inactivates them.   
9.2 Model 
 
The fine morphological details of in situ and in vitro articular chondrocytes have 
been studied in a range of conditions. In this section an attempt has been made to 
bring all these results together so as to formulate a relatively simple working model 




Figure 9.1: A simplified model to account for the variations in chondrocyte 
morphology observed under various experimental conditions. 
Chondrocytes cultured in weak agarose gels/injured cartilage explants display 
morphological changes (production of cytoplasmic processes) possibly due to 
enhanced penetration of factors in serum. Raised medium osmolarity inhibited the 
effect of factors in serum; thereby appeared to prevent alterations to chondrocyte 
morphology in injured cartilage. The red crosses in the figure indicated less 




9.3 Importance in experimental and clinical research 
 
The findings of this work have translational significance in future experimental and 
clinical research in cartilage degeneration and cartilage injury. Some of these 
implications are discussed in the following sections. 
9.3.1 Pathogenesis of cartilage degeneration in OA and other joint disorders 
 
The presence of cytoplasmic processes in grade-0 human cartilage and increase in 
their production with cartilage degeneration (Figs. 3.7 and 3.9) suggests this 
characteristic to be an earlier event in degeneration. Whether these abnormal 
chondrocytes play a role in cartilage degeneration or cartilage degeneration leads to 
the production of these cytoplasmic processes is not known. However, the samples 
were from patients within an age range of 65-89 yrs. which means the donors were 
old aged and this can possibly be a contributing factor for the development of 
cytoplasmic processes due to chondrocyte senescence. In a previous study it has been 
reported that with aging chondrocytes show phenotypic changes contributing to 
cartilage progression OA (Price et al., 2002). It is unknown whether cytoplasmic 
processes are a characteristic of chondrocytes in old age and needs to be investigated. 
The abnormal morphology of chondrocytes (cytoplasmic processes) is not a good 
sign as this indicates possibly deterioration in chondrocyte synthetic activity and 
ultimately cartilage damage (Kouri et al., 1996a, Darling and Athanasiou, 2005, 
Tesche and Miosge, 2005, Yagi et al., 2005, Murray et al., 2010). Therefore, if 
chondrocyte morphology proves to be an earlier component of degenerative joint 
diseases, it may become a potential therapeutic target for slowing disease progression 
such as formulating drugs which can possibly assist chondrocytes to maintain their 
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normal morphology. Chondrocytes cultured in weak agarose gels displayed some 
morphological changes similar to the early OA changes but proposing weak agarose 
gel model as a method to study OA in vitro at this stage would be too early. Further 
studies are needed to investigate the levels of degradative enzymes produced by 
these morphologically abnormal chondrocytes in agarose gels. 
In addition to grade-1 human AC, morphological changes to chondrocytes have also 
been observed in other clinical conditions as OCD and AVN (Figs. 3.16, 3.18, 3.19, 
3.21, 3.22, 3.24 and 3.25). This may suggest that in addition to OA, morphology of 
chondrocytes is an important feature in other joint disorders. However, it is unclear 
whether weakened matrix leads to these morphologically abnormal chondrocytes or 
the shape changes are an earlier event and lead to matrix degradation and weakening.  
9.3.2 Cartilage injury and response of chondrocytes 
 
Cartilage trauma is associated with chondrocyte death and determination of extent of 
cell death is important to estimate the severity of injury as sharp trauma led to less 
cell death as compared to blunt trauma (Redman et al., 2004). PI is a membrane 
impermeable DNA dye which cannot cross intact membrane and therefore labels 
nuclei of dead cells as red. As discussed in chapter 6, in the presence of FCS and SF 
PI-labelled chondrocytes were lost, thus overestimating chondrocyte viability with 
the use of DNA-binding dyes such as PI. Therefore, for cell density measurements in 
cartilage research especially in culture experiments with serum-rich medium instead 
of using fluorescent dyes, trypan blue staining may be used to detect dead cells 
(Zhou et al., 2011). The cytoplasmic processes produced by chondrocytes at the 
injury in the presence of serum attempted to fill in the injured area suggesting the 
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potential of chondrocytes for an active mechanism in response to injury. However 
the evaluation of ECM produced by these abnormal chondrocytes showed decreased 
PGs (Fig. 7.6) and unaffected collagen types II & I (Figs. 7.12 & 7.15 respectively). 
These findings suggest that may be the matrix produced by these cells is 
mechanically an inferior quality matrix unable to withstand compressive forces. 
However, further investigations are required to determine the quantitative and 
qualitative assessment of the matrix produced by these abnormal cells.  
By raising osmolarity of medium for short-term, cell death due to injury was 
significantly reduced and for long-term chondrocyte morphology remained 
unaffected in serum-rich medium even after 14 days and they maintained their 
normal spheroidal shape. This suggested the protective role of hyperosmolarity on 
chondrocyte viability and morphology in response to injury. Raising the osmolarity 
of joint irrigation solutions during orthopaedic surgical procedures may have a 
chondroprotective role and has been reported already (Amin et al., 2010). However, 
the results presented in this work suggest the positive effects of hyperosmolarity on 
chondrocyte morphology also and this may be therapeutically beneficial. By devising 
strategies to increase the osmolarity of synovial fluid, chondrocytes can possibly be 
forced to retain their normal (spheroidal) morphology. As a strong relationship exists 
between chondrocyte morphology and matrix synthesis, therefore this intervention 
may be helpful in maintenance of normal turnover of matrix thereby preventing 
cartilage degeneration.  
By identifying the factors present in SF and FCS that stimulated chondrocytes 
leading to morphological changes in injured/weakened cartilage, treatment strategies 
may be developed or modified to prevent these changes. The stimulatory effect of 
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these specific factors can possibly be inhibited by formulating antagonist drugs 
against the factors.   
9.4 Implications 
 
The work presented in this thesis has implications in the following areas: 
9.4.1 Pathogenesis of OA 
The results from this work show that chondrocytes change shape due to factors 
present in serum. By using separation techniques these factors can be identified and 
possibly used as a diagnostic test in monitoring the progression of cartilage 
degeneration in OA. Additionally, by limiting the access of these factors e.g. FGF-2, 
IGF-1 etc. to the damaged/weakened cartilage matrix progression of degeneration 
can possibly be delayed or prevented. 
9.4.2 Treatment of OA 
The morphologically abnormal chondrocytes observed in this work need to be 
investigated further to identify signalling pathways involved and to identify 
chondrocytic markers associated with these abnormal cells. The possible future 
experiments can be to use techniques such as laser micro dissection to dissect out 
individual cells of interest (cells with processes) and study the RNA expression 
levels of various markers by these cells. These investigations will have implications 
in devising treatment strategies for OA disease progression. 
9.4.3 Cartilage repair following injury 
The observation that hyperosmolarity drives chondrocytes to normal (spheroidal) 
shape following trauma can prove to be useful in promoting cartilage repair after 
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injury. However, further investigations are needed to study the quality of matrix 
produced by chondrocytes following exposure to raised osmolarity. The signalling 
pathways involved in maintaining chondrocyte morphology in hyperosmotic 
environment need to be investigated e.g. expression levels of SOX9 by these 
chondrocytes. 
9.4.4 Role of morphologically abnormal chondrocytes in OA 
The presence of abnormal chondrocyte morphology in non-degenerate cartilage 
raises the possibility of these cells to be a result of normal aging process. Therefore, 
morphology of chondrocytes over wider age ranges needs to be investigated. 
Moreover, the quality of matrix expressed by these chondrocytes (with processes) 
needs to be investigated to establish the role of these cells in the progression of OA. 
 
9.5 Future work 
 
In order to propose weak 3D gel culture an in vitro model to study changes in early 
OA several investigations need to be done further to determine various parameters. 
The cell structure-function relationship has already been studied and reported that 
spheroidal chondrocytic phenotype is necessary to produce a functional matrix 
(Fedewa et al., 1998, Schnabel et al., 2002, Marlovits et al., 2004, Youngstrom et al., 
2015). Therefore, the key future experiments would be to study the quantity and type 
of matrix produced by chondrocytes cultured in weak agarose gels associated to the 
shape changes. The expression of matrix macromolecules can be determined by 
performing PCR, western blotting and hydroxyproline incorporation methods. 
Furthermore, the ECM produced by the chondrocytes cultured in both gel strengths 
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needs to be compared in order to get an insight whether the chondrocytes with 
altered morphology in weak gels produce mechanically inferior matrix. Therefore, 
future experiments in this regard may include IHC for detection of collagen type I 
and II amongst the chondrocytes cultured in strong and weak gels.   
In a study carried out on human osteoarthritic cartilage, increased expression of IL-Iß 
levels and loss of pericellular type VI collagen have already been demonstrated in 
abnormal cells with processes (Murray et al., 2010). IL-Iß is a pro-inflammatory 
cytokine produced in larger quantities in OA responsible for causing damage to the 
cartilage through increased levels of MMPs (Aigner et al., 2007). Collagen type VI is 
localised to the PCM in non-degenerate cartilage and gets disrupted in OA (Soder et 
al., 2002Soder et al., 2002). Fluorescence immunohistochemistry can be performed 
on the cultured chondrocytes in strong and weak gels to determine the expression 
level of IL-Iß and Collagen type VI in normal and abnormal chondrocytes. These 
experiments will assist in correlating these changes to chondrocyte morphology and 
will be additional supportive evidence that this model can be utilised successfully to 
study OA.  
Further detailed studies are needed to investigate the role of chondrocytes (with 
altered morphology) in cartilage repair process at the injury. Whether these 
chondrocytes produce mechanically functional or an altered inferior quality matrix 
needs to be investigated. In this work histological staining for H&E, Alcian blue, 
Masson’s trichrome and IHC for collagen type I & II of the injured cartilage samples 
was performed. However, the results obtained are preliminary and further 
experiments are needed to probe the properties of cells under consideration. The 
future challenge will be to more precisely clarify the relationship between 
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chondrocyte morphology and matrix metabolism (both synthesis and breakdown) by 
determining the type of collagen and the levels of degradative enzymes produced by 
these abnormal cells. Additionally, Identification of morphogenic factors stimulating 
chondrocytes can be determined with the use of dialysed FCS by using dialysing 
membranes of variable slit sizes or commercially available FCS at various molecular 
weight cut-offs. Moreover, thorough investigations can be carried out to determine 
the mechanism through which hyperosmolarity inhibited the effect of serum and 
chondrocyte morphology remained unaffected at the injury. In this regard analysis of 
various genes such as SOX9 over or under expressed by these abnormal 
chondrocytes in hyperosmolar condition can be determined through polymerase 
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